04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

University of Bern (1294)
- 04 Faculty of Medicine (1294)
  - Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) (1294)
    - Clinic of Medical Oncology (1294)

Group by: Date | Name | Item Type | Refereed | No Grouping

Number of items at this level: 3808.

Abbeel, Sarah

Pica, Alessia; Abbeel, Sarah; Von der Weid, Nicolas; Sajadi, Ali; Negretti, Laura; Phan-Hug, Franziska; Haudenschild, Michael; Schmidhalter, Daniel; Schwitzgebel, Valerie; Weber, Damien (2013). Fractionated stereotactic radiotherapy with static field conformal and non coplanar arcs for pediatric patients with craniopharyngioma: analysis of long term visual outcome and endocrine toxicity. Journal of radiosurgery & SBRT, 2(3), pp. 209-216. Old City Publ.

Aebersold, Daniel Matthias

Zwahlen, Daniel R; Schröder, Christina; Holer, Lisa; Bernhard, Jürg; Hölscher, Tobias; Arnold, Winfried; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Putora, Paul Martin; Papachristofilou, Alexandros; Schär, Corinne; Hayoz, Stefanie; Sumila, Marcin; Zaugg, Kathrin; Guckenberger, Matthias; Ost, Piet; Giovanni Bosetti, Davide; Reuter, Christiane; Gomez, Silvia; ... (2024). Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial. Clinical and translational radiation oncology, 47(100786) Elsevier 10.1016/j.ctro.2024.100786

Hovhannisyan, Lusine; Riether, Carsten; Aebersold, Daniel M; Medova, Michaela; Zimmer, Yitzhak (2023). CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks. Molecular cancer, 22(1), p. 82. BioMed Central 10.1186/s12943-023-01775-1

Orlando, Eleonora; Medo, Matúš; Bensimon, Ariel; Quintin, Aurélie; Riedo, Rahel; Roth, Selina M; Riether, Carsten; Marti, Thomas M; Aebersold, Daniel M; Medová, Michaela; Aebersold, Ruedi; Zimmer, Yitzhak (2023). Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS, 80(4), p. 85. Springer 10.1007/s00018-023-04725-8

Orlando, Eleonora; Medo, Matúš; Bensimon, Ariel; Quintin, Aurélie; Riedo, Rahel; Roth, Selina M; Riether, Carsten; Marti, Thomas M; Aebersold, Daniel M; Medova, Michaela; Aebersold, Ruedi; Zimmer, Yitzhak; quintin, a (2022). An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS, 80(1), p. 6. Springer 10.1007/s00018-022-04634-2

Ghadjar, Pirus; Hayoz, Stefanie; Bernhard, Jürg; Zwahlen, Daniel R; Hölscher, Tobias; Gut, Philipp; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Plasswilm, Ludwig; Papachristofilou, Alexandros; Schär, Corinne; Sumila, Marcin; Zaugg, Kathrin; Guckenberger, Matthias; Ost, Piet; Reuter, Christiane; Bosetti, Davide G; Khanfir, Kaouthar; Gomez, Silvia; ... (2021). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. European urology, 80(3), pp. 306-315. Elsevier 10.1016/j.eururo.2021.05.033

Eychmüller, Steffen; Zwahlen, Susanne; Fliedner, Monika; Jüni, Peter; Aebersold, Daniel; Aujesky, Drahomir; Fey, Martin; Maessen, Maud; Trelle, Sven (2021). Single early palliative care intervention added to usual oncology care for patients with advanced cancer: A randomized controlled trial (SENS Trial). Palliative medicine, 35(6), pp. 1108-1117. Sage 10.1177/02692163211005340

Panje, Cédric; Lupatsch, J; Barbier, M; Pardo, E; Lorez, M; Dedes, K J; Aebersold, D. M.; Plasswilm, Ludwig; Gautschi, O.; Schwenkglenks, M. (2020). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of oncology, 31(4), pp. 501-506. Oxford University Press 10.1016/j.annonc.2020.01.007

Eliçin, Olgun; Sermaxhaj, Burim; Bojaxhiu, Beat; Shelan, Mohamed; Giger, Roland; Rauch, Daniel; Aebersold, Daniel (2019). Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients. Strahlentherapie und Onkologie, 195(6), pp. 468-474. Springer 10.1007/s00066-018-1400-5

Eychmüller, Steffen; Zwahlen, Susanne; Fliedner, Monica; Trelle, Sven; Maessen, Maud; Aebersold, Daniel; Aujesky, Drahomir; Fey, Martin; Jüni, Peter (April 2018). A Structured Early Palliative Care Intervention for Patients with Advanced Cancer - A Randomized Controlled Trial. Palliative medicine, 32(1_suppl), p. 17. Sage

Ghadjar, Pirus; Hayoz, Stefanie; Bernhard, Jürg; Zwahlen, Daniel R; Stein, Jürgen; Hölscher, Tobias; Gut, Philipp; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Putora, Paul Martin; Papachristofilou, Alexandros; Schär, Corinne; Dal Pra, Alan; Biaggi Rudolf, Christine; Wust, Peter; Aebersold, Daniel; Thalmann, George (2018). Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. Radiotherapy and oncology, 126(2), pp. 257-262. Elsevier 10.1016/j.radonc.2017.10.025

Cihoric, Nikola; Tsikkinis, Alexandros; Vlaskou Badra, Eugenia; Glatzer, Markus; Novak, Urban; Scherz, Amina; Shelan, Mohamed; Soldatovic, Ivan; Chittazhathu Kurian Kuruvilla, Yojena; Aebersold, Daniel; Lössl, Kristina (2017). Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiation oncology, 12(1), p. 202. BioMed Central 10.1186/s13014-017-0938-1

Eliçin, Olgun; Schmücking, Michael; Brömme, Jens; Rauch, Daniel; Ambarcioglu, Pinar; Plasswilm, Ludwig; Geretschläger, Andreas; Ghadjar, Pirus; Giger, Roland; Aebersold, Daniel (2016). Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. JBUON, 21(1), pp. 175-181. Imprimatur Publications

Cathomas, Richard; Schmid, Hans-Peter; Aebersold, Daniel; Amram, Marie-Laure; Berthold, Dominik; Eberli, Daniel; Gillessen, Silke; Iselin, Christophe; Jichlinski, Patrice; Müntener, Michael; Rentsch, Cyrill; Schäfer, Niklaus; Stenner, Frank; Thalmann, George; Wild, Peter; Wyler, Stephen; Omlin, Aurelius Gabriel (2016). Medikamentöse Behandlung des metastasierten Prostatakarzinoms. Swiss Medical Forum, 16(11), pp. 266-272. EMH Swiss Medical Publishers

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph; Aebersold, Daniel; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; ... (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. The lancet oncology, 16(16), pp. 1651-1658. Elsevier 10.1016/S1470-2045(15)00208-9

Humbert, Magali; Medova, Michaela; Aebersold, Daniel; Blaukat, Andree; Bladt, Friedhelm; Fey, Martin; Zimmer, Yitzhak; Tschan, Mario P. (2013). Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells. Biochemical and biophysical research communications, 431(2), pp. 264-269. Academic Press 10.1016/j.bbrc.2012.12.120

Brömme, J. O.; Schmücking, M.; Arnold, A.; Giger, R.; Rauch, D.; Leiser, D.; Plasswilm, L.; Geretschläger, A.; Ghadjar, P.; Aebersold, D. M. (2013). Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer. Strahlentherapie und Onkologie, 189(8), pp. 618-624. Heidelberg: Springer Berlin Heidelberg 10.1007/s00066-013-0397-z

Aebi, Stefan

Jolidon, Vladimir; Eicher, Manuela; Peytremann-Bridevaux, Isabelle; Aebi, Stefan; Anchisi, Sandro; Bettini, Adrienne; Chalandon, Yves; Dietrich, Pierre-Yves; Duchosal, Michel A; Dürr, Donat; Peters, Solange; von Moos, Roger; Wicki, Andreas; Arditi, Chantal (2024). Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study. (In Press). Cancer Wiley 10.1002/cncr.35506

Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719

Zander, T; Aebi, Stefan; Pabst, T; Renner, C; Driessen, C (2017). Spotlight on pomalidomide: could less be more? Leukemia, 31(9), pp. 1987-1989. Nature Publishing Group 10.1038/leu.2017.156

Burmeister, H; Aebi, S; Studer, C; Fey, M.F.; Gautschi, O (2012). Adherence to ESMO clinial recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Supportive care in cancer, 20(1), pp. 141-7. Berlin: Springer 10.1007/s00520-010-1079-3

Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448

Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809

Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat (2011). Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers. Oncology - international journal of cancer research and treatment, 81(3-4), pp. 160-166. Karger 10.1159/000333396

Aebi, S; Davidson, T; Gruber, G; Cardoso, F (2011). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 22(Suppl 6), vi12-24. Oxford University Press 10.1093/annonc/mdr371

Antonov, Janine; Popovici, Vlad; Delorenzi, Mauro; Wirapati, Pratyaksha; Baltzer, Anna; Oberli, Andrea; Thürlimann, Beat; Giobbie-Hurder, Anita; Viale, Giuseppe; Altermatt, Hans Jörg; Aebi, Stefan; Jaggi, Rolf (2010). Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue. BMC cancer, 10, p. 37. London: BioMed Central 10.1186/1471-2407-10-37

Aebi, S.; Davidson, T.; Gruber, G.; Castiglione, M. (2010). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 21(Suppl.), pp. 9-14. Oxford: Oxford University Press 10.1093/annonc/mdq159

Diel, Ingo; Aebi, Stefan (2010). Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against. Critical reviews in oncology, hematology, 74 Suppl 1, S11-S15. Boca Raton, Fla.: Elsevier

Farese, Simone Anna; Aebi, Stefan (2009). Infiltrating Lobular Carcinoma of the Breast: Systemic Treatment. Breast disease, 30, pp. 45-52. Amsterdam: IOS Press

Aebi, Stefan (2009). The voice of a special patient. Cancer Treatment and Research, 151, pp. 461-466. New York, N.Y.: Springer Science+Business Media

Aebi, Stefan; Castiglione, Monica (2009). Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 20(Suppl 4), pp. 21-23. Oxford: Oxford University Press 10.1093/annonc/mdp117

Gelber, Richard D; Aebi, Stefan (2009). Endocrine therapy plus zoledronic acid in premenopausal breast cancer. New England journal of medicine NEJM, 360(22), 2367; author reply 2369-70. Waltham, Mass.: Massachusetts Medical Society MMS

Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A (2009). The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of oncology, 20(8), pp. 1344-51. Oxford: Oxford University Press 10.1093/annonc/mdp024

Amstutz, Ursula; Farese, Simone; Aebi, Stefan; Largiadèr, Carlo R (2008). Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy. Clinical cancer research, 27(1), p. 54. Philadelphia, Pa.: American Association for Cancer Research 10.1186/1756-9966-27-54

Bartholomeyczik, S; Schnell, M; Aebi, S (2008). [Effectiveness of specialized nursing for patients with breast cancer and other gynecologic cancers: a prospective, longitudinal, two-arm pilot study in Switzerland]. Pflege - die wissenschaftliche Zeitschrift für Pflegeberufe, 21(5), pp. 353-4. Bern: H. Huber 10.1024/1012-5302.21.5.353

Aebi, S; Loibl, S (2008). Breast cancer during pregnancy: medical therapy and prognosis. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 45-55. Berlin: Springer

Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 98(1), pp. 25-33. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604092

Wapnir, Irene L; Aebi, Stefan; Gelber, Shari; Anderson, Stewart J; Láng, István; Robidoux, André; Mamounas, Eleftherios P; Wolmark, Norman (2008). Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer. Annals of surgical oncology, 15(11), pp. 3227-31. New York, N.Y.: Springer 10.1245/s10434-008-0129-2

Wapnir, Irene L; Aebi, Stefan; Geyer, Charles E; Zahrieh, David; Gelber, Richard D; Anderson, Stewart J; Robidoux, André; Bernhard, Jürg; Maibach, Rudolf; Castiglione-Gertsch, Monica; Coates, Alan S; Piccart, Martine J; Clemons, Mark J; Costantino, Joseph P; Wolmark, Norman (2008). A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clinical breast cancer, 8(3), pp. 287-92. New York, N.Y.: Elsevier 10.3816/CBC.2008.n.035

Aebi, S; Castiglione, M (2008). Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii14-6. Oxford: Oxford University Press 10.1093/annonc/mdn073

Lorenzo, Gianni; Cole, Bernard F; Panzini, Ilaria; Snyder, Raymond; Holmberg, Stig B; Byrne, Michael; Crivellari, Diana; Colleoni, Marco; Aebi, Stefan; Simoncini, Edda; Pagani, Olivia; Castiglione-Gertsch, Monica; Price, Karen N; Goldhirsch, Aron; Coates, Alan S; Ravaioli, Alberto (2008). Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group. Supportive care in cancer, 16(1), pp. 67-74. Berlin: Springer 10.1007/s00520-007-0295-y

Oberli, Andrea; Popovici, Vlad; Delorenzi, Mauro; Baltzer, Anna; Antonov, Janine; Matthey, Sybille; Aebi, Stefan; Altermatt, Hans Jörg; Jaggi, Rolf (2008). Expression profiling with RNA from formalin-fixed, paraffin-embeeded material. BMC Genomics, 1(1), p. 9. London: BioMed Central 10.1186/1755-8794-1-9

Harter, P; Aebi, S; Hilpert, F; du Bois, A (2008). Primär- und Rezidivtherapie des Ovarialkarzinoms. Onkologe, 14(11), pp. 1140-1150. Heidelberg: Springer-Medizin-Verlag 10.1007/s00761-008-1473-3

Eicher, M; Aebi, S (2008). Breast Care Nurses: Erstes Deutschsprachiges Lehrbuch erschienen. Schweizer Krebsbulletin / Bulletin suisse du cancer(4), p. 297. Bellinzona: Istituto oncologico della Svizzera Italiana

Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393

Rabaglio, Manuela; Aebi, Stefan; Castiglione-Gertsch, Monica (2007). Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference. Lancet oncology, 8(10), pp. 940-9. Oxford: Elsevier 10.1016/S1470-2045(07)70317-0

Aebi, Stefan; Pagani, Olivia (2007). Treatment of premenopausal women with early breast cancer: old challenges and new opportunities. Drugs, 67(10), pp. 1393-401. Auckland (NZ): Adis International 10.2165/00003495-200767100-00002

Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492

Aebi, S; Castiglione, M (2006). The enigma of young age. Annals of oncology, 17(10), pp. 1475-7. Oxford: Oxford University Press 10.1093/annonc/mdl330

Eicher, Manuela R E; Marquard, Sara; Aebi, Stefan (2006). A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer. European journal of cancer, 42(18), pp. 3117-26. Amsterdam: Elsevier 10.1016/j.ejca.2006.07.007

Colleoni, M; Gelber, S; Goldhirsch, A; Aebi, S; Castiglione-Gertsch, M; Price, KN; Coates, AS; Gelber, RD; International, Breast Cancer Study Group (2006). Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. Journal of clinical oncology, 24(9), pp. 1332-41. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.0783

Basser, RL; O'Neill, A; Martinelli, G; Green, MD; Peccatori, F; Cinieri, S; Coates, AS; Gelber, RD; Aebi, S; Castiglione-Gertsch, M; Viale, G; Price, KN; Goldhirsch, A; International, Breast Cancer Study Group (2006). Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of clinical oncology, 24(3), pp. 370-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.5196

Aebi, Stefan (2006). Chemotherapy - overview and future perspectives. Breast, 2(15), S11-4. Amsterdam: Elsevier

Gick, Ute; Rochlitz, Christoph; Mingrone, Walter; Pestalozzi, Bernhard; Rauch, Daniel; Ballabeni, Pierluigi; Lanz, Doris; Hess, Viviane; Aebi, Stefan (2006). Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK. Oncology - international journal of cancer research and treatment, 71(1-2), pp. 54-60. Basel: Karger 10.1159/000100449

Kaiser, P C; Körner, M; Kappeler, A; Aebi, S (2005). Retinoid receptors in ovarian cancer: expression and prognosis. Annals of oncology, 16(9), pp. 1477-1487. Oxford University Press 10.1093/annonc/mdi265

Aebi, Stefan (2004). Endometrial cancer: a frequent orphan disease. Annals of oncology, 15(8), pp. 1149-1150. Oxford University Press 10.1093/annonc/mdh325

Kralidis, E.; Aebi, S.; Friess, H.; Büchler, M. W.; Borner, M. M. (2003). Activity of raltitrexed and gemcitabine in advanced pancreatic cancer. Annals of oncology, 14(4), pp. 574-579. Oxford University Press 10.1093/annonc/mdg150

Novak, Urban; Grob, T. J.; Baskaynak, G.; Peters, U. R.; Aebi, Stefan; Zwahlen, D.; Tschan, Mario; Kreuzer, K.-A.; Oppliger Leibundgut, Elisabeth; Cajot, J.-F.; Tobler, Andreas; Fey, Martin (2001). Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Annals of oncology, 12(7), pp. 981-986. Oxford University Press 10.1023/A:1011153206003

Aebi, S.; Castiglione-Gertsch, M. (2001). High-dose chemotherapy for ovarian cancer: Are we ready to go? Annals of oncology, 12(5), pp. 583-584. Oxford University Press 10.1023/A:1011134312452

Buetler, T. M.; Wilder-Smith, O. H. G.; Wilder-Smith, C. H.; Aebi, S.; Cerny, T.; Brenneisen, R. (2000). Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British journal of anaesthesia, 84(1), pp. 97-99. Oxford University Press 10.1093/oxfordjournals.bja.a013391

Zahnd, D.; Aebi, S.; Rusterholz, S.; Fey, M. F.; Borner, M. M. (1999). A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices. Annals of oncology, 10(6), pp. 727-729. Oxford University Press 10.1023/A:1008334313918

Aeschbacher, Pauline

Aeschbacher, P; Kollár, A; Candinas, D; Beldi, G; Lachenmayer, A (2022). The Role of Surgical Expertise and Surgical Access in Retroperitoneal Sarcoma Resection - A Retrospective Study. Frontiers in Surgery, 9, p. 883210. Frontiers 10.3389/fsurg.2022.883210

Affolter Baumberger, Barbara

Luethi, Nora; Wermelinger, Sarah D; Haynes, Alan G.; Roumet, Marie; Maessen, Maud; Affolter, Barbara; Müller, Martin; Schefold, Joerg; Eychmueller, Steffen; Cioccari, Luca (2022). Development of an electronic Poor Outcome Screening (ePOS) Score to identify critically ill patients with potential palliative care needs. Journal of critical care, 69, p. 154007. Elsevier 10.1016/j.jcrc.2022.154007

Michel, Claudia; Felber, Sibylle J.; Affolter, Barbara; Greusing, Marie-Hélène; Eychmüller, Steffen (2021). [Compassionate Cities: Strengthening Social Resources in Communities for Mutual Support at the End of Life]. Praxis, 110(15), pp. 866-871. Hogrefe 10.1024/1661-8157/a003779

Afshar Oromieh, Ali

Beyer, Jörg; Cathomas, Richard; Afshar Oromieh, Ali (2020). Die Rolle der 18F-FDG-PET/CT in der Diagnostik von gonadalen und extragonadalen Keimzelltumoren des Mannes. Der Nuklearmediziner, 43(04), pp. 327-331. 10.1055/a-1118-4683

Akhoundova Sanoyan, Dilara

Ayçiçek, Selin G; Akhoundova, Dilara; Bacher, Ulrike; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R.; Pabst, Thomas (2024). Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International journal of molecular sciences, 25(15) MDPI 10.3390/ijms25158215

Martinez Flores, Danaë; Akhoundova, Dilara; Seipel, Katja; Legros, Myriam; Kronig, Marie-Noelle; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines, 12(7) MDPI 10.3390/biomedicines12071616

Akhoundova, Dilara; Fischer, Stefanie; Triscott, Joanna; Lehner, Marika; Thienger, Phillip; Maletti, Sina; Jacquet, Muriel; Lubis, Dinda S H; Bubendorf, Lukas; Jochum, Wolfram; Rubin, Mark A (2024). Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course. Diagnostic pathology, 19(1) BioMed Central 10.1186/s13000-024-01511-3

Eggimann, Matthias; Akhoundova, Dilara; Nilius, Henning; Hoffmann, Michèle; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers, 16(10) MDPI AG 10.3390/cancers16101887

Mehl, Julian; Akhoundova, Dilara; Bacher, Ulrike; Jeker, Barbara; Rhyner Agocs, Gaëlle; Ruefer, Axel; Soltermann, Susanne; Soekler, Martin; Winkler, Annette; Daskalakis, Michael; Pabst, Thomas (2024). Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers, 16(10) MDPI AG 10.3390/cancers16101854

Akhoundova, Dilara; Francica, Paola; Rottenberg, Sven; Rubin, Mark A (2024). DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer. Advances in anatomic pathology, 31(2), pp. 61-69. Lippincott Williams & Wilkins 10.1097/PAP.0000000000000422

Akhoundova, Dilara; Rubin, Mark Andrew (2024). The grand challenge of moving cancer whole-genome sequencing into the clinic. Nature medicine, 30(1), pp. 39-40. Nature Publishing Group 10.1038/s41591-023-02697-7

Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984

Speicher, Philip; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Beyer, Jörg; Akhoundova, Dilara (2023). Excellent survival in relapsed stage I testicular cancer. BMC cancer, 23(1), p. 870. BioMed Central 10.1186/s12885-023-11388-y

Treichler, G.; Hoeller, S.; Rueschoff, J.H.; Rechsteiner, M.; Britschgi, C.; Arnold, F.; Zoche, M.; Hiltbrunner, S.; Moch, H.; Akhoundova, D.; Opitz, I.; Curioni-Fontecedro, A. (2023). Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches. Pathology, research and practice, 248, p. 154660. Elsevier 10.1016/j.prp.2023.154660

Gillich, Cédric; Akhoundova, Dilara; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Seipel, Katja; Daskalakis, Michael; Bacher, Vera; Pabst, Thomas (2023). Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers, 15(10) MDPI AG 10.3390/cancers15102699

Akhoundova, Dilara; Beyer, Jörg (2023). Weitere Fortschritte bei Blasen- und Hodenkrebs (In Press). Leading Opinions. Hämatologie & Onkologie Universimed

Akhoundova Sanoyan, Dilara; Seipel, Katja; Bacher, Ulrike; Kronig, Marie-Noelle; Porret, Naomi; Wiedemann, Gertrud; Daskalakis, Michael; Pabst, Thomas (2023). Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients. BMC cancer, 23(1), p. 345. BioMed Central 10.1186/s12885-023-10824-3

Gallon, John; Rodríguez-Calero, Antonio; Benjak, Andrej; Akhoundova, Dilara; Maletti, Sina; Amstutz, Ursula; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; Bubendorf, Lukas; Moch, Holger; Thalmann, George; Feng, Felix Y; Gillessen, Silke; ... (2023). DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. Cancer research, 83(8), pp. 1203-1213. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-22-2236

Wittibschlager, Valerie; Bacher, Ulrike; Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Haslebacher, Claudia; Hoffmann, Michèle; Daskalakis, Michael; Akhoundova, Dilara; Pabst, Thomas (2023). CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences, 24(6) MDPI 10.3390/ijms24065688

Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2) MDPI 10.3390/biom13020382

Bühler, Selina; Akhoundova, Dilara; Jeker, Barbara; Legros, Myriam; Seipel, Katja; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers, 15(2) MDPI AG 10.3390/cancers15020430

Hoch, Dennis; Rabaglio, Manuela; Grob, Tobias; von Gunten, Michael; Beyer, Jörg; Akhoundova, Dilara (2023). Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report. Case reports in oncology, 16(1), pp. 1280-1286. Karger 10.1159/000534177

Seipel, Katja; Frey, Michèle; Nilius, Henning; Akhoundova, Dilara; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2023). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology, 30(12), pp. 10463-10476. MDPI 10.3390/curroncol30120762

Akhoundova, Dilara; Hussung, Saskia; Sivakumar, Smruthy; Töpfer, Antonia; Rechsteiner, Markus; Kahraman, Abdullah; Arnold, Fabian; Angst, Florian; Britschgi, Christian; Zoche, Martin; Moch, Holger; Weber, Achim; Sokol, Ethan; Fritsch, Ralph M (2022). ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer. International journal of cancer, 151(12), pp. 2161-2171. Wiley-Blackwell 10.1002/ijc.34257

Akhoundova, Dilara; Feng, Felix Y; Pritchard, Colin C; Rubin, Mark A (2022). Molecular Genetics of Prostate Cancer and Role of Genomic Testing. Surgical pathology clinics, 15(4), pp. 617-628. 10.1016/j.path.2022.08.002

Gerger, Armin; Eisterer, Wolfgang; Fuxius, Stefan; Bastian, Sara; Koeberle, Dieter; Welslau, Manfred; Akhoundova Sanoyan, Dilara; Maas, Christian; Uhlig, Jens; Fenchel, Klaus; Greil, Richard; von der Heyde, Eyck; Rhyner Agocs, Gaëlle; Weide, Rudolf; Schwager, Monika; Reichenbach, Frank; Modest, Dominik Paul; Fritsch, Ralph (2022). Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC. Anticancer research, 42(10), pp. 4773-4785. International Inst. of Anticancer Research 10.21873/anticanres.15982

Akhoundova, Dilara; Rubin, Mark A (2022). Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future. Cancer cell, 40(9), pp. 920-938. Cell Press 10.1016/j.ccell.2022.08.011

Akhoundova, Dilara; Haberecker, Martina; Fritsch, Ralph; Höller, Sylvia; Kiessling, Michael K; Rechsteiner, Markus; Rüschoff, Jan H; Curioni-Fontecedro, Alessandra (2022). Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in oncology, 12, p. 911294. Frontiers Research Foundation 10.3389/fonc.2022.911294

Hiltbrunner, Stefanie; Spohn, Meta-Lina; Wechsler, Ramona; Akhoundova, Dilara; Bankel, Lorenz; Kasser, Sabrina; Bihr, Svenja; Britschgi, Christian; Maathuis, Marloes H; Curioni-Fontecedro, Alessandra (2022). Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer. Cancers, 14(1) MDPI AG 10.3390/cancers14010075

Akhoundova, Dilara; Pietge, Heike; Hussung, Saskia; Kiessling, Michael; Britschgi, Christian; Zoche, Martin; Rechsteiner, Markus; Weber, Achim; Fritsch, Ralph M (2021). Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer. JCO precision oncology, 5, pp. 1082-1087. American Society of Clinical Oncology 10.1200/PO.21.00107

Al Sayed, Mohamad

Bührer, Elias D; Amrein, Michael A; Forster, Stefan; Isringhausen, Stephan; Schürch, Christian M; Bhate, Salil S; Brodie, Tess; Zindel, Joel; Stroka, Deborah; Al Sayed, Mohamad; Nombela-Arrieta, César; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian F (2022). Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance. Leukemia, 36(11), pp. 2634-2646. Springer Nature 10.1038/s41375-022-01682-2

Al Sayed, Mohamad; Ruckstuhl, Carla Alicia; Hilmenyuk, Tamara; Claus, Christina; Bourquin, Jean-Pierre; Bornhauser, Beat C; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian (2017). CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood, 130(3), pp. 297-309. American Society of Hematology 10.1182/blood-2016-12-756585

Albers, Christoph

Riether, Carsten; Radpour, Ramin; Kallen, Nils M.; Bürgin, Damian T.; Bachmann, Chantal; Schürch, Christian M.; Lüthi, Ursina; Arambasic, Miroslav; Hoppe, Sven; Albers, Christoph E.; Baerlocher, Gabriela M.; Ochsenbein, Adrian (2021). Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells. Cell reports, 34(4), p. 108663. Cell Press 10.1016/j.celrep.2020.108663

Alberts, Ian Leigh

Bührer, Elias D; Alberts, Ian L; Christ, Lisa; Özdemir, Berna C (2024). Successful treatment of immune checkpoint inhibitor-related periaortitis. Swiss medical weekly, 154(2) SMW supporting association 10.57187/s.3631

Altermatt, H.J.

Buser, K.; Joncourt, F.; Altermatt, H.J.; Bacchi, M.; Oberli, A.; Cerny, Th. (1997). Breast cancer: Pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Annals of oncology, 8(4), pp. 335-341. Kluwer Academic Publishers 10.1023/A:1008202723066

Ambrodji, Alisa

Ambrodji, Alisa; Sadlon, Angélique; Amstutz, Ursula; Hoch, Dennis; Berger, Martin D.; Bastian, Sara; Offer, Steven M; Largiadèr, Carlo R. (2024). Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International journal of molecular sciences, 25(14) MDPI 10.3390/ijms25147599

Ammann, Roland

Karow, Axel; Wilhelm, Anna; Ammann, Roland R.; Baerlocher, Gabriela M.; Pabst, Thomas; Mansouri Taleghani, Behrouz; Rössler, Jochen Karl; Leibundgut, Kurt (2019). Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow. Bone marrow transplantation, 54(6), pp. 885-893. Nature Publishing Group 10.1038/s41409-018-0353-8

Amrein, Martin Lukas

Amrein, M. A.; Bührer, E. D.; Amrein, M. L.; Li, Q.; Rothschild, S.; Riether, C.; Jaggi, R.; Savic-Prince, S.; Bubendorf, L.; Gautschi, O.; Ochsenbein, A. (2021). Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study. Cancer immunology, immunotherapy : CII, 70(2), pp. 405-415. Springer 10.1007/s00262-020-02688-4

Al Sayed, M; Amrein, Martin Lukas; Bührer, Emanuel; Huguenin, AL; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian (2019). T-cell-Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer. Cancer research, 79(2), pp. 346-359. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-17-3026

Amrein, Michael Alex

Jaeger-Ruckstuhl, Carla A.; Hinterbrandner, Magdalena; Höpner, Sabine; Correnti, Colin E; Lüthi, Ursina; Friedli, Olivier; Freigang, Stefan; Al Sayed, Mohamad F; Bührer, Elias D.; Amrein, Michael A.; Schürch, Christian M.; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian F. (2020). TNIK signaling imprints CD8+ T cell memory formation early after priming. Nature communications, 11(1), p. 1632. Nature Publishing Group 10.1038/s41467-020-15413-7

Tièche, Colin; Gao, Yanyun; Bührer, Elias; Hobi, Nina; Berezowska, Sabina Anna; Wyler, Kurt; Froment, Laurène; Weis, Stefan; Peng, Ren-Wang; Bruggmann, Rémy; Schär, Primo; Amrein, Michael Alex; Hall, Sean; Dorn, Patrick; Kocher, Gregor; Riether, Carsten; Ochsenbein, Adrian; Schmid, Ralph; Marti, Thomas (2019). Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549. Neoplasia, 21(2), pp. 185-196. Elsevier 10.1016/j.neo.2018.09.008

Shun-Qing, Liang; Bührer, Elias; Berezowska, Sabina Anna; Marti, Thomas; Xu, Duo; Froment, Laurène; Yang, Haitang; Hall, Sean; Vassella, Erik; Zhang, Yang; Kocher, Gregor; Amrein, Michael Alex; Riether, Carsten; Ochsenbein, Adrian; Schmid, Ralph; Peng, Ren-Wang (2019). mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Oncogene, 38(5), pp. 622-636. Nature Publishing Group 10.1038/s41388-018-0479-6

Rothschild, S; Amrein, Michael; Riether, Carsten; Gautschi, O; Schuster, N; Li, Q; Savic, S; Schneider, M; Biaggi, C; Bubendorf, L; Brutsche, M; Zippelius, A; Zander, T; Betticher, D; Früh, M; Stahel, R; Cathomas, R; Rauch, Daniel; Pless, M; Ochsenbein, Adrian; ... (October 2017). CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09). Journal of thoracic oncology, 12(11S2), S1864-S1865. Elsevier

Schürch, Christian; Riether, Carsten; Amrein, Michael A.; Ochsenbein, Adrian F. (2013). Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ. Journal of experimental medicine, 210(3), pp. 605-621. Rockefeller University Press 10.1084/jem.20121229

Amsler, Jennifer Susann

Kölzer, Viktor H.; Lugli, Alessandro; Dawson, Heather; Hädrich, Marion; Berger, Martin D.; Borner, Markus; Mallaev, Makhmudbek; Galván Hernández, José Alberto; Amsler, Jennifer; Schnüriger, Beat; Zlobec, Inti; Inderbitzin, Daniel (2014). CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. Journal of translational medicine, 12(81), p. 81. BioMed Central 10.1186/1479-5876-12-81

Amstutz, Ursula

Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Novak, Urban; Gfeller, Eva; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & lymphoma, 60(10), pp. 2588-2590. Taylor & Francis 10.1080/10428194.2019.1585838

Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Angelillo, Anne; Trümper, Lorenz; Fiedler, Georg Martin; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology, 37(3), pp. 319-322. Wiley 10.1002/hon.2603

Bacher, Vera Ulrike; Shumilov, Evgenii; Flach, Johanna; Porret, Naomi; Joncourt, Raphael; Wiedemann, Gertrud; Fiedler, Martin; Novak, Urban; Amstutz, Ursula; Pabst, Thomas (2018). Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood cancer journal, 8(11), p. 113. Nature Publishing Group 10.1038/s41408-018-0148-6

Andreou, Andreas

Wenning, Anna Silvia; Ryser, Christoph O.; Andreou, Andreas; Gloor, Beat; Berger, Martin D (2021). Du nouveau dans le traitement du cancer pancréatique: de l’espoir à l’horizon? Schweizer Gastroenterologie, 2(4), pp. 138-147. Springer 10.1007/s43472-021-00054-y

Andres, Anne Catherine

Britschgi, Christian; Jenal, Mathias; Rizzi, Mattia; Mueller, Beatrice U; Torbett, Bruce E; Andres, Anne-Catherine; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2008). HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. British journal of haematology, 141(2), pp. 179-87. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.06992.x

Britschgi, C; Rizzi, M; Grob, T J; Tschan, M P; Hügli, B; Reddy, V A; Andres, Anne Catherine; Torbett, B E; Tobler, A; Fey, M F (2006). Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene, 25(14), pp. 2030-2039. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1209240

Andres, Martin

Perroud, Camille; Thurian, Dario; Andres, Martin; Künzi, Arnaud; Wiedemann, Gertrud; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas; Banz, Yara; Porret, Naomi; Rebmann, Ekaterina (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), pp. 912-921. Wiley 10.1002/hon.3208

Rebmann Chigrinova, Ekaterina; Porret, Naomi A; Andres, Martin; Wiedemann, Gertrud; Banz, Yara; Legros, Myriam; Pollak, Matthias; Oppliger Leibundgut, Elisabeth; Pabst, Thomas; Bacher, Ulrike (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC medical genomics, 15(1), p. 203. BioMed Central 10.1186/s12920-022-01346-1

Pellegrini, Luca; Novak, Urban; Andres, Martin; Suter, Thomas; Nagler, Michael (2021). Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis. Critical reviews in oncology/hematology, 159, p. 103238. Elsevier 10.1016/j.critrevonc.2021.103238

Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; ... (2020). Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 4(15), pp. 3699-3707. American Society of Hematology 10.1182/bloodadvances.2020002160

Rindlisbacher, Barbara; Schild, Christof; Egger, Florence; Bacher, Vera U.; Pabst, Thomas; Leichtle, Alexander; Andres, Martin; Sédille-Mostafaie, Nazanin (2020). Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. The journal of applied laboratory medicine, 5(1), pp. 114-125. Oxford University Press 10.1093/jalm.2019.029330

Berger, Martin Dave; Meisel, Alexander; Andres, Martin; Schanz, Urs; Schwarz, Urs; Stussi, Georg (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of clinical oncology, 32(9), e33-e34. American Society of Clinical Oncology 10.1200/JCO.2012.47.5194

Angelillo, Anne

Germic, Nina; Hosseini, Aref; Stojkov, Darko; Oberson, Kevin; Claus, Meike; Benarafa, Charaf; Calzavarini, Sara; Angelillo-Scherrer, Anne; Arnold, Isabelle C; Müller, Anne; Riether, Carsten; Yousefi, Shida; Simon, Hans-Uwe (2021). ATG5 promotes eosinopoiesis, but inhibits eosinophil effector functions. Blood, 137(21), pp. 2958-2969. American Society of Hematology 10.1182/blood.2020010208

Angelillo-Scherrer, Anne; Mansouri Taleghani, Behrouz; Förger, Frauke; Baerlocher, Gabriela M.; Pabst, Thomas; Pöllinger, Alexander; Banz, Yara; Geiser, Thomas; Kremer Hovinga, Johanna A.; Rovó, Alicia (2019). Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood advances, 3(17), pp. 2664-2667. American Society of Hematology 10.1182/bloodadvances.2019000465

Shumilov, Evgenii; Flach, Johanna; Pabst Müller, Thomas Niklaus; Fiedler, Georg Martin; Angelillo, Anne; Trümper, Lorenz; Joncourt, Raphael; Kohlmann, Alexander; Bacher, Vera Ulrike (2018). Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology. Critical reviews in oncology, hematology, 126, pp. 64-79. Elsevier 10.1016/j.critrevonc.2018.03.020

Berger, Martin Dave; Heini, Alexander D; Seipel, Katja; Mueller, Beatrice; Angelillo-Scherrer, Anne; Pabst, Thomas (2017). Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia. Hematological oncology, 35(4), pp. 789-796. Wiley 10.1002/hon.2307

Antonov, Janine

April-Monn, Simon

April-Monn, Simon L; Kirchner, Philipp; Detjen, Katharina; Bräutigam, Konstantin; Trippel, Mafalda A; Grob, Tobias; Statzer, Cyril; Maire, Renaud S; Kollár, Attila; Chouchane, Aziz; Kunze, Catarina A; Horst, David; Sadowski, Martin C; Schrader, Jörg; Marinoni, Ilaria; Wiedenmann, Bertram; Perren, Aurel (2024). Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies. NPJ precision oncology, 8(59) Springer Nature 10.1038/s41698-024-00549-2

Arambasic, Miroslav

Mandhair, Harpreet K; Radpour, Ramin; Westerhuis, Mira; Banz, Yara; Humbert, Magali; Arambasic, Miroslav; Dengjel, Jörn; Davies, Andrew; Tschan, Mario P; Novak, Urban (2024). Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia, 38(2), pp. 424-429. Nature Publishing Group 10.1038/s41375-024-02147-4

Mandhair, Harpreet K.; Arambasic, Miroslav; Novak, Urban; Radpour, Ramin (2020). Molecular modulation of autophagy: New venture to target resistant cancer stem cells. World journal of stem cells, 12(5), pp. 303-322. 10.4252/wjsc.v12.i5.303

Burkhard, Regula; Keller, Irene; Arambasic, Miroslav; Juskevicius, Darius; Tzankov, Alexandar; Lundberg, Pontus; Bruggmann, Rémy; Dirnhofer, Stephan; Radpour, Ramin; Novak, Urban (2019). TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells. Haematologica - the hematology journal, 104(4), pp. 766-777. Ferrata-Storti Foundation 10.3324/haematol.2018.201590

Arcaro, Alexandre

Höland, Katrin; Boller, Danielle; Hagel, Christian; Dolski, Silvia; Treszl, András; Pardo, Olivier E.; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Shepherd, Peter R; Styp-Rekowska, Beata; Djonov, Valentin; von Bueren, André O.; Frei, Karl; Arcaro, Alexandre (2014). Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma. PLoS ONE, 9(4), e94132. Public Library of Science 10.1371/journal.pone.0094132

Wojtalla, Anna; Fischer, Barbara; Kotelevets, Nataliya; Mauri, Francesco A; Sobek, Jens; Rehrauer, Hubert; Wotzkow, Carlos; Tschan, Mario P; Seckl, Michael J; Zangemeister-Wittke, Uwe; Arcaro, Alexandre (2013). Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer. Clinical cancer research, 19(1), pp. 96-105. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-12-1138

Arenas Hoyos, Isabel

Lese, Ioana; Baesu, Crinu; Arenas Hoyos, Isabel; Pais, Michael-Alexander; Klenke, Frank; Kollár, Attila; Ionescu, Codruta; Constantinescu, Mihai; Olariu, Radu (2023). Flap Reconstruction Outcome Following Surgical Resection of Soft Tissue and Bone Sarcoma in the Setting of (Neo)adjuvant Therapy: A Sarcoma Center Experience. Cancers, 15(9) MDPI AG 10.3390/cancers15092423

Arnold, Andreas Michael

Arnold, Marcel

Göcmen, Jayan; Steinauer, Fabienne; Kielkopf, Moritz; Branca, Mattia; Kurmann, Christoph C; Clénin, Leander; Mujanovic, Adnan; Silimon, Norbert; Boronylo, Anna; Scutelnic, Adrian; Meinel, Thomas; Kaesmacher, Johannes; Bücke, Philipp; Seiffge, David; Costamagna, Gianluca; Michel, Patrik; Fischer, Urs; Arnold, Marcel; Navi, Babak B; Pabst, Thomas; ... (2024). Mortality in acute ischemic stroke patients with new cancer diagnosed during the index hospitalization versus after discharge. Journal of stroke and cerebrovascular diseases, 33(10), p. 107899. Elsevier 10.1016/j.jstrokecerebrovasdis.2024.107899

Steinauer, Fabienne; Bücke, Philipp; Buffle, Eric; Branca, Mattia; Göcmen, Jayan; Navi, Babak Benjamin; Liberman, Ava; Boronylo, Anna; Clénin, Leander; Goeldlin, Martina Beatrice; Lippert, Julian; Volbers, Bastian; Meinel, Thomas; Seiffge, David J; Mujanovic, Adnan; Kaesmacher, Johannes; Fischer, Urs; Arnold, Marcel; Pabst, Thomas; Berger, Martin; ... (2024). Prevalence of right-left shunt in stroke patients with cancer. (In Press). International journal of stroke, 17474930241260589, p. 17474930241260589. SAGE 10.1177/17474930241260589

Beyeler, Morin; Rea, Erich; Weber, Loris; Belachew, Nebiyat Filate; Barvulsky Aleman, Enrique; Kielkopf, Moritz; Kurmann, Christoph C; Grunder, Lorenz; Piechowiak, Eike Immo I; Meinel, Thomas R; Heldner, Mirjam R; Seiffge, David; Pilgram-Pastor, Sara; Dobrocky, Tomas; Pabst, Thomas; Berger, Martin D; Jung, Simon; Arnold, Marcel; Gralla, Jan; Fischer, Urs; ... (2023). Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy. (In Press). Journal of neurointerventional surgery BMJ Publishing Group 10.1136/jnis-2023-020793

Beyeler, Morin; Grunder, Lorenz; Göcmen, Jayan; Steinauer, Fabienne; Belachew, Nebiyat F; Kielkopf, Moritz; Clénin, Leander; Mueller, Madlaine; Silimon, Norbert; Kurmann, Christoph; Meinel, Thomas; Bücke, Philipp; Seiffge, David Julian; Dobrocky, Tomas; Piechowiak, Eike I; Pilgram-Pastor, Sara; Mattle, Heinrich P; Navi, Babak B; Arnold, Marcel; Fischer, Urs; ... (2023). Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke. Frontiers in neurology, 14(1148152), p. 1148152. Frontiers Media S.A. 10.3389/fneur.2023.1148152

Beyeler, Morin; Castigliego, Pasquale; Baumann, Joel; Ziegler, Victor; Kielkopf, Moritz; Mueller, Madlaine; Bauer-Gambelli, Stefan A; Mujanovic, Adnan; Meinel, Thomas; Horvath, Thomas; Fischer, Urs; Kaesmacher, Johannes; Heldner, Mirjam R; Seiffge, David; Arnold, Marcel; Pabst, Thomas; Berger, Martin D; Navi, Babak B; Jung, Simon and Bücke, Philipp (2023). Transient ischemic attacks in patients with active and occult cancer. Frontiers in neurology, 14(1268131), p. 1268131. Frontiers Media S.A. 10.3389/fneur.2023.1268131

Beyeler, Morin; Belachew, Nebiyat F; Kielkopf, Moritz; Aleman, Enrique B; Léon Betancourt, Alejandro Xavier; Genceviciute, Kotryna; Kurmann, Christoph; Grunder, Lorenz; Birner, Barbara; Meinel, Thomas R; Scutelnic, Adrian; Bücke, Philipp; Seiffge, David J; Dobrocky, Tomas; Piechowiak, Eike I; Pilgram-Pastor, Sara; Mattle, Heinrich P; Mordasini, Pasquale; Arnold, Marcel; Fischer, Urs; ... (2022). Absence of Susceptibility Vessel Sign in Patients With Malignancy-Related Acute Ischemic Stroke Treated With Mechanical Thrombectomy. Frontiers in neurology, 13, p. 930635. Frontiers Media S.A. 10.3389/fneur.2022.930635

Beyeler, Morin; Birner, Barbara; Branca, Mattia; Meinel, Thomas; Vynckier, Jan; Buffle, Eric; Scutelnic, Adrian; Heldner, Mirjam R; Bücke, Philipp; Seiffge, David; Mordasini, Pascale; Dobrocky, Tomas; Piechowiak, Eike I; Kaesmacher, Johannes; Gralla, Jan; Mattle, Heinrich P; Arnold, Marcel; Fischer, Urs; Pabst, Thomas; Berger, Martin D; ... (2022). Development of a score for prediction of occult malignancy in stroke patients (occult-5 score). Journal of stroke and cerebrovascular diseases, 31(8), p. 106609. Elsevier 10.1016/j.jstrokecerebrovasdis.2022.106609

Cresto, Nicola; Barth, Alain; Arnold, Marlene; Weimann, Rosemarie; Gschossmann, Jürgen; Ochsenbein, Adrian F; Kolotas, Christos; Peter, Hans-Jakob; Schiemann, Uwe (2007). Aussergewöhnliche Manifestation eines Magenkarzinoms mit Meningeosis carcinomatosa und spinaler Metastase. Medizinische Klinik, 102(3), pp. 255-8. München: Urban & Vogel 10.1007/s00063-007-1030-7

Arnold, Nicolas

Özdemir, Berna C; Arnold, Nicolas; Fleischmann, Achim; Hensel, Janine; Klima, Irena; Kruithof-de Julio, Marianna; Burkhard, Fiona; Hayoz, Stefanie; Kiss, Bernhard; Thalmann, George N (2022). Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy. European urology open science, 44, pp. 1-10. Elsevier 10.1016/j.euros.2022.07.005

Atkinson, Andrew

Moret, Fabienne; Marschall, Jonas; Atkinson, Andrew; Farag, Sarah; Zimmerli, Stefan; Pabst, Thomas; Sommerstein, Rami (2021). Characteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017. Infectious diseases, 53(4), pp. 274-280. Taylor & Francis 10.1080/23744235.2021.1871642

Aujesky, Drahomir

Babiichuk, Eduard

Köffel, René; Wolfmeier, Heidi Annemarie; Larpin, Yu Noël; Besançon, Hervé; Schönauer, Roman; Babiychuk, Victoria; Drücker, Patrick; Pabst, Thomas; Mitchell, TJ; Babiychuk, Eduard; Draeger, Annette (2018). Host-Derived Microvesicles Carrying Bacterial Pore-Forming Toxins Deliver Signals to Macrophages: A Novel Mechanism of Shaping Immune Responses. Frontiers in immunology, 9(1688), p. 1688. Frontiers Research Foundation 10.3389/fimmu.2018.01688

Babiichuk, Viktoriia

Bacher, Vera Ulrike

Kartal-Kaess, Mutlu; Karow, Axel; Bacher, Vera; Pabst, Thomas; Joncourt, Raphael; Zweier, Christiane; Kuehni, Claudia E; Porret, Naomi Azur; Roessler, Jochen (2024). Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation. Pediatric hematology and oncology, 41(7), pp. 530-539. Taylor & Francis 10.1080/08880018.2024.2362885

Pabst, Thomas; Bacher, Ulrike (2024). Boosting CAR T cells against lymphomas. Blood, 144(7), pp. 689-691. American Society of Hematology 10.1182/blood.2024025378

Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schliemann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; ... (2024). Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Annals of hematology, 103(5), pp. 1587-1599. Springer-Verlag 10.1007/s00277-023-05587-7

Aydilek, Enver; Wulf, Gerald; Schwarz, Friedrich; Bacher, Ulrike; Rummel, Mathias; Stiefel, Olga; Kerkhoff, Andrea; Maulhardt, Markus; Melchardt, Thomas; Pabst, Thomas; Lenz, Georg; Shumilov, Evgenii (2024). Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe. Cancer medicine, 13(10) Wiley 10.1002/cam4.7289

Hoffmann, Michèle; Banz, Yara; Halter, Jörg; Schoumans, Jacqueline; Tchinda, Joëlle; Bacher, Ulrike; Pabst, Thomas (2024). True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology, 31(4), pp. 2067-2075. MDPI 10.3390/curroncol31040153

Seipel, Katja; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2024). FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology, 46(4), pp. 2946-2960. MDPI 10.3390/cimb46040184

Berning, Philipp; Shumilov, Evgenii; Maulhardt, Markus; Boyadzhiev, Hristo; Kerkhoff, Andrea; Call, Simon; Reicherts, Christian; Saidy, Anna O.; Aydilek, Enver; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Schmitz, Norbert; Stelljes, Matthias; Wulf, Gerald; Bacher, Ulrike; Lenz, Georg; Pabst, Thomas Niklaus (2024). Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study. HemaSphere, 8(3), pp. 1-12. Wiley 10.1002/hem3.54

Schmid, Jonas Andreas; Festl, Yasmin; Severin, Yannik; Bacher, Vera; Kronig, Marie-Noëlle; Snijder, Berend; Pabst, Thomas (2024). Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options. Haematologica - the hematology journal, 109(2), pp. 617-621. Ferrata-Storti Foundation 10.3324/haematol.2023.283224

Heini, Alexander D; Bacher, Ulrike; Pabst, Thomas (2024). Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology, 204(2), pp. 389-390. Wiley-Blackwell 10.1111/bjh.19195

Bacher, Vera; Shumilov, Evgenii; Pabst, Thomas (2024). Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era. British journal of haematology, 204(2), pp. 386-388. Wiley 10.1111/bjh.19221

Bacher, Ulrike; Shumilov, Evgenii; Pabst, Thomas (2023). Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies. British journal of haematology, 202(6), pp. 1081-1083. Wiley-Blackwell 10.1111/bjh.19005

Messerli, Christian; Wiedemann, Gertrud; Porret, Naomi; Nagler, Michael; Seipel, Katja; Jeker, Barbara; Novak, Urban; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas (2023). Correlation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL). Turkish journal of haematology, 40(3), pp. 187-196. Turkish Society of Haematology 10.4274/tjh.galenos.2023.2023.0136

Seipel, Katja; Kohler, Scarlett; Bacher, Ulrike; Pabst, Thomas (2023). HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology, 45(9), pp. 7011-7026. MDPI 10.3390/cimb45090443

Maechler, Melanie; Bacher, Ulrike; Daskalakis, Michael; Nilius, Henning; Nagler, Michael; Mansouri Taleghani, Behrouz; Jeker, Barbara; Pabst, Thomas (2023). Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. Hematological oncology, 41(3), pp. 583-586. Wiley 10.1002/hon.3055

Pabst, Thomas; Vey, Norbert; Adès, Lionel; Bacher, Ulrike; Bargetzi, Mario; Fung, Samson; Gaidano, Gianluca; Gandini, Domenica; Hultberg, Anna; Johnson, Amy; Ma, Xuewen; Müller, Rouven; Nottage, Kerri; Papayannidis, Cristina; Recher, Christian; Riether, Carsten; Shah, Priya; Tryon, Jeffrey; Xiu, Liang and Ochsenbein, Adrian F (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica - the hematology journal, 108(7), pp. 1793-1802. Ferrata-Storti Foundation 10.3324/haematol.2022.281563

Seipel, Katja; Abbühl, Mariesol; Bacher, Vera; Nilius, Henning; Daskalakis, Michael; Pabst, Thomas (2023). Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers, 15(11) MDPI AG 10.3390/cancers15113058

von Matt, Stefanie; Bacher, Ulrike; Banz, Yara; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2023). Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment. Mediterranean journal of hematology and infectious diseases, 15(1), e2023025. Università Cattolica del Sacro Cuore 10.4084/MJHID.2023.025

Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas (2023). Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers, 15(7) MDPI AG 10.3390/cancers15072091

Heini, Alexander D; Beck, Philipp; Bacher, Ulrike; Seipel, Katja; Zander, Thilo; Daskalakis, Michael; Pabst, Thomas (2023). BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of Clinical Medicine, 12(6) MDPI 10.3390/jcm12062378

Bohler, Jeanne; Bacher, Ulrike; Banz, Yara; Stadelmann, Raphael; Medinger, Michael; Zander, Thilo; Pabst, Thomas (2023). Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers, 15(1), p. 44. MDPI AG 10.3390/cancers15010044

Seipel, Katja; Brügger, Yvo; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2022). Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 23(20) MDPI 10.3390/ijms232012587

Rausch, Christian; Bacher, Ulrike; Rabaglio, Manuela; Vorburger, Corinne; Klingenberg, Anke; Banz, Yara; Daskalakis, Michael; Pabst, Thomas (2022). Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine, 11(18) MDPI 10.3390/jcm11185378

Heini, Alexander D; Bacher, Ulrike; Porret, Naomi; Wiedemann, Gertrud; Legros, Myriam; Stalder Zeerleder, Denise; Seipel, Katja; Novak, Urban; Daskalakis, Michael; Pabst, Thomas (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17) MDPI 10.3390/cells11172747

Gössi, Simona; Bacher, Ulrike; Haslebacher, Claudia; Nagler, Michael; Suter, Franziska; Staehelin, Cornelia; Novak, Urban; Pabst, Thomas (2022). Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers, 14(14) MDPI AG 10.3390/cancers14143527

Stoffel, Tanja; Bacher, Ulrike; Banz, Yara; Daskalakis, Michael; Novak, Urban; Pabst, Thomas (2022). BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine, 11(13) MDPI 10.3390/jcm11133748

Heini, Alexander D; Bacher, Ulrike; Kronig, Marie-Noëlle; Wiedemann, Gertrud; Novak, Urban; Zeerleder, Sacha; Mansouri Taleghani, Behrouz; Daskalakis, Michael; Pabst, Thomas (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), pp. 1010-1012. Springer Nature 10.1038/s41409-022-01658-x

Farag, Sarah; Bacher, Ulrike; Jeker, Barbara; Legros, Myriam; Rhyner, Gaelle; Lüthi, Jean-Marc; Schardt, Julian; Zander, Thilo; Daskalakis, Michael; Mansouri, Behrouz; Manz, Chantal; Pabst, Thomas (2022). Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone marrow transplantation, 57(6), pp. 990-997. Springer Nature 10.1038/s41409-022-01681-y

Rentsch, Vera; Seipel, Katja; Banz, Yara; Wiedemann, Gertrud; Porret, Naomi; Bacher, Ulrike; Pabst, Thomas (2022). Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers, 14(10) MDPI AG 10.3390/cancers14102516

Mathys, Anina; Bacher, Ulrike; Banz, Yara; Legros, Myriam; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2022). Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter. Hematological oncology, 40(2), pp. 292-296. Wiley 10.1002/hon.2952

Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Jeker, Barbara; Bacher, Vera Ulrike; Pabst, Thomas (2022). sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology, 44(4), pp. 1463-1471. MDPI 10.3390/cimb44040098

Gurevich, Ekaterina; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4) MDPI AG 10.3390/cancers14041024

Shumilov, Evgenii; Shakhanova, Inna; Flach, Johanna; Schmidt, Nicole; Buerki, Susanne; Legros, Myriam; Kronig, Marie-Noëlle; Ofran, Yishai; Gerull, Sabine; Medinger, Michael; Mansouri Taleghani, Behrouz; Passweg, Jakob; Halter, Jörg; Bacher, Ulrike; Pabst, Thomas (2022). Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation. Bone marrow transplantation, 57(2), pp. 224-231. Springer Nature 10.1038/s41409-021-01521-5

Shumilov, Evgenii; Mazzeo, Paolo; Zinkernagel, Martin S.; Legros, Myriam; Porret, Naomi; Romagna, Lorenz; Haase, Detlef; Lenz, Georg; Novak, Urban; Banz, Yara; Pabst, Thomas; Bacher, Vera (2022). Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology, 29(2), pp. 766-776. MDPI 10.3390/curroncol29020065

Messmer, Anna S; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). CAR T-cell therapy and critical care : A survival guide for medical emergency teams. Wiener klinische Wochenschrift, 133(23-24), pp. 1318-1325. Springer-Verlag 10.1007/s00508-021-01948-2

Condoluci, Adalgisa; Théaudin, Marie; Schwotzer, Rahel; Pazhenkottil, Aju P; Arosio, Paolo; Averaimo, Manuela; Bacher, Ulrike; Bode, Peter; Cavalli, Andrea; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Gerull, Sabine; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2021). Management of transthyretin amyloidosis. Swiss medical weekly, 151(w30053), w30053. EMH Media 10.4414/smw.2021.w30053

Messmer, Anna Sarah; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland. Critical care explorations, 3(10), e0552. Wolters Kluwer Health 10.1097/CCE.0000000000000552

Damonti, Lauro; Buetti, Niccolò; Droz, Sara; Bacher, Ulrike; Pabst, Thomas; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela Maria; Marschall, Jonas (2021). Prevalence and significance of bacterial contamination of autologous stem cell products. The journal of hospital infection, 114, pp. 175-179. Elsevier 10.1016/j.jhin.2021.04.006

Seipel, Katja; Graber, Carolyn; Flückiger, Laura; Bacher, Vera; Pabst, Thomas (2021). Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 22(15) MDPI 10.3390/ijms22158092

Heini, Alexander D.; Porret, Naomi; Zenhaeusern, Reinhard; Winkler, Annette; Bacher, Ulrike; Pabst, Thomas (2021). Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML. Cancers, 13(13) MDPI AG 10.3390/cancers13133190

Pabst, Thomas; Bacher, Ulrike (2021). Risk stratification systems for allogeneic haematopoietic stem-cell transplantation. The Lancet. Haematology, 8(3), e166-e167. Elsevier 10.1016/S2352-3026(20)30403-8

Seipel, Katja; Kopp, Basil; Bacher, Ulrike; Pabst, Thomas (2021). BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers, 13(3) MDPI AG 10.3390/cancers13030581

Betticher, Christophe; Bacher, Ulrike; Legros, Myriam; Zimmerli, Stefan; Banz, Yara; Mansouri Taleghani, Behrouz; Pabst, Thomas (2021). Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological oncology, 39(1), pp. 97-104. Wiley 10.1002/hon.2813

Brechbühl, Simon; Bacher, Ulrike; Jeker, Barbara; Pabst, Thomas (2021). Real-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy. Mediterranean journal of hematology and infectious diseases, 13(1), e2021012. Università Cattolica del Sacro Cuore 10.4084/MJHID.2021.012

Nydegger, Anna; Novak, Urban; Kronig, Marie-Noëlle; Legros, Myriam; Zeerleder, Sacha; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers, 13(23) MDPI AG 10.3390/cancers13236073

Schwotzer, Rahel; Flammer, Andreas J; Gerull, Sabine; Pabst, Thomas; Arosio, Paolo; Averaimo, Manuela; Bacher, Vera; Bode, Peter; Cavalli, Andrea; Concoluci, Adalgisa; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan W.; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2020). Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss medical weekly, 150(w20364), w20364. EMH Media 10.4414/smw.2020.20364

Idle, Jeffrey R; Seipel, Katja; Bacher, Ulrike; Pabst, Thomas; Beyoğlu, Diren (2020). (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers, 12(10) MDPI AG 10.3390/cancers12102842

Jeker, Barbara; Farag, Sarah; Mansouri Taleghani, Behrouz; Novak, Urban; Mueller, Beatrice U; Li, Qiyu; Betticher, Daniel; Luethi, Jean-Marc; Farese, Simone; Ruefer, Axel; Bacher, Ulrike; Pabst, Thomas (2020). A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients. Bone marrow transplantation, 55(10), pp. 2047-2051. Springer Nature 10.1038/s41409-020-0875-8

Flach, Johanna; Shumilov, Evgenii; Wiedemann, Gertrud; Porret, Naomi; Shakhanova, Inna; Bürki, Susanne; Legros, Myriam; Joncourt, Raphael; Pabst, Thomas; Bacher, Ulrike (2020). Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematological oncology, 38(4), pp. 425-431. Wiley 10.1002/hon.2739

Eicher, Florian; Mansouri Taleghani, Behrouz; Schild, Christof; Bacher, Vera; Pabst, Thomas (2020). Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels. Hematological oncology, 38(4), pp. 523-530. Wiley 10.1002/hon.2774

Riether, Carsten; Pabst, Thomas; Höpner, Sabine; Bacher, Ulrike; Hinterbrandner, Magdalena; Banz, Yara; Müller, Rouven; Manz, Markus G.; Gharib, Walid H.; Francisco, David; Bruggmann, Remy; van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; de Haard, Hans; Leupin, Nicolas; ... (2020). Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature medicine, 26(9), pp. 1459-1467. Springer Nature 10.1038/s41591-020-0910-8

Sula, Martin; Bacher, Vera; Oppliger Leibundgut, Elisabeth; Mansouri, Behrouz; Novak, Urban; Pabst, Thomas (2020). Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia. Bone marrow transplantation, 55(8), pp. 1690-1693. Springer Nature 10.1038/s41409-019-0762-3

Pabst, Thomas; Joncourt, Raphael; Shumilov, Evgenii; Heini, Alexander; Wiedemann, Gertrud; Legros, Myriam; Seipel, Katja; Schild, Christof; Jalowiec, Katarzyna; Mansouri, Behrouz; Fux, Michaela; Novak, Urban; Porret, Naomi; Zeerleder, Sacha; Bacher, Vera (2020). Analysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS). Experimental hematology, 88, 7-14.e3. Elsevier 10.1016/j.exphem.2020.07.003

Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Novak, Urban; Pabst, Thomas; Bacher, Ulrike (2020). Current concepts and future directions for hemato-oncologic diagnostics. Critical reviews in oncology, hematology, 151, p. 102977. Elsevier 10.1016/j.critrevonc.2020.102977

Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Tchinda, Joëlle; Legros, Myriam; Scarpelli, Ilaria; Hewer, Ekkehard; Novak, Urban; Schoumans, Jacqueline; Bacher, Vera; Pabst, Thomas (2020). Detection of rare reciprocal RUNX1 rearrangements by next‐generation sequencing (NGS) in acute myeloid leukemia. Genes, chromosomes & cancer, 59(4), pp. 268-274. Wiley 10.1002/gcc.22829

Heini, Alexander D.; Hugo, Rebecca; Berger, Martin D.; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology, 38(1), pp. 74-81. Wiley 10.1002/hon.2696

Seipel, Katja; Messerli, Christian; Wiedemann, Gertrud; Bacher, Ulrike; Pabst, Thomas (2020). MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leukemia research, 89(106296), p. 106296. Elsevier 10.1016/j.leukres.2020.106296

De Santiago de Benito, Alvaro; Jeker, Barbara; Gfeller, Eva; Porret, Naomi; Banz, Yara; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia. Haematologica - the hematology journal, 105(1), e9-e12. Ferrata-Storti Foundation 10.3324/haematol.2019.216457

Flach, Johanna; Shumilov, Evgenii; Porret, Naomi; Shakhanova, Inna; Legros, Myriam; Kronig, Marie-Noëlle; Joncourt, Raphael; Bacher, Ulrike; Pabst, Thomas (2020). Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series. Mediterranean journal of hematology and infectious diseases, 12(1), e2020068. Università Cattolica del Sacro Cuore 10.4084/MJHID.2020.068

Moser, Sebastian; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Betticher, Daniel; Ruefer, Axel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2019). Autologous stem cell transfusions on multiple days in patients with multiple myeloma ‐ does it matter? Hematological oncology, 37(5), pp. 649-651. Wiley 10.1002/hon.2673

Prediletto, Irene; Farag, Sarah Ahmed Ibrahim; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bregy, Rachel; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst Müller, Thomas Niklaus (2019). High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients. Bone marrow transplantation, 54(12), pp. 1923-1925. Nature Publishing Group 10.1038/s41409-019-0508-2

Seipel, Katja; Schmitter, Karin; Bacher, Ulrike; Pabst Müller, Thomas Niklaus (2019). Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia. Cancers, 11(11) MDPI AG 10.3390/cancers11111779

Fassbind, Priska; Jeker, Barbara; Müller, Beatrice Ursula; Bacher, Vera Ulrike; Zimmerli, Stefan; Endrich, Olga; Gahl, Brigitta; Novak, Urban; Pabst Müller, Thomas Niklaus (2019). Improved survival rates of AML patients following admission to the intensive care unit. Leukemia & lymphoma, 60(10), pp. 2423-2431. Informa Healthcare 10.1080/10428194.2019.1594213

Engelbrecht, Laura; Götze, Katharina; Schwamborn, Kristina; Müller-Thomas, Catharina; Alpermann, Tamara; Bonadies, Nicolas; Legros, Myriam; Flach, Johanna; Pabst, Thomas; Banz, Yara; Bacher, Vera (2019). Correlation of cytomorphology and histopathology in the diagnostic process of myeloid malignancies. Hematology & medical oncology OAT 10.15761/HMO.1000190

Amsler, Isabel G; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Luethi, Jean-Marc; Novak, Urban; Pabst, Thomas (2019). Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma. Leukemia & lymphoma, 60(2), pp. 511-514. Taylor & Francis 10.1080/10428194.2018.1473577

Shumilov, Evgenyi; Novak, Urban; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2019). Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients. HemaSphere, 3(2), e176. Wolters Kluwer Health 10.1097/HS9.0000000000000176

Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180

Riether, Carsten; Pabst, Thomas; Höpner, Sabine; Bacher, Vera; Hinterbrandner, Magdalena; Banz, Yara; Müller, Rouven; Manz, Markus G.; Gharib, Walid H.; Ferreira, David; Bruggmann, Remy; Van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; De Haard, Hans; Leupin, Nicolas; ... (2 December 2018). 2680 Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial (Unpublished). In: ASCO 2018. 2. Dezember 2018.

Moor, Ivana; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Keller, Heinz Peter; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2018). Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma. Bone marrow transplantation, 53(12), pp. 1599-1602. Nature Publishing Group 10.1038/s41409-018-0245-y

Shumilov, Evgenii; Flach, Johanna; Kohlmann, Alexander; Banz Wälti, Yara; Bonadies, Nicolas; Fiedler, Martin; Pabst, Thomas; Bacher, Ulrike (2018). Current status and trends in the diagnostics of AML and MDS. Blood reviews, 32(6), pp. 508-519. Elsevier 10.1016/j.blre.2018.04.008

Bacher, Vera Ulrike; Porret, Naomi; Joncourt, Raphael; Sanz, Javier; Aliu, Nijas; Wiedemann, Gertrud; Jeker, Barbara; Banz Wälti, Yara; Pabst, Thomas (2018). Pitfalls in the molecular follow up of mutant acute myeloid leukemia. Haematologica - the hematology journal, 103(10), e486-e488. Ferrata-Storti Foundation 10.3324/haematol.2018.192104

Farag, Sarah Ahmed Ibrahim; Jeker, Barbara; Bacher, Vera Ulrike; Mansouri Taleghani, Behrouz; Müller, Beatrice Ursula; Novak, Urban; Pabst Müller, Thomas Niklaus (2018). Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients. Hematological oncology, 36(4), pp. 671-678. Wiley 10.1002/hon.2546

Alva, Laura C; Bacher, Vera Ulrike; Seipel, Katja; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Novak, Urban; Pabst, Thomas (2018). Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia. Transfusion, 58(10), pp. 2365-2373. Wiley-Blackwell 10.1111/trf.14895

Junge, Alexandra; Bacher, Vera Ulrike; Mueller, Beatrice U; Keller, Peter; Solenthaler, Max; Pabst Müller, Thomas Niklaus (2018). Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression. (In Press). Hematological oncology Wiley 10.1002/hon.2516

Bacher, Vera Ulrike; Pabst Müller, Thomas Niklaus (2018). Aktuelle Entwicklungen in der hämato-onkologischen Diagnostik. JATROS. Hämatologie & Onkologie, 2018(5), pp. 46-49. Universimed

Gössi, Ursina; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Vera Ulrike; Novak, Urban; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Pabst, Thomas (2018). Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological oncology, 36(2), pp. 436-444. Wiley 10.1002/hon.2490

Mueller, Beatrice; Seipel, Katja; Bacher, Vera Ulrike; Pabst, Thomas (2018). Autologous Transplantation for Older Adults with AML. Cancers, 10(9), p. 340. MDPI AG 10.3390/cancers10090340

Bachmann, Chantal Lea

Bachmann, Kaspar

Bachmann, Kaspar F.; Nebiker, Mathias; Johner, Caroline; Bregy, Rachel; Schaller, André; Novak, Urban; Jakob, Stephan M. (2019). Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem. A&A practice, 12(4), pp. 96-98. Lippincott Williams & Wilkins 10.1213/XAA.0000000000000855

Bachmann, Martin

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 137. BioMed Central 10.1186/s40425-019-0616-y

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Mohsen, Mona O.; Vogel, Monique; Riether, Carsten; Muller, Julius; Salatino, Silvia; Ternette, Nicola; Gomes, Ariane C; Cabral-Miranda, Gustavo; El-Turabi, Aadil; Ruedl, Christiane; Kundig, Thomas M; Dermime, Said; Knuth, Alexander; Speiser, Daniel E; Bachmann, Martin F. (2019). Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Frontiers in immunology, 10, p. 1015. Frontiers Research Foundation 10.3389/fimmu.2019.01015

Badmann, Anastasia

Schneider-Jakob, S; Corazza, N; Badmann, A; Sidler, D; Stuber-Roos, R; Keogh, A; Frese, S; Tschan, M; Brunner, T (2010). Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell death & disease, 1(e86), e86. London: Nature Publishing Group 10.1038/cddis.2010.66

Baerlocher, Gabriela M.

Jeker, Barbara; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, K; Mueller, B U; Bigler, M; Betticher, D; Luethi, J-M; Farese, S; Ruefer, A; Pabst, Thomas (2018). NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma. Bone marrow transplantation, 53(2), pp. 175-179. Nature Publishing Group 10.1038/bmt.2017.234

Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Baerlocher, Gabriela M.; Bargetzi, Mario; Chalandon, Yves; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Halter, Jörg P; Heim, Dominik; Hess, Urs; Leibundgut, Kurt; Masouridi-Levrat, Stavroula; Müller, Antonia; Nair, Gayathri; Pabst, Thomas; Renner, Christoph; Schmidt, Adrian; Stussi, Georg; ... (2018). Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Swiss medical weekly, 148(w14589), w14589. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14589

Blum, Veronika; Heini, A D; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Seipel, K; Banz Wälti, Yara; Bargetzi, M; Pabst, Thomas (2017). Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML. Bone marrow transplantation, 52(5), pp. 786-788. Nature Publishing Group 10.1038/bmt.2017.2

Oberson, JS; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Mueller, BU; Leibundgut, Kurt; Zimmerli, Stefan; Pabst, Thomas (2017). Revisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients. Annals of Hematology & Oncology, 4(5), p. 1148. Austin Publishing Group 10.26420/annhematoloncol.2017.1148

Heini, Alexander D; Berger, Martin Dave; Seipel, Katja; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Novak, Urban; Pabst, Thomas (2017). Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years. Leukemia research, 53, pp. 28-34. Elsevier 10.1016/j.leukres.2016.12.001

Stettler, Jasmin; Novak, Urban; Baerlocher, Gabriela M.; Seipel, Katja; Mansouri Taleghani, Behrouz; Pabst, Thomas (2017). Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leukemia & lymphoma, 58(5), pp. 1076-1083. Informa Healthcare 10.1080/10428194.2016.1233542

Gilli, Stefanie; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Rauch, Daniel; Pabst, Thomas (2017). BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of hematology, 96(3), pp. 421-429. Springer 10.1007/s00277-016-2900-y

Riether, Carsten; Schürch, Christian; Flury, Christoph; Hinterbrandner, Magdalena; Drück, Linda; Huguenin, Anne-Laure; Baerlocher, Gabriela M.; Radpour, Ramin; Ochsenbein, Adrian (2015). Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling. Science translational medicine, 7(298), 298ra119. American Association for the Advancement of Science 10.1126/scitranslmed.aab1740

Mager, Lukas; Riether, Carsten; Schürch, Christian; Banz Wälti, Yara; Wasmer, Marie-Hélène Christin; Stuber Roos, Regula; Theocharides, Alexandre; Li, Xiaohong; Xia, Yu; Saito, Hirohisa; Nakae, Susumu; Baerlocher, Gabriela M.; Manz, Markus G; McCoy, Kathleen; Macpherson, Andrew; Ochsenbein, Adrian; Beutler, Bruce; Krebs, Philippe (2015). IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. Journal of clinical investigation, 125(7), pp. 2579-2591. American Society for Clinical Investigation 10.1172/JCI77347

Wetzel, Dana; Müller, Beatrice Ursula; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Leibundgut, Kurt; Pabst, Thomas (2015). Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. British journal of haematology, 168(2), pp. 268-273. Wiley-Blackwell 10.1111/bjh.13118

Schmid, Andrea; Friess, Dorothea; Mansouri Taleghani, Behrouz; Keller, Peter; Müller, Beatrice Ursula; Baerlocher, Gabriela M.; Leibundgut, Kurt; Pabst, Thomas (2014). Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Leukemia & lymphoma, 56(3), pp. 608-614. Informa Healthcare 10.3109/10428194.2014.927454

Humbert, Magali; Halter, Veronika; Shan, Deborah; Laedrach, Judith; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2011). Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leukemia research, 35(7), pp. 909-13. Amsterdam: Elsevier 10.1016/j.leukres.2011.03.010

Tschan, Mario P; Shan, Deborah; Laedrach, Judith; Eyholzer, Marianne; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Stroka, Deborah; Fey, Martin F (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leukemia research, 34(3), pp. 393-8. Amsterdam: Elsevier 10.1016/j.leukres.2009.08.037

Wampfler, Julian; Tschan, Mario P; Shan, Deborah; Laemmle, Alexander; Leibundgut, Elisabeth O; Baerlocher, Gabriela M; Stroka, Deborah; Fey, Martin F; Britschgi, Christian (2009). SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells. British journal of haematology, 146(3), pp. 337-41. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2009.07749.x

Bains, Lauren

Bains, Lauren J; Zweifel, Martin; Thoeny, Harriet C (2012). Therapy response with diffusion MRI: an update. Cancer imaging, 12(2), pp. 395-402. London: e-med 10.1102/1470-7330.2012.9047

Baltzer, Anna

Banz Wälti, Yara Sarah

Alizadeh Zeinabad, Hojjat; Yeoh, Wen Jie; Arif, Maryam; Lomora, Mihai; Banz, Yara; Riether, Carsten; Krebs, Philippe; Szegezdi, Eva (2023). Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells. Biomaterials, 298(122126), p. 122126. Elsevier 10.1016/j.biomaterials.2023.122126

Dislich, Bastian; Hoch, Dennis; Dirnhofer, Stefan; Novak, Urban; Banz, Yara (2022). An unusual pseudolymphoma in the context of necrotizing fasciitis: A case report. Medicine, 101(51), e32457. Wolters Kluwer Health 10.1097/MD.0000000000032457

Markopoulos, Konstantinos; Bührer, Emanuel; Banz, Yara; Dawson, Heather; Engelbrecht, Swantje; Essig, Manfred; Misselwitz, Benjamin (2022). Challenges in the diagnosis of marginal zone lymphoma with symptoms of small intestinal disease: a case report and scoping review of the literature. Journal of gastrointestinal oncology, 13(5), pp. 2583-2607. AME Publishing 10.21037/jgo-22-74

Brune, Magdalena M; Stüssi, Georg; Lundberg, Pontus; Vela, Visar; Heim, Dominik; Manz, Markus G; Haralambieva, Eugenia; Pabst, Thomas; Banz, Yara; Bargetzi, Mario; Grobholz, Rainer; Fehr, Martin; Cogliatti, Sergio; Ossenkoppele, Gert J; Löwenberg, Bob; Rudolf, Christina Biaggi; Li, Qiyu; Passweg, Jakob; Mazzuchelli, Luca; Medinger, Michael; ... (2021). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Annals of hematology, 100(5), pp. 1169-1179. Springer-Verlag 10.1007/s00277-021-04467-2

Murone, Maximilien; Radpour, Ramin; Attinger, Antoine; Chessex, Anne Vaslin; Huguenin, Anne-Laure; Schürch, Christian M; Banz Wälti, Yara; Sengupta, Saumitra; Aguet, Michel; Rigotti, Stefania; Bachhav, Yogeshwar; Massière, Frédéric; Ramachandra, Murali; McAllister, Andres; Riether, Carsten (2017). The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells. Molecular cancer therapeutics, 16(8), pp. 1497-1510. American Association for Cancer Research AACR 10.1158/1535-7163.MCT-16-0889

Zysset, Daniel; Weber, Benjamin; Rihs, Silvia; Brasseit, Jennifer; Freigang, Stefan Bernd; Riether, Carsten; Banz Wälti, Yara; Cerwenka, Adelheid; Simillion, Cedric; Marques-Vidal, Pedro; Ochsenbein, Adrian; Saurer, Leslie; Müller, Christoph (2016). TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis. Nature communications, 7(13151), p. 13151. Nature Publishing Group 10.1038/ncomms13151

Berger, Martin Dave; Branger, Giacomo; Klaeser, Bernd; Mansouri Taleghani, Behrouz; Novak, Urban; Banz Wälti, Yara; Müller, Beatrice Ursula; Pabst, Thomas (2016). Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma. Hematological oncology, 34(3), pp. 133-139. Wiley 10.1002/hon.2197

Juilland, M.; Gonzalez, M.; Erdmann, T.; Banz Wälti, Yara; Jevnikar, Z.; Hailfinger, S.; Tzankov, A.; Grau, M.; Lenz, G.; Novak, Urban; Thome, M. (2016). CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. Blood, 127(14), pp. 1780-1789. American Society of Hematology 10.1182/blood-2015-07-655647

Galli, Serena; Zlobec, Inti; Schürch, Christian; Perren, Aurel; Ochsenbein, Adrian; Banz Wälti, Yara (2015). CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis. Leukemia research, 39(7), pp. 749-756. Elsevier 10.1016/j.leukres.2015.04.007

Koechli, Valentin; Klaeser, Bernd; Banz Wälti, Yara; Müller, Beatrice Ursula; Pabst, Thomas (2015). Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma. Leukemia research, 39(3), pp. 307-310. Elsevier 10.1016/j.leukres.2014.12.016

Klenke, Frank M.; Wirtz, Christian; Banz Wälti, Yara; Keel, Marius; Klass, Natalie Désirée; Novak, Urban; Benneker, Lorin Michael (2014). Multiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature. Global Spine Journal, 4(2), pp. 109-114. Thieme 10.1055/s-0033-1360724

Raschle, Joëlle; Banz Wälti, Yara; Suter, Thomas; Pabst, Thomas (2014). A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation. Swiss medical weekly, 144, w13922. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13922

Reber, Rebekka; Banz Wälti, Yara; Garamvölgyi, Esther; Perren, Aurel; Novak, Urban (2013). Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland. Swiss medical weekly, 143, w13748. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13748

Mans, Sarah; Banz, Yara; Mueller, Beatrice U; Pabst, Thomas (2012). The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients. Blood, 120(13), pp. 2690-9. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-412759

Banz Wüthrich, Vanessa

Magyar, Christian Tibor Josef; Vashist, Yogesh K; Stroka, Deborah; Kim-Fuchs, Corina; Berger, Martin D; Banz, Vanessa M (2023). Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review. Journal of cancer research and clinical oncology, 149(10), pp. 8039-8050. Springer 10.1007/s00432-023-04689-z

Al Hasani, Farah; Knoepfli, Marina; Gemperli, Armin; Kollár, Attila; Banz, Vanessa; Kettenbach, Joachim; Jüni, Peter; Dufour, Jean-François (2014). Factors affecting screening for hepatocellular carcinoma. Annals of hepatology, 13(2), pp. 204-210. Sociedad Mexicana de Hepatologia

Basile, Giulia

Esposito, Roberta; Lanzos, Andrés; Uroda, Tina; Ramnarayanan, Sunandini; Büchi, Isabel; Polidori, Taisia; Guillen-Ramirez, Hugo; Mihaljevic, Ante; Merlin, Bernard Mefi; Mela, Lia; Zoni, Eugenio; Hovhannisyan, Lusine; McCluggage, Finn; Medo, Matúš; Basile, Giulia; Meise, Dominik F; Zwyssig, Sandra; Wenger, Corina; Schwarz, Kyriakos; Vancura, Adrienne; ... (2023). Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness. Nature communications, 14(1), p. 5463. Nature Publishing Group 10.1038/s41467-023-41288-5

Esposito, Roberta; Lanzós, Andrés; Uroda, Tina; Ramnarayanan, Sunandini; Büchi, Isabel; Polidori, Taisia; Guillen-Ramirez, Hugo; Mihaljevic, Ante; Merlin, Bernard Mefi; Lia, Mela; Zoni, Eugenio; Hovhannisyan, Lusine; McCluggage, Finn; Medo, Matúš; Basile, Giulia; Meise, Dominik F; Zwyssig, Sandra; Wenger, Corina; Schwarz, Kyriakos; Vancura, Adrienne; ... (2023). Tumour mutations in long noncoding RNAs enhance cell fitness. Nature communications, 14(1), p. 3342. Nature Publishing Group 10.1038/s41467-023-39160-7

Esposito, Roberta; Polidori, Taisia; Meise, Dominik F; Pulido-Quetglas, Carlos; Chouvardas, Panagiotis; Forster, Stefan; Schaerer, Paulina; Kobel, Andrea; Schlatter, Juliette; Kerkhof, Erik; Roemmele, Michaela; Rice, Emily S.; Zhu, Lina; Lanzós, Andrés; Guillen-Ramirez, Hugo A; Basile, Giulia; Carrozzo, Irene; Vancura, Adrienne; Ullrich, Sebastian; Andrades, Alvaro; ... (2022). Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities. Cell genomics, 2(9), p. 100171. Elsevier 10.1016/j.xgen.2022.100171

Bassetti, Claudio L.A.

Panos, Leonidas; Brunel, Christophe; Berezowska, Sabina; Engisch, Renate; Kollár, Attila; Bassetti, Claudio; Sturzenegger, Mathias; Krestel, Heinz Eric (2020). Early and delayed neurological manifestations of cardiac myxomas. Clinical neurology and neurosurgery, 190(105673), p. 105673. Elsevier 10.1016/j.clineuro.2020.105673

Batliner, Jasmin

Rothschild, Sacha; Gautschi, Oliver; Batliner, Jasmin; Gugger, Mathias; Fey, Martin; Tschan, Mario (2017). MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Lung cancer, 107, pp. 73-83. Elsevier 10.1016/j.lungcan.2016.06.004

Bauer, Daniel

Felber, Sibylle Jeanine; Lerch, Seraina Petra; Bauer, Daniel; Liaudet, Florence; Eychmüller, Steffen; Lörwald, Andrea (2023). Compassion training: Towards a better understanding of patients through self-exposure. Medical education, 57(5), pp. 478-479. Wiley 10.1111/medu.15032

Bauer, Stefan

Baumann, Christa Katharina

Vetsch, Gabi; Baumann, Christa K; Kläy, Marco; Leupin, Nicolas; Rentsch, Cyrill; Mueller-Garamvölgyi, Esther; Bürgi, Ulrich; Schiemann, Uwe (2008). [Malignant lymphoma of the prostate--diagnosis on the second biopsy]. Medizinische Klinik, 103(4), pp. 245-8. München: Urban & Vogel 10.1007/s00063-008-1034-y

Baumann, Christa K; Castiglione-Gertsch, Monica (2007). Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer. Drugs, 67(16), pp. 2335-53. Auckland (NZ): Adis International 10.2165/00003495-200767160-00004

Baumann, CK (2007). Trastiui,ab. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(7), pp. 879-883. Basel: EMH Editores Medicorum Helveticorum

Baumann, CK (2007). Trastuzumab. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(7), pp. 879-83. Basel: EMH Editores Medicorum Helveticorum

Martinelli, S; Kostylina, G; Niggli, V; Baumann, C; Fey, M F; Wendel, H-G; Lowe, S W; Yousefi, S; Simon, H-U (2006). Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils. Oncogene, 25(52), pp. 6915-23. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1209692

Baumgartner, Annic Catherine

Schönenberger, Katja A; Reber, Emilie; Schläppi, Karin; Baumgartner, Annic; Stanga, Zeno; Kollár, Attila (2023). Determinants of Treatment Toxicity in Patients with Soft Tissue Sarcomas. Nutrition and cancer - an international journal, 75(8), pp. 1638-1645. Routledge 10.1080/01635581.2023.2227405

Becker, Antje

Peters, S; Felip, E; Dafni, U; Belka, C; Guckenberger, M; Irigoyen, A; Nadal, E; Becker, Antje; Vees, H; Pless, M; Martinez-Marti, A; Tufman, A; Lambrecht, M; Andratschke, N; Piguet, A C; Kassapian, M; Roschitzki-Voser, H; Rabaglio, Manuela; Stahel, R A; Vansteenkiste, J; ... (2019). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. Lung cancer, 133, pp. 83-87. Elsevier 10.1016/j.lungcan.2019.05.001

Belachew, Nebiyat Filate

Beldi, Guido

Bello, Corina Manuela

Zens, Philipp; Bello, Corina Manuela; Scherz, Amina; von Gunten, Michael; Ochsenbein, Adrian; Schmid, Ralph A; Berezowska, Sabina (2022). The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer. Modern pathology, 35(12), pp. 1848-1859. Springer Nature 10.1038/s41379-022-01139-y

Zens, Philipp; Bello, Corina; Scherz, Amina; Koenigsdorf, Julia; Pöllinger, Alexander; Schmid, Ralph A.; Ochsenbein, Adrian; Neppl, Christina; Langer, Rupert; Berezowska, Sabina Anna (2021). A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response. Modern pathology, 34(7), pp. 1333-1344. Springer Nature 10.1038/s41379-021-00777-y

Benarafa, Charaf

Benjak, Andrej

Haas, Quentin; Markov, Nikita; Muerner, Lukas; Rubino, Viviana; Benjak, Andrej; Haubitz, Monika; Baerlocher, Gabriela M; Ng, Charlotte K Y; Münz, Christian; Riether, Carsten; Ochsenbein, Adrian F; Simon, Hans-Uwe; von Gunten, Stephan (2022). Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities. Frontiers in immunology, 13, p. 996746. Frontiers Research Foundation 10.3389/fimmu.2022.996746

Benneker, Lorin Michael

Benzaquen, Michael Joseph

Benzaquen, M; Christ, L; Sutter, N; Özdemir, B C (2023). Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners. Annales de dermatologie et de vénéréologie, 150(4), pp. 304-307. Elsevier 10.1016/j.annder.2023.07.001

Berezowska, Sabina Anna

Yang, Haitang; Gao, Yanyun; Xu, Duo; Xu, Ke; Shun-Qing, Liang; Yang, Zhang; Scherz, Amina; Hall, Sean R R; Forster, Stefan; Berezowska, Sabina; Yao, Feng; Ochsenbein, Adrian F; Marti, Thomas M; Kocher, Gregor J; Schmid, Ralph A; Dorn, Patrick; Peng, Ren-Wang (2023). MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell death discovery, 9(1), p. 55. Nature 10.1038/s41420-023-01307-2

Kündig, Alexandra; Zens, Philipp; Fung, Christian; Scherz, Amina; Cerciello, Ferdinando; Herrmann, Evelyn; Ermis, Ekin; Schmid, Ralph A; Vassella, Erik; Berezowska, Sabina (2022). Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients. JTO clinical and research reports, 3(11), p. 100413. 10.1016/j.jtocrr.2022.100413

Vassella, Erik; Kashani, Elham; Zens, Philipp; Kündig, Alexandra; Fung, Christian; Scherz, Amina; Herrmann, Evelyn; Ermis, Ekin; Schmid, Ralph A.; Berezowska, Sabina (2021). Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations. European journal of cancer, 159, pp. 227-236. Elsevier 10.1016/j.ejca.2021.10.006

Losmanová, Tereza; Zens, Philipp; Scherz, Amina; Schmid, Ralph; Tschan, Mario P.; Berezowska, Sabina Anna (2021). Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy. Cells, 10(10) MDPI 10.3390/cells10102731

Schmiedel, Yvonne; Büchi, Annina E.; Berezowska, Sabina; Pöllinger, Alexander; Mühlethaler, Konrad; Funke-Chambour, Manuela (2021). Autochthonous Case of Pulmonary Histoplasmosis, Switzerland. Emerging infectious diseases, 27(3), pp. 966-969. Centers for Disease Control and Prevention 10.3201/eid2703.191831

Trachsel, Maria; Wertli, Maria M.; Novak, Urban; Berezowska, Sabina; Pöllinger, Alexander; Wenemoser, Eliane (2020). Ein protrahiertes «fever of unknown origin». Swiss medical forum, 20(43-44), pp. 616-619. EMH Schweizerischer Ärzteverlag AG

Neppl, Christina; Keller, Manuel D; Scherz, Amina; Dorn, Patrick; Schmid, Ralph A.; Zlobec, Inti; Berezowska, Sabina (2019). Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases. Frontiers in medicine, 6(196), p. 196. Frontiers 10.3389/fmed.2019.00196

Xu, Duo; Shun-Qing, Liang; Yang, Haitang; Lüthi, Ursina; Riether, Carsten; Berezowska, Sabina Anna; Marti, Thomas; Hall, Sean; Bruggmann, Rémy; Kocher, Gregor; Schmid, Ralph; Peng, Ren-Wang (2018). Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma. British journal of cancer, 119(1), pp. 65-75. Nature Publishing Group 10.1038/s41416-018-0145-3

Scherz, Amina; Feller, Katrin; Berezowska, Sabina Anna; Genitsch Gratwohl, Vera; Zweifel, Martin (2017). Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy. Anticancer research, 37(6), pp. 3111-3115. International Inst. of Anticancer Research 10.21873/anticanres.11668

Bergada Pijuan, Judith

Bergada Pijuan, Judith; Pulido Quetglas, Carlos; Vancura, Adrienne; Johnson, Rory (2020). CASPR, an analysis pipeline for single and paired guide RNA CRISPR screens, reveals optimal target selection for long noncoding RNAs. Bioinformatics, 36(6), pp. 1673-1680. Oxford University Press 10.1093/bioinformatics/btz811

Berger, Martin Dave

Williams, Hannah L.; Frei, Ana Leni; Koessler, Thibaud; Berger, Martin D.; Dawson, Heather; Michielin, Olivier; Zlobec, Inti (2024). The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition. NPJ precision oncology, 8(1), p. 178. Springer Nature 10.1038/s41698-024-00671-1

Brouwer, N P M; Khan, A; Bokhorst, J M; Ayatollahi, F; Hay, J; Ciompi, F; Simmer, F; Hugen, N; de Wilt, J H W; Berger, M D; Lugli, A; Zlobec, I; Edwards, J; Nagtegaal, I D (2024). The complexity of shapes; how the circularity of tumor nodules impacts prognosis in colorectal cancer. Modern pathology, 37(1), p. 100376. Elsevier 10.1016/j.modpat.2023.100376

Tran, Linh Chi; Özdemir, Berna C; Berger, Martin D (2023). The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook. Pharmaceuticals, 16(10) MDPI 10.3390/ph16101411

Zimmer, Kai; Kocher, Florian; Untergasser, Gerold; Kircher, Brigitte; Amann, Arno; Baca, Yasmine; Xiu, Joanne; Korn, W Micheal; Berger, Martin D; Lenz, Heinz-Josef; Puccini, Alberto; Fontana, Elisa; Shields, Anthony F; Marshall, John L; Hall, Michael; El-Deiry, Wafik S; Hsiehchen, David; Macarulla, Teresa; Tabernero, Josep; Pichler, Renate; ... (2023). PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system. NPJ precision oncology, 7(1), p. 64. Springer Nature 10.1038/s41698-023-00409-5

Wahli, Murielle N; Hayoz, Stefanie; Hoch, Dennis; Ryser, Christoph O; Hoffmann, Michèle; Scherz, Amina; Schwacha-Eipper, Birgit; Häfliger, Simon; Wampfler, Julian; Berger, Martin D; Novak, Urban; Özdemir, Berna C (2023). The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex. Journal of cancer research and clinical oncology, 149(7), pp. 3847-3858. Springer 10.1007/s00432-022-04309-2

Hecht, J R; Raman, S S; Chan, A; Kalinsky, K; Baurain, J-F; Jimenez, M M; Garcia, M M; Berger, M D; Lauer, U M; Khattak, A; Carrato, A; Zhang, Y; Liu, K; Cha, E; Keegan, A; Bhatta, S; Strassburg, C P; Roohullah, A (2023). Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases. ESMO open, 8(2), p. 100884. BMJ 10.1016/j.esmoop.2023.100884

Frehner, Lorenz; Berger, Martin D. (2023). Update: Metastasiertes Pankreaskarzinom. info@onco-suisse(04), pp. 12-14. Aerzteverlag medinfo AG

Mlecnik, Bernhard; Lugli, Alessandro; Bindea, Gabriela; Marliot, Florence; Bifulco, Carlo; Lee, Jiun-Kae Jack; Zlobec, Inti; Rau, Tilman T; Berger, Martin D; Nagtegaal, Iris D; Vink-Börger, Elisa; Hartmann, Arndt; Geppert, Carol I; Kolwelter, Julie; Merkel, Susanne; Grützmann, Robert; Van den Eynde, Marc; Jouret-Mourin, Anne; Kartheuser, Alex; Léonard, Daniel; ... (2023). Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer. Cancers, 15(2) MDPI AG 10.3390/cancers15020418

Wartenberg, Martin; Moser, Nina; Obmann, Verena C; Berger, Martin D; Wenning, Anna S (2022). Pancreatic Ductal Adenocarcinoma and “Pseudo-IPMN”. Annals of case reports, 7 Gavin Publishers 10.29011/2574-7754.101058

Puccini, Alberto; Seeber, Andreas; Berger, Martin D (2022). Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective. Cancers, 14(19) MDPI AG 10.3390/cancers14194828

Noti, Luca; Galván, José; Dawson, Heather; Lugli, Alessandro; Kirsch, Richard; Assarzadegan, Naziheh; Messenger, David; Krebs, Philippe; Berger, Martin D; Zlobec, Inti (2022). A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer. BMC cancer, 22(1), p. 987. BioMed Central 10.1186/s12885-022-10048-x

Mlecnik, Bernhard; Torigoe, Toshihiko; Bindea, Gabriela; Popivanova, Boryana; Xu, Mingli; Fujita, Tomonobu; Hazama, Shoichi; Suzuki, Nobuaki; Nagano, Hiroaki; Okuno, Kiyotaka; Hirohashi, Yoshihiko; Furuhata, Tomohisa; Takemasa, Ichiro; Patel, Prabhudas; Vora, Hemangini; Shah, Birva; Patel, Jayendrakumar B; Rajvik, Kruti N; Pandya, Shashank J; Shukla, Shilin N; ... (2022). Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study. Cancers, 14(18) MDPI AG 10.3390/cancers14184346

Adamina, Michel; Warlaumont, Maxime; Berger, Martin D; Däster, Silvio; Delaloye, Raphaël; Digklia, Antonia; Gloor, Beat; Fritsch, Ralph; Köberle, Dieter; Koessler, Thibaud; Lehmann, Kuno; Müller, Phaedra; Peterli, Ralph; Ris, Frédéric; Steffen, Thomas; Weisshaupt, Christian Stefan; Hübner, Martin (2022). Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin. Cancers, 14(17) MDPI AG 10.3390/cancers14174275

Puccini, Alberto; Poorman, Kelsey; Catalano, Fabio; Seeber, Andreas; Goldberg, Richard M; Salem, Mohamed E; Shields, Anthony F; Berger, Martin D; Battaglin, Francesca; Tokunaga, Ryuma; Naseem, Madiha; Zhang, Wu; Philip, Philip A; Marshall, John L; Korn, W Michael; Lenz, Heinz-Josef (2022). Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets. Oncogene, 41(26), pp. 3455-3460. Springer Nature 10.1038/s41388-022-02350-6

Seeber, Andreas; Battaglin, Francesca; Zimmer, Kai; Kocher, Florian; Baca, Yasmine; Xiu, Joanne; Spizzo, Gilbert; Novotny-Diermayr, Veronica; Rieder, Dietmar; Puccini, Alberto; Swensen, Jeffrey; Ellis, Michelle; Goldberg, Richard M; Grothey, Axel; Shields, Anthony F; Marshall, John L; Weinberg, Benjamin A; Sackstein, Paul E; Hon Lim, Kiat; San Tan, Gek; ... (2022). Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer. Clinical cancer research, 28(9), pp. 1863-1870. American Association for Cancer Research 10.1158/1078-0432.CCR-21-3018

Zlobec, Inti; Bächli, Melanie; Galuppini, Francesca; Berger, Martin D.; Dawson, Heather E.; Nagtegaal, Iris D; Lugli, Alessandro (2021). Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer. Virchows Archiv, 479(6), pp. 1085-1090. Springer 10.1007/s00428-021-03090-w

Puccini, Alberto; Seeber, Andreas; Xiu, Joanne; Goldberg, Richard M; Soldato, Davide; Grothey, Axel; Shields, Anthony F; Salem, Mohamed E; Battaglin, Francesca; Berger, Martin Dave; El-Deiry, Wafik S; Tokunaga, Ryuma; Naseem, Madiha; Zhang, Wu; Arora, Sukeshi Patel; Khushman, Moh'd M; Hall, Michael J; Philip, Philip A; Marshall, John L; Korn, W Michael; ... (2021). Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. NPJ precision oncology, 5(1), p. 95. Springer Nature 10.1038/s41698-021-00230-y

Berger, Martin D.; Trelle, Sven; Büchi, Annina E.; Jegerlehner, Sabrina; Ionescu, Codruta; Lamy de la Chapelle, Thierry; Novak, Urban (2021). Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis. Haematologica - the hematology journal, 106(7), pp. 1923-1931. Ferrata-Storti Foundation 10.3324/haematol.2020.249680

Naseem, Madiha; Cao, Shu; Yang, Dongyun; Millstein, Joshua; Puccini, Alberto; Loupakis, Fotios; Stintzing, Sebastian; Cremolini, Chiara; Tokunaga, Ryuma; Battaglin, Francesca; Soni, Shivani; Berger, Martin D.; Barzi, Afsaneh; Zhang, Wu; Falcone, Alfredo; Heinemann, Volker; Lenz, Heinz-Josef (2021). Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients. Scientific reports, 11(1), p. 12191. Springer Nature 10.1038/s41598-021-91330-z

Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Cremolini, Chiara; Lonardi, Sara; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Soni, Shivani; Barzi, Afsaneh; Yamaguchi, Toshiharu; Loupakis, Fotios; Falcone, Alfredo; Lenz, Heinz-Josef (2021). Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer. The pharmacogenomics journal, 21(3), pp. 285-295. Springer Nature 10.1038/s41397-021-00207-x

Suenaga, Mitsukuni; Zhang, W U; Mashima, Tetsuo; Schirripa, Marta; Cao, Shu; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Barzi, Afsaneh; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2021). Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer genomics & proteomics, 18(3), pp. 317-324. International Institute of Anticancer Research 10.21873/cgp.20262

Hemmatazad, Hossein; Berger, Martin D. (2021). CCR5 is a potential therapeutic target for cancer. Expert opinion on therapeutic targets, 25(4), pp. 311-327. Taylor & Francis 10.1080/14728222.2021.1902505

Lugli, Alessandro; Zlobec, Inti; Berger, Martin D.; Kirsch, Richard; Nagtegaal, Iris D (2021). Tumour budding in solid cancers. Nature reviews. Clinical oncology, 18(2), pp. 101-115. Springer Nature 10.1038/s41571-020-0422-y

Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Matsusaka, Satoshi; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Schirripa, Marta; Barzi, Afsaneh; Yamamoto, Noriko; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2021). Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer. Pharmacogenetics and genomics, 31(1), pp. 10-16. Lippincott Williams & Wilkins 10.1097/FPC.0000000000000416

Burren, Sandra; Reche, Katharina; Blank, Annika; Galván, José A.; Dawson, Heather; Berger, Martin D.; Zlobec, Inti; Lugli, Alessandro (2021). RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1. Pathology, research and practice, 223, p. 153486. Elsevier 10.1016/j.prp.2021.153486

Rhyner Agocs, Gaëlle; Assarzadegan, Naziheh; Kirsch, Richard; Dawson, Heather; Galván, José A.; Lugli, Alessandro; Zlobec, Inti; Berger, Martin D. (2021). LAG-3 Expression Predicts Outcome in Stage II Colon Cancer. Journal of personalized medicine, 11(8) MDPI 10.3390/jpm11080749

Puccini, Alberto; Poorman, Kelsey; Salem, Mohamed E; Soldato, Davide; Seeber, Andreas; Goldberg, Richard M; Shields, Anthony F; Xiu, Joanne; Battaglin, Francesca; Berger, Martin D.; Tokunaga, Ryuma; Naseem, Madiha; Barzi, Afsaneh; Iqbal, Syma; Zhang, Wu; Soni, Shivani; Hwang, Jimmy J; Philip, Philip A; Sciallero, Stefania; Korn, W Michael; ... (2020). Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Clinical cancer research, 26(22), pp. 5943-5951. American Association for Cancer Research 10.1158/1078-0432.CCR-20-1804

Mlecnik, Bernhard; Bifulco, Carlo; Bindea, Gabriela; Marliot, Florence; Lugli, Alessandro; Lee, J Jack; Zlobec, Inti; Rau, Tilman T.; Berger, Martin D.; Nagtegaal, Iris D; Vink-Börger, Elisa; Hartmann, Arndt; Geppert, Carol; Kolwelter, Julie; Merkel, Susanne; Grützmann, Robert; Van den Eynde, Marc; Jouret-Mourin, Anne; Kartheuser, Alex; Léonard, Daniel; ... (2020). Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. Journal of clinical oncology, 38(31), pp. 3638-3651. American Society of Clinical Oncology 10.1200/JCO.19.03205

Tokunaga, Ryuma; Xiu, Joanne; Goldberg, Richard M; Philip, Philip A; Seeber, Andreas; Battaglin, Francesca; Arai, Hiroyuki; Lo, Jae Ho; Naseem, Madiha; Puccini, Alberto; Berger, Martin D.; Soni, Shivani; Zhang, Wu; Chen, Sting; Hwang, Jimmy J; Shields, Anthony F; Marshall, John L; Baba, Hideo; Korn, W Michael and Lenz, Heinz-Josef (2020). The impact of ARID1A mutation on molecular characteristics in colorectal cancer. European journal of cancer, 140, pp. 119-129. Elsevier 10.1016/j.ejca.2020.09.006

Volz, Nico B; Hanna, Diana L; Stintzing, Sebastian; Zhang, Wu; Yang, Dongyun; Cao, Shu; Ning, Yan; Matsusaka, Satoshi; Sunakawa, Yu; Berger, Martin D.; Cremolini, Chiara; Loupakis, Fotios; Falcone, Alfredo; Lenz, Heinz-Josef (2020). Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients. Cancers, 12(10) MDPI AG 10.3390/cancers12102947

Zlobec, Inti; Berger, Martin D.; Lugli, Alessandro (2020). Tumour budding and its clinical implications in gastrointestinal cancers. British journal of cancer, 123(5), pp. 700-708. Nature Publishing Group 10.1038/s41416-020-0954-z

Glatzer, Markus; Horber, D.; Montemurro, M.; Winterhalder, R.; Inauen, R.; Berger, M. D.; Pestalozzi, B.; Pederiva, S.; Pless, M.; Putora, P. M. (2020). Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology, 20(4), pp. 686-690. Elsevier 10.1016/j.pan.2020.03.012

Berger, Martin D.; Ning, Yan; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Zhang, Wu; Yang, Dongyun; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Tokunaga, Ryuma; Naseem, Madiha; Battaglin, Francesca; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios and Lenz, Heinz-Josef (2020). A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. European journal of cancer, 131, pp. 89-97. Elsevier 10.1016/j.ejca.2020.02.048

Dislich, Bastian; Blaser, Nicola; Berger, Martin D; Gloor, Beat; Langer, Rupert (2020). Preservation of Epstein-Barr-Virus Status and Mismatch Repair Protein Status along the Metastatic Course of Gastric Cancer. Histopathology, 76(5), pp. 740-747. Wiley 10.1111/his.14059

Zlobec, Inti; Dawson, Heather E.; Blank, Annika; Bokhorst, John-Melle; Berger, Martin D.; Nagtegaal, Iris D; Lugli, Alessandro (2020). Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients. European journal of cancer, 130, pp. 139-145. Elsevier 10.1016/j.ejca.2020.02.007

Matsusaka, Satoshi; Hanna, Diana L; Ning, Yan; Yang, Dongyun; Cao, Shu; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Dan, Shingo; Mashima, Tetsuo; Seimiya, Hiroyuki; Zhang, Wu; Lenz, Heinz-Josef (2020). Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib. Cancer science, 111(2), pp. 441-450. Wiley 10.1111/cas.14273

Miyamoto, Yuji; Schirripa, Marta; Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Okazaki, Satoshi; Berger, Martin D.; Matsusaka, Satoshi; Yang, Dongyun; Ning, Yan; Baba, Hideo; Loupakis, Fotios; Lonardi, Sara; Pietrantonio, Filippo; Borelli, Beatrice; Cremolini, Chiara; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2020). A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. PLoS ONE, 15(9), e0239439. Public Library of Science 10.1371/journal.pone.0239439

Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Schirripa, Marta; Soni, Shivani; Barzi, Afsaneh; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2019). Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients. International journal of cancer, 144(10), pp. 2567-2577. Wiley-Blackwell 10.1002/ijc.31968

Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha; Battaglin, Francesca; Lo, Jae Ho; Arai, Hiroyuki; Loupakis, Fotios; Stintzing, Sebastian; Puccini, Alberto; Berger, Martin D.; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Salhia, Bodour; Mumenthaler, Shannon M; Weisenberger, Daniel J; Liang, Gangning; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; ... (2019). AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3. International journal of cancer, 145(8), pp. 2082-2090. Wiley-Blackwell 10.1002/ijc.32261

Dawson, Heather; Galuppini, Francesca; Träger, Peter; Berger, Martin D.; Studer, Peter; Brügger, Lukas; Zlobec, Inti; Inderbitzin, Daniel; Lugli, Alessandro (2019). Validation of the international tumor budding consensus conference (ITBCC 2016) recommendations on tumor budding in stage I-IV colorectal cancer. Human pathology, 85, pp. 145-151. Elsevier 10.1016/j.humpath.2018.10.023

Wyss, Jacqueline; Dislich, Bastian; Kölzer, Viktor; Galván, José A.; Dawson, Heather; Hädrich, Marion; Inderbitzin, Daniel; Lugli, Alessandro; Zlobec, Inti; Berger, Martin D. (2019). Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients. Clinical colorectal cancer, 18(1), e20-e38. Elsevier 10.1016/j.clcc.2018.09.007

Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha; Lo, Jae Ho; Battaglin, Francesca; Puccini, Alberto; Berger, Martin Dave; Soni, Shivani; Millstein, Joshua; Zhang, Wu; Stintzing, Sebastian; Loupakis, Fotios; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; Lenz, Heinz-Josef (2019). Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Clinical colorectal cancer, 18(1), e8-e19. Elsevier 10.1016/j.clcc.2018.09.003

Tokunaga, Ryuma; Naseem, Madiha; Lo, Jae Ho; Battaglin, Francesca; Soni, Shivani; Puccini, Alberto; Berger, Martin Dave; Zhang, Wu; Baba, Hideo; Lenz, Heinz-Josef (2019). B cell and B cell-related pathways for novel cancer treatments. Cancer treatment reviews, 73, pp. 10-19. Elsevier 10.1016/j.ctrv.2018.12.001

Suenaga, Mitsukuni; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Schirripa, Marta; Soni, Shivani; Barzi, Afsaneh; Heinemann, Volker; Lenz, Heinz-Josef (2019). Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial. European journal of cancer, 107, pp. 100-114. Elsevier 10.1016/j.ejca.2018.11.019

Neppl, Christina; Kaderli, Reto M.; Trepp, Roman; Schmitt, Anja M.; Berger, Martin D.; Wehrli, Marc; Seiler, Christian A.; Langer, Rupert (2018). Histology of Nivolumab-Induced Thyroiditis. Thyroid, 28(12), pp. 1727-1728. Mary Ann Liebert 10.1089/thy.2018.0418

Graule, Janina; Uth-Gottardi, Kristin; Fischer, Elia Luca; Centeno Ramos, Irene; Galván Hernández, José Alberto; Eichmann, Micha David; Rau, Tilman; Langer, Rupert; Dawson, Heather; Nitsche, Ulrich; Traeger, Peter; Berger, Martin Dave; Schnüriger, Beat; Hädrich, Marion; Studer, Peter; Inderbitzin, Daniel; Lugli, Alessandro; Tschan, Mario; Zlobec, Inti (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical epigenetics, 10(1), p. 120. Springer 10.1186/s13148-018-0548-2

Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Cremolini, Chiara; Lonardi, Sara; Bergamo, Francesca; Ning, Yang; Yamamoto, Noriko; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Stintzing, Sebastian; Heinemann, Volker; Loupakis, Fotios; Falcone, Alfredo; ... (2018). Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. The pharmacogenomics journal, 18(5), pp. 623-632. Nature Publishing Group 10.1038/s41397-018-0030-8

Hanna, Diana L; Loupakis, Fotios; Yang, Dongyun; Cremolini, Chiara; Schirripa, Marta; Li, Meng; Matsusaka, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Zhang, Wu; Ning, Yan; Antoniotti, Carlotta; Salvatore, Lisa; Moran, Miriana; Zeger, Gary; Astrow, Stephanie H; Falcone, Alfredo; Lenz, Heinz-Josef (2018). Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clinical colorectal cancer, 17(3), e471-e488. Elsevier 10.1016/j.clcc.2018.03.006

Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios and Lenz, Heinz-Josef (2018). Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clinical colorectal cancer, 17(2), e395-e414. Elsevier 10.1016/j.clcc.2018.02.010

Pagès, Franck; Mlecnik, Bernhard; Marliot, Florence; Bindea, Gabriela; Ou, Fang-Shu; Bifulco, Carlo; Lugli, Alessandro; Zlobec, Inti; Rau, Tilman T.; Berger, Martin D.; Nagtegaal, Iris D; Vink-Börger, Elisa; Hartmann, Arndt; Geppert, Carol; Kolwelter, Julie; Merkel, Susanne; Grützmann, Robert; Van den Eynde, Marc; Jouret-Mourin, Anne; Kartheuser, Alex; ... (2018). International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet, 391(10135), pp. 2128-2139. Elsevier 10.1016/S0140-6736(18)30789-X

Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine; Puccini, Alberto; Berger, Martin Dave; Tokunaga, Ryuma; Battaglin, Francesca; Soni, Shivani; McSkane, Michelle; Zhang, Wu; Lenz, Heinz-Josef (2018). Outlooks on Epstein-Barr virus associated gastric cancer. Cancer treatment reviews, 66, pp. 15-22. Elsevier 10.1016/j.ctrv.2018.03.006

Matsusaka, S; Wu, A H; Cao, S; Hanna, D L; Chin, K; Yang, D; Zhang-Wu, Xiaxia; Ning, Y; Stintzing, S; Sebio, A; Sunakawa, Y; Stremitzer, S; Yamauchi, S; Okazaki, S; Berger, Martin Dave; Parekh, A; Miyamoto, Y; Mizunuma, N; Lenz, H-J (2018). Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics journal, 18(2), pp. 262-269. Nature Publishing Group 10.1038/tpj.2017.9

Berger, Martin Dave; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios and Lenz, Heinz-Josef (2018). A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. Clinical cancer research, 24(4), pp. 784-793. American Association for Cancer Research 10.1158/1078-0432.CCR-17-1663

Tokunaga, Ryuma; Zhang, Wu; Naseem, Madiha; Puccini, Alberto; Berger, Martin Dave; Soni, Shivani; McSkane, Michelle; Baba, Hideo; Lenz, Heinz-Josef (2018). CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer treatment reviews, 63, pp. 40-47. Elsevier 10.1016/j.ctrv.2017.11.007

von Moos, Roger; Koeberle, Dieter; Schacher, Sabina; Hayoz, Stefanie; Winterhalder, Ralph C; Roth, Arnaud; Bodoky, György; Samaras, Panagiotis; Berger, Martin D.; Rauch, Daniel; Saletti, Piercarlo; Plasswilm, Ludwig; Zwahlen, Daniel; Meier, Urs R; Yan, Pu; Izzo, Paola; Klingbiel, Dirk; Bärtschi, Daniela; Zaugg, Kathrin (2018). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). European journal of cancer, 89, pp. 82-89. Elsevier 10.1016/j.ejca.2017.11.005

Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin Dave; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker; ... (2018). NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. PLoS ONE, 13(3), e0193640. Public Library of Science 10.1371/journal.pone.0193640

Puccini, Alberto; Berger, Martin Dave; Naseem, Madiha; Tokunaga, Ryuma; Battaglin, Francesca; Cao, Shu; Hanna, Diana L; McSkane, Michelle; Soni, Shivani; Zhang, Wu; Lenz, Heinz-Josef (2017). Colorectal cancer: epigenetic alterations and their clinical implications. Biochimica et biophysica acta, 1868(2), pp. 439-448. Elsevier 10.1016/j.bbcan.2017.09.003

Matsusaka, S; Cao, S; Hanna, D L; Sunakawa, Y; Ueno, M; Mizunuma, N; Zhang-Wu, Xiaxia; Yang, D; Ning, Y; Stintzing, S; Sebio, A; Stremitzer, S; Yamauchi, S; Parekh, A; Okazaki, S; Berger, Martin Dave; El-Khoueiry, R; Mendez, A; Ichikawa, W; Loupakis, F; ... (2017). CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy. Pharmacogenomics journal, 17(6), pp. 543-550. Nature Publishing Group 10.1038/tpj.2016.59

Sunakawa, Y; Cao, S; Volz, N B; Berger, Martin Dave; Yang, D; Parekh, A; Zhang-Wu, Xiaxia; Matsusaka, S; Ning, Y; Stremitzer, S; Stintzing, S; Sebio, A; Okazaki, S; Wakatsuki, T; Azuma, M; Watanabe, M; Koizumi, W; Wu, A H; Lenz, H-J (2017). Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. Pharmacogenomics journal, 17(6), pp. 528-534. Nature Publishing Group 10.1038/tpj.2016.46

Okazaki, Satoshi; Schirripa, Marta; Loupakis, Fotios; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Berger, Martin Dave; Miyamoto, Yuji; Suenaga, Mitsukuni; Iqubal, Syma; Barzi, Afsaneh; Cremolini, Chiara; Falcone, Alfredo; Battaglin, Francesca; Salvatore, Lisa; Borelli, Beatrice; Helentjaris, Timothy G; Lenz, Heinz-Josef (2017). Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Cancer, 123(22), pp. 4506-4514. John Wiley & Sons 10.1002/cncr.30880

Berger, Martin Dave; Stintzing, S; Heinemann, V; Yang, D; Cao, S; Sunakawa, Y; Ning, Y; Matsusaka, S; Okazaki, S; Miyamoto, Y; Suenaga, M; Schirripa, M; Soni, S; Zhang, W; Falcone, A; Loupakis, F; Lenz, H-J (2017). Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials. Annals of oncology, 28(11), pp. 2780-2785. Oxford University Press 10.1093/annonc/mdx412

Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Dadduzio, Vincenzo; Salvatore, Lisa; Borelli, Beatrice; Pietrantonio, Filippo; Ning, Yan; Okazaki, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Loupakis, Fotios; Lenz, Heinz-Josef (2017). Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer. European journal of cancer, 86, pp. 197-206. Elsevier 10.1016/j.ejca.2017.08.033

Okazaki, Satoshi; Stintzing, Sebastian; Sunakawa, Yu; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin Dave; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; West, Jordan D; Gopez, Roel; Akihito, Tsuji; Ichikawa, Wataru; Heinemann, Volker; DePaolo, R William; Lenz, Heinz-Josef (2017). Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. International journal of cancer, 141(6), pp. 1222-1230. Wiley-Blackwell 10.1002/ijc.30810

Schirripa, Marta; Zhang-Wu, Xiaxia; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin Dave; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F; West, Jordan D; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian; Lenz, Heinz-Josef (2017). Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial. International journal of cancer, 141(2), pp. 383-392. Wiley-Blackwell 10.1002/ijc.30715

Rieger, Gregor; Kölzer, Viktor; Dawson, Heather; Berger, Martin Dave; Hädrich, Marion; Inderbitzin, Daniel; Lugli, Alessandro; Zlobec, Inti (2017). Comprehensive assessment of tumour budding on cytokeratin stains in colorectal cancer. Histopathology, 70(7), pp. 1044-1051. Blackwell Scientific Publications 10.1111/his.13164

Puccini, Alberto; Berger, Martin Dave; Zhang, Wu; Lenz, Heinz-Josef (2017). What We Know About Stage II and III Colon Cancer: It's Still Not Enough. Targeted oncology, 12(3), pp. 265-275. Springer 10.1007/s11523-017-0494-5

Suenaga, M; Schirripa, M; Cao, S; Zhang-Wu, Xiaxia; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, Martin Dave; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J (2017). Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer. Annals of oncology, 28(5), pp. 1015-1022. Oxford University Press 10.1093/annonc/mdx035

Berger, Martin Dave; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian; ... (2017). Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. European journal of cancer, 77, pp. 13-20. Elsevier 10.1016/j.ejca.2017.02.020

Sunakawa, Y; Cao, S; Berger, Martin Dave; Matsusaka, S; Yang, D; Zhang-Wu, Xiaxia; Ning, Y; Parekh, A; Stremitzer, S; Mendez, A; Okazaki, S; Wakatsuki, T; Azuma, M; Shimada, K; Watanabe, M; Koizumi, W; Wu, A H; Lenz, H-J (2017). Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Pharmacogenomics journal, 17(1), pp. 36-41. Nature Publishing Group 10.1038/tpj.2015.77

Kölzer, Viktor; Sokol, Lena; Zahnd, Stefan Patrick; Christe, Lucine; Dawson, Heather; Berger, Martin Dave; Inderbitzin, Daniel; Zlobec, Inti; Lugli, Alessandro (2017). Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer. Oncoimmunology, 6(4), e1288330. Landes Bioscience 10.1080/2162402X.2017.1288330

Berger, Martin Dave; Branger, Giacomo; Leibundgut, Kurt; Baerlocher, Gabriela M; Seipel, Katja; Mueller, Beatrice U; Gregor, Michael; Ruefer, Axel; Pabst, Thomas (2015). CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma. Leukemia research, 39(6), pp. 561-567. Elsevier 10.1016/j.leukres.2015.03.004

Galván Hernández, José Alberto; Helbling, Melina; Kölzer, Viktor; Tschan, Mario; Berger, Martin Dave; Hädrich, Marion; Schnüriger, Beat; Karamitopoulou, Evanthia; Dawson, Heather; Inderbitzin, Daniel; Lugli, Alessandro; Zlobec, Inti (2015). TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer. OncoTarget, 6(2), pp. 874-885. Impact Journals LLC 10.18632/oncotarget.2716

Kölzer, Viktor; Zlobec, Inti; Berger, Martin Dave; Cathomas, G; Dawson, Heather; Dirschmid, K; Hädrich, Marion; Inderbitzin, Daniel; Offner, F; Puppa, G; Seelentag, W; Schnüriger, Beat; Tornillo, L; Lugli, Alessandro (6 November 2014). Tumor budding in colorectal cancer: a multicenter inter-observer study on behalf of the Swiss Association of Gastrointestinal Pathology (SAGIP). In: Swiss Society of Pathology 2014. Lausanne, Switzerland.. 06.-08.11.2014.

Kölzer, Viktor; Zlobec, Inti; Cathomas, Marionna Myrta; Dirschmid, Klaus; Offner, Felix; Puppa, Giacomo; Tornillo, Luigi; Berger, Martin Dave; Borner, Markus; Dawson, Heather; Hädrich, Marion; Mallaev, Makhmudbek; Schnüriger, Beat; Inderbitzin, Daniel; Lugli, Alessandro (1 September 2014). A multicentre inter-observer study on tumour budding using a 10HPF method in colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP) (Unpublished). In: European Congress of Pathology 2014. London, UK. 30.08.-03.09.2014.

Helbling, Melina; Lukesch, Anne Carolin; Haimovici, Aladin; Karamitopoulou, Evanthia; Berger, Martin Dave; Hädrich, Marion; Mallaev, Makhmud; Schnüriger, Beat; Kölzer, Viktor; Dawson, Heather; Borner, Markus; Langer, Rupert; Rosenberg, Robert; Nitsche, Ulrich; Inderbitzin, Daniel; Lugli, Alessandro; Tschan, Mario; Zlobec, Inti (2014). Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients. OncoTarget, 5(13), pp. 4671-4682. Impact Journals LLC

Berger, Martin D.; Banz, Yara; Pabst, Thomas (2013). Pitfalls in the diagnosis of intravascular large B-cell lymphoma. European journal of haematology, 91(6), pp. 563-564. Wiley-Blackwell 10.1111/ejh.12162

Berger, Martin D.; Schneider, Jakob; Ballmer, Peter E.; Eckhardt, Boris P.; Dommann-Scherrer, Corina (2013). Mucin-producing adenocarcinoma arising in an atrial myxoma. Annals of diagnostic pathology, 17(1), pp. 104-107. Elsevier 10.1016/j.anndiagpath.2012.02.002

Berlin, Claudia

Panczak, Radoslaw; von Wyl, Viktor; Reich, Oliver; Luta, Xhyljeta; Maessen, Maud; Stuck, Andreas E; Berlin, Claudia; Schmidlin, Kurt; Goodman, David C; Egger, Matthias; Clough-Gorr, Kerri; Zwahlen, Marcel (2018). Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland. BMC health services research, 18(1), p. 178. BioMed Central 10.1186/s12913-018-2984-2

Bernhard, Jürg Theodor

Schneider, Caroline; Reimann, Sina; Schmid, Julia; Bernhard, Jürg; Rabaglio, Manuela; Campbell, Kristin L.; Wilhelm, Matthias; Eser, Prisca (2022). Qualitative analysis of facilitators and barriers to centre- and home-based exercise training in breast cancer patients - a Swiss tertiary centre experience. Swiss medical weekly, 152(19-20) EMH Media 10.4414/smw.2022.w30155

Hauk, Helen; Bernhard, Jürg; McConnell, Meghan; Wohlfarth, Benny (2021). Breaking bad news to cancer patients in times of COVID-19. Supportive care in cancer, 29(8), pp. 4195-4198. Springer-Verlag 10.1007/s00520-021-06167-z

Kollár, Attila; Müller, Sabrina; Limacher, Andreas; Briner, Irene; Klenke, Frank; Bernhard, Jürg (2021). Return to Work and Quality of Life in Disease-Free Adult Patients with Soft-Tissue and Bone Sarcoma of the Extremity. Praxis - schweizerische Rundschau für Medizin, 110(1), pp. 22-29. Hogrefe 10.1024/1661-8157/a003592

Kreissl, Stefanie; Müller, Horst; Goergen, Helen; Meissner, Julia; Topp, Max; Sökler, Martin; Markova, Jana; Bernhard, Jürg; Greil, Richard; von Tresckow, Bastian; Behringer, Karolin; Rüffer, Jens-Ulrich; Flechtner, Hans-Henning; Möstl, Michaela; Fuchs, Michael; Engert, Andreas; Diehl, Volker; Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. Journal of clinical oncology, 38(25), pp. 2839-2848. American Society of Clinical Oncology 10.1200/JCO.19.03160

Stojkov, Kristina; Silzle, Tobias; Stussi, Georg; Schwappach, David; Bernhard, Juerg; Bowen, David; Čermák, Jaroslav; Dinmohamed, Avinash G; Eeltink, Corien; Eggmann, Sabrina; Fenaux, Pierre; Germing, Ulrich; Haschke, Manuel; Hellstrom-Lindberg, Eva; Heger, Monika; van de Loosdrecht, Arjan A; Passweg, Jakob; Pfeilstöcker, Michael; Platzbecker, Uwe; Malcovati, Luca; ... (2020). Guideline-based indicators for adult patients with myelodysplastic syndromes. Blood advances, 4(16), pp. 4029-4044. American Society of Hematology 10.1182/bloodadvances.2020002314

Ribi, Karin; Luo, Weixiu; Walley, Barbara A; Burstein, Harold J; Chirgwin, Jacquie; Ansari, Rafat H; Salim, Muhammed; van der Westhuizen, Andre; Abdi, Ehtesham; Francis, Prudence A; Chia, Stephen; Harvey, Vernon J; Giobbie-Hurder, Anita; Fleming, Gini F; Pagani, Olivia; Di Leo, Angelo; Colleoni, Marco; Gelber, Richard D; Goldhirsch, Aron; Coates, Alan S; ... (2020). Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast cancer research and treatment, 181(2), pp. 347-359. Springer 10.1007/s10549-020-05622-5

Zambrano Ramos, Sofia C.; Kollár, Attila; Bernhard, Jürg (2020). Experiences of return to work after treatment for extremital soft tissue or bone sarcoma: Between distraction and leaving the disease behind. Psycho-oncology, 29(4), pp. 781-787. Wiley-Blackwell 10.1002/pon.5349

Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2020). Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 122(7), p. 1119. Nature Publishing Group 10.1038/s41416-019-0709-x

Ribi, Karin; Bernhard, Jürg (2019). ASO Author Reflections: What is the Impact of Different Rectal Reconstruction Techniques After Total Mesorectal Excision on Quality of Life? Annals of surgical oncology, 26(Suppl 3), pp. 772-773. Springer 10.1245/s10434-019-07929-0

Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2019). Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 120(10), pp. 959-967. Springer Nature 10.1038/s41416-019-0435-4

Kienle, Dirk L.; Dietrich, Daniel; Ribi, Karin; Wicki, Andreas; Quagliata, Luca; Winterhalder, Ralph C.; Koeberle, Dieter; Horber, Daniel; Bastian, Sara; Kueng, Marc; Saletti, Piercarlo; Helbling, Daniel; Baertschi, Daniela; Lugli, Alessandro; Bernhard, Jürg; Andrieu, Christiane; von Moos, Roger (2019). Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. Journal of geriatric oncology, 10(2), pp. 304-310. Elsevier 10.1016/j.jgo.2018.11.011

Dellapasqua, Silvia; Gray, Kathryn P.; Munzone, Elisabetta; Rubino, Daniela; Gianni, Lorenzo; Johansson, Harriet; Viale, Giuseppe; Ribi, Karin; Bernhard, Jürg; Kammler, Roswitha; Maibach, Rudolf; Rabaglio, Manuela; Ruepp, Barbara; Di Leo, Angelo; Coates, Alan S.; Gelber, Richard D.; Regan, Meredith M.; Goldhirsch, Aron; Colleoni, Marco (2019). Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology, 37(5), pp. 386-395. American Society of Clinical Oncology 10.1200/JCO.18.00296

Ribi, Karin; Marti, Walter R.; Bernhard, Jürg; Grieder, Felix; Graf, Michael; Gloor, Beat; Curti, Gaudenz; Zuber, Markus; Demartines, Nicolas; Andrieu, Christiane; Bigler, Martin; Hayoz, Stefanie; Wehrli, Heinz; Kettelhack, Christoph; Lerf, Bruno; Fasolini, Fabrizio; Hamel, Christian (2019). Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04). Annals of surgical oncology, 26(11), pp. 3568-3576. Springer 10.1245/s10434-019-07525-2

Gennari, A; Sun, Z; Hasler-Strub, U; Colleoni, M; Kennedy, M J; Von Moos, R; Cortés, J; Vidal, M J; Hennessy, B; Walshe, J; Amillano Parraga, K; Ribi, K; Bernhard, Jürg; Morales, S Murillo; Pagani, O; Barbeaux, A; Borstnar, S; Rabaglio, Manuela; Maibach, R; Regan, M M; ... (2018). A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. Annals of oncology, 29(3), pp. 661-668. Oxford University Press 10.1093/annonc/mdx772

Lee, Chee Khoon; Hudson, Malcolm; Simes, John; Ribi, Karin; Bernhard, Jürg; Coates, Alan S (2018). When do patient reported quality of life indicators become prognostic in breast cancer? Health and quality of life outcomes, 16(1), p. 13. BioMed Central 10.1186/s12955-017-0834-2

Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seamus; Di Lauro, Vincenzo; Gombos, Andrea; ... (2018). Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet oncology, 19(1), pp. 127-138. Elsevier 10.1016/S1470-2045(17)30715-5

Ribi, Karin; Coates, Alan; Blacher, Lynette; Regan, Meredith M; Gelber, Richard D; Bernhard, Jürg (2018). Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al. Quality of life research, 27(1), pp. 149-152. Springer 10.1007/s11136-017-1695-1

Saha, Poornima; Regan, Meredith M; Pagani, Olivia; Francis, Prudence A; Walley, Barbara A; Ribi, Karin; Bernhard, Jürg; Luo, Weixiu; Gómez, Henry L; Burstein, Harold J; Parmar, Vani; Torres, Roberto; Stewart, Josephine; Bellet, Meritxell; Perelló, Antonia; Dane, Faysal; Moreira, Antonio; Vorobiof, Daniel; Nottage, Michelle; Price, Karen N; ... (2017). Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. Journal of clinical oncology, 35(27), pp. 3113-3122. American Society of Clinical Oncology 10.1200/JCO.2016.72.0946

Zwingmann, Jelena; Baile, Walter F; Schmier, Johann W; Bernhard, Jürg; Keller, Monika (2017). Effects of patient-centered communication on anxiety, negative affect, and trust in the physician in delivering a cancer diagnosis: A randomized, experimental study. Cancer, 123(16), pp. 3167-3175. John Wiley & Sons 10.1002/cncr.30694

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, Jürg; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, Manuela; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; von Moos, R; Zaman, K; ... (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. Annals of oncology, 28(2), pp. 305-312. Oxford University Press 10.1093/annonc/mdw622

Bourquin, Céline; Stiefel, Friedrich; Bernhard, Jürg; Bianchi Micheli, Gabriella; Dietrich, Liselotte; Hürny, Christoph; Wössmer, Brigitta; Kiss, Alexander (2014). Mandatory communication skills training for oncologists: enforcement does not substantially impact satisfaction. Supportive care in cancer, 22(10), pp. 2611-2614. Springer 10.1007/s00520-014-2240-1

Pagani, Olivia; Regan, Meredith M; Walley, Barbara A; Fleming, Gini F; Colleoni, Marco; Láng, István; Gomez, Henry L; Tondini, Carlo; Burstein, Harold J; Perez, Edith A; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Hervé R; Martino, Silvana; Geyer, Charles E; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P; ... (2014). Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. New England journal of medicine NEJM, 371(2), pp. 107-118. Massachusetts Medical Society MMS 10.1056/NEJMoa1404037

Bohlius, J; Tonia, T; Nüesch, E; Jüni, P; Fey, M F; Egger, M; Bernhard, J (2014). Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. British journal of cancer, 111(1), pp. 33-45. Nature Publishing Group 10.1038/bjc.2014.171

Bernhard, Jürg; Dietrich, Daniel; Glimelius, Bengt; Bodoky, György; Scheithauer, Werner; Herrmann, Richard (2014). Clinical benefit response in pancreatic cancer trials revisited. Oncology research and treatment, 37(1-2), pp. 42-48. Karger 10.1159/000357965

Bernhard, J.; Aldridge, J.; Butow, P. N.; Zoller, P.; Brown, R.; Smith, A.; Juraskova, I. (2013). Patient–doctor agreement on recall of clinical trial discussion across cultures. Annals of oncology, 24(2), pp. 391-397. Oxford University Press 10.1093/annonc/mds288

Pesce, Gianfranco A; Klingbiel, Dirk; Ribi, Karin; Zouhair, Abderahim; von Moos, Roger; Schlaeppi, Marc; Caspar, Clemens B; Fischer, Natalie; Anchisi, Sandro; Peters, Solange; Cathomas, Richard; Bernhard, Jürg; Kotrubczik, Nina M; D'Addario, Giannicola; Pilop, Christiane; Weber, Damien C; Bodis, Stephan; Pless, Miklos; Mayer, Michael and Stupp, Roger (2012). Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). European journal of cancer, 48(3), pp. 377-84. Amsterdam: Elsevier 10.1016/j.ejca.2011.10.016

Ribi, K; Aldridge, J; Phillips, K-A; Thompson, A; Harvey, V; Thürlimann, B; Cardoso, F; Pagani, O; Coates, A S; Goldhirsch, A; Price, K N; Gelber, R D; Bernhard, J (2012). Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British journal of cancer, 106(10), pp. 1618-1625. Basingstoke: Nature Publishing Group 10.1038/bjc.2012.156

Brown, Richard; Butow, Phyllis; Wilson-Genderson, Maureen; Bernhard, Juerg; Ribi, Karin; Juraskova, Ilona (2012). Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes. Journal of clinical oncology, 30(8), pp. 857-62. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.37.7952

Bernhard, Jürg; Butow, Phyllis; Aldridge, Julie; Juraskova, Ilona; Ribi, Karin; Brown, Richard (2012). Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes? Psycho-oncology, 21(12), pp. 1265-1274. Malden, Mass.: Wiley-Blackwell 10.1002/pon.2044

Phillips, Kelly-Anne; Aldridge, Julie; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2011). Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, 126(1), pp. 221-6. Dordrecht: Springer US; http://www.springer-ny.com 10.1007/s10549-010-1235-y

Brown, Richard F; Butow, Phyllis N; Juraskova, Ilona; Ribi, Karin; Gerber, Daniela; Bernhard, Jurg; Tattersall, Martin H N (2011). Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations. Health expectations, 14(1), pp. 29-37. Oxford: Blackwell Publishing 10.1111/j.1369-7625.2010.00613.x

Smith, Allan; Juraskova, Ilona; Butow, Phyllis; Miguel, Caroline; Lopez, Anna-Lena; Chang, Sarah; Brown, Richard; Bernhard, Jurg (2011). Sharing vs. caring--the relative impact of sharing decisions versus managing emotions on patient outcomes. Patient education and counseling, 82(2), pp. 233-9. Shannon: Elsevier Ireland 10.1016/j.pec.2010.04.001

Phillips, Kelly-Anne; Ribi, Karin; Sun, Zhuoxin; Stephens, Alisa; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2010). Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast, 19(5), pp. 388-95. Amsterdam: Elsevier 10.1016/j.breast.2010.03.025

Münger-Beyeler, C; Bernhard, J; Rufibach, K; Morant, R; Schmid, H-P (2008). Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience. Supportive care in cancer, 16(5), pp. 461-467. Berlin: Springer-Verlag 10.1007/s00520-007-0335-7

Ribi, Karin; Bernhard, Jürg; Schuller, Jan C; Weder, Walter; Bodis, Stephan; Jörger, Markus; Betticher, Daniel; Schmid, Ralph A; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung cancer, 61(3), pp. 398-404. Amsterdam: Elsevier 10.1016/j.lungcan.2008.01.013

Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt; Bajetta, Emilio; Schüller, Johannes; Saletti, Piercarlo; Bauer, Jean; Figer, Arie; Pestalozzi, Bernhard C; Köhne, Claus-Henning; Mingrone, Walter; Stemmer, Salomon M; Tàmas, Karin; Kornek, Gabriela V; Koeberle, Dieter; Herrmann, Richard; ... (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, 26(22), pp. 3695-701. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.15.6240

Ribi, K; Bernhard, J; Rufibach, K; Thürlimann, B; von Moos, R; Ruhstaller, T; Glaus, A; Böhme, C (2007). Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Supportive care in cancer, 15(12), pp. 1349-56. Berlin: Springer 10.1007/s00520-007-0258-3

Weder, W; Stahel, RA; Bernhard, J; Bodis, S; Vogt, P; Ballabeni, P; Lardinois, D; Betticher, D; Schmid, R; Stupp, R; Ris, HB; Jermann, M; Mingrone, W; Roth, AD; Spiliopoulos, A; Swiss, Group for Clinical Cancer Research (2007). Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Annals of oncology, 18(7), pp. 1196-202. Oxford: Oxford University Press 10.1093/annonc/mdm093

Roth, AD; Fazio, N; Stupp, R; Falk, S; Bernhard, J; Saletti, P; Köberle, D; Borner, MM; Rufibach, K; Maibach, R; Wernli, M; Leslie, M; Glynne-Jones, R; Widmer, L; Seymour, M; de Braud, F; Swiss, Group for Clinical Cancer Research (2007). Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology, 25(22), pp. 3217-23. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.08.0135

Herrmann, R; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B; Köhne, CH; Mingrone, W; Stemmer, SM; Tàmas, K; Kornek, GV; Koeberle, D; Cina, S; Bernhard, J; Dietrich, D; Scheithauer, W; ... (2007). Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. Journal of clinical oncology, 25(16), pp. 2212-7. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.0886

Bernhard, Jürg (2007). Quality of life and quality-adjusted survival. British journal of cancer, pp. 40-50. Basingstoke: Nature Publishing Group

Rudenstam, CM; Zahrieh, D; Forbes, JF; Crivellari, D; Holmberg, SB; Rey, P; Dent, D; Campbell, I; Bernhard, J; Price, KN; Castiglione-Gertsch, M; Goldhirsch, A; Gelber, RD; Coates, AS; International, Breast Cancer Study Group (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. Journal of clinical oncology, 24(3), pp. 337-44. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.01.5784

Bernhard, J. (2005). Timing of quality of life assessment in cancer clinical trials: fine tuning remains a challenge. Annals of oncology, 16(4), pp. 523-524. Oxford University Press 10.1093/annonc/mdi135

Bernhard, Jürg; Lowy, Adam; Mathys, Natascha; Herrmann, Richard; Hürny, Christoph (2004). Health related quality of life: a changing construct? Quality of life research, 13(7), pp. 1187-97. Dordrecht: Springer 10.1023/B:QURE.0000037485.59681.7d

Sabbioni, Marzio E E; Bernhard, Jürg; Siegrist, Hans-Peter; Schmitz, Shu-Fang Hsu; Gertsch, Monica Castiglione; Thürlimann, Beat; Bonnefoi, Hervé; Perey, Lucien; Herrmann, Richard; Goldhirsch, Aron; Hürny, Christoph; Swiss Group for Clinical Cancer Research, (SAKK) (2004). Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy? Breast cancer research and treatment, 87(1), pp. 75-86. Dordrecht: Springer 10.1023/B:BREA.0000041584.53863.a7

Phillips, Kelly-Anne; Bernhard, Jürg (2003). Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute JNCI, 95(3), pp. 190-7. Cary, N.C.: Oxford University Press 10.1093/jnci/95.3.190

Schmid, Hans-Peter; Morant, Rudolf; Bernhard, Jürg; Maibach, Rudolf; Swiss Group for Clinical Cancer Research, (SAKK) (2003). Prostate specific antigen doubling time as auxiliary end point in hormone refractory prostatic carcinoma. European urology, 43(1), pp. 28-30. Amsterdam: Elsevier 10.1016/S0302-2838(02)00539-0

Berzigotti, Annalisa

D'Alitto, Felicia; Scherz, Amina; Margini, Cristina; von Tengg-Kobligk, Hendrik; Montani, Matteo; Pabst, Thomas; Berzigotti, Annalisa (2018). Portal Hypertension and a Stiff Liver. Cureus, 10(6), e2768. 10.7759/cureus.2768

Besançon, Hervé

Betticher, Daniel

Rothschild, Sacha I; Zippelius, Alfred; Eboulet, Eric I; Savic Prince, Spasenija; Betticher, Daniel; Bettini, Adrienne; Früh, Martin; Joerger, Markus; Lardinois, Didier; Gelpke, Hans; Mauti, Laetitia A; Britschgi, Christian; Weder, Walter; Peters, Solange; Mark, Michael; Cathomas, Richard; Ochsenbein, Adrian F; Janthur, Wolf-Dieter; Waibel, Christine; Mach, Nicolas; ... (2021). SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial. Journal of clinical oncology, 39(26), pp. 2872-2880. American Society of Clinical Oncology 10.1200/JCO.21.00276

Kamber, C; Zimmerli, Stefan; Suter, Franziska Marta; Müller, Beatrice Ursula; Mansouri Taleghani, Behrouz; Betticher, Daniel; Zander, T; Pabst, Thomas (2015). Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients. Bone marrow transplantation, 50(4), pp. 573-578. Nature Publishing Group 10.1038/bmt.2014.290

Gautschi, Oliver; Hugli, Barbara; Ziegler, Annemarie; Bigosch, Colette; Bowers, Naomi L; Ratschiller, Daniel; Jermann, Monika; Stahel, Rolf A; Heighway, Jim; Betticher, Daniel C (2006). Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung cancer, 51(3), pp. 303-11. Amsterdam: Elsevier 10.1016/j.lungcan.2005.10.025

Jermann, M.; Jost, L. M.; Taverna, Ch.; Jacky, E.; Honegger, H. P.; Betticher, D. C.; Egli, F.; Kroner, Th.; Stahel, R. A. (2004). Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Annals of oncology, 15(3), pp. 511-516. Oxford University Press 10.1093/annonc/mdh093

Rosell, R.; Gatzemeier, U.; Betticher, D. C.; Keppler, U.; Macha, H. N.; Pirker, R.; Berthet, P.; Breau, J. L.; Lianes, P.; Nicholson, M.; Ardizzoni, A.; Chemaissani, A.; Bogaerts, J.; Gallant, G. (2002). Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Annals of oncology, 13(10), pp. 1539-1549. Oxford University Press 10.1093/annonc/mdf332

Von Rohr, A.; Schmitz, S.-F. H.; Tichelli, A.; Hess, U.; Piguet, D.; Wernli, M.; Frickhofen, N.; Konwalinka, G.; Zulian, G.; Ghielmini, M.; Rufener, B.; Racine, C.; Fey, M. F.; Cerny, T.; Betticher, D.; Tobler, A. (2002). Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology, 13(10), pp. 1641-1649. Oxford University Press 10.1093/annonc/mdf272

Cerny, Thomas; Betticher, Daniel (2000). Non-Hodgkin's lymphoma: Role of high-dose therapy in diffuse large B-cell lymphoma. Annals of oncology, 11(suppl 3), pp. 117-121. Oxford University Press 10.1093/annonc/11.suppl_3.117

Pirnia, Farzaneh; Breuleux, Madlaina; Schneider, Erasmus; Hochmeister, Manfred; Bates, Susan E.; Marti, Andreas; Hotz, Michel A.; Betticher, Daniel C.; Borner, Markus M. (2000). Uncertain Identity of Doxorubicin-Resistant MCF-7 Cell Lines Expressing Mutated p53. Journal of the National Cancer Institute JNCI, 92(18), pp. 1535-1536. Oxford University Press 10.1093/jnci/92.18.1535

Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598

Betticher, Daniel C. (1996). Cyclin D1, another molecule of the year? Annals of oncology, 7(3), pp. 223-225. Oxford University Press 10.1093/oxfordjournals.annonc.a010563

Betticher, D. C.; Zucca, E.; Von Rohr, A.; Egger, T.; Radford, J. A.; Ambrosetti, A.; Bürki, K.; Rufener, B.; Hsu Schmitz, S. F.; Cerny, Thomas (1996). 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma. Annals of oncology, 7(8), pp. 793-799. Oxford University Press 10.1093/oxfordjournals.annonc.a010757

Beyeler, Morin

Beyer, Jörg

Bührer, Emanuel; D'Haese, David; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; Chovanec, Michal; ... (2024). Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium. European journal of cancer, 202(114042), p. 114042. Elsevier 10.1016/j.ejca.2024.114042

Helnwein, Simon; Hoch, Dennis; Beyer, Jörg (2024). [No Differences in Testis Cancer Outcomes between urban and rural regions in the Canton of Berne]. Praxis, 113(1), pp. 12-14. Hogrefe

Lauritsen, Jakob; Sauvé, Nicolas; Tryakin, Alexey; Jiang, Di Maria; Huddart, Robert; Heng, Daniel Y C; Terbuch, Angelika; Winquist, Eric; Chovanec, Michal; Hentrich, Marcus; Fankhauser, Christian D; Shamash, Jonathan; Del Muro, Xavier Garcia; Vaughn, David; Heidenreich, Axel; Sternberg, Cora N; Sweeney, Christopher; Necchi, Andrea; Bokemeyer, Carsten; Bandak, Mikkel; ... (2023). Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database. British journal of cancer, 129(11), pp. 1759-1765. Nature Publishing Group 10.1038/s41416-023-02443-3

Fankhauser, Christian D; Jandari, Abolghassem; Collette, Laurence; Tandstad, Torgrim; Jiang, Di Maria; De Giorgi, Ugo; Sweeney, Christopher; Terbuch, Angelika; Chovanec, Michal; Huddart, Robert; Bokemeyer, Carsten; Beyer, Jörg; Gillessen, Silke (2023). Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma. European urology open science, 56, pp. 25-28. Elsevier 10.1016/j.euros.2023.08.008

Templeton, Arnoud J; Omlin, Aurelius; Berthold, Dominik; Beyer, Jörg; Burger, Irene A; Eberli, Daniel; Engeler, Daniel; Fankhauser, Christian; Fischer, Stefanie; Gillessen, Silke; Nicolas, Guillaume; Kroeze, Stephanie; Lorch, Anja; Müntener, Michael; Papachristofilou, Alexandros; Schaefer, Niklaus; Seiler, Daniel; Stenner, Frank; Tsantoulis, Petros; Vlajnic, Tatjana; ... (2023). Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. Swiss medical weekly, 153, p. 40108. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40108

Akhoundova, Dilara; Beyer, Jörg (2023). Weitere Fortschritte bei Blasen- und Hodenkrebs (In Press). Leading Opinions. Hämatologie & Onkologie Universimed

Notarfrancesco, Marco; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Thalmann, George; Beyer, Jörg (2023). Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review. Swiss medical weekly, 153, p. 40053. SMW supporting association 10.57187/smw.2023.40053

Beyer, Jörg; Schlögi, Mathias (2023). Krebstherapie bei alten und hochbetagten Menschen. info@onco-suisse(3), pp. 9-12. Aerzteverlag medinfo AG

Hoch, Dennis; Helnwein, Simon; Adrizzone, Davide; Lorch, Anja; Fankhauser, Christian; Hermanns, Thomas; Thalmann, George; Beyer, Jörg (2023). No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas. Oncology research and treatment, 46(10), pp. 435-439. Karger 10.1159/000533505

Christiansen, Ailsa J; Lobo, João; Fankhauser, Christian D; Rothermundt, Christian; Cathomas, Richard; Batavia, Aashil A; Grogg, Josias B; Templeton, Arnoud J; Hirschi-Blickenstorfer, Anita; Lorch, Anja; Gillessen, Silke; Moch, Holger; Beyer, Jörg; Hermanns, Thomas (2022). Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. Frontiers in oncology, 12(1056823), p. 1056823. Frontiers Research Foundation 10.3389/fonc.2022.1056823

Grogg, Josias Bastian; Dursun, Zeynep Hafza; Beyer, Joerg; Eberli, Daniel; Poyet, Cedric; Hermanns, Thomas; Fankhauser, Christian Daniel (2022). Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases. World journal of urology, 40(9), pp. 2293-2303. Springer 10.1007/s00345-022-04048-6

Lobo, João; Rodrigues, Ângelo; Henrique, Rui; Christiansen, Ailsa; Beyer, Jörg; Moch, Holger; Bode, Peter Karl (2022). Morphological spectrum and molecular features of somatic malignant transformation in germ cell tumours. Histopathology, 81(1), pp. 84-98. Wiley 10.1111/his.14667

Pratsinis, Manolis; Fankhauser, Christian; Pratsinis, Katerina; Beyer, Jörg; Bührer, Emanuel; Cathomas, Richard; Fischer, Natalie; Hermanns, Thomas; Hirschi-Blickenstorfer, Anita; Kamradt, Jörn; Alex Kluth, Luis; Zihler, Deborah; Mingrone, Walter; Müller, Beat; Nestler, Tim; Rothschild, Sacha I; Seifert, Bettina; Templeton, Arnoud J; Terbuch, Angelika; Ufen, Mark-Peter; ... (2022). Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. European urology open science, 40, pp. 16-18. Elsevier 10.1016/j.euros.2022.03.013

Fankhauser, Christian D; Christiansen, Ailsa J; Rothermundt, Christian; Cathomas, Richard; Wettstein, Marian S; Grossmann, Nico C; Grogg, Josias B; Templeton, Arnoud J; Hirschi-Blickenstorfer, Anita; Lorch, Anja; Gillessen, Silke; Moch, Holger; Beyer, Joerg; Hermanns, Thomas (2022). Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. British journal of cancer, 126(8), pp. 1140-1144. Springer Nature 10.1038/s41416-021-01643-z

Radke, Alexander; Beyer, Jörg (2022). [Diagnosis and Therapy of Anal Carcinoma]. Praxis, 110(2), pp. 89-96. Hogrefe 10.1024/1661-8157/a003804

Fankhauser, Christian Daniel; Roth, Lisa; Kranzbühler, Benedikt; Eberli, Daniel; Bode, Peter; Moch, Holger; Oliveira, Pedro; Ramani, Vijay; Beyer, Joerg; Hermanns, Thomas (2021). The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis. European urology focus, 7(6), pp. 1400-1402. Elsevier 10.1016/j.euf.2020.06.019

Grogg, Josias Bastian; Fronzaroli, Jordi Nicola; Oliveira, Pedro; Bode, Peter-Karl; Lorch, Anja; Issa, Allaudin; Beyer, Joerg; Eberli, Daniel; Sangar, Vijay; Hermanns, Thomas; Clarke, Noel William; Fankhauser, Christian Daniel (2021). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. Journal of cancer research and clinical oncology, 147(9), pp. 2671-2679. Springer 10.1007/s00432-021-03533-6

Beyer, Jörg; Berthold, Dominik; Bode, Peter-Karl; Cathomas, Richard; Fankhauser, Christian D; Fischer, Stefanie; Gillessen, Silke; Gross, Tobias; Hermanns, Thomas; Honecker, Friedemann; Lorch, Anja; Omlin, Aurelius; Papachristofilou, Alexandros; Roth, Beat; Rothermundt, Christian; Seiler, Roland; Spahn, Martin; Stenner, Frank; Bührer, Emanuel (2021). Swiss germ-cell cancer consensus recommendations. Swiss medical weekly, 151(33-34) EMH Schweizerischer Ärzteverlag 10.4414/SMW.2021.w30023

Beyer, Jörg; Collette, Laurence; Sauvé, Nicolas; Daugaard, Gedske; Feldman, Darren R; Tandstad, Torgrim; Tryakin, Alexey; Stahl, Olof; Gonzalez-Billalabeitia, Enrique; De Giorgi, Ugo; Culine, Stéphane; de Wit, Ronald; Hansen, Aaron R; Bebek, Marko; Terbuch, Angelika; Albany, Costantine; Hentrich, Marcus; Gietema, Jourik A; Negaard, Helene; Huddart, Robert A; ... (2021). Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of clinical oncology, 39(14), pp. 1553-1562. American Society of Clinical Oncology 10.1200/JCO.20.03292

Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296

Gallo, Alessandra; Fankhauser, Christian; Hermanns, Thomas; Beyer, Jörg; Christiansen, Ailsa; Moch, Holger; Bode, Peter Karl (2020). HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors. Modern pathology, 33(11), pp. 2354-2360. Springer Nature 10.1038/s41379-020-0597-x

Grogg, Josias Bastian; Schneider, Kym; Bode, Peter-Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Joerg; Lorch, Anja; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data. Journal of cancer research and clinical oncology, 146(11), pp. 2829-2841. Springer 10.1007/s00432-020-03326-3

Grogg, Josias; Schneider, Kym; Bode, Peter Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Lorch, Anja; Beyer, Joerg; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients. The oncologist, 25(7), pp. 585-590. AlphaMed Press 10.1634/theoncologist.2019-0692

Fischer, Stefanie; Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Thibault, Constance; Vincenzi, Bruno; Klingbiel, Dirk; Albany, Costantine; Necchi, Andrea; Terbuch, Angelika; Lorch, Anja; Aparicio, Jorge; Heidenreich, Axel; Hentrich, Marcus; Wheater, Matthew; Langberg, Carl W; Ståhl, Olof; Fankhauser, Christian Daniel; Hamid, Anis A; Koutsoukos, Konstantinos; Shamash, Jonathan; ... (2020). Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. Journal of clinical oncology, 38(12), pp. 1322-1331. American Society of Clinical Oncology 10.1200/JCO.19.01876

Beyer, J. (2019). Prognostic factors in metastatic germ‐cell cancer. Andrology, 7(4), pp. 475-478. Wiley 10.1111/andr.12615

Fankhauser, Christian Daniel; Gerke, Travis A.; Roth, Lisa; Sander, Sophia; Grossmann, Nico Christian; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Jörg; Hermanns, Thomas (2019). Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment. Journal of cancer research and clinical oncology, 145(3), pp. 781-785. Springer 10.1007/s00432-019-02844-z

Oing, Christoph; Giannatempo, Patrizia; Honecker, Friedemann; Oechsle, Karin; Bokemeyer, Carsten; Beyer, Jörg (2018). Palliative treatment of germ cell cancer. Cancer treatment reviews, 71, pp. 102-107. Elsevier 10.1016/j.ctrv.2018.10.007

Cathomas, Richard; Klingbiel, Dirk; Bernard, Brandon; Lorch, Anja; Garcia Del Muro, Xavier; Morelli, Franco; De Giorgi, Ugo; Fedyanin, Mikhail; Oing, Christoph; Haugnes, Hege Sagstuen; Hentrich, Marcus; Fankhauser, Christian; Gillessen, Silke; Beyer, Jörg (2018). Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry. Journal of clinical oncology, 36(34), pp. 3381-3387. American Society of Clinical Oncology 10.1200/JCO.18.00210

Honecker, F; Aparicio, J; Berney, D; Beyer, Jörg; Bokemeyer, C; Cathomas, R; Clarke, N; Cohn-Cedermark, G; Daugaard, G; Dieckmann, K-P; Fizazi, K; Fosså, S; Germa-Lluch, J R; Giannatempo, P; Gietema, J A; Gillessen, Silke; Haugnes, H S; Heidenreich, A; Hemminki, K; Huddart, R; ... (2018). ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of oncology, 29(8), pp. 1658-1686. Oxford University Press 10.1093/annonc/mdy217

Sandmeier, Nadja; Rothschild, Sacha I; Rothermundt, Christian; Cathomas, Richard; Schardt, Julian; Berthold, Dominik; von Burg, Philippe; Müller, Beat; Beyer, Jörg; Vogt, Deborah R; Stenner, Frank (2018). Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in Switzerland. Clinical genitourinary cancer, 16(4), e711-e718. Elsevier 10.1016/j.clgc.2018.01.002

Gössi, Flavio; Spahn, Martin; Samaras, Panagiotis; Beyer, Jörg; Schardt, Julian; Pabst Müller, Thomas Niklaus (2018). Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients. Bone marrow transplantation, 53(7), pp. 820-825. Nature Publishing Group 10.1038/s41409-018-0089-5

Fankhauser, Christian Daniel; Sander, Sophia; Roth, Lisa; Gross, Oliver; Eberli, Daniel; Sulser, Tullio; Seifert, Burkhardt; Beyer, Jörg; Hermanns, Thomas (2018). Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. British journal of cancer, 118(6), pp. 825-830. Nature Publishing Group 10.1038/bjc.2017.467

Beyer, Jörg; Schrader, Mark (2018). Hodentumor: Medikamentöse Therapie bei refraktären Tumoren und Rezidiven. In: Michel, Maurice Stephan; Thüroff, Joachim W.; Janetschek, Günther; Wirth, Manfred (eds.) Die Urologie. Springer Reference Medizin (pp. 1-8). Springer 10.1007/978-3-642-41168-7_172-2

Nilius, Verena; Killer, Madeleine C; Timmesfeld, Nina; Schmitt, Melina; Moll, Roland; Lorch, Anja; Beyer, Jörg; Mack, Elisabeth; Lohoff, Michael; Burchert, Andreas; Neubauer, Andreas; Brendel, Cornelia (2018). High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion. Oncoimmunology, 7(5), e1423169. Taylor & Francis 10.1080/2162402X.2017.1423169

Fankhauser, C D; Sander, S; Roth, L; Beyer, Jörg; Hermanns, T (2018). Improved survival in metastatic germ-cell cancer. Annals of oncology, 29(2), pp. 347-351. Oxford University Press 10.1093/annonc/mdx741

Omlin, Aurelius Gabriel; Spahn*, Martin; Beyer, Jörg; Eberli, Daniel; Gillessen, Silke; Jochum, Wolfram; Kueng, Marc; Nitzsche, Egbert; Rentsch, Cyrill A.; Roggero, Enrico; Schmid, Hans-Peter; Stenner, Frank; Templeton, Arnoud J.; Wild, Damian; Wyler, Stephen; Zwahlen, Daniel; Cathomas, Richard (2018). [Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]. Praxis, 107(19), pp. 1043-1051. Hogrefe 10.1024/1661-8157/a003054

Beyoglu, Diren

Pabst, Thomas; Kortz, Linda; Fiedler, Georg Martin; Ceglarek, Uta; Idle, Jeffrey; Beyoglu, Diren (2017). The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA clinical, 7, pp. 105-114. Elsevier 10.1016/j.bbacli.2017.03.002

Bill, Anna Magdalena

Humbert, Magali; Federzoni, Elena; Britschgi, Adrian; Schläfli, Anna; Valk, PJ; Kaufmann, Thomas; Haferlach, T.; Behre, G.; Simon, Hans-Uwe; Torbett, BE; Fey, Martin; Tschan, Mario (2014). The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL. Journal of leukocyte biology, 95(1), pp. 83-93. Society for Leukocyte Biology 10.1189/jlb.1112608

Schläfli, Anna; Torbett, Bruce E.; Fey, Martin F.; Tschan, Mario P. (2012). BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation. Experimental hematology & oncology, 1(1), p. 25. London: Biomed Central 10.1186/2162-3619-1-25

Bill, Ruben

Bill, Ruben; Faquin, William C; Pai, Sara I (2023). Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations. Head and neck pathology, 17(4), pp. 969-975. Springer 10.1007/s12105-023-01590-6

Bill, Ruben; Wirapati, Pratyaksha; Messemaker, Marius; Roh, Whijae; Zitti, Beatrice; Duval, Florent; Kiss, Máté; Park, Jong Chul; Saal, Talia M; Hoelzl, Jan; Tarussio, David; Benedetti, Fabrizio; Tissot, Stéphanie; Kandalaft, Lana; Varrone, Marco; Ciriello, Giovanni; McKee, Thomas A; Monnier, Yan; Mermod, Maxime; Blaum, Emily M; ... (2023). CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science, 381(6657), pp. 515-524. American Association for the Advancement of Science 10.1126/science.ade2292

Fernandez-Rodriguez, Laura; Cianciaruso, Chiara; Bill, Ruben; Trefny, Marcel P; Klar, Richard; Kirchhammer, Nicole; Buchi, Mélanie; Festag, Julia; Michel, Sven; Kohler, Rainer H; Jones, Elham; Maaske, Andre; Kashyap, Abhishek S; Jaschinski, Frank; Dixon, Karen O; Pittet, Mikael J; Zippelius, Alfred (2023). Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for immunotherapy of cancer, 11(5) BioMed Central 10.1136/jitc-2023-006714

Gungabeesoon, Jeremy; Gort-Freitas, Nicolas A; Kiss, Máté; Bolli, Evangelia; Messemaker, Marius; Siwicki, Marie; Hicham, Mehdi; Bill, Ruben; Koch, Peter; Cianciaruso, Chiara; Duval, Florent; Pfirschke, Christina; Mazzola, Michael; Peters, Solange; Homicsko, Krisztian; Garris, Christopher; Weissleder, Ralph; Klein, Allon M; Pittet, Mikael J (2023). A neutrophil response linked to tumor control in immunotherapy. Cell, 186(7), pp. 1448-1464. Cell Press 10.1016/j.cell.2023.02.032

Wang, Chen; Barnoud, Coline; Cenerenti, Mara; Sun, Mengzhu; Caffa, Irene; Kizil, Burak; Bill, Ruben; Liu, Yuanlong; Pick, Robert; Garnier, Laure; Gkountidi, Olga A; Ince, Louise M; Holtkamp, Stephan; Fournier, Nadine; Michielin, Olivier; Speiser, Daniel E; Hugues, Stéphanie; Nencioni, Alessio; Pittet, Mikaël J; Jandus, Camilla; ... (2023). Dendritic cells direct circadian anti-tumor immune responses. Nature, 614(7946), pp. 136-143. Springer Nature 10.1038/s41586-022-05605-0

Bill, Ruben; Deschler, Daniel G; Pittet, Mikael J; Pai, Sara I; Sadow, Peter M; Park, Jong Chul (2022). Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands. Cancer reports, 5(3), e1491. Wiley 10.1002/cnr2.1491

Siwicki, Marie; Gort-Freitas, Nicolas A; Messemaker, Marius; Bill, Ruben; Gungabeesoon, Jeremy; Engblom, Camilla; Zilionis, Rapolas; Garris, Christopher; Gerhard, Genevieve M; Kohl, Anna; Lin, Yunkang; Zou, Angela E; Cianciaruso, Chiara; Bolli, Evangelia; Pfirschke, Christina; Lin, Yi-Jang; Piot, Cecile; Mindur, John E; Talele, Nilesh; Kohler, Rainer H; ... (2021). Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy. Science immunology, 6(61) American Association for the Advancement of Science 10.1126/sciimmunol.abi7083

Kashyap, Abhishek S; Schmittnaegel, Martina; Rigamonti, Nicolò; Pais-Ferreira, Daniela; Mueller, Philipp; Buchi, Melanie; Ooi, Chia-Huey; Kreuzaler, Matthias; Hirschmann, Petra; Guichard, Alan; Rieder, Natascha; Bill, Ruben; Herting, Frank; Kienast, Yvonne; Dirnhofer, Stefan; Klein, Christian; Hoves, Sabine; Ries, Carola H; Corse, Emily; De Palma, Michele; ... (2020). Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 117(1), pp. 541-551. National Academy of Sciences NAS 10.1073/pnas.1902145116

Bill, Ruben; Schardt, Julian (2019). [Immunotherapies - Overview, mode of action and clinical implications]. Therapeutische Umschau, 76(4), pp. 187-194. Hogrefe 10.1024/0040-5930/a001083

Lüönd, Fabiana; Bill, Ruben; Vettiger, Andrea; Oller, Heide; Pelczar, Pawel; Christofori, Gerhard (2019). A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models. Journal of mammary gland biology and neoplasia, 24(1), pp. 39-45. Springer 10.1007/s10911-018-9412-4

Tiede, Stefanie; Meyer-Schaller, Nathalie; Kalathur, Ravi Kiran Reddy; Ivanek, Robert; Fagiani, Ernesta; Schmassmann, Philip; Stillhard, Patrick; Häfliger, Simon; Kraut, Norbert; Schweifer, Norbert; Waizenegger, Irene C; Bill, Ruben; Christofori, Gerhard (2018). The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer. Oncogenesis, 7(9), p. 73. Springer Nature 10.1038/s41389-018-0083-1

Bill, Ruben; Montani, Matteo; Blum, Benedikt; Dufour, Jean-François; Escher, Robert; Bühlmann, Michael (2018). Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver. Hepatology, 68(1), pp. 384-386. Wiley Interscience 10.1002/hep.29853

Birner, Barbara

Blank, Annika

Kollár, Attila; Blank, Annika; Perren, Aurel; Bütikofer, Lukas; Stettler, Christoph; Christ, Emanuel (2016). Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry. Swiss medical weekly, 146, w14362. EMH Schweizerischer Ärzteverlag 10.4414/smw.2016.14362

Blarer, Jennifer

Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Wyatt, Alexander W; Gibb, Ewan A; Kruithof-de Julio, Marianna; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(11), pp. 826-836. Elsevier 10.1016/j.urolonc.2019.09.025

Genitsch, V.; Kollár, A.; Blarer, J.; Vandekerkhove, G.; Furrer, M.; Krentel, A.; Gibb, E.; Davicioni, E.; Wyatt, A.; Seiler, R. (15 March 2019). Molecular decoding of sarcomatoid variant of muscle-invasive bladder cancer might reveal treatment strategies. European Urology Supplements, 18(1), e1449-e1449. Elsevier 10.1016/S1569-9056(19)31044-9

Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J.; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Gibb, Ewan A.; Kruithof-de Julio, Marianna; Wyatt, Alexander W.; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(9), 573.e19-573.e29. Elsevier 10.1016/j.urolonc.2019.06.021

Blaser, Nicola Andrea

Blum-Halter, Veronika

Bocchi, Federica

Bocchi, F; Häfliger, S; Schmid, S; Sidler, D (2024). Immune checkpoint inhibitors and renal toxicity. Heliyon, 10(11) Elsevier 10.1016/j.heliyon.2024.e31911

Bodmer, Nils Sven

Naef, Pascal; Radpour, Ramin; Jaeger-Ruckstuhl, Carla A; Bodmer, Nils; Baerlocher, Gabriela M; Doehner, Hartmut; Doehner, Konstanze; Riether, Carsten; Ochsenbein, Adrian F (2023). IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Science signaling, 16(800), eadd7705. 10.1126/scisignal.add7705

Bohlius, Julia Friederike

Rohner, Eliane; Wyss, Natascha; Heg, Zina; Faralli, Zully; Mbulaiteye, Sam M; Novak, Urban; Zwahlen, Marcel; Egger, Matthias; Bohlius, Julia (2016). HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis. International journal of cancer, 138(1), pp. 45-54. Wiley-Blackwell 10.1002/ijc.29687

Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Mike J; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Napoli, Maryann; Rades, Dirk; Steensma, David; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane database of systematic reviews, 2009(3), CD007303. Chichester: WileyInterscience 10.1002/14651858.CD007303.pub2

Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Michael; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Rades, Dirk; Steensma, David P; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Machtay, Mitchell; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet, 373(9674), pp. 1532-42. London: Elsevier 10.1016/S0140-6736(09)60502-X

Bojaxhiu, Beat

Bonadies, Nicolas

Bonadies, Nicola; Pabst, Thomas; Mueller, Beatrice U (2010). Heterozygous deletion of the PU.1 locus in human AML. Blood, 115(2), pp. 331-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-03-212225

Bonadies, N; Neururer, Ch; Steege, A; Vallabhapurapu, S; Pabst, T; Mueller, B U (2010). PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element. Oncogene, 29(7), pp. 1062-72. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2009.371

Borner, Markus

Rothschild, Sacha I; Betticher, Daniel; Zenhäusern, Reinhard; Anchisi, Sandro; von Moos, Roger; Pless, Miklos; Moosmann, Peter; Popescu, Razvan A; Calderoni, Antonello; Dressler, Marco; Rauch, Daniel; Pederiva, Stefanie; Woelky, Regina; Papet, Claudia; Bühler, Vera; Borner, Markus (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer chemotherapy and pharmacology, 84(4), pp. 881-889. Springer 10.1007/s00280-019-03927-x

Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC cancer, 17(1), p. 265. BioMed Central 10.1186/s12885-017-3261-1

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies: A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Laboratory investigation, 93(S1), 148A. Nature Publishing Group

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Dawson, Heather; Hädrich, Marion; Kölzer, Viktor; Borner, Markus; Mallaev, M.; Schnüriger, Beat; Inderbitzin, Daniel; Zlobec, Inti; Lugli, Alessandro (2013). Intratumoral budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastasis in colon and rectal cancer patients. Pathologe, 34(6), p. 602. Springer-Medizin-Verlag

Karamitopoulou, Eva; Zlobec, Inti; Tornillo, Luigi; Carafa, Vincenza; Schaffner, Thomas; Brunner, Thomas; Borner, Markus; Diamantis, Ioannis; Zimmermann, Arthur; Terracciano, Luigi (2010). Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology, 42(3), pp. 229-34. London: Wolters Kluwer Lippincott Williams & Wilkins 10.3109/00313021003631379

Karamitopoulou, Eva; Pallante, Pierlorenzo; Zlobec, Inti; Tornillo, Luigi; Carafa, Vincenza; Schaffner, Thomas; Borner, Markus; Diamantis, Ioannis; Esposito, Francesco; Brunner, Thomas; Zimmermann, Arthur; Federico, Antonella; Terracciano, Luigi; Fusco, Alfredo (2010). Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. European journal of cancer, 46(8), pp. 1438-44. Amsterdam: Elsevier 10.1016/j.ejca.2010.01.033

Dufour, Jean-François; Hoppe, Hanno; Heim, Markus H; Helbling, Beat; Maurhofer, Olivier; Szucs-Farkas, Zsolt; Kickuth, Ralph; Borner, Markus; Candinas, Daniel; Saar, Bettina (2010). Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. Oncologist, 15(11), pp. 1198-204. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2010-0180

Ruhstaller, Thomas; Templeton, Arnoud; Ribi, Karin; Schuller, Jan C; Borner, Markus; Thierstein, Sandra; von Moos, Roger; Pederiva, Stefanie; Lohri, Andreas; Lombriser, Norbert; von Briel, Christian; Koeberle, Dieter; Popescu, Razvan (2010). Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie, 33(5), pp. 222-8. Basel: Karger 10.1159/000305094

Koeberle, Dieter; Montemurro, Michael; Samaras, Panagiotis; Majno, Pietro; Simcock, Mathew; Limacher, Andreas; Lerch, Stefanie; Kovàcs, Katalin; Inauen, Roman; Hess, Vivianne; Saletti, Piercarlo; Borner, Markus; Roth, Arnaud; Bodoky, György (2010). Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). Oncologist, 15(3), pp. 285-92. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2009-0316

Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; Balmermajno, S; Köberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology, 20(9), pp. 1522-8. Oxford: Oxford University Press 10.1093/annonc/mdp045

Cmelak, Anthony J; Lordick, Florian; Borner, Markus; Goldberg, Richard M; Saif, M Wasif (2009). Management of infusion reactions in clinical trials and beyond: the US and EU perspectives. Oncology, 23(2 Suppl 1), pp. 18-25. Norwalk, Conn.: UBM Medica

Ribi, Karin; Koeberle, Dieter; Schuller, Jan C; Honegger, Hanspeter; Roth, Arnaud; Hess, Viviane; Moosmann, Peter; von Moos, Roger; Borner, Markus; Lombriser, Norbert; Pestalozzi, Bernhard; Ruhstaller, Thomas (2009). Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer, 17(8), pp. 1109-1116. Berlin: Springer 10.1007/s00520-008-0570-6

Karamitopoulou, Eva; Tornillo, Luigi; Zlobec, Inti; Cioccari, Lukas; Carafa, Vincenza; Borner, Markus; Schaffner, Thomas; Brunner, Thomas; Diamantis, Ioannis; Zimmermann, Arthur; Terracciano, Luigi (2008). Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. American journal of clinical pathology, 130(5), pp. 780-6. Chicago, Ill.: American Society for Clinical Pathology 10.1309/AJCP35FDCAVANWMM

Borner, M; Koeberle, D; Von Moos, R; Saletti, P; Rauch, D; Hess, V; Trojan, A; Helbling, D; Pestalozzi, B; Caspar, C; Ruhstaller, T; Roth, A; Kappeler, A; Dietrich, D; Lanz, D; Mingrone, W (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, 19(7), pp. 1288-92. Oxford: Oxford University Press 10.1093/annonc/mdn058

Wagner, Oliver J; Inglin, Roman A; Bisch-Knaden, Sonja; Mettler, Daniel; Borner, Markus; Candinas, Daniel; Egger, Bernhard (2008). Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses. Transplant international, 21(6), pp. 554-63. Oxford: Wiley-Blackwell 10.1111/j.1432-2277.2007.00635.x

Koeberle, Dieter; Saletti, Piercarlo; Borner, Markus; Gerber, Daniela; Dietrich, Daniel; Caspar, Clemens B; Mingrone, Walter; Beretta, Kurt; Strasser, Florian; Ruhstaller, Thomas; Mora, Oreste; Herrmann, Richard (2008). Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology, 26(22), pp. 3702-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.16.5704

Sternberg, Cora N; Krainer, Michael; Oh, William K; Bracarda, Sergio; Bellmunt, Joaquim; Ozen, Haluk; Zlotta, Alexandre; Beer, Tomasz M; Oudard, Stephane; Rauchenwald, Michael; Skoneczna, Iwona; Borner, Markus M; Fitzpatrick, John M (2007). The medical management of prostate cancer: a multidisciplinary team approach. BJU international, 99(1), pp. 22-7. Oxford: Blackwell Science 10.1111/j.1464-410X.2006.06477.x

Salzberg, Marc; Rochlitz, Christoph; Morant, Rudolf; Thalmann, George; Pedrazzini, Augusto; Roggero, Enrico; Schönenberger, Astrid; Knuth, Alexander; Borner, Markus (2007). An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer. Onkologie, 30(7), pp. 355-60. Basel: Karger 10.1159/000102452

Helbling, D; Borner, M (2007). Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab. Annals of oncology, 18(5), pp. 963-4. Oxford: Oxford University Press 10.1093/annonc/mdm130

Tscharner, Gion Gudench; Bühler, Sabine; Borner, Markus; Hunziker, Thomas (2006). Grover's disease induced by cetuximab. Dermatology, 213(1), pp. 37-9. Basel: Karger 10.1159/000092836

Pirnia, Farzaneh; Frese, Steffen; Gloor, Beat; Hotz, Michel A; Luethi, Alexander; Gugger, Mathias; Betticher, Daniel C; Borner, Markus M (2006). Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples. Anticancer research, 26(3A), pp. 1765-72. Kapandriti: International Inst. of Anticancer Research

Borner, M M (2006). [Molecular targets in colon cancer]. Therapeutische Umschau, 63(4), pp. 243-8. Bern: Huber 10.1024/0040-5930.63.4.243

Salzberg, Marc; Borner, Markus; Bauer, Jean-Alexandre; Morant, Rudolf; Rauch, Daniel; Rochlitz, Christoph (2006). Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. European journal of cancer, 42(15), pp. 2660-1. Amsterdam: Elsevier 10.1016/j.ejca.2006.06.009

Roth, A. D.; Maibach, R.; Fazio, N.; Sessa, C.; Stupp, R.; Morant, R.; Herrmann, R.; Borner, M. M.; Goldhirsch, A.; De Braud, F. (2004). 5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere®)–cisplatin in advanced gastric carcinoma: a phase I–II trial. Annals of oncology, 15(5), pp. 759-764. Oxford University Press 10.1093/annonc/mdh187

Waeber, M.; Castiglione-Gertsch, M.; Dietrich, D.; Thürlimann, B.; Goldhirsch, A.; Brunner, K. W.; Borner, M. M. (2003). Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Annals of oncology, 14(8), pp. 1215-1221. Oxford University Press 10.1093/annonc/mdg347

Scheithauer, W.; Mckendrick, J.; Begbie, S.; Borner, M.; Burns, W. I.; Burris, H. A.; Cassidy, J.; Jodrell, D.; Koralewski, P.; Levine, E. L.; Marschner, N.; Maroun, J.; Garcia-Alfonso, P.; Tujakowski, J.; Van Hazel, G.; Wong, A.; Zaluski, J.; Twelves, C. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of oncology, 14(12), pp. 1735-1743. Oxford University Press 10.1093/annonc/mdg500

Scholz, M.; Zehender, M.; Thalmann, G. N.; Borner, M.; Thöni, H.; Studer, U. E. (2002). Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Annals of oncology, 13(1), pp. 121-124. Oxford University Press 10.1093/annonc/mdf003

Pirnia, Farzaneh; Borner, Markus M. (2002). RESPONSE: Multidrug-Resistant MCF-7 Cells: An Identity Crisis? Journal of the National Cancer Institute JNCI, 94(21), p. 1654. Oxford University Press 10.1093/jnci/94.21.1654

Crivellari, D.; Pagani, O.; Veronesi, A.; Lombardi, D.; Nolè, F.; Thürlimann, B.; Hess, D.; Borner, M.; Bauer, J.; Martinelli, G.; Graffeo, R.; Sessa, C.; Goldhirsch, A. (2001). High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Annals of oncology, 12(3), pp. 353-356. Oxford University Press 10.1023/A:1011132609055

Pagani, O.; Sessa, C.; Nolè, F.; Crivellari, D.; Lombardi, D.; Thürlimann, B.; Hess, D.; Borner, M.; Bauer, J.; Martinelli, G.; Graffeo, R.; Zucchetti, M.; D'Incalci, M.; Goldhirsch, A. (2000). Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study. Annals of oncology, 11(8), pp. 985-991. Oxford University Press 10.1023/A:1008392927656

Roth, A. D.; Maibach, R.; Martinelli, G.; Fazio, N.; Aapro, M. S.; Pagani, O.; Morant, R.; Borner, M. M.; Herrmann, R.; Honegger, H.; Cavalli, F.; Alberto, P.; Castiglione, M.; Goldhirsch, A. (2000). Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma. Annals of oncology, 11(3), pp. 301-306. Oxford University Press 10.1023/A:1008342013224

Pagani, O.; Sessa, C.; Martinelli, G.; Crivellari, D.; Buonadonna, A.; Thürlimann, B.; Hess, D.; Borner, M.; Bauer, J.; Zampino, G.; Zimatore, M.; Graffeo, R.; Riva, A.; Goldhirsch, A. (1999). Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer. Annals of oncology, 10(5), pp. 539-545. Oxford University Press 10.1023/A:1026437731354

Borner, M. M. (1999). Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true? Annals of oncology, 10(6), pp. 623-626. Oxford University Press 10.1023/A:1008353227103

Sessa, C.; Minoia, C.; Ronchi, A.; Zucchetti, M.; Bauer, J.; Borner, M.; De Jong, J.; Pagani, O.; Renard, J.; Weil, C.; D'Lncalci, M. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of oncology, 9(12), pp. 1315-1322. Oxford University Press 10.1023/A:1008441416790

Borner, M. M.; Castiglione, M.; Bacchi, M.; Weber, Walter; Herrmann, R.; Fey, M. F.; Pagani, O.; Leyvraz, S.; Morant, R.; Pestalozzi, B.; Hanselmann, S.; Goldhirsch, A. (1998). The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial. Annals of oncology, 9(5), pp. 535-541. Oxford University Press 10.1023/A:1008270916325

Maurer, Christoph A.; Borner, Markus M.; Läuffer, Jörg; Friess, Helmut; Z'Graggen, Kaspar; Triller, Jürgen; Büchler, Markus W. (1998). Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer. International journal of pancreatology, 23(3), pp. 181-186. Humana Press 10.1007/BF02788395

Boronylo, Anna

Bosch Guiteras, Nuria

Bosch-Guiteras, Núria; Uroda, Tina; Guillen-Ramirez, Hugo A.; Riedo, Rahel; Gazdhar, Amiq; Esposito, Roberta; Pulido-Quetglas, Carlos; Zimmer, Yitzhak; Medová, Michaela; Johnson, Rory (2021). Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs. Genome research, 31(3), pp. 461-471. Cold Spring Harbor, N.Y 10.1101/gr.265736.120

Bovet, Cédric

Liu, He; He, Zhaoyue; Germič, Nina; Ademi, Hyrijie; Frangež, Živa; Felser, Andrea; Peng, Shuang; Riether, Carsten; Djonov, Valentin; Nuoffer, Jean-Marc; Bovet, Cédric; Mlinarič-Raščan, Irena; Zlobec, Inti; Fiedler, Georg; Perren, Aurel; Simon, Hans-Uwe (2020). ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics. Cell death and differentiation, 27(6), pp. 1965-1980. Springer Nature 10.1038/s41418-019-0476-5

Rindlisbacher, Barbara; Strebel, Carina; Guler, Sabina; Kollár, Attila; Geiser, Thomas; Fiedler, Georg Martin; Leichtle, Alexander Benedikt; Bovet, Cédric; Funke-Chambour, Manuela (2017). Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis - a pilot study. Journal of breath research, 12(1), 016003. IOP Science 10.1088/1752-7163/aa840a

Bracher, Lisa Maria

Bracher, Lisamaria; Ferro, Iolanda; Pulido-Quetglas, Carlos; Ruepp, Marc-David; Johnson, Rory; Polacek, Norbert (2020). Human vtRNA1-1 Levels Modulate Signaling Pathways and Regulate Apoptosis in Human Cancer Cells. Biomolecules, 10(4), p. 614. MDPI 10.3390/biom10040614

Branca, Mattia

Brasseit, Jennifer

Bratschi, Irina Claudia

Weidlinger, Susanna; Graber, Satu; Bratschi, Irina; Pape, Janna; Kollár, Attila; Karrer, Tanya; von Wolff, Michael (2024). A Systematic Review of the Gonadotoxicity of Osteosarcoma and Ewing's Sarcoma Chemotherapies in Postpubertal Females and Males. Journal of Adolescent and Young Adult Oncology, 13(4), pp. 597-606. Mary Ann Liebert 10.1089/jayao.2023.0185

Braun, Christian Tasso

Stähli Klenk, Laurence; Iucolano, Nicoletta Milena; Braun, Christian Tasso; Exadaktylos, Aristomenis; Eychmüller, Steffen (2014). [Emergency department as final destination: perception and reception of the palliative patient" concept as well as approach toward improving interdisciplinary collaboration - a survey of emergency personnel of a Swiss emergency department]. Praxis - schweizerische Rundschau für Medizin, 104(1), pp. 19-25. Huber 10.1024/1661-8157/a001884

Bregy, Rachel

Brem, Beate

Felber, Sibylle J.; Zambrano, Sofia C.; Guffi, Tommaso; Schmitz, Felix M.; Brem, Beate G.; Schnabel, Kai P.; Guttormsen, Sissel; Eychmüller, Steffen (2024). How to talk about dying? The development of an evidence-based model for communication with patients in their last days of life and their family caregivers. PEC innovation, 5, p. 100309. Elsevier 10.1016/j.pecinn.2024.100309

Felber, Sibylle J; Guffi, Tommaso; Brem, Beate G; Schmitz, Felix M; Schnabel, Kai P; Guttormsen Schär, Sissel; Eychmüller, Steffen; Zambrano, Sofia C (2023). Talking about dying and death: Essentials of communicating about approaching death from the perspective of major stakeholders. (In Press). Palliative & Supportive Care, pp. 1-10. Cambridge University Press 10.1017/S1478951523001621

Guffi, Tommaso; Brem, Beate; Felber, Sibylle Jeanine; Schmitz, Felix M.; Schnabel, Kai P.; Guttormsen Schär, Sissel; Eychmüller, Steffen; Zambrano, Sofia C. (April 2023). Identifying the essentials of communicating about imminent death from key stakeholders' perspectives. Patent education and counseling, 109(Supplement), p. 13. Elsevier 10.1016/j.pec.2022.10.039

Schmitz, Felix Michael; Felber, Sibylle Jeanine; Buzzi, Ann-Lea; Schnabel, Kai Philipp; Eychmüller, Steffen; Brem, Beate; Zambrano, Sofia; Guttormsen, Sissel (16 September 2022). Über das Sterben sprechen: Zur Wirksamkeit eines Blended-Learning-Angebots für den deutschsprachigen Raum. In: Gemeinsame Jahrestagung der Gesellschaft für Medizinische Ausbildung (GMA) und des Arbeitskreises zur Weiterentwicklung der Lehre in der Zahnmedizin (AKWLZ). Düsseldorf: German Medical Science GMS Publishing House 10.3205/22gma076

Felber, Sibylle Jeanine; Guffi, Tommaso; Brem, Beate; Schmitz, Felix Michael; Schnabel, Kai; Guttormsen, Sissel (7 September 2022). Identifying the essentials of communicating about imminent death from key stakeholders’ perspectives (Unpublished). In: International Conference on Communication in Healthcare 2022. Glasgow. 05.09.-09.09.2022.

Felber, Sibylle J.; Guffi, Tommaso; Brem, Beate; Schmitz, Felix M.; Schnabel, Kai; Guttormsen Schär, Sissel; Eychmüller, Steffen; Zambrano, Sofia C. (September 2021). Über’s Sterben sprechen: Das Wesentliche der Kommunikation über den nahenden Tod aus unterschiedlichen Perspektiven. In: Jahrestagung der Gesellschaft für Medizinische Ausbildung (GMA). Düsseldorf: German Medical Science GMS Publishing House 10.3205/21gma077

Brenneisen, Rudolf Max

Brigger, Daniel

Brigger, Daniel; Riether, Carsten; van Brummelen, Robin; Mosher, Kira I; Shiu, Alicia; Ding, Zhaoqing; Zbären, Noemi; Gasser, Pascal; Guntern, Pascal; Yousef, Hanadie; Castellano, Joseph M; Storni, Federico; Graff-Radford, Neill; Britschgi, Markus; Grandgirard, Denis; Hinterbrandner, Magdalena; Siegrist, Mark; Moullan, Norman; Hofstetter, Wilhelm; Leib, Stephen L.; ... (2020). Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age. Nature metabolism, 2(8), pp. 688-702. Springer Nature 10.1038/s42255-020-0228-3

Haimovici, Aladin; Brigger, Daniel; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2014). Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation. Leukemia research, 38(9), pp. 1041-1047. Elsevier 10.1016/j.leukres.2014.06.010

Britschgi, Adrian

Britschgi, A; Trinh, E; Rizzi, M; Jenal, M; Ress, A; Tobler, A; Fey, M F; Helin, K; Tschan, M P (2008). DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function. Oncogene, 27(43), pp. 5706-16. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2008.179

Britschgi, Christian

Jenal, Mathias; Britschgi, Christian; Fey, Martin F; Tschan, Mario P (2010). Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation? Swiss medical weekly, 140, w13106. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13106

Jenal, Mathias; Trinh, Emmanuelle; Britschgi, Christian; Britschgi, Adrian; Roh, Vincent; Vorburger, Stephan A; Tobler, Andreas; Leprince, Dominique; Fey, Martin F; Helin, Kristian; Tschan, Mario P (2009). The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Molecular cancer research, 7(6), pp. 916-22. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1541-7786.MCR-08-0359

Britschgi, Christian; Fey, Martin F (2009). Tumor suppressor genes in myeloid differentiation and leukemogenesis. Future oncology, 5(2), pp. 245-57. London: Future Medicine Ltd. 10.2217/14796694.5.2.245

Brodie, Tess Melinda

Bruggmann, Rémy

Deng, Haibin; Gao, Yanyun; Trappetti, Verdiana; Hertig, Damian; Karatkevich, Darya; Losmanová, Tereza; Urzì, Christian; Ge, Huixiang; Geest, Gerrit Adriaan; Bruggmann, Remy; Djonov, Valentin; Nuoffer, Jean-Marc; Vermathen, Peter; Zamboni, Nicola; Riether, Carsten; Ochsenbein, Adrian; Peng, Ren-Wang; Kocher, Gregor Jan; Schmid, Ralph; Dorn, Patrick; ... (2022). Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage. Cellular and molecular life sciences, 79(8), p. 445. SP Birkhäuser Verlag Basel 10.1007/s00018-022-04453-5

Radpour, Ramin; Riether, Carsten; Simillion, Cedric; Höpner, Sabine; Bruggmann, Rémy; Ochsenbein, Adrian (2019). CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia. Leukemia, 33(10), pp. 2379-2392. Nature Publishing Group 10.1038/s41375-019-0441-9

Brunner, Kurt

Joss, Rudolph A.; Richner, Jürg; Brunner, Kurt W.; Rohrbach, Daniela; Pirovino, Mauro; Terrey, Jean-Pierre; Upward, James (1988). BRL 43694: A Novel Antiemetic to Prevent Nausea and Vomiting Induced by Chemotherapy. Journal of the National Cancer Institute JNCI, 80(16), pp. 1340-1341. Oxford University Press 10.1093/jnci/80.16.1340

Brunner, Thomas

Bräutigam, Konstantin

Bräutigam, Konstantin; Rodríguez-Calero, Antonio; Kim-Fuchs, Corina; Kollár, Attila; Trepp, Roman; Marinoni, Ilaria; Perren, Aurel (2021). Update on Histological Reporting Changes in Neuroendocrine Neoplasms. Current Oncology Reports, 23(6), p. 65. Springer 10.1007/s11912-021-01062-6

Brömme, Jens

Brönnimann, Paulina

Brügger, Lukas

Brügger, Yvo Andreas

Brühl, Frido

Ruzgys, Paulius; Böhringer, Stephan; Dokumaci, Ayse Sila; Hari, Yvonne; Schürch, Christian M; Brühl, Frido; Schürch, Stefan; Szidat, Sönke; Riether, Carsten; Šatkauskas, Saulius; Geiser, Thomas; Hradetzky, David; Gazdhar, Amiq (2021). Electrospray Mediated Localized and Targeted Chemotherapy in a Mouse Model of Lung Cancer. Frontiers in Pharmacology, 12, p. 643492. Frontiers 10.3389/fphar.2021.643492

Buetti, Niccolò Ivo Marco-Aurelio

Buffle, Eric Jacques

Burkhard, Fiona Christine

Ghadjar, Pirus; Burkhard, Fiona C; Gautschi, Oliver; Thalmann, George N; Studer, Urs E (2011). Induction chemotherapy for unresectable urothelial carcinoma of the bladder. BJU international, 107(6), pp. 894-7. Oxford: Blackwell Science 10.1111/j.1464-410X.2010.09574.x

Burkhard, Regula

Burkhard, Regula; Bhagat, Govind; Cogliatti, Sergio B; Rossi, Davide; Gaidano, Gianluca; Pasqualucci, Laura; Novak, Urban (2014). BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. Hematological oncology, 33(1), pp. 23-30. Wiley 10.1002/hon.2132

Burmeister, Henning

Burren, Sandra

Buzzi, Ann-Lea

Bächli, Melanie

Bärlocher, Gabriela Maria

Hinterbrandner, Magdalena; Rubino, Viviana; Stoll, Carina; Forster, Stefan; Schnüriger, Noah Samuel; Radpour, Ramin; Bärlocher, Gabriela M.; Ochsenbein, Adrian F.; Riether, Carsten (2021). Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells. JCI insight, 6(23) JCI Insight 10.1172/jci.insight.151797

Höpner, S. S.; Raykova, Ana; Radpour, R.; Amrein, M. A.; Koller, D.; Bärlocher, G. M.; Riether, C.; Ochsenbein, A. F. (2021). LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells. Nature Communications, 12(1), p. 1065. Springer Nature 10.1038/s41467-021-21317-x

Böhm, Ingrid

Schmid, Adrian A; Hungerbühler, Martin N; Lombardo, Paolo; Boehm, Ingrid B (2024). Intradermal testing of iodinated contrast media: Should we test up to pure or with diluted compounds only? Fundamental & clinical pharmacology, 38(4), pp. 789-798. Blackwell Science 10.1111/fcp.12998

Büchi, Annina Elisabeth

Büchi, Isabel

Büchler, Markus Wolfgang

Bücke, Philipp Jonas

Bühler, Sabine

Tscharner, Gion Gudench; Bühler, Sabine; Borner, Markus; Hunziker, Thomas (2006). Grover's disease induced by cetuximab. Dermatology, 213(1), pp. 37-9. Basel: Karger 10.1159/000092836

Bühlmann, Michael

Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054

Bührer, Elias

Riether, Carsten; Schürch, Christian M.; Bührer, Elias D.; Hinterbrandner, Magdalena; Huguenin, Anne-Laure; Höpner, Sabine; Zlobec, Inti; Pabst, Thomas; Radpour, Ramin; Ochsenbein, Adrian F. (2017). CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. The Journal of experimental medicine, 214(2), pp. 359-380. Rockefeller Univ. Press 10.1084/jem.20152008

Bührer, Emanuel

Bükki, Johannes

Bükki, Johannes; Stanga, Zeno; Buitrago Tellez, Firouzeh; Duclos, Kathleen; Kolev, Mirjam; Krähenmann, Peter; Pabst, Thomas; Iff, Samuel; Jüni, Peter (2013). Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 65(6), pp. 834-842. Routledge 10.1080/01635581.2013.801998

Bürger, Alexandra

Mueller, B U; Buerger, A U; Solenthaler, M; Garamvoelgyi, E M; Oppliger-Leibundgut, E; Fey, M F; Pabst, T (2006). Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology, 17(4), pp. 722-3. Oxford: Oxford University Press 10.1093/annonc/mdj062

Bürgi, Ulrich

Mueller, Beatrice U; Pabst, Thomas; Fos, José; Petkovic, Vibor; Fey, Martin F; Asou, Norio; Buergi, Ulrich; Tenen, Daniel G (2006). ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood, 107(8), pp. 3330-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2005-07-3068

Bürgin, Damian Timo

Bürki, Kurt

Bürki, Susanne

Bürki, S; Novak, U (2020). Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction. Annals of Hematology & Oncology, 7(3) Austin Publishing Group

Bütikofer, Lukas

Walter, Martin A; Nesti, C; Spanjol, Marko; Kollár, A; Bütikofer, L; Gloy, Viktoria L; Dumont, Rebecca A; Seiler, Christian A; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Kaderli, Reto M (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane database of systematic reviews, 11(11), CD013700. WileyInterscience 10.1002/14651858.CD013700.pub2

Walter, Martin A; Spanjol, Marko; Kollár, Attila; Bütikofer, Lukas; Gloy, Viktoria L; Dumont, Rebecca A; Seiler, Christian A.; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Kaderli, Reto M (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis [protocol]. Cochrane database of systematic reviews, 8, CD013700. WileyInterscience 10.1002/14651858.CD013700

Kollár, Attila; Bütikofer, Lukas; Ochsenbein, Adrian; Stettler, Christoph; Trepp, Roman (2020). Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry. Swiss medical weekly, 150, w20176. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20176

Hagemann, Monika; Zambrano Ramos, Sofia Carolina; Bütikofer, Lukas; Bergmann, Antje; Voigt, Karen; Eychmüller, Steffen (2020). Which Cost Components Influence the Cost of Palliative Care in the Last Hospitalization? A Retrospective Analysis of Palliative Care vs. Usual Care at a Swiss University Hospital. Journal of pain and symptom management, 59(1), 20-29.e9. Elsevier 10.1016/j.jpainsymman.2019.08.026

Kaderli, Reto Martin; Spanjol, Marko; Kollár, Attila; Bütikofer, Lukas; Gloy, Viktoria; Dumont, Rebecca A; Seiler, Christian A.; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Walter, Martin A (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA oncology, 5(4), pp. 480-489. American Medical Association 10.1001/jamaoncol.2018.6720

Cabral de Miranda, Gustavo

Calzavarini, Sara

Candinas, Daniel

Richani, Mandy; Kolly, Philippe; Knoepfli, Marina; Herrmann, Evelyn; Zweifel, Martin; von Tengg-Kobligk, Hendrik; Candinas, Daniel; Dufour, Jean-François (2016). Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm. Annals of hepatology, 15(1), pp. 82-90. Sociedad Mexicana de Hepatologia

Laemmle, Alexander; Lechleiter, Antje; Roh, Vincent; Schwarz, Christa; Portmann, Simone; Furer, Cynthia; Keogh, Adrian; Tschan, Mario P; Candinas, Daniel; Vorburger, Stephan A; Stroka, Deborah (2012). Inhibition of SIRT1 Impairs the Accumulation and Transcriptional Activity of HIF-1α Protein under Hypoxic Conditions. PLoS ONE, 7(3), e33433. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0033433

Carlevaro Fita, Joana

Rheinbay, Esther; Nielsen, Morten Muhlig; Abascal, Federico; Wala, Jeremiah A; Shapira, Ofer; Tiao, Grace; Hornshøj, Henrik; Hess, Julian M; Juul, Randi Istrup; Lin, Ziao; Feuerbach, Lars; Sabarinathan, Radhakrishnan; Madsen, Tobias; Kim, Jaegil; Mularoni, Loris; Shuai, Shimin; Lanzos, Andrés; Herrmann, Carl; Maruvka, Yosef E; Shen, Ciyue; ... (2023). Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 614(7948), E40. Springer Nature 10.1038/s41586-022-05599-9

Carlevaro-Fita, Joana; Lanzós, Andrés; Feuerbach, Lars; Hong, Chen; Mas-Ponte, David; Pedersen, Jakob Skou; Johnson, Rory (2022). Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Communications biology, 5(1), p. 1347. Springer Nature 10.1038/s42003-022-03769-z

Carlevaro Fita, Joana; Lanzós, Andrés; Feuerbach, Lars; Hong, Chen; Mas-Ponte, David; Pedersen, Jakob Skou; Johnson, Rory (2020). Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Communications biology, 3(1), p. 56. Springer Nature 10.1038/s42003-019-0741-7

Rheinbay, Esther; Nielsen, Morten Muhlig; Abascal, Federico; Wala, Jeremiah A; Shapira, Ofer; Tiao, Grace; Hornshøj, Henrik; Hess, Julian M; Juul, Randi Istrup; Lin, Ziao; Feuerbach, Lars; Sabarinathan, Radhakrishnan; Madsen, Tobias; Kim, Jaegil; Mularoni, Loris; Shuai, Shimin; Lanzos, Andrés; Herrmann, Carl; Maruvka, Yosef E; Shen, Ciyue; ... (2020). Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 578(7793), pp. 102-111. Springer Nature 10.1038/s41586-020-1965-x

Carlevaro-Fita, Joana; Liu, Leibo; Zhou, Yuan; Zhang, Shan; Chouvardas, Panagiotis; Johnson, Rory; Li, Jianwei (2019). LnCompare: gene set feature analysis for human long non-coding RNAs. Nucleic acids research, 47(W1), W523-W529. Oxford University Press 10.1093/nar/gkz410

Carlevaro-Fita, Joana; Johnson, Rory (2019). Global Positioning System: Understanding Long Noncoding RNAs through Subcellular Localization. Molecular cell, 73(5), pp. 869-883. Cell Press 10.1016/j.molcel.2019.02.008

Carlevaro-Fita, Joana; Polidori, Taisia; Das, Monalisa; Navarro, Carmen; Zoller, Tatjana I.; Johnson, Rory (2019). Ancient exapted transposable elements promote nuclear enrichment of human long noncoding RNAs. Genome research, 29(2), pp. 208-222. Cold Spring Harbor, N.Y 10.1101/gr.229922.117

Mas-Ponte, David; Carlevaro Fita, Joana; Palumbo, Emilio; Hermoso Pulido, Toni; Guigo, Roderic; Johnson, Rory (2017). LncATLAS database for subcellular localization of long noncoding RNAs. RNA - a publication of the RNA Society, 23(7), pp. 1080-1087. Cold Spring Harbor Laboratory Press 10.1261/rna.060814.117

Carlevaro Fita, Joana; Rahim, Anisa; Guigó, Roderic; Vardy, Leah A; Johnson, Rory Baldwin (2016). Cytoplasmic long noncoding RNAs are frequently bound to and degraded at ribosomes in human cells. RNA - a publication of the RNA Society, 22(6), pp. 867-882. Cold Spring Harbor Laboratory Press 10.1261/rna.053561.115

Carrel, Thierry

Vetter, Christian; Zweifel, Martin; Zuppinger, Christian; Carrel, Thierry; Martin, David; Haefliger, Jacques-Antoine; Delacrétaz, Etienne (2010). Connexin 43 expression in human hypertrophied heart due to pressure and volume overload. Physiological research / Academia Scientiarum Bohemoslovaca, 59(1), pp. 35-42. Praha: Academia Scientiarum Bohemoslovaca

Castiglione, Monica

Viale, G.; Giobbie-Hurder, A.; Gusterson, B. A.; Maiorano, E.; Mastropasqua, M. G.; Sonzogni, A.; Mallon, E.; Colleoni, M.; Castiglione-Gertsch, M.; Regan, M. M.; Price, K. N.; Brown, R. W.; Golouh, R.; Crivellari, D.; Karlsson, P.; Öhlschlegel, C.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S. (2009). Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Annals of oncology, 21(2), pp. 245-254. Oxford University Press 10.1093/annonc/mdp317

Viale, Giuseppe; Regan, Meredith M.; Mastropasqua, Mauro G.; Maffini, Fausto; Maiorano, Eugenio; Colleoni, Marco; Price, Karen N.; Golouh, Rastko; Perin, Tiziana; Brown, R. W.; Kovács, Anikó; Pillay, Komala; Öhlschlegel, Christian; Gusterson, Barry A.; Castiglione-Gertsch, Monica; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S. (2008). Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer. Journal of the National Cancer Institute JNCI, 100(3), pp. 207-212. Oxford University Press 10.1093/jnci/djm289

Ravaioli, A.; Monti, F.; Regan, M. M.; Maffini, F.; Mastropasqua, M. G.; Spataro, V.; Castiglione-Gertsch, Monica; Panzini, I.; Gianni, L.; Goldhirsch, A.; Coates, A.; Price, K. N.; Gusterson, B. A.; Viale, G. (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of oncology, 19(4), pp. 660-668. Oxford University Press 10.1093/annonc/mdm547

Francis, Prudence; Crown, John; Di Leo, Angelo; Buyse, Marc; Balil, Ana; Andersson, Michael; Nordenskjöld, Bo; Lang, Istvan; Jakesz, Raimund; Vorobiof, Daniel; Gutiérrez, Jorge; Van Hazel, Guy; Dolci, Stella; Jamin, Sophie; Bendahmane, Belguendouz; Gelber, Richard D.; Goldhirsch, Aron; Castiglione-Gertsch, Monica; Piccart-Gebhart, Martine (2008). Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02–98 Randomized Trial. Journal of the National Cancer Institute JNCI, 100(2), pp. 121-133. Oxford University Press 10.1093/jnci/djm287

Regan, M. M.; Pagani, O.; Walley, B.; Torrisi, R.; Perez, E. A.; Francis, P.; Fleming, G. F.; Price, K. N.; Thürlimann, B.; Maibach, R.; Castiglione-Gertsch, M.; Coates, A. S.; Goldhirsch, A.; Gelber, R. D. (2008). Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Annals of oncology, 19(7), pp. 1231-1241. Oxford University Press 10.1093/annonc/mdn037

Regan, MM; Viale, G; Mastropasqua, MG; Maiorano, E; Golouh, R; Carbone, A; Brown, B; Suurküla, M; Langman, G; Mazzucchelli, L; Braye, S; Grigolato, P; Gelber, RD; Castiglione-Gertsch, M; Price, KN; Coates, AS; Goldhirsch, A; Gusterson, B; International, Breast Cancer Study Group (2006). Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Journal of the National Cancer Institute JNCI, 98(21), pp. 1571-81. Cary, N.C.: Oxford University Press 10.1093/jnci/djj415

Castiglione-Gertsch, M (2006). Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy. Annals of oncology, 17 Suppl 10, x51-x53. Oxford: Oxford University Press 10.1093/annonc/mdl236

Pestalozzi, BC; Zahrieh, D; Price, KN; Holmberg, SB; Lindtner, J; Collins, J; Crivellari, D; Fey, MF; Murray, E; Pagani, O; Simoncini, E; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A; International, Breast Cancer Study Group (IBCSG) (2006). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Annals of oncology, 17(6), pp. 935-44. Oxford: Oxford University Press 10.1093/annonc/mdl064

Gianni, L; Panzini, I; Li, S; Gelber, RD; Collins, J; Holmberg, SB; Crivellari, D; Castiglione-Gertsch, M; Goldhirsch, A; Coates, AS; Ravaioli, A; International, Breast Cancer Study Group (IBCSG) (2006). Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Cancer, 106(3), pp. 505-13. New York, N.Y.: John Wiley & Sons 10.1002/cncr.21651

Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Cameron, David A.; Palmer, Michael J.; Pater, Joseph L. (2005). Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17. Journal of the National Cancer Institute JNCI, 97(17), pp. 1262-1271. Oxford University Press 10.1093/jnci/dji250

Aebi, S.; Castiglione-Gertsch, M. (2001). High-dose chemotherapy for ovarian cancer: Are we ready to go? Annals of oncology, 12(5), pp. 583-584. Oxford University Press 10.1023/A:1011134312452

Goldhirsch, A.; Coates, A. S.; Castiglione-Gertsch, M.; Gelber, R. D. (1998). New treatments for breast cancer: Breakthroughs for patient care or just steps in the right direction? Annals of oncology, 9(9), pp. 973-976. Oxford University Press 10.1023/A:1008436810268

Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; O'Neill, A.; Thürlimann, B.; Rudenstam, C.-M; Lindtner, J.; Collins, J.; Forbes, J.; Crivellari, D.; Coates, A.; Cavalli, F.; Simoncini, E.; Fey, M. F.; Pagani, O.; Price, K.; Senn, H.-J. (1997). Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology, 8(8), pp. 751-756. Oxford University Press 10.1023/A:1008220301866

Thürlimann, B.; Beretta, K.; Bacchi, M.; Castiglione-Gertsch, M.; Goldhirsch, A.; Jungi, W. F.; Cavalli, F.; Senn, H.-J.; Fey, M.; Löhnert, T. (1996). First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Annals of oncology, 7(5), pp. 471-479. Oxford University Press 10.1093/oxfordjournals.annonc.a010635

Cathomas, Marionna Myrta

Cavalli, Franco

Ryan, G.; Martinelli, G.; Kuper-Hommel, M.; Tsang, R.; Pruneri, G.; Yuen, K.; Roos, D.; Lennard, A.; Devizzi, L.; Crabb, S.; Hossfeld, D.; Pratt, G.; Dell'Olio, M.; Choo, S. P.; Bociek, R. G.; Radford, J.; Lade, S.; Gianni, A. M.; Zucca, E.; Cavalli, F.; ... (2007). Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Annals of oncology, 19(2), pp. 233-241. Oxford University Press 10.1093/annonc/mdm471

Centeno Ramos, Irene

Cerciello, Ferdinando

Cavallari, Ilaria; Cerciello, Ferdinando; Giovannetti, Elisa; Urso, Loredana (2023). Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets. Frontiers in oncology, 13, p. 1163144. Frontiers Research Foundation 10.3389/fonc.2023.1163144

Frehner, Lorenz; Haefliger, Simon; Cerciello, Ferdinando; Grob, Tobias; Schmid, Sabine (2023). Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer. Case reports in oncology, 16(1), pp. 871-877. Karger 10.1159/000533572

Sun, Suna; Qi, Weihong; Rehrauer, Hubert; Ronner, Manuel; Hariharan, Ananya; Wipplinger, Martin; Meiller, Clément; Stahel, Rolf; Früh, Martin; Cerciello, Ferdinando; Fonteneau, Jean-François; Jean, Didier; Felley-Bosco, Emanuela (2022). Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma. JTO clinical and research reports, 3(12), p. 100430. 10.1016/j.jtocrr.2022.100430

Martens, Marvin; Kreidl, Franziska; Ehrhart, Friederike; Jean, Didier; Mei, Merlin; Mortensen, Holly M; Nash, Alistair; Nymark, Penny; Evelo, Chris T; Cerciello, Ferdinando (2022). A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma. Frontiers in oncology, 12, p. 849640. Frontiers Research Foundation 10.3389/fonc.2022.849640

Cerciello, Ferdinando; Choi, Meena; Sinicropi-Yao, Sara L; Lomeo, Katie; Amann, Joseph M; Felley-Bosco, Emanuela; Stahel, Rolf A; Robinson, Bruce W S; Creaney, Jenette; Pass, Harvey I; Vitek, Olga; Carbone, David P (2020). Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma. Cancer epidemiology, biomarkers & prevention, 29(10), pp. 1973-1982. American Association for Cancer Research AACR 10.1158/1055-9965.EPI-20-0543

Cerny, David

Cerny, David; Cerny, Thomas; Ess, Silvia; D'Addario, Giannicola; Früh, Martin (2009). Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival. Onkologie, 32(10), pp. 569-573. Karger 10.1159/000232581

Cerny, Thomas

Stupp, R.; Bauer, J.; Pagani, O.; Gerard, B.; Cerny, T.; Sessa, C.; Bastian, G.; Sarkany, M.; Schläpfer, J.; Giroux, B.; Leyvraz, S. (1998). Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of oncology, 9(11), pp. 1233-1242. Oxford University Press 10.1023/A:1008495919071

Als, C.; Laeng, H.; Cerny, T.; Kinser, J. A.; Rösler, H.; Häusler, R. (1998). Primary cervical malignant teratoma with a rib metastasis in an adult: Five-year survival after surgery and chemotherapy. Annals of oncology, 9(9), pp. 1015-1022. Oxford University Press 10.1023/A:1008277227111

Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A. (1997). Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation. Annals of oncology, 8(6), pp. 604-606. Oxford University Press 10.1023/A:1008245709924

Pagani, O.; Sessa, C.; Martinelli, G.; Cerny, Thomas; De Jong, J.; Goldhirsch, A.; Zimatore, M.; Cavalli, F. (1997). Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer. Annals of oncology, 8(7), pp. 655-661. Oxford University Press 10.1023/A:1008211629858

Chittazhathu Kurian Kuruvilla, Yojena

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; ... (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of thoracic oncology, 12(4), pp. 752-762. Elsevier 10.1016/j.jtho.2016.12.017

Chouchane, Aziz

Chouvardas, Panagiotis

Mihaljevic, Ante; Rubin, Philip D; Chouvardas, Panagiotis; Esposito, Roberta (2024). Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal cancer transcriptomes. Scientific Reports, 14(10939) Nature Publishing Group 10.1038/s41598-024-61430-7

Dhaka, Bhavya; Zimmerli, Marc; Hanhart, Daniel; Moser, Mario B; Guillen-Ramirez, Hugo; Mishra, Sanat; Esposito, Roberta; Polidori, Taisia; Widmer, Maro; García-Pérez, Raquel; Kruithof-de Julio, Marianna; Pervouchine, Dmitri; Melé, Marta; Chouvardas, Panagiotis; Johnson, Rory (2024). Functional identification of cis-regulatory long noncoding RNAs at controlled false discovery rates. Nucleic acids research, 52(6), pp. 2821-2835. Oxford University Press 10.1093/nar/gkae075

Aghagolzadeh, Parisa; Plaisance, Isabelle; Bernasconi, Riccardo; Treibel, Thomas A; Pulido Quetglas, Carlos; Wyss, Tania; Wigger, Leonore; Nemir, Mohamed; Sarre, Alexandre; Chouvardas, Panagiotis; Johnson, Rory; González, Arantxa; Pedrazzini, Thierry (2023). Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER, a Conserved Profibrogenic Long Noncoding RNA. Circulation, 148(9), pp. 778-797. American Heart Association 10.1161/CIRCULATIONAHA.122.062601

Plaisance, Isabelle; Chouvardas, Panagiotis; Sun, Yuliangzi; Nemir, Mohamed; Aghagolzadeh, Parisa; Aminfar, Farhang; Shen, Sophie; Shim, Woo Jun; Rochais, Francesca; Johnson, Rory; Palpant, Nathan; Pedrazzini, Thierry (2023). A transposable element into the human long noncoding RNA CARMEN is a switch for cardiac precursor cell specification. Cardiovascular research, 119(6), pp. 1361-1376. Oxford University Press 10.1093/cvr/cvac191

Christ, Emanuel

Sadowski, Samira Mercedes; Christ, Emanuel; Bedat, Benoit; Kollár, Attila; Karenovics, Wolfram; Perren, Aurel; Triponez, Frederic (2018). Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors. Endocrine Connections, 7(1), pp. 8-15. BioScientifica 10.1530/EC-17-0271

Christ, Lisa Alexandra

Liu, Michael; Christ, Lisa; Richters, Anke; Özdemir, Berna C (2023). Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease. Oncology letters, 26(3), p. 377. Spandidos Publications 10.3892/ol.2023.13963

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 1991-2001. Springer 10.1007/s00262-023-03436-0

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Christe, Lucine Constance

Joder, Carmen; Gmür, Andrea; Solass, Wiebke; Christe, Lucine; Rabaglio, Manuela; Fluri, Muriel; Rau, Tilman T; Saner, Flurina A M; Knabben, Laura; Imboden, Sara; Mueller, Michael D; Siegenthaler, Franziska (2024). Real-World Data on Institutional Implementation of Screening for Mismatch Repair Deficiency and Lynch Syndrome in Endometrial Cancer Patients. Cancers, 16(3) MDPI AG 10.3390/cancers16030671

Christen-Cevallos Rosero, Andri

González-Jaramillo, Valentina; Luethi, Nora; Egloff, Martina; Roa-Díaz, Zayne M; González-Jaramillo, Nathalia; Díaz-Ríos, Catalina; Christen-Cevallos Rosero, Andri; Dodd, Susanna; Eychmüller, Steffen; Zambrano, Sofía C (2024). Outcomes of care during the last month of life: a systematic review to inform the development of a core outcome set. Annals of palliative medicine, 13(3), pp. 627-640. AME Publishing Company 10.21037/apm-23-435

González-Jaramillo, Valentina; Krikorian, Alicia; Tripodoro, Vilma; Jorge, Margarita; Zambrano, Sofia C; López, Francy; Vélez, Maria Clara; Noguera, Tatiana; Orellana, Sebastián; Montilla, Silvina; Christen-Cevallos Rosero, Andri; Eychmüller, Steffen (2023). Compassionate communities: How to assess their benefit? A protocol of a collaborative study between different countries. Palliative care and social practice, 17, p. 26323524231170885. Sage 10.1177/26323524231170885

Ebneter, Andreas S.; Sauter, Thomas C.; Christen, Andri; Eychmueller, Steffen (2022). Feasibility, acceptability and needs in telemedicine for palliative care. Swiss medical weekly, 152(9-10) EMH Media 10.4414/smw.2022.w30148

Yildiz, Berivan; Allan, Simon; Bakan, Misa; Barnestein-Fonseca, Pilar; Berger, Michael; Boughey, Mark; Christen, Andri; De Simone, Gustavo G; Egloff, Martina; Ellershaw, John; Elsten, Eline E C M; Eychmüller, Steffen; Fischer, Claudia; Fürst, Carl Johan; Geijteman, Eric C T; Goldraij, Gabriel; Goossensen, Anne; Halfdanardottir, Svandis Iris; Haugen, Dagny Faksvåg; Hedman, Christel; ... (2022). Live well, die well – an international cohort study on experiences, concerns and preferences of patients in the last phase of life: the research protocol of the iLIVE study. BMJ open, 12(8), e057229. BMJ Publishing Group 10.1136/bmjopen-2021-057229

Christoph, Cina

Maessen, Maud; Streit, Sven; Gerber, Andreas; Christoph, Cina; Kläui, Heinrich; Salis Gross Cöplü, Corina; Mitchell, Geoffrey; Egger, Matthias; Eychmüller, Steffen (April 2018). The “PROAKTIV" Study Protocol: A Cluster-randomized Trial of Primary Palliative Care. Palliative medicine, 32(1_suppl), pp. 207-208. Sage

Cihoric, Nikola

Riggenbach, Elena; Mose, Lucas; Imboden, Sarah; Siegenthaler, Franziska Anna; Krause, Elke; Schlootz, Saskia; Rabaglio, Manuela Elena; Cihoric, Nikola; Lössl, Kristina; Wampfler, Julian (May 2024). Safety and efficacy of modern concurrent radiochemotherapy with Cisplatin and Gemcitabine. Radiotherapy and oncology, 194(1), S1119-S1120. Elsevier

Deressa, Biniyam Tefera; Assefa, Mathewos; Tafesse, Ephrem; Kantelhardt, Eva Johanna; Soldatovic, Ivan; Cihoric, Nikola; Rauch, Daniel; Jemal, Ahmedin (2021). Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia. BMC cancer, 21(1), p. 1102. BioMed Central 10.1186/s12885-021-08817-1

Deressa, Biniyam Tefera; Cihoric, Nikola; Vlaskou Badra, Eugenia; Tsikkinis, Alexandros; Rauch, Daniel (2019). Breast cancer care in northern Ethiopia - cross-sectional analysis. BMC cancer, 19(1), p. 393. BioMed Central 10.1186/s12885-019-5612-6

Deressa, Biniyam Tefera; Rauch, Daniel; Vlaskou Badra, Eugenia; Glatzer, Markus; Jeremic, Branislav; Lössl, Kristina; Igrutinovic, Ivan; Cihoric, Nikola (2018). CURRENT STATUS OF CLINICAL TRIALS IN ETHIOPIA: HOW MUCH IS DONE? Ethiopian medical journal, 56(2), pp. 167-174. Ethiopian Medical Association

Grogg, André; Trippel, Mafalda; Pfaltz, Katrin; Lädrach, Claudia; Droeser, Raoul A; Cihoric, Nikola; Salhia, Bodour; Zweifel, Martin; Tapia, Coya (2015). Androgen receptor status is highly conserved during tumor progression of breast cancer. BMC cancer, 15, p. 872. BioMed Central 10.1186/s12885-015-1897-2

Cioccari, Luca

Lüthi, Nora; Cioccari, Luca; Eastwood, Glenn; Biesenbach, Peter; Morgan, Rhys; Sprogis, Stephanie; Young, Helen; Peck, Leah; Knee Chong, Christine; Moore, Sandra; Moon, Kylie; Ekinci, Elif I; Deane, Adam M; Bellomo, Rinaldo; Mårtensson, Johan (2019). Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol. Acta anaesthesiologica Scandinavica, 63(6), pp. 761-768. Wiley-Blackwell 10.1111/aas.13354

Bitker, Laurent; Cutuli, Salvatore L; Cioccari, Luca; Osawa, Eduardo A; Toh, Lisa; Luethi, Nora; Young, Helen; Peck, Leah; Eastwood, Glenn M; Mårtensson, Johan; Bellomo, Rinaldo (2019). Sepsis uncouples serum C-peptide and insulin levels in critically ill patients with type 2 diabetes mellitus. Critical care and resuscitation, 21(2), pp. 87-95. College of Intensive Care Medicine of Australia and New Zealand

Cioccari, Luca; Luethi, Nora; Glassford, Neil J; Bellomo, Rinaldo (2019). The normal cardiac index in older healthy individuals: a scoping review. Critical care and resuscitation, 21(1), pp. 9-17. College of Intensive Care Medicine of Australia and New Zealand

Claus, Christina

Claus, Christina; Riether, Carsten; Schürch, Christian; Matter, Matthias S; Hilmenyuk, Tamara; Ochsenbein, Adrian (2012). CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. Cancer research, 72(14), pp. 3664-76. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-11-2791

Matter, Matthias S; Hilmenyuk, Tamara; Claus, Christina; Marone, Romina; Schürch, Christian; Tinguely, Marianne; Terracciano, Luigi; Luther, Sanjiv A; Ochsenbein, Adrian (2011). Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS ONE, 6(9), e24772. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0024772

Mumprecht, Sabine Barbara; Schürch, Christian; Scherrer, Sandro; Claus, Christina; Ochsenbein, Adrian (2010). Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling. European journal of immunology, 40(10), pp. 2720-2730. Weinheim: Wiley-VCH 10.1002/eji.201040404

Claus, Meike Janina

Clough, Kerri

Ribi, Karin; Rondeau, Stéphanie; Hitz, Felicitas; Mey, Ulrich; Enoiu, Milica; Pabst, Thomas; Stathis, Anastasios; Fischer, Natalie; Clough-Gorr, Kerri M (2017). Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma. Supportive care in cancer, 25(9), pp. 2833-2842. Springer 10.1007/s00520-017-3698-4

Clénin, Leander Caspar

Constantinescu, Mihai Adrian

Salemi, Souzan; Yousefi, Shida; Constantinescu, Mihai A; Fey, Martin F; Simon, Hans-Uwe (2012). Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell research, 22(2), pp. 432-5. London: Nature Publishing Group 10.1038/cr.2011.200

Corazza, Nadia

Cuenca Vera, Miguelangel

Balmer, Maria L; Schürch, Christian; Saito, Yasuyuki; Geuking, Markus; Li, Hai; Cuenca, Miguelangel; Kovtonyuk, Larisa V; McCoy, Kathleen; Hapfelmeier, Siegfried; Ochsenbein, Adrian; Manz, Markus G; Slack, Emma; Macpherson, Andrew (2014). Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. Journal of immunology, 193(10), pp. 5273-5283. American Association of Immunologists 10.4049/jimmunol.1400762

Cullmann, Jennifer

Kollár, Attila; Langer, Rupert; Ionescu, Codruta; Cullmann, Jennifer L.; Klenke, Frank M (2016). Pleomorphic rhabdomyosarcoma with an impressive response to chemotherapy: case report and review of the literature. Tumori, 102(Suppl.2), S57-S60. Wichtig Publishing 10.5301/tj.5000476

Dahinden, Clemens A.

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection revealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.2014.

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Dal Pra, Alan

Damonti, Lauro

Daskalakis, Michael

Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Arber, Caroline; Chalandon, Yves; Daskalakis, Michael; Diepold, Miriam; Diesch-Furlanetto, Tamara; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Heim, Dominik; Hitz, Felicitas; Holbro, Andreas; Masouridi-Levrat, Stavroula; Nair, Gayathri; Novak, Urban; Pabst, Thomas; Renner, Christoph; Stussi, Georg; ... (2024). Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematological oncology, 42(1), e3241. Wiley 10.1002/hon.3241

Penack, Olaf; Peczynski, Christophe; Koenecke, Christian; Polge, Emmanuelle; Kuhnl, Andrea; Fegueux, Nathalie; Daskalakis, Michael; Kröger, Nicolaus; Dreger, Peter; Besley, Caroline; Schanz, Urs; Bloor, Adrian; Ganser, Arnold; Forcade, Edouard; Corral, Lucia López; Passweg, Jakob R; Novak, Urban; Moiseev, Ivan; Schoemans, Hélène; Basak, Grzegorz W; ... (2023). Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. Journal for immunotherapy of cancer, 11(4) BMJ Publishing Group 10.1136/jitc-2022-006406

Penack, Olaf; Peczynski, Christophe; Koenecke, Christian; Polge, Emmanuelle; Sanderson, Robin; Yakoub-Agha, Ibrahim; Fegueux, Nathalie; Daskalakis, Michael; Collin, Matthew; Dreger, Peter; Kröger, Nicolaus; Schanz, Urs; Bloor, Adrian; Ganser, Arnold; Besley, Caroline; Wulf, Gerald G; Novak, Urban; Moiseev, Ivan; Schoemans, Hélène; Basak, Grzegorz W; ... (2023). Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party. Frontiers in immunology, 14, p. 1252811. Frontiers Research Foundation 10.3389/fimmu.2023.1252811

Jeker, Barbara; Daskalakis, Michael; Zeerleder, Sacha; Pabst, Thomas; Novak, Urban (January 2021). CAR T Cells: Immuntherapie mit grossem Potenzial. Onkologie & Hämatologie, 2021, pp. 16-19. Prime Public Media AG

Dawson, Heather

Baumhoer, Daniel; Harder, Dorothee; Ameline, Baptiste; Dawson, Heather; Kollár, Attila (2021). Metastasizing chondroblastoma: a rare bone tumor no longer supported by the WHO classification. Skeletal radiology, 50(1), pp. 255-260. Springer 10.1007/s00256-020-03525-6

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Delacrétaz, Etienne

Deng, Haibin

Dettmer, Matthias

Hoffmann, Michèle; Schardt, Julian; Ionescu, Codruta; Wolf-Schnurrbusch, Ute E.; Wagner, Franca; Dettmer, Matthias S.; Olariu, Radu; Özdemir, Berna C. (2021). Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature. Current problems in cancer: case reports, 4, p. 100088. Elsevier 10.1016/j.cpccr.2021.100088

Diaz Rios, Catalina

Dibbern, Jens

Winkler, Jessica; Dibbern, Jens; Heinzl, Armin (2009). The Influence of product-specific determinants on software firms’ international entry mode choices (Working papers in general management and information systems 02/2009). Mannheim: University of Mannheim, Department of General Management and Information Systems

Dickgreber, Nina

Weber, Benjamin; Schuster, Steffen; Zysset, Daniel; Rihs, Silvia; Dickgreber, Nina; Schürch, Christian; Riether, Carsten; Siegrist, Mark; Schneider, Christoph; Pawelski, Helga; Gurzeler, Ursina; Ziltener, Pascal; Genitsch, Vera; Tacchini-Cottier, Fabienne; Ochsenbein, Adrian; Hofstetter, Willy; Kopf, Manfred; Kaufmann, Thomas; Oxenius, Annette; Reith, Walter; ... (2014). TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS pathogens, 10(1), e1003900. Public Library of Science 10.1371/journal.ppat.1003900

Diepold, Miriam

Dingeldein, Irène

Siegenthaler, Franziska; Imboden, Sara; Lössl, Kristina; Novak, Urban; Dingeldein, Irène; Mueller, Michael (2021). [Diversity of malignant uterine disease]. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2021(17–18), pp. 290-296. EMH Schweizerischer Ärzteverlag 10.4414/smf.2021.08724

Dirnhofer, Stephan

Dislich, Bastian

Djonov, Valentin Georgiev

Frangež, Živa; Fernández-Marrero, Yuniel; Stojkov, Darko; Seyed Jafari, S. Morteza; Hunger, Robert E.; Djonov, Valentin; Riether, Carsten; Simon, Hans-Uwe (2020). BIF-1 inhibits both mitochondrial and glycolytic ATP production: its downregulation promotes melanoma growth. Oncogene, 39(26), pp. 4944-4955. Springer Nature 10.1038/s41388-020-1339-8

Dobner, Stephan

Dobrocky, Tomas

Dokumaci, Ayse Sila

Dorn, Patrick

Eliçin, Olgun; Häfliger, Simon; Dorn, Patrick (May 2024). SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC. Radiotherapy and oncology, 194(1), S1610-S1610. Elsevier

Draeger, Annette

Droz, Sara Christine

Jent, Philipp; Thalmann, Laura; Pabst, Thomas; Droz, Sara; Sendi, Parham (2019). Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study. Infectious diseases, 51(6), pp. 409-416. Taylor & Francis 10.1080/23744235.2019.1581946

Drücker, Patrick

Dubach, Patrick

Fricker, Michael Peter; Dubach, Patrick; Helbling, Arthur; Diamantis, E; Villiger, Peter; Novak, Urban (2015). Not all facial swellings are angioedemas! Journal of investigational allergology & clinical immunology, 25(2), pp. 146-147. Esmon Publicidad

Duclos, Kathleen

Dufour, Jean-François

Patterson, Andrew D; Maurhofer, Olivier; Beyoglu, Diren; Lanz, Christian; Krausz, Kristopher W; Pabst, Thomas; Gonzalez, Frank J; Dufour, Jean-François; Idle, Jeffrey R (2011). Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer research, 71(21), pp. 6590-600. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-11-0885

Dufour, Jean-François; Fey, Martin F (2006). What is the current treatment of PTLD after liver transplantation? Journal of hepatology, 44(1), pp. 23-6. Amsterdam: Elsevier 10.1016/j.jhep.2005.10.009

Ebneter, Andreas Samuel

Ebneter, Andreas Samuel; Fliedner, Monika; Trapp, Daniela; Ramseier, Friederike; Sauter, Thomas C.; Eychmüller, Steffen (2021). [Telemedicine in Palliative Care: Digital Communication in a Relationship-Based Speciality - Does It Make Sense?]. Praxis, 110(15), pp. 845-850. Hogrefe 10.1024/1661-8157/a003781

Eggel, Alexander

Egger, Matthias

Wick, C; Egger, M; Trelle, S; Jüni, P; Fey, M F (2007). The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry. Annals of oncology, 18(9), pp. 1580-2. Oxford: Oxford University Press 10.1093/annonc/mdm402

Egloff, Martina

Eicher, Manuela

Eicher, M; Rabaglio, M (2008). Kinderwunsch und Krebs: Wie kann Bedürfnissen betroffener Frauen und deren Partner begegnet werden? Hämato-onkologische Nachrichten(12) Köln: Biermann

Eichmann, Micha David

Eliçin, Olgun

Endrich, Olga

Rajput, Abdul Mateen; Triep, Karen; Endrich, Olga (2023). Semi-Automated Approach to Retrieve SNOMED CT Hierarchy of Clinical Terms by Using Terminology Server. Studies in health technology and informatics, 301, pp. 142-147. IOS Press 10.3233/SHTI230029

Engelbrecht, Swantje

Engeroff, Paul Simon

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Engisch, Renate

Ermis, Ekin

Eser, Prisca Christina

Schneider, Caroline; Ryffel, Christoph; Stütz, Laura; Rabaglio, Manuela; Suter, Thomas M; Campbell, Kristin L; Eser, Prisca; Wilhelm, Matthias (2023). Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity: a randomized-controlled-trial. Frontiers in cardiovascular medicine, 10(1283153), p. 1283153. Frontiers 10.3389/fcvm.2023.1283153

Eser, Priska Christina

Esposito, Roberta

Esposito, Roberta; Bosch, Núria; Lanzos Camaioni, Andrés Arturo; Polidori, Taisia; Pulido-Quetglas, Carlos; Johnson, Rory (2019). Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening. Cancer cell, 35(4), pp. 545-557. Cell Press 10.1016/j.ccell.2019.01.019

Ess, Silvia

Essig, Manfred

Exadaktylos, Aristomenis

Eychmüller, Steffen

Elsten, E E C M; Pot, I E; Geijteman, E C T; Hedman, C; van der Heide, A; van der Kuy, H; Fürst, C J; Eychmüller, S; van Zuylen, L; van der Rijt, C C D (2024). 'Recommendations for deprescribing of medication in the last phase of life: an international Delphi study'. (In Press). Journal of pain and symptom management Elsevier 10.1016/j.jpainsymman.2024.07.029

Gonzalez Jaramillo, Valentina; Arenas Ochoa, Luisa Fernanda; Saldarriaga, Clara; Krikorian, Alicia; Vargas, John Jairo; Gonzalez-Jaramillo, Nathalia; Eychmüller, Steffen; Maessen, Maud (2024). The 'Surprise question' in heart failure: a prospective cohort study. BMJ supportive & palliative care, 14(1), pp. 68-75. BMJ Publishing Group 10.1136/bmjspcare-2021-003143

Gonzalez-Jaramillo, Valentina; Maessen, Maud; Luethi, Nora; Guyer, Jelena; Hunziker, Lukas; Eychmüller, Steffen; Zambrano, Sofia C. (2022). Unmet Needs in Patients With Heart Failure: The Importance of Palliative Care in a Heart Failure Clinic. Frontiers in cardiovascular medicine, 9, p. 866794. Frontiers 10.3389/fcvm.2022.866794

White, Nicola; Oostendorp, Linda Jm; Vickerstaff, Victoria; Gerlach, Christina; Engels, Yvonne; Maessen, Maud; Tomlinson, Christopher; Wens, Johan; Leysen, Bert; Biasco, Guido; Zambrano, Sofia; Eychmüller, Steffen; Avgerinou, Christina; Chattat, Rabih; Ottoboni, Giovanni; Veldhoven, Carel; Stone, Patrick (2022). An online international comparison of palliative care identification in primary care using the Surprise Question. Palliative medicine, 36(1), pp. 142-151. Sage 10.1177/02692163211048340

Arenas Ochoa, Luisa Fernanda; González-Jaramillo, Valentina; Saldarriaga, Clara; Lemos, Mariantonia; Krikorian, Alicia; Vargas, John Jairo; Gómez-Batiste, Xavier; Gonzalez-Jaramillo, Nathalia; Eychmüller, Steffen (2021). Prevalence and characteristics of patients with heart failure needing palliative care. BMC Palliative Care, 20(1), p. 184. BioMed Central 10.1186/s12904-021-00850-y

Eychmüller, Steffen; Ramseier, Friederike; Zürcher, Claudia (2021). [Communicating Prognosis and Expectations in Advanced Disease - A Balancing Act in Practice]. Praxis, 110(15), pp. 861-865. Hogrefe 10.1024/1661-8157/a003777

Janett-Pellegri, Camilla; Eychmüller, Steffen (2021). 'I Don't Have a Crystal Ball' - Why Do Doctors Tend to Avoid Prognostication? Praxis, 110(15), pp. 914-924. Hogrefe 10.1024/1661-8157/a003785

Blum, David; Eychmüller, Steffen (2021). [The Broad Spectrum of Palliative Care]. Praxis, 110(15), pp. 829-830. Hogrefe 10.1024/1661-8157/a003776

Gonzalez Jaramillo, Valentina; Guyer, Jelena; Luethi, Nora; Sobanski, Piotr; Zbinden, Rut; Rodriguez, Eveline; Hunziker, Lukas; Eychmüller, Steffen; Maessen, Maud (2021). Validation of the German version of the needs assessment tool: progressive disease-heart failure. Health and quality of life outcomes, 19(1), p. 214. BioMed Central 10.1186/s12955-021-01817-6

Gonzalez-Jaramillo, Valentina; Fuhrer, Valérie; Gonzalez-Jaramillo, Nathalia; Kopp-Heim, Doris; Eychmüller, Steffen; Maessen, Maud (2021). Impact of home-based palliative care on health care costs and hospital use: A systematic review. Palliative & Supportive Care, 19(4), pp. 474-487. Cambridge University Press 10.1017/S1478951520001315

Fliedner, Monika; Halfens, Ruud J G; King, Cynthia R; Eychmüller, Steffen; Lohrmann, Christa; Schols, Jos M G A (2021). Roles and Responsibilities of Nurses in Advance Care Planning in Palliative Care in the Acute Care Setting-A Scoping Review. Journal of hospice and palliative nursing, 23(1), pp. 59-68. The Hospice and Palliative Nurses Association 10.1097/NJH.0000000000000715

Kleiner, Nadine; Zambrano, Sofia C.; Eychmüller, Steffen; Zwahlen, Susanne (2021). Early palliative care integration trial: consultation content and interaction dynamics. (In Press). BMJ supportive & palliative care BMJ Publishing Group 10.1136/bmjspcare-2020-002419

Fliedner, Monika C.; Zambrano, Sofia C.; Eychmueller, Steffen (2021). Public perception of palliative care: a survey of the general population. Palliative care and social practice, 15, p. 26323524211017546. Sage 10.1177/26323524211017546

Fliedner, Monika C.; Hagemann, Monika; Eychmüller, Steffen; King, Cynthia; Lohrmann, Christa; Halfens, Ruud J G; Schols, Jos M G A (2020). Does Time for (in)Direct Nursing Care Activities at the End of Life for Patients With or Without Specialized Palliative Care in a University Hospital Differ? A Retrospective Analysis. The American journal of hospice and palliative care, 37(10), pp. 844-852. Sage 10.1177/1049909120905779

Gonzalez-Jaramillo, Valentina; Sobanski, Piotr; Calvache, Jose A; Arenas-Ochoa, Luisa F; Franco, Oscar H; Hunziker, Lukas; Eychmüller, Steffen; Maessen, Maud (2020). Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis. Palliative medicine, 34(8), pp. 1019-1029. Sage 10.1177/0269216320929548

Zambrano, Sofia C.; Centeno, Carlos; Larkin, Philip J; Eychmüller, Steffen (2020). Using the Term "Palliative Care": International Survey of How Palliative Care Researchers and Academics Perceive the Term "Palliative Care". Journal of palliative medicine, 23(2), pp. 184-191. Liebert 10.1089/jpm.2019.0068

White, Nicola; Oostendorp, Linda; Vickerstaff, Victoria; Gerlach, Christina; Engels, Yvonne; Maessen, Maud; Tomlinson, Christopher; Wens, Johan; Leysen, Bert; Biasco, Guido; Zambrano Ramos, Sofia Carolina; Eychmüller, Steffen; Avgerinou, Christina; Chattat, Rabih; Ottoboni, Giovanni; Veldhoven, Carel; Stone, Patrick (2020). Correction to: An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol. BMC Palliative Care, 19(1), p. 15. BioMed Central 10.1186/s12904-020-0518-2

Zambrano, Sofia C.; Haugen, Dagny Faksvåg; van der Heide, Agnes; Tripodoro, Vilma A.; Ellershaw, John; Fürst, Carl Johan; Voltz, Raymond; Mason, Stephen; Daud, María L.; De Simone, Gustavo; Kremeike, Kerstin; Halfdanardottir, Svandis Iris; Sigurdardottir, Valgerdur; Johnson, Jeremy; Allan, Simon; Hafeez, Haroon; Simões, Catarina; Sigurdardottir, Katrin Ruth; Rasmussen, Birgit H.; Williamson, Paula; ... (2020). Development of an international Core Outcome Set (COS) for best care for the dying person: study protocol. BMC Palliative Care, 19(1), p. 184. 10.1186/s12904-020-00654-6

Gaertner, Jan; Eychmüller, Steffen; Leyhe, Thomas; Bueche, Daniel; Savaskan, Egemen; Schlögl, Mathias (2019). Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials. Annals of palliative medicine, 8(4), pp. 504-515. AME Publishing Company 10.21037/apm.2019.03.06

Fliedner, Monika; Zambrano, Sofia; Schols, Jos Mga; Bakitas, Marie; Lohrmann, Christa; Halfens, Ruud Jg; Eychmüller, Steffen (2019). An early palliative care intervention can be confronting but reassuring: A qualitative study on the experiences of patients with advanced cancer. Palliative medicine, 33(7), pp. 783-792. Sage 10.1177/0269216319847884

White, Nicola; Oostendorp, Linda; Vickerstaff, Victoria; Gerlach, Christina; Engels, Yvonne; Maessen, Maud; Tomlinson, Christopher; Wens, Johan; Leysen, Bert; Biasco, Guido; Zambrano, Sofia; Eychmüller, Steffen; Avgerinou, Christina; Chattat, Rabih; Ottoboni, Giovanni; Veldhoven, Carel; Stone, Patrick (2019). An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol. BMC Palliative Care, 18(1), p. 36. BioMed Central 10.1186/s12904-019-0413-x

Fliedner, Monika; Mitchell, G; Bueche, D; Mettler, M; Schols, J.M.G.A.; Eychmüller, Steffen (2019). Development and Use of the ‘SENS’-Structure to Proactively Identify Care Needs in Early Palliative Care—An Innovative Approach. Healthcare, 7(1) MDPI 10.3390/healthcare7010032

Maessen, Maud; Steck, N; Zwahlen, M; Eychmüller, Steffen (2018). Potential economic impact of mobile specialist palliative care teams in Switzerland Bern: Bundesamt für Gesundheit BAG

Maessen, Maud; Steck, Nicole; Zwahlen, Marcel; Eychmüller, Steffen (April 2018). Potential Economic Impact of Specialist Palliative Care Mobile Teams in Switzerland: Baseline Data for Future Development. Palliative medicine, 32(1_suppl), pp. 60-61. Sage

Eychmüller, Steffen; Zwahlen, Diana; Fliedner, Monica (2018). The Oncological Patient in the Palliative Situation. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 210, pp. 67-85. Springer 10.1007/978-3-319-64310-6_5

Eychmüller, Steffen (2018). Das Sterben ins Leben integrieren. UniPress - Forschung und Wissenschaft an der Universität Bern, 173, pp. 28-31. Abteilung Kommunikation, Universität Bern

Fliedner, MC; Zambrano, S; Lohrmann, C; Schols, JMGA; Halfens, R; Eychmüller, S (2018). Cancer patients’ experiences with an early palliative care conversation: A qualitative study of an intervention based on the SENS-structure (Unpublished). In: Support Care Cancer 2018.

Eychmüller, Steffen; Felber, Sibylle (2018). Vorausplanung am Lebensende – eine kritische Reflexion für die Praxis. Therapeutische Umschau, 75(2), pp. 117-122. Huber 10.1024/0040-5930/a000976

Groeneveld, E Iris; Cassel, J Brian; Bausewein, Claudia; Csikós, Ágnes; Krajnik, Malgorzata; Ryan, Karen; Haugen, Dagny Faksvåg; Eychmüller, Steffen; Gudat Keller, Heike; Allan, Simon; Hasselaar, Jeroen; García-Baquero Merino, Teresa; Swetenham, Kate; Piper, Kym; Fürst, Carl Johan; Murtagh, Fliss Em (2017). Funding models in palliative care: Lessons from international experience. Palliative medicine, 31(4), pp. 296-305. Sage 10.1177/0269216316689015

Fliedner, M.C.; Eychmüller, S.; Zambrano, S.; Lohrmann, C.; Schols, J.M.G.A.; Halfens, R.J.G (2017). How Do Cancer Patients in Early Palliative Care Experience a Structured Advance Care Planning Intervention? A Qualitative Study. In: 115th World Congress of the European Association for Palliative Care. Madrid, Spain. 18-20 May 2017.

Eychmüller, Steffen (2017). Die Reifeprüfung. Vitamin G : für Health Professionals mit Weitblick, 2017(2), pp. 10-13. ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Departement Gesundheit

Zambrano, Sofia C; Fliedner, Monica C; Eychmüller, Steffen (2016). The impact of early palliative care on the quality of care during the last days of life: what does the evidence say? Current opinion in supportive and palliative care, 10(4), pp. 310-315. Wolters Kluwer Health 10.1097/SPC.0000000000000240

Fliedner, M. C.; Eychmüller, Steffen (2016). Demands on interprofessional collaboration. Onkologe, 22(9), pp. 631-637. Springer-Medizin-Verlag 10.1007/s00761-016-0070-0

Murray, Scott A; Firth, Adam; Schneider, Nils; Van den Eynden, Bart; Gomez-Batiste, Xavier; Brogaard, Trine; Villanueva, Tiago; Abela, Jurgen; Eychmüller, Steffen; Mitchell, Geoffrey; Downing, Julia; Sallnow, Libby; van Rijswijk, Erik; Barnard, Alan; Lynch, Marie; Fogen, Frederic; Moine, Sébastien (2015). Promoting palliative care in the community: production of the primary palliative care toolkit by the European Association of Palliative Care Taskforce in primary palliative care. Palliative medicine, 29(2), pp. 101-111. Sage 10.1177/0269216314545006

Eychmüller, Steffen; Forster, M; Gudat, H; Lütolf, U M; Borasio, G D (2015). Undergraduate palliative care teaching in Swiss medical faculties: a nationwide survey and improved learning objectives. BMC medical education, 15, p. 213. BioMed Central 10.1186/s12909-015-0485-0

Eychmüller, Steffen; Zwahlen, Diana; Fliedner, Monica (2014). The oncological patient in the palliative situation. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 197, pp. 59-72. Springer 10.1007/978-3-642-40187-9_5

Domeisen Benedetti, Franzisca; Ostgathe, Christoph; Clark, Jean; Costantini, Massimo; Daud, Maria Laura; Grossenbacher-Gschwend, Barbara; Latten, Richard; Lindqvist, Olav; Peternelj, Andreja; Schuler, Stefanie; Tal, Kali; van der Heide, Agnes; Eychmüller, Steffen (2013). International palliative care experts' view on phenomena indicating the last hours and days of life. Supportive care in cancer, 21(6), pp. 1509-1517. Springer-Verlag 10.1007/s00520-012-1677-3

Eyholzer, Marianne

Pabst, Thomas; Eyholzer, Marianne; Haefliger, Simon; Schardt, Julian; Mueller, Beatrice U (2008). Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. Journal of clinical oncology, 26(31), pp. 5088-93. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.16.5563

Falke, Monika Juliana

Tisch, Carmen; Ernst, Daniel; Falke, Monika; Speicher, Philip; Ziaka, Mairi (2024). Systemic embolization due to non-bacterial thrombotic endocarditis: An autopsy case report and mini review of the literature. SAGE open medical case reports, 12(2050313X241229576) Sage 10.1177/2050313X241229576

Farag, Sarah Ahmed Ibrahim

Farese, Simone Anna

Farese, Simone Anna; Aebi, Stefan (2009). Infiltrating Lobular Carcinoma of the Breast: Systemic Treatment. Breast disease, 30, pp. 45-52. Amsterdam: IOS Press

Federzoni, Elena

Wampfler, Julian; Federzoni, Elena; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2016). The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation. Leukemia research, 41, pp. 96-102. Elsevier 10.1016/j.leukres.2015.12.006

Wampfler, Julian; Federzoni, Elena; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2015). Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells. Journal of leukocyte biology, 98(3), pp. 357-363. Society for Leukocyte Biology 10.1189/jlb.1AB0514-258R

Federzoni, Elena; Gloor, Severin; Jin, Jing; Krauer, Deborah; Fey, Martin; Torbett, Bruce E; Tschan, Mario (2015). Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells. Leukemia research reports, 4(1), pp. 32-35. Elsevier 10.1016/j.lrr.2015.04.002

Federzoni, Elena; Humbert, Magali; Torbett, Bruce E; Behre, Gerhard; Fey, Martin; Tschan, Mario (2014). CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation. Scientific Reports, 4(1), p. 4261. Nature Publishing Group 10.1038/srep04261

Federzoni, Elena A.; Humbert, Magali; Valk, Peter J. M.; Behre, Gerhard; Leibundgut, Elisabeth O.; Torbett, Bruce E; Fey, Martin F.; Tschan, Mario (2013). The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients. British journal of haematology, 160(6), pp. 855-859. Oxford: Wiley-Blackwell 10.1111/bjh.12170

Felber, Sibylle

Eychmüller, Steffen; Felber, Sibylle (2018). Vorausplanung am Lebensende – eine kritische Reflexion für die Praxis. Therapeutische Umschau, 75(2), pp. 117-122. Huber 10.1024/0040-5930/a000976

Felber, Sibylle Jeanine

Feldmeyer, Laurence

Feller, Katrin Madeleine

Felser, Andrea Debora

Fernández Marrero, Yuniel

Ferreira Francisco, David Miguel

Ferro, Iolanda

Fey, Martin

Fey, Martin F; O'Reilly, Seamus; Awada, Ahmad H; Crowley, John; Gelmon, Karen A (2024). Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials. Current opinion in oncology, 36(5), pp. 418-420. Wolters Kluwer Health 10.1097/CCO.0000000000001056

Fey, Martin (2024). The GLOW trial in chronic lymphocytic leukaemia. The Lancet. Oncology, 25(2) Elsevier 10.1016/S1470-2045(23)00620-4

von Wolff, Michael; Fey, Martin F. (2020). Other Malignancies. In: von Wolff, Michael; Nawroth, Frank (eds.) Fertility Preservation in Oncological and Non-Oncological Diseases (pp. 105-113). Cham: Springer 10.1007/978-3-030-47568-0_13

Schüring, A N; Fehm, T; Behringer, K; Goeckenjan, M; Wimberger, P; Henes, M; Henes, J; Fey, Martin; von Wolff, Michael (2018). Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Archives of gynecology and obstetrics, 297(1), pp. 241-255. Springer 10.1007/s00404-017-4594-3

Metzelder, S K; Schroeder, T; Lübbert, M; Ditschkowski, M; Götze, K; Scholl, S; Meyer, R G; Dreger, P; Basara, N; Fey, Martin; Salih, H R; Finck, A; Pabst, Thomas; Giagounidis, A; Kobbe, G; Wollmer, E; Finke, J; Neubauer, A; Burchert, A (2017). Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. European journal of cancer, 86, pp. 233-239. Elsevier 10.1016/j.ejca.2017.09.016

Fey, Martin (2017). The costs of care in haematological cancers: Health economic issues. Hematological oncology, 35(S1), pp. 15-19. Wiley 10.1002/hon.2394

Vidal, A D; Thalmann, George; Karamitopoulou, Evanthia; Fey, Martin; Studer, Urs (2015). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. Annals of oncology, 26(2), pp. 374-377. Oxford University Press 10.1093/annonc/mdu518

Cornelissen, J J; Versluis, J; Passweg, Jakob; van Putten, W L J; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J M; van Marwijk Kooy, M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M-C; Breems, D A; Verdonck, L F; Fey, Martin; Jongen-Lavrencic, M; Janssen, J J W M; Huls, G; Kuball, J; ... (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), pp. 1041-1050. Nature Publishing Group 10.1038/leu.2014.332

Stutz, Emanuel; Gautschi, Oliver; Fey, Martin F.; Gugger, Mathias; Tschan, Mario; Rothschild, Sacha I. (2014). Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology. Future oncology, 10(2), pp. 211-217. Future Medicine Ltd. 10.2217/fon.13.179

Fey, Martin; Buske, C. (2013). Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 24(6), vi138-vi143. Oxford University Press 10.1093/annonc/mdt320

Brigger, Daniel; Torbett, Bruce E.; Chen, Joy; Fey, Martin; Tschan, Mario (2013). Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation. Biochemical and biophysical research communications, 438(2), pp. 283-288. Academic Press 10.1016/j.bbrc.2013.07.056

Batliner, Jasmin; Buehrer, Emanuel; Federzoni, Elena A; Jenal, Mathias; Tobler, Andreas; Torbett, Bruce E; Fey, Martin F; Tschan, Mario P (2012). Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. British journal of haematology, 157(2), pp. 270-274. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2011.08964.x

Batliner, Jasmin; Buehrer, Emanuel; Fey, Martin F; Tschan, Mario P (2012). Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells. Leukemia research, 36(2), pp. 237-40. Amsterdam: Elsevier 10.1016/j.leukres.2011.10.006

Rothschild, S I; Tschan, M P; Federzoni, E A; Jaggi, R; Fey, M F; Gugger, M; Gautschi, O (2012). MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene, 31(38), pp. 4221-32. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2011.578

Rothschild, Sacha I; Tschan, Mario P; Jaggi, Rolf; Fey, Martin F; Gugger, Mathias; Gautschi, Oliver (2012). MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma. Journal of thoracic oncology, 7(7), pp. 1069-77. Hagerstown, Md.: Wolters Kluwer Health/Lippincott Williams & Wilkins 10.1097/JTO.0b013e31824fe976

Metzelder, S K; Schroeder, T; Finck, A; Scholl, S; Fey, M; Götze, K; Linn, Y C; Kröger, M; Reiter, A; Salih, H R; Heinicke, T; Stuhlmann, R; Müller, L; Giagounidis, A; Meyer, R G; Brugger, W; Vöhringer, M; Dreger, P; Mori, M; Basara, N; ... (2012). High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia, 26(11), pp. 2353-2359. Basingstoke: Nature Publishing Group 10.1038/leu.2012.105

Federzoni, Elena A; Valk, Peter J M; Torbett, Bruce E; Haferlach, Torsten; Löwenberg, Bob; Fey, Martin F; Tschan, Mario P (2012). PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood, 119(21), pp. 4963-70. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-09-378117

Humbert, Magali; Mueller, Chantal; Fey, Martin F; Tschan, Mario P (2012). Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells. Leukemia research, 36(12), pp. 1552-6. Amsterdam: Elsevier 10.1016/j.leukres.2012.08.024

Batliner, Jasmin; Mancarelli, Maria Michela; Jenal, Mathias; Reddy, Venkateshwar A; Fey, Martin F; Torbett, Bruce E; Tschan, Mario P (2011). CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. Molecular immunology, 48(4), pp. 714-9. Amsterdam: Elsevier 10.1016/j.molimm.2010.10.016

Fey, Martin F; Tobler, Andreas (2011). Marriage risk of cancer research fellows. Lancet, 378(9809), p. 2070. London: Elsevier 10.1016/S0140-6736(11)61898-9

Fey, ; Martin, F (2011). [Recombinant proteins as therapeutic compounds in clinical oncology]. Therapeutische Umschau, 68(11), pp. 618-30. Bern: Huber 10.1024/0040-5930/a000222

Vellenga, Edo; van Putten, Wim; Ossenkoppele, Gert J; Verdonck, Leo F; Theobald, Matthias; Cornelissen, Jan J; Huijgens, Peter C; Maertens, Johan; Gratwohl, Alois; Schaafsma, Ron; Schanz, Urs; Graux, Carlos; Schouten, Harry C; Ferrant, Augustin; Bargetzi, Mario; Fey, Martin F; Löwenberg, Bob; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), ; Swiss Group for Clinical Cancer Research Collaborative Group (SA, (2011). Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood, 118(23), pp. 6037-42. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-07-370247

Fey, M. F. (2011). VI. DNA microarray technology. Principles and application to the analysis of malignant tumours (with special emphasis on lymphoma). Annals of oncology, 22(Suppl. 4), iv44-iv46. Oxford University Press 10.1093/annonc/mdr172

Jenal, M; Batliner, J; Reddy, V A; Haferlach, T; Tobler, A; Fey, M F; Torbett, B E; Tschan, M P (2010). The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia, 24(5), pp. 1073-6. Basingstoke: Nature Publishing Group 10.1038/leu.2010.26

Britschgi, Adrian; Simon, Hans-Uwe; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2010). Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. British journal of haematology, 149(1), pp. 55-64. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2009.08040.x

Fey, Martin (2010). Lymphoma--a topic with seven seals. Therapeutische Umschau, 67(10), p. 489. Bern: Huber

Fey, Martin (2010). Salient clinical features of lymphoma and related lymphoproliferative disorders. Therapeutische Umschau, 67(10), pp. 491-495. Bern: Huber 10.1024/0040-5930/a000083

Fey, M F; Dreyling, M (2010). Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 21 Suppl 5, v158-v161. Oxford: Oxford University Press 10.1093/annonc/mdq179

Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen; Gelber, Richard; Holmberg, Stig; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin; Murray, Elizabeth; Forbes, John; Coates, Alan; Goldhirsch, Aron (2009). Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, 116(3), pp. 491-500. Dordrecht: Springer 10.1007/s10549-008-0225-9

Andina, N; Conus, S; Schneider, E M; Fey, M F; Simon, H U (2009). Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell death and differentiation, 16(9), pp. 1248-55. Basingstoke: Nature Publishing Group 10.1038/cdd.2009.50

Fey, M; Dreyling, M (2009). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 20 Suppl 4, pp. 100-101. Oxford: Oxford University Press 10.1093/annonc/mdp141

Pagani, Olivia; Price, Karen N; Gelber, Richard D; Castiglione-Gertsch, Monica; Holmberg, Stig B; Lindtner, Jurij; Thürlimann, Beat; Collins, John; Fey, Martin F; Coates, Alan S; Goldhirsch, Aron (2009). Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast cancer research and treatment, 117(2), pp. 319-24. Dordrecht: Springer 10.1007/s10549-008-0282-0

Fey, M F (2008). New insights into molecular mechanisms of haematological malignancies. Annals of oncology, 19 Suppl 5, v59-62. Oxford: Oxford University Press 10.1093/annonc/mdn312

Fey, M; Dreyling, M (2008). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii58-9. Oxford: Oxford University Press 10.1093/annonc/mdn089

Gruber, G; Cole, B F; Castiglione-Gertsch, M; Holmberg, S B; Lindtner, J; Golouh, R; Collins, J; Crivellari, D; Thürlimann, B; Simoncini, E; Fey, M F; Gelber, R D; Coates, A S; Price, K N; Goldhirsch, A; Viale, G; Gusterson, B A (2008). Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of oncology, 19(8), pp. 1393-401. Oxford: Oxford University Press 10.1093/annonc/mdn123

Fey, M F; Surbek, D (2008). Leukaemia and pregnancy. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 97-110. Berlin: Springer

Tschan, M P; Reddy, V A; Ress, A; Arvidsson, G; Fey, M F; Torbett, B E (2008). PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene, 27(24), pp. 3489-93. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1211004

Westermann, Dirk H; Schefer, Hubert; Thalmann, George N; Karamitopoulou-Diamantis, Evanthia; Fey, Martin F; Studer, Urs E (2008). Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Journal of urology, 179(1), pp. 163-6. New York, N.Y.: Elsevier 10.1016/j.juro.2007.08.172

Kuhn, A; Leupin, N; Fey, M.F.; Yousefi, S; Simon, H.U. (2008). Leukaemia cell lines are robust in vitro models - response to MacLeod & Drexler. British journal of haematology(142), pp. 138-141. Oxford: Wiley-Blackwell

Laurencet, F; Ballabeni, P; Rufener, B; Hess, U; Cerny, T; Fey, M; Luthi, JM; Plancherel, C; Zulian, GB; Swiss, Group for Clinical Research (SAKK) (2007). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica, 117(1), pp. 40-7. Basel: Karger 10.1159/000096787

Karlsson, Per; Cole, Bernard F; Price, Karen N; Coates, Alan S; Castiglione-Gertsch, Monica; Gusterson, Barry A; Murray, Elizabeth; Lindtner, Jurij; Collins, John P; Holmberg, Stig B; Fey, Martin F; Thürlimann, Beat; Crivellari, Diana; Forbes, John F; Gelber, Richard D; Goldhirsch, Aron; Wallgren, Arne (2007). The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of clinical oncology, 25(15), pp. 2019-26. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.8152

Rizzi, Mattia; Tschan, Mario P; Britschgi, Christian; Britschgi, Adrian; Hügli, Barbara; Grob, Tobias J; Leupin, Nicolas; Mueller, Beatrice U; Simon, Hans-Uwe; Ziemiecki, Andrew; Torbett, Bruce E; Fey, Martin F; Tobler, Andreas (2007). The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. Journal of leukocyte biology, 81(6), pp. 1599-608. Bethesda, Md.: Society for Leukocyte Biology 10.1189/jlb.0606400

van den Heuvel-Eibrink, Marry M; van der Holt, Bronno; Burnett, Alan K; Knauf, Wolfgang U; Fey, Martin F; Verhoef, Gregor E G; Vellenga, Edo; Ossenkoppele, Gert J; Löwenberg, Bob; Sonneveld, Pieter (2007). CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Annals of hematology, 86(5), pp. 329-37. Berlin: Springer 10.1007/s00277-007-0269-7

Fey, M F (2007). Normal and malignant hematopoiesis. Annals of oncology, 18 Suppl 1, i9-i13. Oxford: Oxford University Press 10.1093/annonc/mdl444

Fey, M F (2007). Salient features of hematological diseases. Annals of oncology, 18 Suppl 1, i54-i64. Oxford: Oxford University Press 10.1093/annonc/mdl452

Tschan, M P; Gullberg, U; Shan, D; Torbett, B E; Fey, M F; Tobler, A (2007). The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. Leukemia, 22(5), pp. 1087-1090. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2405018

Fey, Martin (2007). Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of oncology, 18(suppl_2), ii47-ii48. Oxford University Press 10.1093/annonc/mdm033

Leupin, Nicolas; Kuhn, Alexandre; Hügli, Barbara; Grob, Tobias J; Jaggi, Rolf; Tobler, Andreas; Delorenzi, Mauro; Fey, Martin F (2006). Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines. British journal of haematology, 135(4), pp. 520-3. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2006.06342.x

Leyvraz, S; Herrmann, R; Guillou, L; Honegger, HP; Christinat, A; Fey, MF; Sessa, C; Wernli, M; Cerny, T; Dietrich, D; Pestalozzi, B; Swiss, Group for Clinical Cancer Research (SAKK) (2006). Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies. British journal of cancer, 95(10), pp. 1342-7. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6603420

Leyvraz, S; Zweifel, M; Jundt, G; Lissoni, A; Cerny, T; Sessa, C; Fey, M; Dietrich, D; Honegger, HP; Swiss, Group for Clinical Cancer Research (2006). Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas. Annals of oncology, 17(4), pp. 646-51. Oxford: Oxford University Press 10.1093/annonc/mdl020

de Botton, S; Sanz, MA; Chevret, S; Dombret, H; Martin, G; Thomas, X; Mediavilla, JD; Recher, C; Ades, L; Quesnel, B; Brault, P; Fey, M; Wandt, H; Machover, D; Guerci, A; Maloisel, F; Stoppa, AM; Rayon, C; Ribera, JM; Chomienne, C; ... (2006). Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia, 20(1), pp. 35-41. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404006

Fey, M. F.; Greil, R.; Jost, L. M. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. Annals of oncology, 16(suppl_1), i48-i49. Oxford University Press 10.1093/annonc/mdi802

Fey, M. F. (2005). Principles of Molecular Oncology. Annals of oncology, 16(1), pp. 175-176. Oxford University Press 10.1093/annonc/mdi011

Altznauer, Frank; Martinelli, Sibylla; Yousefi, Shida; Thürig, Christine; Schmid, Inès; Conway, Edward M; Schöni, Martin H; Vogt, Peter; Mueller, Christoph; Fey, Martin F; Zangemeister-Wittke, Uwe; Simon, Hans-Uwe (2004). Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. The Journal of experimental medicine, 199(10), pp. 1343-1354. Rockefeller Univ. Press 10.1084/jem.20032033

Fey, M. F. (2003). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of acute myeloblastic leukaemia (AML) in adult patients. Annals of oncology, 14(8), pp. 1161-1162. Oxford University Press 10.1093/annonc/mdg337

Fey, M. F. (2002). The impact of chip technology on cancer medicine. Annals of oncology, 13(suppl 4), pp. 109-113. Oxford University Press 10.1093/annonc/mdf647

Peters, Uwe R; Hasse, Urs; Oppliger Leibundgut, Elisabeth; Tschan, Mario; Ong, S Tiong; Rassool, Feyruz V; Borisch, Bettina; Tobler, Andreas; Fey, Martin (1999). Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. Oncogene, 18(1), pp. 79-85. Nature Publishing Group 10.1038/sj.onc.1202256

Hasse, Urs; Tinguely, Marianne; Oppliger Leibundgut, Elisabeth; Cajot, Jean-François; Garvin, Alex M.; Tobler, Andreas; Borisch, Bettina; Fey, Martin F. (1999). Clonal Loss of Heterozygosity in Microdissected Hodgkin and Reed-Sternberg Cells. Journal of the National Cancer Institute JNCI, 91(18), pp. 1581-1583. Oxford University Press 10.1093/jnci/91.18.1581

Fey, M. F.; Tobler, Andreas (1996). Tumour heterogeneity and clonality - an old theme revisited. Annals of oncology, 7(2), pp. 121-128. Oxford University Press 10.1093/oxfordjournals.annonc.a010537

Nagel, S.; Borisch, B.; Von Rohr, A.; Tobler, Andreas; Fey, Martin (1996). Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lymphocytic leukaemia. Annals of oncology, 7(9), pp. 953-960. Oxford University Press 10.1093/oxfordjournals.annonc.a010799

Seitz, M.; Loetscher, P.; Fey, M. F.; Tobler, Andreas (1994). CONSTITUTIVE mRNA AND PROTEIN PRODUCTION OF MACROPHAGE COLONY-STIMULATING FACTOR BUT NOT OF OTHER CYTOKINES BY SYNOVIAL FIBROBLASTS FROM RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS. Rheumatology, 33(7), pp. 613-619. Oxford University Press 10.1093/rheumatology/33.7.613

Fiedler, Georg Martin

Fischer, Elia Luca

Fischer, Urs Martin

Fleischmann, Achim

Fliedner, Monika

Lo Priore, Elia; Fliedner, Monica; Heverhagen, Johannes; Novak, Urban; Marschall, Jonas (2017). The role of a surveillance programme for introducing peripherally inserted central catheters: a 2-year observational study in an academic hospital. Swiss medical weekly, 147(w14441), w14441. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14441

Fontana, Stefano

Pabst, T; Fontana, S; Groebli, R; Leibundgut, K; Zwicky, C; Taleghani, BM (2006). Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency. Transfusion, 46(8), pp. 1408-16. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2006.00910.x

Forster, Stefan

Forster, Stefan; Radpour, Ramin; Ochsenbein, Adrian F (2023). Molecular and immunological mechanisms of clonal evolution in multiple myeloma. Frontiers in immunology, 14(1243997), p. 1243997. Frontiers Research Foundation 10.3389/fimmu.2023.1243997

Forster, Stefan; Radpour, Ramin (2022). Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease. Frontiers in oncology, 12, p. 941437. Frontiers Research Foundation 10.3389/fonc.2022.941437

Forster, Stefan; Radpour, Ramin (2020). Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells. Frontiers in oncology, 10, p. 569017. Frontiers Research Foundation 10.3389/fonc.2020.569017

Fos Trigas, José

Fos, José; Pabst, Thomas; Petkovic, Vibor; Ratschiller, Daniel; Mueller, Beatrice U (2011). Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis. Blood, 117(18), pp. 4881-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-11-320747

Francica, Paola

Franco Duran, Oscar Horacio

Frangez, Ziva

Frehner, Lorenz Hermann

Frehner, Lorenz; Berger, Martin D. (2023). Update: Metastasiertes Pankreaskarzinom. info@onco-suisse(04), pp. 12-14. Aerzteverlag medinfo AG

Frei, Ana Leni

Freigang, Stefan Bernd

Frese, Steffen R.

Fricker, Michael

Friedemann Krentel, Andreas

Friedli, Olivier

Friess, Dorothea

Friess, Helmut

Froment, Laurène

Früh, Martin

Plomer, Eva; Früh, Martin; Lauber, Arno; Demmer, Izadora; Jochum, Wolfram; Koster, Kira-Lee (2024). Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR-, HER2-, MET- and ROS1-Alterated Lung Adenocarcinoma. International journal of molecular sciences, 25(11) MDPI 10.3390/ijms25115698

Mark, Michael; Froesch, Patrizia; Gysel, Katrin; Rothschild, Sacha I; Addeo, Alfredo; Ackermann, Christoph J; Chiquet, Sabrina; Schneider, Martina; Ribi, Karin; Maranta, Angela Fischer; Bastian, Sara; von Moos, Roger; Joerger, Markus; Früh, Martin (2024). First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17. European journal of cancer, 200(113600), p. 113600. Elsevier 10.1016/j.ejca.2024.113600

Schuler, A; Huser, J; Schmid, S; Schär, S; Scherz, A; Gautschi, O; Mauti, L; von Briel, T; Waibel, C; Wannesson, L; Pankovics, J; Mark, M T; Rothschild, S I; Addeo, A; Janthur, W D; Siano, M; Boos, L; Britschgi, C; Früh, M (2024). Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study. Lung cancer, 187(107427), p. 107427. Elsevier 10.1016/j.lungcan.2023.107427

Vermeille, Matthieu; Koster, Kira-Lee; Benzaquen, David; Champion, Ambroise; Taussky, Daniel; Kaulanjan, Kevin; Früh, Martin (2023). A Literature Review of Racial Disparities in Prostate Cancer Research. Current oncology, 30(11), pp. 9886-9894. MDPI 10.3390/curroncol30110718

König, D; Savic Prince, S; Hayoz, S; Zens, P; Berezowska, S; Jochum, W; Stauffer, E; Braunersreuther, V; Trachsel, B; Thierstein, S; Mark, M; Schmid, S; Curioni-Fontecedro, A; Addeo, A; Opitz, I; Guckenberger, M; Früh, M; Betticher, D C; Ris, H-B; Stupp, R; ... (2023). Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14. ESMO open, 8(4), p. 101595. BMJ 10.1016/j.esmoop.2023.101595

Nuñez, Nicolas Gonzalo; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; Gomez, Julia Martinez; Purde, Mette-Triin; Niederer, Rebekka; Porsch, Maximilian; Lichtensteiger, Christa; Kramer, Rafaela; Erdmann, Michael; Schmitt, Christina; Heinzerling, Lucie; Abdou, Marie-Therese; Karbach, Julia; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma; Klümper, Niklas; ... (2023). Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. Med (N Y), 4(2), 113-129.e7. Cell Press 10.1016/j.medj.2022.12.007

Furrer, Katarzyna; Weder, Walter; Eboulet, Eric Innocents; Betticher, Daniel; Pless, Miklos; Stupp, Roger; Krueger, Thorsten; Perentes, Jean Yannis; Schmid, Ralph A; Lardinois, Didier; Furrer, Markus; Früh, Martin; Peters, Solange; Curioni-Fontecedro, Alessandra; Stahel, Rolf A; Rothschild, Sacha I; Hayoz, Stefanie; Opitz, Isabelle (2022). Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment. The journal of thoracic and cardiovascular surgery, 164(6), 1587-1602.e5. Elsevier 10.1016/j.jtcvs.2022.03.034

Addeo, Alfredo; Rothschild, Sacha I; Holer, Lisa; Schneider, Martina; Waibel, Christine; Haefliger, Simon; Mark, Michael; Fernandez, Eugenio; Mach, Nicolas; Mauti, Laetitia; Jermann, Philip M; Alborelli, Ilaria; Calgua, Byron; Savic-Prince, Spasenija; Joerger, Markus; Früh, Martin (2022). Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. Lung cancer, 172, pp. 154-159. Elsevier 10.1016/j.lungcan.2022.08.016

Berner, Fiamma; Bomze, David; Lichtensteiger, Christa; Walter, Vincent; Niederer, Rebekka; Hasan Ali, Omar; Wyss, Nina; Bauer, Jens; Freudenmann, Lena Katharina; Marcu, Ana; Wolfschmitt, Eva-Maria; Haen, Sebastian; Gross, Thorben; Abdou, Marie-Therese; Diem, Stefan; Knöpfli, Stella; Sinnberg, Tobias; Hofmeister, Kathrin; Cheng, Hung-Wei; Toma, Marieta; ... (2022). Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade. Science immunology, 7(75), eabn9644. American Association for the Advancement of Science 10.1126/sciimmunol.abn9644

Mark, M; Rusakiewicz, S; Früh, M; Hayoz, S; Grosso, F; Pless, M; Zucali, P; Ceresoli, G L; Maconi, A; Schneider, M; Froesch, P; Tarussio, D; Benedetti, F; Dagher, J; Kandalaft, L; von Moos, R; Tissot-Renaud, S; Schmid, S; Metaxas, Y (2022). Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO open, 7(3), p. 100446. BMJ 10.1016/j.esmoop.2022.100446

König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO open, 7(3), p. 100494. Elsevier 10.1016/j.esmoop.2022.100494

Dafni, U; Soo, R A; Peters, S; Tsourti, Z; Zygoura, P; Vervita, K; Han, J-Y; De Castro, J; Coate, L; Früh, M; Hashemi, S M S; Nadal, E; Carcereny, E; Sala, M A; Bernabé, R; Provencio, M; Cuffe, S; Roschitzki-Voser, H; Ruepp, B; Rosell, R; ... (2022). Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis. ESMO open, 7(3), p. 100507. Elsevier 10.1016/j.esmoop.2022.100507

Purde, Mette‑Triin; Niederer, Rebekka; Wagner, ikolaus B.; Diem, Stefan; Berner, Fiamma; Hasan Ali, Omar; Hillmann, Dorothea; Bergamin, Irina; Joerger, Markus; Risch, Martin; Niederhauser, Christoph; Lenz, Tobias L.; Früh, Martin; Risch, Lorenz; Semela, David; Flatz, Lukas (2022). Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology, 148(3), pp. 647-656. Springer 10.1007/s00432-021-03870-6

Koster, Kira-Lee; Appenzeller, Christina; Lauber, Arno; Früh, Martin; Schmid, Sabine (2022). Sotorasib Shows Intracranial Activity in Patients with KRAS G12C-Mutated Adenocarcinoma of the Lung and Untreated Active Brain Metastases. Case reports in oncology, 15(2), pp. 720-725. Karger 10.1159/000525341

Neff, Dominik; Padberg Sgier, Barbara-Christina; Dietze, Hannah; Müller, Joachim; Früh, Martin (2022). Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports. Case reports in oncology, 15(3), pp. 1001-1008. Karger 10.1159/000526974

Putora, Paul Martin; Fischer, G F; Früh, Martin; Califano, R; Faivre-Finn, C; Van Houtte, P; McDonald, F; Nestle, U; Dziadziuszko, R; Le Pechoux, C; Ramella, S; Belderbos, J; Slotman, B J; Troost, E G C; Peeters, S; Widder, J; Pöttgen, C; Reck, M; Blackhall, F; Cappuzzo, F; ... (2020). Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 149, pp. 84-88. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2020.04.015

Früh, M.; Panje, C.M.; Reck, M; Blackhall, F; Califano, R; Cappuzzo, F; Besse, B; Novello, S; Garrido, P; Felip, E; O'Brien, M; Paz Ares, L; de Marinis, F; Westeel, V; De Ruysscher, D; Putora, P.M. (2020). Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung cancer, 146, pp. 6-11. Elsevier 10.1016/j.lungcan.2020.03.024

Früh, Martin; Betticher, Daniel C; Stupp, Roger; Xyrafas, Alexandros; Peters, Solange; Ris, Hans Beat; Mirimanoff, Rene Olivier; Ochsenbein, Adrian F.; Schmid, Ralph; Matzinger, Oscar; Stahel, Rolf A; Weder, Walter; Guckenberger, Matthias; Rothschild, Sacha I; Lardinois, Didier; Mach, Nicholas; Mark, Michael; Gautschi, Oliver; Thierstein, Sandra; Biaggi Rudolf, Christine; ... (2019). Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01). Journal of thoracic oncology, 14(1), pp. 115-123. Elsevier 10.1016/j.jtho.2018.09.011

Peters, Solange; Gettinger, Scott; Johnson, Melissa L; Jänne, Pasi A; Garassino, Marina C; Christoph, Daniel; Toh, Chee Keong; Rizvi, Naiyer A; Chaft, Jamie E; Carcereny Costa, Enric; Patel, Jyoti D; Chow, Laura Q M; Koczywas, Marianna; Ho, Cheryl; Früh, Martin; van den Heuvel, Michel; Rothenstein, Jeffrey; Reck, Martin; Paz-Ares, Luis; Shepherd, Frances A; ... (2017). Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). Journal of clinical oncology, 35(24), pp. 2781-2789. American Society of Clinical Oncology 10.1200/JCO.2016.71.9476

Delaunay, Myriam; Cadranel, Jacques; Lusque, Amélie; Meyer, Nicolas; Gounant, Valérie; Moro-Sibilot, Denis; Michot, Jean-Marie; Raimbourg, Judith; Girard, Nicolas; Guisier, Florian; Planchard, David; Metivier, Anne-Cécile; Tomasini, Pascale; Dansin, Eric; Pérol, Maurice; Campana, Marion; Gautschi, Oliver; Früh, Martin; Fumet, Jean-David; Audigier-Valette, Clarisse; ... (2017). Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients. European respiratory journal, 50(2) European Respiratory Society 10.1183/13993003.00050-2017

Baty, Florent; Joerger, Markus; Früh, Martin; Klingbiel, Dirk; Zappa, Francesco; Brutsche, Martin (2017). 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling. Journal of translational medicine, 15(1), p. 66. BioMed Central 10.1186/s12967-017-1174-z

Fung, Christian

Funke, Manuela

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Funke-Chambour, Manuela

Furrer, Hansjakob

Castillo, Jorge J; Bower, Mark; Brühlmann, Jérémy; Novak, Urban; Furrer, Hansjakob; Tanaka, Paula Y; Besson, Caroline; Montoto, Silvia; Cwynarski, Kate; Abramson, Jeremy S; Dalia, Samir; Bibas, Michele; Connors, Joseph M; Furman, Michael; Nguyen, Minh-Ly; Cooley, Timothy P; Beltran, Brady E; Collins, Jaime A; Vose, Julie M; Xicoy, Blanca; ... (2014). Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study. Cancer research, 121(3), pp. 423-431. American Association for Cancer Research AACR 10.1002/cncr.29066

Furrer, Marc

Fux, Michaela

Simonis, Alexander; Fux, Michaela; Nair, Gayathri; Mueller, Nicolas J; Haralambieva, Eugenia; Pabst Müller, Thomas Niklaus; Pachlopnik Schmid, Jana; Schmidt, Adrian; Schanz, Urs; Manz, Markus G; Müller, Antonia M S (2018). Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature. Annals of hematology, 97(10), pp. 1961-1973. Springer-Verlag 10.1007/s00277-018-3388-4

Förger, Frauke

Gahl, Brigitta

Galván Hernández, José Alberto

Gao, Yanyun

Gasser, Pascal

Gautschi, Oliver

Barbier, Michaela Carla; Fengler, Alicia; Pardo, Esther; Bhadhuri, Arjun; Meier, Niklaus; Gautschi, Oliver (2023). Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland. PharmacoEconomics, 41(12), pp. 1641-1655. Springer 10.1007/s40273-023-01305-3

Mushtaq, Rao; Cortot, Alexis B; Gautschi, Oliver; Mazieres, Julien; Camidge, D Ross (2022). PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case series. Translational lung cancer research, 11(12), pp. 2412-2417. AME Publishing 10.21037/tlcr-22-329

Rothschild, Sacha I; Kappeler, Andreas; Ratschiller, Daniel; Betticher, Daniel C; Tschan, Mario P; Gugger, Mathias; Gautschi, Oliver (2011). The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung cancer, 71(3), pp. 306-11. Amsterdam: Elsevier 10.1016/j.lungcan.2010.06.018

Ruhstaller, Thomas; Pless, Miklos; Dietrich, Daniel; Kranzbuehler, Helmut; von Moos, Roger; Moosmann, Peter; Montemurro, Michael; Schneider, Paul M; Rauch, Daniel; Gautschi, Oliver; Mingrone, Walter; Widmer, Lucas; Inauen, Roman; Brauchli, Peter; Hess, Viviane (2011). Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, 29(6), pp. 626-31. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.31.9715

Rothschild, Sacha I; Gautschi, Oliver; Haura, Eric B; Johnson, Faye M (2010). Src inhibitors in lung cancer: current status and future directions. Clinical lung cancer, 11(4), pp. 238-42. New York, N.Y.: Elsevier 10.3816/CLC.2010.n.030

Gautschi, Oliver (2010). The polyamine metabolism: renaissance of an old pathway in oncology. Clinical lung cancer, 11(2), pp. 80-1. New York, N.Y.: Elsevier 10.3816/CLC.2010.n.010

Gautschi, O; Mack, PC; Gandara, DR; Rosell, R. (2010). Pharmacogenomics in Lung Cancer: Predictive Biomarkers for Chemotherapy. In: Pass, HL; Carbone, DP; Johnson, DH; Minna, JD; Turrisi, AT; Scagliotti, GV (eds.) Lung Cancer, Prinicples and Practice. Baltimore USA: Lippincott Williams & Wilkins

Rothschild, S; Gautschi, O (2010). KRAS bei anderen Tumoren. In: Bremen et al.: UNI-MED

Gautschi, Ol; Pless, M (2010). Swiss Trials in Thoracic Oncology. In: Magazine of European Medical Oncology.

Rothschild, S; Betticher, D; Ochsenbein, A; Stahel, R; Bubendorf L.Gugger, M.; Brutsche, M; Pless, M; Gautschi, O (2010). Bedeutung der Histologie für die Therapie des fortgeschrittenen, nicht-kleinzelligen Bronchuskarzinoms. In: Swiss Med Forum

Rothschild, S; Gautschi, O (2010). NSCLC bei Patienten in reduziertem Allgemeinzustand: Mehr oder weniger Chemotherapie? In: Leading Opinions Hämatologie & Onkologie

Rothschild, S; Gautschi, O (2010). Die molekulare Behandlung des Kolonkarzinoms. In: Schweizer Zeitschrift für Onkologie

Purnell, Phillip R; Mack, Philip C; Tepper, Clifford G; Evans, Christopher P; Green, Tim P; Gumerlock, Paul H; Lara, Primo N; Gandara, David R; Kung, Hsing-Jien; Gautschi, Oliver (2009). The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells. Journal of thoracic oncology, 4(4), pp. 448-54. Hagerstown, Md.: Wolters Kluwer Health/Lippincott Williams & Wilkins 10.1097/JTO.0b013e31819c78fb

Gandara, DR; Kawaguchi, T; Crowley, J; Moon, J; Furuse, K; Kawahara, M; Teramukai, S; Ohe, Y; Kubota, K; Williamson, SK; Gautschi, O; Lenz, HJ; McLeod, HL; Lara, PN Jr; Coltman, CA Jr; Fukuoka, M; Saijo, N; Fukushima, M; Mack, PC (2009). Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. Journal of clinical oncology, 27(21), pp. 3540-3546. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.20.8793

Ho, Cheryl; Ochsenbein, Adrian F; Gautschi, Oliver; Davies, Angela M (2008). Early clinical trial experience with vaccine therapies in non-small-cell lung cancer. Clinical lung cancer, 9 Suppl 1, S20-S27. New York, N.Y.: Elsevier 10.3816/CLC.2008.s.004

Gautschi, Oliver; Heighway, Jim; Mack, Philip C; Purnell, Phillip R; Lara, Primo N; Gandara, David R (2008). Aurora kinases as anticancer drug targets. Clinical cancer research, 14(6), pp. 1639-48. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-07-2179

Gautschi, Oliver; Tepper, Clifford G; Purnell, Phillip R; Izumiya, Yoshihiro; Evans, Christopher P; Green, Tim P; Desprez, Pierre Y; Lara, Primo N; Gandara, David R; Mack, Philip C; Kung, Hsing-Jien (2008). Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer research, 68(7), pp. 2250-8. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-07-6403

Gautschi, O (2008). Pharmacogenomic Approaches to Individualizing Chemotherapy for Non-.Small Cell Lung Cancer. Clinical lung cancer, 2008;9(S3), pp. 129-38. New York, N.Y.: Elsevier 10.3816/CLC.2008.s.019

Gautschi, Oliver; Ratschiller, Daniel; Gugger, Mathias; Betticher, Daniel C; Heighway, Jim (2007). Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung cancer, 55(1), pp. 1-14. Amsterdam: Elsevier 10.1016/j.lungcan.2006.09.024

Ziegler, Annemarie; Seemayer, Christian A; Hinterberger, Marc; Vogt, Peter; Bigosch, Colette; Gautschi, Oliver; Tornillo, Luigi; Betticher, Daniel C; Moch, Holger; Stahel, Rolf A (2007). Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung cancer, 57(3), pp. 282-91. Amsterdam: Elsevier 10.1016/j.lungcan.2007.03.025

Gautschi, O; Huegli, B; Ziegler, A; Gugger, M; Heighway, J; Ratschiller, D; Mack, P C; Gumerlock, P H; Kung, H J; Stahel, R A; Gandara, D R; Betticher, D C (2007). Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer letters, 254(2), pp. 265-73. Amsterdam: Elsevier 10.1016/j.canlet.2007.03.008

Gandara, David R; Davies, Angela M; Gautschi, Oliver; Mack, Philip C; Lau, Derick H; Lara, Primo N; Hirsch, Fred R (2007). Epidermal growth factor receptor inhibitors plus chemotherapy in non-small-cell lung cancer: biologic rationale for combination strategies. Clinical lung cancer, 8 Suppl 2, S61-S67. New York, N.Y.: Elsevier 10.3816/CLC.2007.s.003

Ho, C; Davies, AM; Lara, PN; Gautschi, O; Mack, PC; Gumerlock, PH; Gandara, DR (2007). Molecular Targeting in Oncology. In: (pp. 20-40). New York: Humana Press

Gautschi, O (2007). Cellular and molecular biology of lung cancer as the basis for targeted therapy. In: (pp. 30-40). Informa Healthcare

Ho, C; Gautschi, O; Lara, PN; Gandara, DR; Davies, AM (2007). Lung cancer vaccines. In: (pp. 50-60). Informa Healthcare

Gautschi, Oliver; Zangemeister-Wittke, U.; Stahel, R. A. (2003). Comment on “A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer”, by C. M. Rudin et al. (Ann Oncol 2002; 13: 539–545). Annals of oncology, 14(1), p. 170. Oxford University Press 10.1093/annonc/mdg001

Gazdhar, Amiq

Ge, Huixiang

Geiser, Thomas

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Genitsch Gratwohl, Vera

Geretschläger, Andreas

Germic, Nina

Geuking, Markus

Ghadjar, Pirus

Gharib, Walid

Giger, Roland

Gillessen, Silke

Marra, Giancarlo; van Leenders, Geert J L H; Zattoni, Fabio; Kesch, Claudia; Rajwa, Pawel; Cornford, Philip; van der Kwast, Theodorus; van den Bergh, Roderick C N; Briers, Erik; Van den Broeck, Thomas; De Meerleer, Gert; De Santis, Maria; Eberli, Daniel; Farolfi, Andrea; Gillessen, Silke; Grivas, Nikolaos; Grummet, Jeremy P; Henry, Ann M; Lardas, Michael; Lieuw, Matt; ... (2023). Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. European urology, 84(1), pp. 65-85. Elsevier 10.1016/j.eururo.2023.03.014

Hussain, Maha; Carducci, Michael A; Clarke, Noel; Fenton, Sarah E; Fizazi, Karim; Gillessen, Silke; Jacene, Heather; Morris, Michael J; Saad, Fred; Sartor, Oliver; Taplin, Mary-Ellen; Vapiwala, Neha; Williams, Scott; Sweeney, Christopher (2022). Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? Journal of clinical oncology, 40(26), pp. 3011-3014. American Society of Clinical Oncology 10.1200/JCO.22.00208

Terbuch, Angelika; Posch, Florian; Bauernhofer, Thomas; Jost, Philipp Jakob; Partl, Richard; Stranzl-Lawatsch, Heidi; Baciarello, Giulia; Fizazi, Karim; Giannatempo, Patrizia; Verzoni, Elena; Sweeney, Christopher; Ravi, Praful; Tran, Ben; Basso, Umberto; White, Jeff; Vincenzi, Bruno; Oing, Christoph; Cutuli, Hernan Javier; Dieckmann, Klaus Peter; Gamulin, Marija; ... (2022). Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy. International journal of radiation oncology, biology, physics, 113(4), pp. 825-832. Elsevier 10.1016/j.ijrobp.2022.03.021

Turco, F; Smith, M; Omlin, A; Gillessen, S (2022). Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.02.010. European urology, 82(1), e13. Elsevier 10.1016/j.eururo.2022.03.029

Mukherji, Deborah; Youssef, Bassem; Dagher, Christelle; El-Hajj, Albert; Nasr, Rami; Geara, Fadi; Rabah, Danny; Al Dousari, Saad; Said, Rabih; Ashou, Raja; Wazzan, Wassim; Jabbour, Michel; Farha, George; Al Hamdani, Nibras; Al Hallaq, Yousuf; Ghazal, Hassan; Dbouk, Haifa; Bachir, Bassel; El Khoury, Clement; Sakr, Ghazi; ... (2020). Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations. World journal of urology, 38(3), pp. 681-693. Springer-Verlag 10.1007/s00345-019-02872-x

Witjes, J Alfred; Babjuk, Marek; Bellmunt, Joaquim; Bruins, H Maxim; De Reijke, Theo M; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J; Shariat, Shahrokh F; Der Kwast, Theo Van; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C; ... (2020). EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European urology, 77(2), pp. 223-250. Elsevier 10.1016/j.eururo.2019.09.035

Gillessen, Silke; de Bono, Johann S; Sartor, Oliver; Omlin, Aurelius Gabriel (2018). Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211. European urology, 73(2), e32-e33. Elsevier 10.1016/j.eururo.2017.08.014

Rothermundt, Christian; Thurneysen, Claudio; Cathomas, Richard; Müller, Beat; Mingrone, Walter; Hirschi-Blickenstorfer, Anita; Wehrhahn, Tobias; Ruf, Christian; Rothschild, Sacha; Seifert, Bettina; Terbuch, Angelika; Grassmugg, Thomas; Woelky, Regina; Fankhauser, Christian; Kunit, Thomas; Fischer, Natalie Fischer; Inauen, Roman; Kamradt, Jörn; Ziegler, Katrin; Haynes, Alan; ... (2018). Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Swiss medical weekly, 148, w14640. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14640

Glatzer, Markus

Gloor, Beat

Storni, Federico; Trepp, Roman; Perren, Aurel; Kollár, Attila; Gloor, Beat; Kim-Fuchs, Corina (2021). [Neuroendocrine tumor of the pancreas: What is new?]. Therapeutische Umschau, 78(10), pp. 615-621. Hogrefe 10.1024/0040-5930/a001318

Vinzens Burgener, Sarah Maria; Zindel, Joel; Zweifel, Martin; Rau, Tilman; Gloor, Beat; Wochner, Annette (2017). Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature. Anticancer research, 37(1), pp. 223-228. International Inst. of Anticancer Research 10.21873/anticanres.11310

Helbling, D.; Bodoky, G.; Gautschi, O.; Sun, H.; Bosman, F.; Gloor, Beat; Burkhard, R.; Winterhalder, R.; Madlung, Axel; Rauch, Daniel; Saletti, P.; Widmer, L.; Borner, M.; Baertschi, D.; Yan, P.; Benhattar, J.; Leibundgut, Elisabeth O.; Bougel, S.; Koeberle, D. (2013). Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of oncology, 24(3), pp. 718-725. Oxford University Press 10.1093/annonc/mds519

Worni, Mathias; Güller, Ulrich; White, Rebekah R.; Castleberry, Anthony W.; Pietrobon, Ricardo; Cerny, Thomas; Gloor, Beat; Köberle, Dieter (2013). Modest Improvement in Overall Survival for Patients With Metastatic Pancreatic Cancer. Pancreas, 42(7), pp. 1157-1163. Lippincott Williams & Wilkins 10.1097/MPA.0b013e318291fbc5

Gmür, Andrea

Goldhirsch, Aron

Gonzalez Jaramillo, Nathalia

Gonzalez Jaramillo, Valentina

Bernardis, Alessandra; Gonzalez-Jaramillo, Valentina; Ebneter, Andreas S; Eychmüller, Steffen (2023). Palliative care and COVID-19: a bibliometric analysis. (In Press). BMJ supportive & palliative care BMJ Publishing Group 10.1136/spcare-2022-004108

Graber, Satu Maria

Gralla, Jan

Grandgirard, Denis

Grandjean, Bastien

Grandjean, Bastien; Scherz, Amina; Rabaglio, Manuela (2023). Eleven Years of Oncogenetic Consultations in a Swiss Center: Patient and Testing Characteristics. The application of clinical genetics, 16, pp. 205-213. Dove Press 10.2147/TACG.S410261

Graule, Janina

Greiner, Richard

Buser, K.; Bacchi, M.; Goldhirsch, A.; Greiner, R.; Diener, P.; Sessa, C.; Jungi, W. F.; Forni, M.; Leyvraz, S.; Engeler, V. (1996). Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation. Annals of oncology, 7(1), pp. 65-70. Oxford University Press 10.1093/oxfordjournals.annonc.a010481

Grob, Tobias

Grogg, André

Gross, Tobias

Grunder, Lorenz Nicolas

Guffi, Tommaso

Gugger, Mathias

Guillen Ramirez, Hugo Armando

Guler, Sabina Anna

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Guntern, Pascal Martin

Gurzeler, Ursina

Guttormsen, Sissel

Guyer, Jelena Anna Simona

Göldlin, Martina Béatrice

Güller, Ulrich

Warschkow, Rene; Güller, Ulrich; Cerny, Thomas; Schmied, Bruno Martin; Plasswilm, Ludwig; Putora, Paul Martin (2017). Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiotherapy and oncology, 123(1), pp. 139-146. Elsevier 10.1016/j.radonc.2017.02.007

Haas, Quentin

Hagemann, Monika

Haimovici, Aladin

Hall, Sean

Hanhart, Daniel Walter

Hapfelmeier, Siegfried Hektor

Hari, Yvonne Ilona

Haschke, Manuel Martin

Haubitz, Monika

Haynes, Alan

He, Zhaoyue

Heg-Bachar, Zina

Heini, Alexander

Heinzl, Armin Horst

Helbling, Arthur

Helbling, Daniel

Helbling, Melina

Heldner, Mirjam Rachel

Hemmatazad, Hossein

Hensel, Janine

Herrmann, Evelyn

Hertig, Damian

Heverhagen, Johannes

Hewer, Ekkehard Walter

Kollár, Attila; Hewer, Ekkehard; Kellner-Weldon, Frauke; Ochsenbein, Adrian (2015). Complete pain relief after bevacizumab in a patient with neurofibromatosis type 2. Acta oncologica, 54(2), pp. 280-288. Acta Oncologica 10.3109/0284186X.2014.956185

Hilmenyuk, Tamara

Hinterbrandner, Magdalena

Hirzel, Cédric

Muehlberg, Leonora; Pabst, Thomas; Largiadèr, Carlo; Aebi, Yolanda; Hayoz, Michael; Mühlethaler, Konrad; Zimmerli, Stefan; Hirzel, Cédric (2024). Evaluation of Posaconazole Serum Concentrations Achieved With Delayed-release Tablets and Oral Suspension in Patients Undergoing Intensive Chemotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Open Forum Infectious Diseases, 11(5) Oxford University Press 10.1093/ofid/ofae263

Hoch, Dennis

Helnwein, Simon; Hoch, Dennis; Beyer, Jörg (2024). [No Differences in Testis Cancer Outcomes between urban and rural regions in the Canton of Berne]. Praxis, 113(1), pp. 12-14. Hogrefe

Hoepner, Robert

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Hoffmann, Michèle

Hoffmann, Michèle; Hayoz, Stefanie; Özdemir, Berna C. (2022). Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis. Biology, 11(3) MDPI 10.3390/biology11030422

Hofstetter-Jenny, Willy

Hoppe, Hanno

Hoppe, Sven

Horvath, Henrik Csaba

Katapodi, Maria C; Viassolo, Valeria; Caiata-Zufferey, Maria; Nikolaidis, Christos; Bührer-Landolt, Rosmarie; Buerki, Nicole; Graffeo, Rossella; Horvath, Henrik Csaba; Kurzeder, Christian; Rabaglio, Manuela; Scharfe, Michael; Urech, Corinne; Erlanger, Tobias E; Probst-Hensch, Nicole; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Pagani, Olivia; Chappuis, Pierre O (2017). Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol. JMIR research protocols, 6(9), e184. JMIR Publications 10.2196/resprot.8138

Horvath, Thomas Nikolaus

Hosseini, Aref

Hotz, Michael André

Hovhannisyan, Lusine

Huguenin, Anne-Laure

Riether, Carsten; Gschwend, T; Huguenin, Anne-Laure; Schürch, Christian; Ochsenbein, Adrian (2015). Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells. Leukemia, 29(8), pp. 1781-1785. Nature Publishing Group 10.1038/leu.2015.26

Humbert, Magali

Seiler, Kristina; Humbert, Magali; Minder, Petra; Mashimo, Iris; Schläfli, Anna M; Krauer, Deborah; Federzoni, Elena A; Vu, Bich; Moresco, James J; Yates, John R; Sadowski, Martin C; Radpour, Ramin; Kaufmann, Thomas; Sarry, Jean-Emmanuel; Dengjel, Joern; Tschan, Mario P; Torbett, Bruce E (2022). Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions. Cell death & disease, 13(5), p. 448. Springer Nature 10.1038/s41419-022-04891-w

Hunger, Robert

Hunger, Robert; Angermeier, Sarina; Seyed Jafari, Seyed Morteza; Ochsenbein, Adrian; Shafighi, Maziar (2015). A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm. Journal of the American Academy of Dermatology, 72(6), pp. 1054-1059. Elsevier 10.1016/j.jaad.2015.03.029

Schlapbach, Christoph; Ochsenbein, André; Kaelin, Ursula; Hassan, Akmal S; Hunger, Robert E; Yawalkar, Nikhil (2010). High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 62(6), pp. 995-1004. New York, N.Y.: Elsevier 10.1016/j.jaad.2009.06.082

Hungerbühler, Martin Nils

Hunziker, Thomas

Tscharner, Gion Gudench; Bühler, Sabine; Borner, Markus; Hunziker, Thomas (2006). Grover's disease induced by cetuximab. Dermatology, 213(1), pp. 37-9. Basel: Karger 10.1159/000092836

Hunziker Munsch, Lukas Christoph

Huwyler, Fabrizio Alexander Francis

Huynh-Do, Uyen

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Hädrich, Marion

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Häfliger, Simon

Mc Laughlin, Anna M; Hess, Dagmar; Michelet, Robin; Colombo, Ilaria; Haefliger, Simon; Bastian, Sara; Rabaglio, Manuela; Schwitter, Michael; Fischer, Stefanie; Eckhardt, Katrin; Hayoz, Stefanie; Kopp, Christoph; Klose, Marian; Sessa, Cristiana; Stathis, Anastasios; Halbherr, Stefan; Huisinga, Wilhelm; Joerger, Markus; Kloft, Charlotte (2024). Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial. Cancer chemotherapy and pharmacology, 94(3), pp. 349-360. Springer 10.1007/s00280-024-04679-z

Schoenfeld, Adam J; Lee, Sylvia M; Doger de Speville, Bernard; Gettinger, Scott N; Hafliger, Simon; Sukari, Ammar; Papa, Sophie; Rodriguez-Moreno, Juan Francisco; Graf Finckenstein, Friedrich; Fiaz, Rana; Catlett, Melissa; Chen, Guang; Qi, Rongsu; Masteller, Emma L; Gontcharova, Viktoria; He, Kai (2024). Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery, 14(8), pp. 1389-1402. American Association for Cancer Research 10.1158/2159-8290.CD-23-1334

Coan, Michela; Haefliger, Simon; Ounzain, Samir; Johnson, Rory (2024). Targeting and engineering long non-coding RNAs for cancer therapy. Nature Reviews. Genetics, 25(8), pp. 578-595. Natue Publishing Group 10.1038/s41576-024-00693-2

Bocchi, F; Häfliger, S; Schmid, S; Sidler, D (2024). Immune checkpoint inhibitors and renal toxicity. Heliyon, 10(11) Elsevier 10.1016/j.heliyon.2024.e31911

Colombo, Ilaria; Koster, Kira-Lee; Holer, Lisa; Haefliger, Simon; Rabaglio, Manuela; Bastian, Sara; Schwitter, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Mc Laughlin, Anna M; Kloft, Charlotte; Klose, Marian; Halbherr, Stefan; Baumgartner, Christian; Sessa, Cristiana; Stathis, Anastasios; Hess, Dagmar; Joerger, Markus (2024). TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16). European journal of cancer, 201(113588), p. 113588. Elsevier 10.1016/j.ejca.2024.113588

Joerger, Markus; Hundsberger, Thomas; Haefliger, Simon; von Moos, Roger; Hottinger, Andreas F; Kaindl, Thomas; Engelhardt, Marc; Marszewska, Michalina; Lane, Heidi; Roth, Patrick; Stathis, Anastasios (2023). Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Investigational new drugs, 41(2), pp. 267-275. Springer 10.1007/s10637-023-01336-9

Bar, J; Peled, N; Schokrpur, S; Wolner, M; Rotem, O; Girard, N; Nana, F Aboubakar; Derijcke, S; Kian, W; Patel, S; Gantz-Sorotsky, H; Zer, A; Moskovitz, M; Metro, G; Rottenberg, Y; Calles, A; Hochmair, M; Cuppens, K; Decoster, L; Reck, M; ... (2023). UNcommon EGFR mutations: International Case series on efficacy of osimertinib in Real-life practice in first liNe setting (UNICORN). Journal of thoracic oncology, 18(2), pp. 169-180. Elsevier 10.1016/j.jtho.2022.10.004

Vancura, Adrienne; Gutierrez, Alejandro H; Hennig, Thorben; Pulido-Quetglas, Carlos; Slack, Frank J; Johnson, Rory; Haefliger, Simon (2022). Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-Coding RNA, 8(6) MDPI 10.3390/ncrna8060082

Krebs, Fanny S; Britschgi, Christian; Pradervand, Sylvain; Achermann, Rita; Tsantoulis, Petros; Haefliger, Simon; Wicki, Andreas; Michielin, Olivier; Zoete, Vincent (2022). Structure-based prediction of BRAF mutation classes using machine-learning approaches. Scientific Reports, 12(1), p. 12528. Nature Publishing Group 10.1038/s41598-022-16556-x

Vancura, Adrienne; Lanzós, Andrés; Bosch-Guiteras, Núria; Esteban, Mònica Torres; Gutierrez, Alejandro H; Haefliger, Simon; Johnson, Rory (2021). Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs. NAR cancer, 3(2), zcab013. Oxford University Press 10.1093/narcan/zcab013

Häfliger, Simon; Seidel, Ann-Katrin; Schoch, Eric; Reichmann, Jan; Wild, Damian; Steinmann-Schwager, Stephanie; Pless, Miklos (2020). Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor. Case reports in oncology, 13(3), pp. 1373-1380. Karger 10.1159/000510334

Häusler, Rudolf

Höland, Katrin

Höpner, Sabine

Idle, Jeffrey

Iff, Samuel

Imboden, Sara

Schlootz, Saskia; Saner, Flurina A M; Rabaglio, Manuela; Imboden, Sara; Wampfler, Julian (2024). Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study. Swiss medical weekly, 154(4) SMW supporting association 10.57187/s.3386

Saner, Flurina Anna-Carina Maria; Ruggeri, Giovanni; Siegenthaler, Franziska; Wampfler, Julian; Imboden, Sara; Mueller, Michael D (2023). Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer. International journal of gynecological cancer, 33(10), pp. 1595-1601. BMJ Publishing Group Ltd 10.1136/ijgc-2023-004540

Inderbitzin, Daniel

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Inglin, Roman

Ionescu, Codruta

Riggenbach, Elena; Zabini, Adam; Kollár, Attila; Klenke, Frank M.; Kurze, Christophe; Olariu, Radu; Lese, Ioana; Stutz, Emanuel; Lössl, Kristina; Ionescu, Codruta (May 2024). Recurrence patterns after multimodal treatment including IORT for extremity soft tissue sarcomas. Journal of the European SocieTy for Radiotherapy and Oncology, 194(1), S197-S198. Elsevier

Zabini, Adam; Ionescu, Codruta; Kollàr, Attila; Klenke, Frank Michael; Kurze, Christophe; Olariu, Radu; Lese, Ioana; Stutz, Emanuel; Lössl, Kristina; Riggenbach, Elena (18 September 2023). Intraoperative radiotherapy (IORT) as a boost in soft tissue sarcomas of the extremity: long-term results of a retrospective cohort. Strahlentherapie und Onkologie, 11(199), pp. 1047-1048. Springer

Iucolano, Nicoletta Milena

Jaggi, Rolf

Gautschi, O.; Mach, N.; Rothschild, S.; Li, Qiyu; Stahel, R. A.; Zippelius, A.; Cathomas, R.; Früh, M.; Betticher, D. C.; Peters, S.; Rauch, D.; Feilchenfeldt, J.; Bubendorf, L.; Savic, S.; Jaggi, Rolf; Oppliger Leibundgut, Elisabeth; Largiadèr, Carlo Rodolfo; Brutsche, M.; Pilop, C.; Stalder, L.; ... (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical lung cancer, 16(5), pp. 358-365. Elsevier 10.1016/j.cllc.2015.02.007

Jakob, Stephan

Jalowiec, Katarzyna Aleksandra

Jegerlehner, Sabrina

Jegerlehner, Sabrina; Rauch, Andri; Novak, Urban (2017). Recurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease! Journal of investigative medicine high impact case reports, 5(3), p. 2324709617725094. Sage 10.1177/2324709617725094

Jegerlehner, Sabrina; Rothenbühler, Simon Paul; Pabst, Thomas (2014). Vision impairment at diagnosis of cancer - choroidal metastasis. Praxis - schweizerische Rundschau für Medizin, 103(11), pp. 641-647. Huber 10.1024/1661-8157/a001671

Jeitziner, Marie-Madlen

Stamm, Simone Lena; Spichiger, Elisabeth; Pabst, Thomas; Bachnick, Stefanie; Jeitziner, Marie-Madlen (2021). Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - A longitudinal observational study. European journal of oncology nursing, 53, p. 101997. Elsevier 10.1016/j.ejon.2021.101997

Jeker, Barbara

Rieger, Max J; Pabst, Thomas; Jeker, Barbara; Paul, Pamella; Bergamini, Fabio; Bühler, Marco M; Condoluci, Adalgisa; Flammer, Andreas J; Rossi, Davide; Stussi, Georg; Gerber, Bernhard; Schwotzer, Rahel (2024). Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expression. (In Press). Annals of hematology Springer-Verlag 10.1007/s00277-024-05901-x

Ghilardi, Guido; Pabst Müller, Thomas Niklaus; Jeker, Barbara; Müller, Rouven; Cairoli, Anne; Müller, Antonia M S; Bargetzi, Mario; Hitz, Felicitas; Baldomero, Helen; Heim, Dominik; Schmidt, Adrian; Rossi, Davide; Ghielmini, Michele; Wannesson, Luciano; Lerch, Erika; Samaras, Panagiotis; Schanz, Urs; Passweg, Jakob R; Stussi, Georg; Kleber, Martina; ... (2019). Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study. Bone marrow transplantation, 54(7), pp. 1029-1037. Nature Publishing Group 10.1038/s41409-018-0379-y

Jeker, Barbara; Pabst Müller, Thomas Niklaus; Novak, Urban (2019). CAR-T-Zelltherapie – eine neue Behandlungsoption. Info@Onkologie, 2019(1), pp. 18-20. Aerzteverlag medinfo AG

Jent, Philipp

Jin, Jing

Johner, Caroline

Johnson, Rory Baldwin

Amaral, Paulo; Carbonell-Sala, Silvia; De La Vega, Francisco M; Faial, Tiago; Frankish, Adam; Gingeras, Thomas; Guigo, Roderic; Harrow, Jennifer L; Hatzigeorgiou, Artemis G; Johnson, Rory; Murphy, Terence D; Pertea, Mihaela; Pruitt, Kim D; Pujar, Shashikant; Takahashi, Hazuki; Ulitsky, Igor; Varabyou, Ales; Wells, Christine A; Yandell, Mark; Carninci, Piero; ... (2023). The status of the human gene catalogue. Nature, 622(7981), pp. 41-47. Springer Nature 10.1038/s41586-023-06490-x

Mattick, John S; Amaral, Paulo P; Carninci, Piero; Carpenter, Susan; Chang, Howard Y; Chen, Ling-Ling; Chen, Runsheng; Dean, Caroline; Dinger, Marcel E; Fitzgerald, Katherine A; Gingeras, Thomas R; Guttman, Mitchell; Hirose, Tetsuro; Huarte, Maite; Johnson, Rory; Kanduri, Chandrasekhar; Kapranov, Philipp; Lawrence, Jeanne B; Lee, Jeannie T; Mendell, Joshua T; ... (2023). Long non-coding RNAs: definitions, functions, challenges and recommendations. Nature reviews. Molecular cell biology, 24(6), pp. 430-447. Springer Nature 10.1038/s41580-022-00566-8

Amaral, Paulo; Carbonell-Sala, Silvia; De La Vega, Francisco M; Faial, Tiago; Frankish, Adam; Gingeras, Thomas; Guigo, Roderic; Harrow, Jennifer L; Hatzigeorgiou, Artemis G; Johnson, Rory; Murphy, Terence D; Pertea, Mihaela; Pruitt, Kim D; Pujar, Shashikant; Takahashi, Hazuki; Ulitsky, Igor; Varabyou, Ales; Wells, Christine A; Yandell, Mark; Carninci, Piero; ... (24 March 2023). The status of the human gene catalogue. (arXiv). Cornell University

Frankish, Adam; Carbonell-Sala, Sílvia; Diekhans, Mark; Jungreis, Irwin; Loveland, Jane E; Mudge, Jonathan M; Sisu, Cristina; Wright, James C; Arnan, Carme; Barnes, If; Banerjee, Abhimanyu; Bennett, Ruth; Berry, Andrew; Bignell, Alexandra; Boix, Carles; Calvet, Ferriol; Cerdán-Vélez, Daniel; Cunningham, Fiona; Davidson, Claire; Donaldson, Sarah; ... (2023). GENCODE: reference annotation for the human and mouse genomes in 2023. Nucleic acids research, 51(D1), D942-D949. Oxford University Press 10.1093/nar/gkac1071

Zamani, Mina; Foroughmand, Ali-Mohammad; Hajjari, Mohammad-Reza; Bakhshinejad, Babak; Johnson, Rory; Galehdari, Hamid (2022). CASC11 and PVT1 spliced transcripts play an oncogenic role in colorectal carcinogenesis. Frontiers in oncology, 12(954634), p. 954634. Frontiers Research Foundation 10.3389/fonc.2022.954634

Pulido-Quetglas, Carlos; Johnson, Rory (2022). Designing libraries for pooled CRISPR functional screens of long noncoding RNAs. Mammalian genome, 33(2), pp. 312-327. Springer-Verlag 10.1007/s00335-021-09918-9

Maquat, Lynne; Johnson, Rory; Valadkhan, Saba; Carninci, Piero (2022). Lessons from the functional characterization of lncRNAs: introduction to mammalian genome special issue. Mammalian genome, 33(2), pp. 245-247. Springer-Verlag 10.1007/s00335-022-09956-x

Arnan, Carme; Ullrich, Sebastian; Pulido-Quetglas, Carlos; Nurtdinov, Ramil; Esteban, Alexandre; Blanco-Fernandez, Joan; Aparicio-Prat, Estel; Johnson, Rory; Pérez-Lluch, Sílvia; Guigó, Roderic (2022). Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages. BMC Genomics, 23(1), p. 402. BioMed Central 10.1186/s12864-022-08612-7

Cable, Jennifer; Heard, Edith; Hirose, Tetsuro; Prasanth, Kannanganattu V; Chen, Ling-Ling; Henninger, Jonathan E; Quinodoz, Sofia A; Spector, David L; Diermeier, Sarah D; Porman, Allison M; Kumar, Dhiraj; Feinberg, Mark W; Shen, Xiaohua; Unfried, Juan Pablo; Johnson, Rory; Chen, Chun-Kan; Wilusz, Jeremy E; Lempradl, Adelheid; McGeary, Sean E; Wahba, Lamia; ... (2021). Noncoding RNAs: biology and applications-a Keystone Symposia report. Annals of the New York Academy of Sciences, 1506(1), pp. 118-141. New York Academy of Sciences 10.1111/nyas.14713

Kang, Wenjing; Fromm, Bastian; Houben, Anna J; Høye, Eirik; Bezdan, Daniela; Arnan, Carme; Thrane, Kim; Asp, Michaela; Johnson, Rory; Biryukova, Inna; Friedländer, Marc R (2021). MapToCleave: High-throughput profiling of microRNA biogenesis in living cells. Cell reports, 37(7), p. 110015. Cell Press 10.1016/j.celrep.2021.110015

Frankish, Adam; Diekhans, Mark; Jungreis, Irwin; Lagarde, Julien; Loveland, Jane E; Mudge, Jonathan M; Sisu, Cristina; Wright, James C; Armstrong, Joel; Barnes, If; Berry, Andrew; Bignell, Alexandra; Boix, Carles; Carbonell Sala, Silvia; Cunningham, Fiona; Di Domenico, Tomás; Donaldson, Sarah; Fiddes, Ian T; García Girón, Carlos; Gonzalez, Jose Manuel; ... (2021). GENCODE 2021. Nucleic acids research, 49(D1), D916-D923. Oxford University Press 10.1093/nar/gkaa1087

Carbonell Sala, Sílvia; Uszczyńska-Ratajczak, Barbara; Lagarde, Julien; Johnson, Rory; Guigó, Roderic (2021). Annotation of Full-Length Long Noncoding RNAs with Capture Long-Read Sequencing (CLS). Methods in molecular biology, 2254, pp. 133-159. Springer 10.1007/978-1-0716-1158-6_9

Reyna, Matthew A; Haan, David; Paczkowska, Marta; Verbeke, Lieven P C; Vazquez, Miguel; Kahraman, Abdullah; Pulido-Tamayo, Sergio; Barenboim, Jonathan; Wadi, Lina; Dhingra, Priyanka; Shrestha, Raunak; Getz, Gad; Lawrence, Michael S; Pedersen, Jakob Skou; Rubin, Mark Andrew; Wheeler, David A; Brunak, Søren; Izarzugaza, Jose M G; Khurana, Ekta; Marchal, Kathleen; ... (2020). Pathway and network analysis of more than 2500 whole cancer genomes. Nature communications, 11(1), p. 729. Nature Publishing Group 10.1038/s41467-020-14367-0

Rheinbay, Esther; Nielsen, Morten Muhlig; Abascal, Federico; Wala, Jeremiah A; Shapira, Ofer; Tiao, Grace; Hornshøj, Henrik; Hess, Julian M; Juul, Randi Istrup; Lin, Ziao; Feuerbach, Lars; Sabarinathan, Radhakrishnan; Madsen, Tobias; Kim, Jaegil; Mularoni, Loris; Shuai, Shimin; Lanzos, Andrés; Herrmann, Carl; Maruvka, Yosef E; Shen, Ciyue; ... (2020). Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 578(7793), pp. 102-111. Springer Nature 10.1038/s41586-020-1965-x

Frankish, Adam; Diekhans, Mark; Ferreira, Anne-Maud; Johnson, Rory Baldwin; Jungreis, Irwin; Loveland, Jane; Mudge, Jonathan M; Sisu, Cristina; Wright, James; Armstrong, Joel; Barnes, If; Berry, Andrew; Bignell, Alexandra; Carbonell Sala, Silvia; Chrast, Jacqueline; Cunningham, Fiona; Di Domenico, Tomás; Donaldson, Sarah; Fiddes, Ian T; García Girón, Carlos; ... (2019). GENCODE reference annotation for the human and mouse genomes. Nucleic acids research, 47(D1), D766-D773. Oxford University Press 10.1093/nar/gky955

Uszczynska-Ratajczak, Barbara; Lagarde, Julien; Frankish, Adam; Guigó, Roderic; Johnson, Rory Baldwin (2018). Towards a complete map of the human long non-coding RNA transcriptome. Nature Reviews. Genetics, 19(9), pp. 535-548. Natue Publishing Group 10.1038/s41576-018-0017-y

Lagarde, Julien; Johnson, Rory Baldwin (2018). Capturing a Long Look at Our Genetic Library. Cell systems, 6(2), pp. 153-155. Elsevier 10.1016/j.cels.2018.02.003

Lagarde, Julien; Uszczynska-Ratajczak, Barbara; Carbonell, Silvia; Pérez-Lluch, Sílvia; Abad, Amaya; Davis, Carrie; Gingeras, Thomas R; Frankish, Adam; Harrow, Jennifer; Guigo, Roderic; Johnson, Rory (2017). High-throughput annotation of full-length long noncoding RNAs with capture long-read sequencing. Nature genetics, 49(12), pp. 1731-1740. Nature America 10.1038/ng.3988

Pulido-Quetglas, Carlos; Aparicio-Prat, Estel; Arnan, Carme; Polidori, Taisia; Hermoso, Toni; Palumbo, Emilio; Ponomarenko, Julia; Guigo, Roderic; Johnson, Rory Baldwin (2017). Scalable Design of Paired CRISPR Guide RNAs for Genomic Deletion. PLoS computational biology, 13(3), e1005341. Public Library of Science 10.1371/journal.pcbi.1005341

Lanzós, Andrés; Carlevaro-Fita, Joana; Mularoni, Loris; Reverter, Ferran; Palumbo, Emilio; Guigó, Roderic; Johnson, Rory (2017). Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features. Scientific Reports, 7(41544), p. 41544. Nature Publishing Group 10.1038/srep41544

Aparicio-Prat, Estel; Arnan, Carme; Sala, Ilaria; Bosch, Núria; Guigó, Roderic; Johnson, Rory Baldwin (2016). Erratum to: 'DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs'. BMC Genomics, 17(215), p. 215. BioMed Central 10.1186/s12864-016-2544-2

Joncourt, Raphael

Jost-Buess, Rahel

Jost, Rahel; Müller, Daniel A.; Lese, Iona; Brodmann, Stefan; Digklia, Antonia; Rothermundt, Christian; Kollár, Attila (2023). Whoops-Resections – how can we improve? info@onco-suisse(3), pp. 16-19. Aerzteverlag medinfo AG

Jung, Simon

Jungo, Katharina Tabea

Deml, Michael J.; Jungo, Katharina Tabea; Maessen, Maud; Martani, Andrea; Ulyte, Agne (2022). Megatrends in Healthcare: Review for the Swiss National Science Foundation’s National Research Programme 74 (NRP74) “Smarter Health Care”. Public health reviews, 43, p. 1604434. BMC (part of Springer Nature), United Kingdom 10.3389/phrs.2022.1604434

Jörger, Marianne

Jörger Messerli, Marianne; Baty, F; Früh, M; Stahel, R A; Betticher, D C; von Moos, Rodica; Ochsenbein, Adrian; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, Dirk; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung cancer, 85(2), pp. 306-313. Elsevier 10.1016/j.lungcan.2014.04.014

Jüni, Peter

Kaderli, Reto Martin

Kaesmacher, Johannes

Kappeler, Andreas

Karamitopoulou Diamantis, Evanthia

Karatkevich, Darya

Karow, Axel

Karrer, Tanya

Steinmann, Marcel; Rietschin, Anita; Pagano, Flavia; Karrer, Tanya; Kollár, Attila; Weidlinger, Susanna; von Wolff, Michael (2024). Systematic Review of the Gonadotoxicity and Risk of Infertility of Soft Tissue Sarcoma Chemotherapies in Pre- and Postpubertal Females and Males. (In Press). Journal of Adolescent and Young Adult Oncology Mary Ann Liebert 10.1089/jayao.2024.0057

Kartal-Kaess, Mutlu

Kashani, Elham

Kaufmann, Thomas

Keel, Marius

Kurze, Christophe; Keel, Marius Johann Baptist; Kollár, Attila; Siebenrock, Klaus-Arno; Klenke, Frank Michael (2019). The pararectus approach-a versatile option in pelvic musculoskeletal tumor surgery. Journal of orthopaedic surgery and research, 14(1), p. 232. BioMed Central 10.1186/s13018-019-1275-x

Keller, Heinz Peter

Keller, Irene

Hensel, Janine; Wetterwald, Antoinette; Temanni, Ramzi; Keller, Irene; Riether, Carsten; van der Pluijm, Gabri; Cecchini, Marco G; Thalmann, George N. (2018). Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma. OncoTarget, 9(48), pp. 28877-28896. Impact Journals LLC 10.18632/oncotarget.25608

Keller, Peter

Kellner-Weldon, Frauke

Keogh-Stroka, Deborah M.

Kerkhof, Erik

Kettenbach, Joachim

Khan, Amjad

Kickuth, Ralph

Kielkopf, Moritz Christopher

Kim-Fuchs, Corina

Kirchner, Paul Philipp

Kiss, Bernhard

Afferi, Luca; Spahn, Martin; Hayoz, Stefanie; Strebel, Räto T; Rothschild, Sacha I; Seifert, Helge; Özdemir, Berna C; Kiss, Bernhard; Maletzki, Philipp; Engeler, Daniel; Wirth, Gregory; Hadaschik, Boris; Lucca, Ilaria; John, Hubert; Sauer, Andreas; Müntener, Michael; Bubendorf, Lukas; Schneider, Martina; Musilova, Jana; Petrausch, Ulf; ... (2024). Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. BJU international, 134(3), pp. 388-397. Wiley 10.1111/bju.16318

Cathomas, Richard; Rothschild, Sacha I; Hayoz, Stefanie; Bubendorf, Lukas; Özdemir, Berna C; Kiss, Bernhard; Erdmann, Andreas; Aeppli, Stefanie; Mach, Nicolas; Strebel, Räto T; Hadaschik, Boris; Berthold, Dominik; John, Hubert; Zihler, Deborah; Schmid, Mathias; Alborelli, Ilaria; Schneider, Martina; Musilova, Jana; Spahn, Martin and Petrausch, Ulf (2023). Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17. Journal of clinical oncology, 41(33), pp. 5131-5139. American Society of Clinical Oncology 10.1200/JCO.23.00363

Klaeser, Bernd

Klass, Natalie Désirée

Klenke, Frank M.

Kollár, Attila; Rothermundt, Christian; Klenke, Frank; Bode, Beata; Baumhoer, Daniel; Arndt, Volker; Feller, Anita (2019). Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer epidemiology, 63(101596), p. 101596. Elsevier 10.1016/j.canep.2019.101596

Klenke, Frank M.; Kollár, Attila; Kurze, Christophe; Büchler, Lorenz; Keel, Marius J.B. (2019). Pathologic Fractures. In: Fractures of the hip. Fracture Management Joint by Joint (pp. 155-167). Cham: Springer International Publishing 10.1007/978-3-030-18838-2_13

Kurze, Christophe; Kollár, Attila; Klenke, Frank M. (2018). Der Stellenwert 3D-gedruckter Individualimplantate in der modernen Tumorchirurgie des Beckens. Leading Opinions. Hämatologie & Onkologie, 2018(4), pp. 29-32. Universimed

Kollár, Attila; Kurze, Christophe; Klenke, Frank (2018). Ewing-Sarkom - Management des zweithäufigsten primären malignen Knochentumors. Info Onkologie & Hämatologie, 6(5) Prime Public Media AG

Klima, Irena

Klingbiel, Dirk

Klingenberg-Rettich, Anke

Knabben, Laura Michelle Tatjana

Knöpfli, Marina Janusheva

Kocher, Gregor

Koenigsdorf, Julia

Kolev, Mirjam

Kollár, Attila

Winer, Leah K; Akumuo, Rita; Fredette, Jordan D; Deng, Mengying; Hasler, Jill S; Greco, Stephanie H; von Mehren, Margaret; Bartholomew, Alex J; Blazer, Dan G; Gabrielova, Lucie; Adamkova, Dagmar; Bernard-Bedard, Ericka; Nessim, Carolyn; Kollár, Attila; Olariu, Radu; Cencelj-Arnez, Romi; Hompes, Daphne; Ford, Samuel J; Cardona, Kenneth; Sato, Kenji; ... (2024). Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi-institutional collaborative. (In Press). Cancer Wiley 10.1002/cncr.35468

Kasper, Bernd; Pink, Daniel; Rothermundt, Christian; Richter, Stephan; Augustin, Marinela; Kollar, Attila; Kunitz, Annegret; Eisterer, Wolfgang; Gaidzik, Verena; Brodowicz, Thomas; Egerer, Gerlinde; Reichardt, Peter; Hohenberger, Peter; Schuler, Markus K (2024). Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13). Cancers, 16(3) MDPI AG 10.3390/cancers16030558

Digklia, A; Kollár, A; Dietrich, D; Kronig, M N; Britschgi, C; Rordorf, T; Joerger, M; Krasniqi, F; Metaxas, Y; Colombo, I; Ribi, K; Rothermundt, C (2024). SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial. European journal of cancer, 197(113470), p. 113470. Elsevier 10.1016/j.ejca.2023.113470

Noh, Sangkyu; Nessim, Carolyn; Keung, Emily Z; Roland, Christina L; Strauss, Dirk; Sivarajah, Gausihi; Fiore, Marco; Biasoni, Davide; Cioffi, Stefano Piero Bernardo; Mehtsun, Winta; Cananzi, Ferdinando Carlo Maria; Sicoli, Federico; Quagliuolo, Vittorio; Chen, Jun; Luo, Chenghua; Gladdy, Rebecca A; Swallow, Carol; Johnston, Wendy; Ford, Samuel J; Evenden, Caroline; ... (2023). Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Annals of surgery, 278(2), pp. 267-273. Lippincott Williams & Wilkins 10.1097/SLA.0000000000005625

Sars, Carl; Sackey, Helena; Frisell, Jan; Dickman, Paul W; Karlsson, Fredrik; Kindts, Isabelle; Marta, Gustavo Nader; Freitas-Junior, Ruffo; Tvedskov, Tove Filtenborg; Kassem, Loay; Ali, Ahmed S; Ihalainen, Hanna; Neron, Mathias; Kontos, Michalis; Kaidar-Person, Orit; Meattini, Icro; Francken, Anne Brecht; van Duijnhoven, Frederieke; Moberg, Ingvild Ona; Marinko, Tanja; ... (2023). Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists. Breast cancer research and treatment, 199(2), pp. 293-304. Springer 10.1007/s10549-023-06896-1

Lindner, Lars; Dimosthenis, Andreou; Bauer, Sebastian; Bielack, Stefan; Grube, Matthias; Hartmann, Wolfgang; Hecker-Nolting, Stefanie; Kollár, Attila; Kraywinkel, Klaus; Szkandera, Joanna; Timmermann, Beate; Tunn, Per Ulf; Wörtler, Klaus (2023). Oestosarkome Leitlinien Onkopedia

Borbath, Ivan; Garcia-Carbonero, Rocio; Bikmukhametov, Damir; Jimenez-Fonseca, Paula; Castaño, Angel; Barkmanova, Jaroslava; Sedlackova, Eva; Kollár, Attila; Christ, Emanuel; Kaltsas, Gregory; Kos-Kudla, Beata; Maasberg, Sebastian; Verslype, Chris; Pape, Ulrich-Frank (2022). The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms. European journal of cancer, 168, pp. 80-90. Elsevier 10.1016/j.ejca.2022.03.007

Notter, Markus; Stutz, Emanuel; Thomsen, Andreas R; Kollár, Attila; Vaupel, Peter (2021). Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814. Cancers, 13(22) MDPI AG 10.3390/cancers13225707

Kollár, Attila (2021). Ripretinib—a new star in the firmament. Gastrointestinal Stromal Tumor, 4, p. 2. 10.21037/gist-21-3

Merola, Elettra; Rinke, Anja; Partelli, Stefano; Gress, Thomas M.; Andreasi, Valentina; Kollár, Attila; Perren, Aurel; Christ, Emanuel; Panzuto, Francesco; Pascher, Andreas; Jann, Henning; Arsenic, Ruza; Cremer, Birgit; Kaemmerer, Daniel; Kump, Patrizia; Lipp, Rainer W.; Agaimy, Abbas; Wiedenmann, Bertram; Falconi, Massimo and Pavel, Marianne E. (2020). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? Annals of surgical oncology, 27(5), pp. 1348-1355. Springer 10.1245/s10434-019-08049-5

Kollár, Attila; Aguiar, Pedro Nazareth; Forones, Nora Manoukian; De Mello, Ramon Andrade (2019). Gastrointestinal Stromal Tumor (GIST): Diagnosis and Treatment. In: De Mello, Ramon Andrade; Mountzios, Giannis; Tavares, Álvaro A. (eds.) International Manual of Oncology Practice (pp. 817-849). Springer 10.1007/978-3-030-16245-0_37

Rothermundt, Christian; Fischer, Galina F; Bauer, Sebastian; Blay, Jean-Yves; Grünwald, Viktor; Italiano, Antoine; Kasper, Bernd; Kollár, Attila; Lindner, Lars H; Miah, Aisha; Sleijfer, Stefan; Stacchiotti, Silvia; Putora, Paul Martin (2018). Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey. Oncologist, 23(4), pp. 461-467. AlphaMed Press 10.1634/theoncologist.2017-0391

Kollár, Attila; Kurze, Christophe; Klenke, Frank (2018). Ewing-Sarkom - Management des zweithäufigsten primären malignen Knochentumors. Info Onkologie & Hämatologie, 6(5) Prime Public Media AG

Umlauft, Maria; Radojewski, Piotr; Spanjol, Petar Marko; Dumont, Rebecca; Marincek, Nicolas; Kollár, Attila; Brunner, Philippe; Beyersmann, Jan; Müller-Brand, Jan; Maecke, Helmut R; Laimer, Markus; Walter, Martin Alexander (2017). Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues. Journal of nuclear medicine, 58(9), p. 1532. Society of Nuclear Medicine 10.2967/jnumed.117.190660

Kollár, Attila; Jones, R. L.; Stacchiotti, S.; Gelderblom, H.; Guida, M.; Grignani, G.; Steeghs, N.; Safwat, A.; Katz, D.; Duffaud, F.; Sleijfer, S.; van der Graaf, W. T.; Touati, N.; Litière, S.; Marreaud, S.; Gronchi, A.; Kasper, B. (2017). Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta oncologica, 56(1), pp. 88-92. Acta Oncologica 10.1080/0284186X.2016.1234068

Kollár, Attila; Kasper, Bernd (2017). Metastatic soft tissue sarcomas: update on new agents and clinical studies. Cancer breaking news, 5(2), pp. 5-11. Health publishing & services, Milan, Rome 10.19156/cbn.2017.0042

Umlauft, M.; Radojewski, P.; Spanjol, P.-M.; Dumont, R.; Marincek, N.; Kollár, Attila; Brunner, P.; Beyersmann, J.; Mueller-Brand, J.; Maecke, H.; Laimer, Markus; Walter, M. (2016). Diabetes mellitus and its effects on all-cause mortalityafter radiopeptide therapy for neuroendocrine tumors. Journal of nuclear medicine, 58(1), pp. 97-102. Society of Nuclear Medicine 10.2967/jnumed.116.180687

Sachpekidis, Christos; Langer, Rupert; Kollár, Attila; Wartenberg, Jan (2016). Detection of a primary tumor in the area of the renal artery with 18F-FDG PET/CT in a patient with metastatic undifferentiated sarcoma and a history of mid-aortic syndrome: A case report. Medicine, 95(34), e4622. Lippincott Williams & Wilkins 10.1097/MD.0000000000004622

Noujaim, Jonathan; Thway, Khin; Jones, Robin L; Miah, Aisha; Khabra, Komel; Langer, Rupert; Kasper, Bernd; Judson, Ian; Benson, Charlotte; Kollár, Attila (2015). Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study. Anticancer research, 35(11), pp. 6213-6217. International Inst. of Anticancer Research

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollár, Attila; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V and Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of oncology, 26(4), pp. 709-714. Oxford University Press 10.1093/annonc/mdv011

Kollár, Attila; Benson, Charlotte (2014). Current management options for liposarcoma and challenges for the future. Expert review of anticancer therapy, 14(3), pp. 297-306. Expert Reviews 10.1586/14737140.2014.869173

Kollár, Attila; Maruzzo, Marco; Messiou, Christina; Cartwright, Elisabeth; Miah, Aisha; Martin-Liberal, Juan; Thway, Khin; McGrath, Ellen; Dunlop, Alison; Khabra, Komel; Seddon, Beatrice; Dileo, Palma; Linch, Mark; Judson, Ian Robert; Benson, Charlotte (2014). Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program. Clinical Sarcoma Research, 4(1), p. 17. Biomed Central 10.1186/2045-3329-4-17

Koeberle, Dieter; Betticher, Daniel; Von Moos, Roger; Dietrich, Daniel; Brauchli, Peter; Baertschi, Daniela; Matter-Walstra, Klazien; Winterhalder, Ralph; Borner, Markus; Anchisi, Sandro; Moosmann, Peter; Kollár, Attila; Saletti, Piercarlo; Roth, Arnaud; Frueh, Martin; Kueng, Marc; Popescu, Razvan; Schacher, Sabina; Hess, Viviane and Herrmann, Richard (2013). O-0028 Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial. Annals of oncology, 24(Suppl 4), iv22-iv22. Oxford University Press 10.1093/annonc/mdt201.28

Kopp, Doris

Kotelevets, Nataliya

Kralidis Zinniker, Elena

Krauer, Deborah

Krause, Elke

Krebs, Philippe

Kremer Hovinga Strebel, Johanna Anna

Krestel, Heinz Eric

Kronig, Marie-Noëlle

Kronig, Marie-Noelle; Wehrli, Marc; Salas-Benito, Diego; Maus, Marcela V (2023). "Hurdles race for CAR T-cell therapy in digestive tract cancer". Immunological reviews, 320(1), pp. 100-119. Wiley 10.1111/imr.13273

Kruithof-de Julio, Marianna

Krähenmann, Peter

Kuhn, Annette

Kurmann, Christoph Carmelino

Kurze, Christophe

Kollár, Attila; Kurze, Christophe; Klenke, Frank (2018). Ewing-Sarkom - Management des zweithäufigsten primären malignen Knochentumors. Info Onkologie & Hämatologie, 6(5) Prime Public Media AG

Köberle, Dieter

Köffel, René

Kölzer, Viktor

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Körner Jachertz, Meike

Kühni, Claudia

Kündig, Alexandra Gabriela

Künzi, Arnaud Yi-Yao

Küpfer, Adrian Hermann

Cerny, T.; Leyvraz, S.; Von Briel, T.; Küpfer, A.; Schaad, R.; Hsu Schmitz, S.-F.; Honegger, P.; Sessa, C.; Brunner, J.; Boddy, A. V. (1999). Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients. Annals of oncology, 10(9), pp. 1087-1094. Oxford University Press 10.1023/A:1008386000547

Lachenmayer, Anja

Laimer, Markus

Langenegger, Simon Matthias

Eisele, Günter; Wick, Antje; Eisele, Anna-Carina; Clément, Paul M; Tonn, Jörg; Tabatabai, Ghazaleh; Ochsenbein, Adrian; Schlegel, Uwe; Neyns, Bart; Krex, Dietmar; Langenegger, Simon Matthias; Nikkhah, Guido; Picard, Martin; Stupp, Roger; Wick, Wolfgang; Weller, Michael (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of neuro-oncology, 117(1), pp. 141-145. Springer 10.1007/s11060-014-1365-x

Langer, Rupert

Lanzos Camaioni, Andrés Arturo

Rheinbay, Esther; Nielsen, Morten Muhlig; Abascal, Federico; Wala, Jeremiah A; Shapira, Ofer; Tiao, Grace; Hornshøj, Henrik; Hess, Julian M; Juul, Randi Istrup; Lin, Ziao; Feuerbach, Lars; Sabarinathan, Radhakrishnan; Madsen, Tobias; Kim, Jaegil; Mularoni, Loris; Shuai, Shimin; Lanzos, Andrés; Herrmann, Carl; Maruvka, Yosef E; Shen, Ciyue; ... (2020). Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 578(7793), pp. 102-111. Springer Nature 10.1038/s41586-020-1965-x

Lanzos, Andrés; Elliott, Kerryn (2019). EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy. FEBS journal, 286(21), pp. 4209-4214. Wiley-Blackwell 10.1111/febs.15063

PCAWG Driver Group, PCAWG Driver Group; Lanzos, Andrés (2019). Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes (bioRxiv). Cold Spring Harbor Laboratory 10.1101/237313

Carlevaro-Fita, Joana; Lanzos, Andrés; Feuerbach, Lars; Hong, Chen; Mas-Ponte, David; Skou Pedersen, Jakob; Johnson, Rory (2019). Unique genomic features and deeply-conserved functions of long non-coding RNAs in the Cancer LncRNA Census (CLC) (bioRxiv). Cold Spring Harbor Laboratory 10.1101/152769

Largiadèr, Carlo Rodolfo

Larpin, Yu-Noël

Lechleiter, Antje

Legros, Myriam

Lehner, Marika

Leib, Stephen

Leibundgut, Kurt

Passweg, Jakob R; Baldomero, Helen; Bargetzi, Mario; Bucher, Christoph; Chalandon, Yves; Duchosal, Michel A; Gratwohl, Alois; Güngör, Tayfun; Hess, Urs; Leibundgut, Kurt; de Faveri, Grazia Nicoloso; Ozsahin, Hulya; Pabst, Thomas; Renner, Christoph; Stern, Martin; Stussi, Georg; Schanz, Urs; SBST (Swiss Blood Stem Cell Transplantation Group), (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss medical weekly, 143, w13757. Muttenz: EMH Schweizerischer Ärzteverlag

Leichtle, Alexander Benedikt

Leiser, Dominic

Leni, Zaira

Lerch, Seraina Petra

Lese, Ioana

Leupin, Nicolas

Li, Hai

Li, Qiyu

Passweg, Jakob R.; Pabst, Thomas; Blum, Sabine; Bargetzi, Mario; Li, Qiyu; Heim, Dominik; Stussi, Georg; Gregor, Michael; Leoncini, Leda; Meyer-Monard, Sandrine; Brauchli, Peter; Chalandon, Yves; Swiss Group for Clinical Cancer Research, SAKK (2013). Azacytidine for acute myeloid leukemia in elderly or frail patients: A phase II trial (SAKK 30/07). Leukemia & lymphoma, 55(1), pp. 87-91. London: Informa Healthcare 10.3109/10428194.2013.790540

Lia, Mela

Limacher, Andreas

Lippert, Julian Peter

Liu, He

Liu, Michael

Lo Priore, Elia Francesco

Lombardo, Paolo

Losmanová, Tereza

Lugli, Alessandro

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Lukesch, Anne Carolin

Luta, Xhyljeta

Lämmle, Alexander

Léon Betancourt, Alejandro Xavier

Lörwald, Andrea Carolin

Lössl, Kristina

Scherz, Amina; Kroll, J; Lössl, Kristina; Novak, Urban (2018). (De)Eskalierung bei der Behandlung des frühen Mammakarzinoms. Swiss Medical Forum, 28(25), pp. 526-531. EMH Swiss Medical Publishers 10.4414/smf.2017.03238

Lüthi, Nora

Luethi, Nora; Bailey, Michael; Higgins, Alisa; Howe, Belinda; Peake, Sandra; Delaney, Anthony; Bellomo, Rinaldo (2020). Gender differences in mortality and quality of life after septic shock: A post-hoc analysis of the ARISE study. Journal of critical care, 55, pp. 177-183. Elsevier 10.1016/j.jcrc.2019.11.002

Hudson, Elizabeth P; Collie, Jake Tb; Fujii, Tomoko; Luethi, Nora; Udy, Andrew A; Doherty, Sarah; Eastwood, Glenn; Yanase, Fumitaka; Naorungroj, Thummaporn; Bitker, Laurent; Abdelhamid, Yasmine Ali; Greaves, Ronda F; Deane, Adam M; Bellomo, Rinaldo (2019). Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock. Critical care and resuscitation, 21(4), pp. 236-242. College of Intensive Care Medicine of Australia and New Zealand

Fujii, Tomoko; Belletti, Alessandro; Carr, Anitra; Furukawa, Toshi A; Luethi, Nora; Putzu, Alessandro; Sartini, Chiara; Salanti, Georgia; Tsujimoto, Yasushi; Udy, Andrew A; Young, Paul J; Bellomo, Rinaldo (2019). Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis. BMJ open, 9(11), e033458. BMJ Publishing Group 10.1136/bmjopen-2019-033458

Fujii, Tomoko; Udy, Andrew A; Deane, Adam M; Luethi, Nora; Bailey, Michael; Eastwood, Glenn M; Frei, Daniel; French, Craig; Orford, Neil; Shehabi, Yahya; Young, Paul J; Bellomo, Rinaldo (2019). Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan. Critical care and resuscitation, 21(2), pp. 119-125. College of Intensive Care Medicine of Australia and New Zealand

Lüthi, Ursina

Bianchi, Matteo; Reichen, Christian; Croset, Amelie; Fischer, Stefanie; Eggenschwiler, Aline; Grübler, Yvonne; Marpakwar, Rajlakshmi; Looser, Thamar; Spitzli, Patricia; Herzog, Christel; Villemagne, Denis; Schiegg, Dieter; Abduli, Liridon; Iss, Chloé; Neculcea, Alexandra; Franchini, Marco; Lekishvili, Tamara; Ragusa, Simone; Zitt, Christof; Kaufmann, Yvonne; ... (2024). The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells. Cancer immunology research, 12(7), pp. 921-943. American Association for Cancer Research 10.1158/2326-6066.CIR-23-0692

Macpherson, Andrew

Madlung, Axel

Maessen, Maud

van Eenennaam, Remko M; Kruithof, Willeke; Beelen, Anita; Bakker, Leonhard A; van Eijk, Ruben P A; Maessen, Maud; Baardman, Joost F; Visser-Meily, Johanna M A; Veldink, Jan H; van den Berg, Leonard H (2023). Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort study. The lancet. Neurology, 22(7), pp. 591-601. Elsevier 10.1016/S1474-4422(23)00155-2

White, Nicola; Oostendorp, Linda; Vickerstaff, Victoria; Gerlach, Christina; Engels, Yvonne; Maessen, Maud; Tomlinson, Christopher; Wens, Johan; Leysen, Bert; Biasco, Guido; Zambrano, Sofia; Eychmüller, Steffen; Avgerinou, Christina; Chattat, Rabih; Ottoboni, Giovanni; Veldhoven, Carel; Stone, Patrick (2019). An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol. BMC Palliative Care, 18(1), p. 36. BioMed Central 10.1186/s12904-019-0413-x

Maessen, Maud; Steck, N; Zwahlen, M; Eychmüller, Steffen (2018). Potential economic impact of mobile specialist palliative care teams in Switzerland Bern: Bundesamt für Gesundheit BAG

Mager, Lukas

Magyar, Christian Tibor Josef

Maire, Renaud Sylvain

Maletti, Sina Laura

Mandhair, Harpreet Kaur

Mandhair, Harpreet K; Novak, Urban; Radpour, Ramin (2021). Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells. World journal of stem cells, 13(6), pp. 542-567. Baishideng Publishing Group 10.4252/wjsc.v13.i6.542

Mansouri Taleghani, Behrouz

Mueller, Beatrice U; Keller, Sandra; Seipel, Katja; Mansouri Taleghani, Behrouz; Rauch, Daniel; Betticher, Daniel; Egger, Thomas; Pabst, Thomas (2015). Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. Leukemia & lymphoma, 57(5), pp. 1122-1129. Informa Healthcare 10.3109/10428194.2015.1079315

Keller, Sandra; Seipel, Katja; Novak, Urban; Mueller, Beatrice U; Mansouri Taleghani, Behrouz; Leibundgut, Kurt; Pabst, Thomas (2015). Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. Leukemia research, 39(7), pp. 786-792. Elsevier 10.1016/j.leukres.2015.03.015

von Grünigen, Isabelle; Raschle, Joëlle; Rüsges-Wolter, Ilka; Taleghani, Behrouz Mansouri; Mueller, Beatrice U; Pabst, Thomas (2012). The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential. Leukemia research, 36(11), pp. 1325-9. Amsterdam: Elsevier 10.1016/j.leukres.2012.05.027

Marincek, Nicolas

Marinoni, Ilaria

Markov, Nikita

Marschall, Jonas

Steinrücken, Julia; Pabst, Thomas; Zimmerli, Stefan; Marschall, Jonas (2016). Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever. Infectious diseases, 48(11-12), pp. 872-874. Taylor & Francis 10.1080/23744235.2016.1205216

Marti, Thomas

Matter, Matthias

Matter, Matthias S; Ochsenbein, Adrian F (2008). Natural antibodies target virus-antibody complexes to organized lymphoid tissue. Autoimmunity reviews, 7(6), pp. 480-6. Amsterdam: Elsevier 10.1016/j.autrev.2008.03.018

Matter, Matthias S; Claus, Christina; Ochsenbein, Adrian F (2008). CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. European journal of immunology, 38(7), pp. 1847-56. Weinheim: Wiley-VCH 10.1002/eji.200737824

Matter, Matthias; Odermatt, Bernhard; Yagita, Hideo; Nuoffer, Jean-Marc; Ochsenbein, Adrian F (2006). Elimination of chronic viral infection by blocking CD27 signaling. Journal of experimental medicine, 203(9), pp. 2145-55. New York, N.Y.: Rockefeller University Press 10.1084/jcm.20060651

Mumprecht, Sabine; Matter, Matthias; Pavelic, Viktor; Ochsenbein, Adrian F (2006). Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood, 108(10), pp. 3406-13. Washington, D.C.: American Society of Hematology 10.1182/blood-2006-04-018705

Lejeune, Ferdy J; Liénard, Danielle; Matter, Maurice; Rüegg, Curzio (2006). Efficiency of recombinant human TNF in human cancer therapy. Cancer immunology, immunotherapy, 6, p. 6. Heidelberg: Springer

Matthey, Sybille

Mattle, Heinrich

McCoy, Kathleen

Medo, Matúš

Medova, Michaela

Meinel, Thomas Raphael

Meise, Dominik Fabio

Mela, Lia

Merlin, Bernard Mefi

Messmer, Anna Sarah

Mihaljevic, Ante

Misselwitz, Benjamin

Mohsen, Mona Omar Mahmoud

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Montani, Matteo

Moor, Jeanne Yvonne

Darphin, Xenia; Moor, Jeanne; da Silva, Cristina Espinosa; Richters, Anke; Özdemir, Berna C (2024). Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians. Cancer reports, 7(2), e1961. Wiley 10.1002/cnr2.1961

Mordasini, Pasquale Renato

Mose, Lucas

Moser, Nina

Mueller, Esther

Mueller, Michael

Mujanović, Adnan

Mumprecht, Sabine Barbara

Mumprecht, Sabine Barbara; Schürch, Christian; Schwaller, Juerg; Solenthaler, Max; Ochsenbein, Adrian F (2009). Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood, 114(8), pp. 1528-1536. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-09-179697

Mühlethaler, Konrad

Müller, Beatrice Ursula

Eyholzer, Marianne; Schmid, Sabine; Schardt, Julian A; Haefliger, Simon; Mueller, Beatrice U; Pabst, Thomas (2010). Complexity of miR-223 regulation by CEBPA in human AML. Leukemia research, 34(5), pp. 672-6. Amsterdam: Elsevier 10.1016/j.leukres.2009.11.019

Schardt, Julian A; Eyholzer, Marianne; Timchenko, Nikolai A; Mueller, Beatrice U; Pabst, Thomas (2010). Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine, 14(6B), pp. 1509-0519. Bucharest (Romania): Wiley 10.1111/j.1582-4934.2009.00870.x

Mueller, Beatrice U; Pabst, Thomas (2010). Lineage-specific transcription factor aberrations in AML. Cancer treatment and research, 145, pp. 109-125. New York, N.Y.: Springer Science+Business Media

Eyholzer, M; Schmid, S; Wilkens, L; Mueller, B U; Pabst, T (2010). The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. British journal of cancer, 103(2), pp. 275-84. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6605751

Pabst, Thomas; Mueller, Beatrice U (2009). Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clinical cancer research, 15(17), pp. 5303-7. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-08-2941

Schardt, Julian A; Weber, Daniel; Eyholzer, Marianne; Mueller, Beatrice U; Pabst, Thomas (2009). Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Clinical cancer research, 15(11), pp. 3834-41. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-08-2870

Pabst, T; Eyholzer, M; Fos, J; Mueller, B U (2009). Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. British journal of cancer, 100(8), pp. 1343-6. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604977

Pabst, T; Mueller, B U (2007). Transcriptional dysregulation during myeloid transformation in AML. Oncogene, 26(47), pp. 6829-37. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1210765

Mueller, B U; Pabst, T; Hauser, P; Gilliland, G; Neuberg, D; Tenen, D G (2006). Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia. British journal of cancer, 94(12), pp. 1918-20. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6603198

Pabst, Thomas; Stillner, Erica; Neuberg, Donna; Nimer, Stephen; Willman, Cheryl L; List, Alan F; Melo, Junia V; Tenen, Daniel G; Mueller, Beatrice U (2006). Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia. British journal of haematology, 133(4), pp. 400-2. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2006.06057.x

Mueller, Beatrice U; Pabst, Thomas (2006). C/EBPalpha and the pathophysiology of acute myeloid leukemia. Current opinion in hematology, 13(1), pp. 7-14. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/01.moh.0000190110.08156.96

Müller, Christoph

Müller, Madlaine

Müller, Martin

Mürner, Lukas Dominic

Nagler, Michael

Nebiker, Mathias

Neppl, Christina

Nesti, Cédric

Neururer, Christine

Ng, Kiu Yan Charlotte

Niederhauser-Lüthi, Christoph Peter

Niggli, Verena

Nilius, Henning Jürgen Jean

Notarfrancesco, Marco

Noth, Isabelle

Noth, Isabelle; Salis Gross Cöplü, Corina (7 May 2019). Der Club SRF: Impfskepsis – ein Virus mit tödlichen Folgen? In: Der Club. TV SRF 1

Noti, Luca Lorenz

Noti, Mario

Novak, Urban

Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; ... (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. The lancet, 403(10441), pp. 2293-2306. Elsevier 10.1016/S0140-6736(24)00184-3

de Ramon Ortiz, Carmen; Wang, Sisi; Stathis, Anastasios; Bertoni, Francesco; Zenz, Thorsten; Novak, Urban; Simonetta, Federico (2024). How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? Hematological oncology, 42(1), e3237. Wiley 10.1002/hon.3237

Chamuleau, Martine E D; Stenner, Frank; Chitu, Dana A; Novak, Urban; Minnema, Monique C; Geerts, Paul; Stevens, Wendy B C; Zenz, Thorsten; van Imhoff, Gustaaf W; Wu, Ka Lung; Demandt, Astrid M P; Kersten, Marie Jose; Terpstra, Wim E; Tick, Lidwine W; Deeren, Dries; Van Den Neste, Eric; Gregor, Michael; Veelken, Hendrik; Böhmer, Lara H; Caspar, Clemens B; ... (2023). R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial. The Lancet. Haematology, 10(12), e966-e975. Elsevier 10.1016/S2352-3026(23)00279-X

Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; ... (2023). Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine, 64, p. 102221. Elsevier 10.1016/j.eclinm.2023.102221

Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; ... (2023). Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(15), pp. 2718-2723. American Society of Clinical Oncology 10.1200/JCO.23.00033

Mamot, Christoph; Wicki, Andreas; Hasler-Strub, Ursula; Riniker, Salome; Li, Qiyu; Holer, Lisa; Bärtschi, Daniela; Zaman, Khalil; von Moos, Roger; Dedes, Konstantin J; Boos, Laura A; Novak, Urban; Bodmer, Alexandre; Ritschard, Reto; Obermann, Ellen C; Tzankov, Alexandar; Ackermann, Christoph; Membrez-Antonioli, Véronique; Zürrer-Härdi, Ursina; Caspar, Clemens B; ... (2023). A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer. Scientific Reports, 13(1), p. 3705. Nature Publishing Group 10.1038/s41598-023-30950-z

Novak, Urban; Žerovnik, Eva; Taler-Verčič, Ajda; Žnidarič, MagdaTušek; Zupančič, Barbara; Grdadolnik, Jože (2023). Amyloid Formation of Stefin B Protein Studied by Infrared Spectroscopy. Frontiers in bioscience (Landmark edition), 28(3), p. 46. IMR Press 10.31083/j.fbl2803046

Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner Agocs, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rüfer, Axel; Renner, Christoph; Driessen, Christoph (2023). Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia, 37(3), pp. 699-701. Springer Nature 10.1038/s41375-023-01809-z

Jeran, Marko; Romolo, Anna; Spasovski, Vesna; Hočevar, Matej; Novak, Urban; Štukelj, Roman; Šuštar, Vid; Kisovec, Matic; Bedina Zavec, Apolonija; Kogej, Ksenija; Iglič, Aleš; Trebše, Polonca; Kralj-Iglič, Veronika (2023). Small Cellular Particles from European Spruce Needle Homogenate. International journal of molecular sciences, 24(5) MDPI 10.3390/ijms24054349

Lang, Noémie; Novak, Urban (2023). Numerous Hot Topics in Lymphoproliferative Disorders. Leading opinions - Hämatologie und Onkologie Universimed

Paoletti, Francesca; Covaceuszach, Sonia; Cassetta, Alberto; Calabrese, Antonio N; Novak, Urban; Konarev, Petr; Grdadolnik, Jože; Lamba, Doriano; Golič Grdadolnik, Simona (2023). Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2. Protein science, 32(2), e4563. Wiley-Blackwell 10.1002/pro.4563

Hitz, Felicitas; Lang, Noémie; Mey, Ulrich; Mingrone, Walter; Moccia, Alden; Taverna, Christian; Novak, Urban; Stenner, Frank; Schmidt, Adrian; Mamot, Christoph; Fischer, Natalie; Putora, Paul M (2023). Decision-making among experts in advanced Hodgkin Lymphoma. Oncology, 101(3), pp. 159-165. Karger 10.1159/000526360

Stathis, Anastasios; Mey, Ulrich J M; Schär, Sämi; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; ... (2022). SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances, 6(13), pp. 3911-3920. American Society of Hematology 10.1182/bloodadvances.2021006520

Bertschinger, Martina; Novak, Urban (June 2022). Spannende Daten zu aggressiven Lymphomen. Leading Opinions. Hämatologie & Onkologie(5), pp. 6-8. Universimed

Novak, Urban; Golobič, Amalija; Klančnik, Natalija; Mohaček-Grošev, Vlasta; Stare, Jernej; Grdadolnik, Jože (2022). Strong Hydrogen Bonds in Acetylenedicarboxylic Acid Dihydrate. International journal of molecular sciences, 23(11) MDPI 10.3390/ijms23116164

Schmitt, Andreas Michael; Walter, Martin; Herbrand, Amanda Katherina; Jörger, Markus; Moffa, Giusi; Novak, Urban; Hemkens, Lars; Kasenda, Benjamin (2022). Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ open, 12(5), e060453. BMJ Publishing Group 10.1136/bmjopen-2021-060453

Novak, U (March 2022). CD19-gerichtete CAR-T-Zell-Therapie in der Schweiz: der klinische Alltag. Leading Opinions. Hämatologie & Onkologie, pp. 18-20. Universimed

Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386

Pirosa, Maria C; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios (2022). A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Leukemia & lymphoma, 63(1), pp. 117-123. Taylor & Francis 10.1080/10428194.2021.1966780

Novak, Urban; Grdadolnik, Jože (2021). Infrared spectra of hydrogen bond network in lamellar perfluorocarboxylic acid monohydrates. Spectrochimica acta. Part A - molecular and biomolecular spectroscopy, 253, p. 119551. Elsevier 10.1016/j.saa.2021.119551

Moccia, A A; Aeppli, S; Güsewell, S; Bargetzi, M; Caspar, C; Brülisauer, D; Ebnöther, M; Fehr, M; Fischer, N; Ghilardi, G; Krasniqi, F; Lang, N; Mey, U; Mingrone, W; Novak, U; Pfleger, C; Richter, P; Rütti, M; Schmidt, A; Stenner, F; ... (2021). Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematological oncology, 39(2), pp. 196-204. Wiley 10.1002/hon.2830

Herbrand, Amanda Katherina; Schmitt, Andreas M; Briel, Matthias; Ewald, Hannah; Goldkuhle, Marius; Diem, Stefan; Hoogkamer, Anouk; Joerger, Markus; Moffa, Giusi; Novak, Urban; Hemkens, Lars G; Kasenda, Benjamin (2021). Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA network open, 4(3), e210380. American Medical Association 10.1001/jamanetworkopen.2021.0380

Moccia, Alden Alberto; Schär, Sämi; Hayoz, Stefanie; Pirosa, Maria Cristina; Taverna, Christian; Novak, Urban; Kimby, Eva; Ghielmini, Michele; Zucca, Emanuele (2021). Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK). British journal of haematology, 192(6), pp. 1031-1034. Wiley-Blackwell 10.1111/bjh.17045

Ferreri, Andrés J M; Doorduijn, Jeanette K; Re, Alessandro; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Luppi, Mario; Calimeri, Teresa; Cattaneo, Chiara; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2021). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. The Lancet. Haematology, 8(2), e110-e121. Elsevier 10.1016/S2352-3026(20)30366-5

Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Pabst, Tobias; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rufer, Axel; Renner, Christoph; Driessen, Christoph (2021). P-227: Alternate day dosing of pomalidomide in patients with refractory/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39/16 OptiPOM Study). Clinical lymphoma, myeloma and leukemia, 21(Suppl. 2), S165-S165. Elsevier 10.1016/S2152-2650(21)02354-5

Novak, Urban (2020). CAR-T cell therapy of lymphoma: where do we stand? CAR-T will replace allo-SCT – PRO. Schweizer Krebsbulletin / Bulletin suisse du cancer, 40(4), pp. 295-299. Istituto oncologico della Svizzera Italiana

Novak, Urban (June 2020). Update zur CAR-T-Zell-Therapie. Leading Opinions. Hämatologie & Onkologie, 2020(6), pp. 6-9. Universimed

Hitz, F; Kraus, M; Pabst, Thomas; Hess, D; Besse, L; Silzle, T; Novak, Urban; Seipel, Katja; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C (2019). Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood cancer journal, 9(9), p. 70. Springer Nature 10.1038/s41408-019-0228-2

Herbrand, Amanda; Schmitt, Andreas; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars; Kasenda, Benjamin (29 July 2019). Contrasting Evidence to Reimbursement Reality for Off-label use 1 (OLU) of Drug Treatments in Cancer Care – Rationale and Design of 2 the CEIT-OLU-project (medRxiv). Cold Spring Harbor Laboratory 10.1101/19003152

Jeker, Barbara; Pabst Müller, Thomas Niklaus; Novak, Urban (2019). CAR-T-Zelltherapie – eine neue Behandlungsoption. Info@Onkologie, 2019(1), pp. 18-20. Aerzteverlag medinfo AG

Davies, Andrew; Cummin, Thomas E; Barrans, Sharon; Maishman, Tom; Mamot, Christoph; Novak, Urban; Caddy, Josh; Stanton, Louise; Kazmi-Stokes, Shamim; McMillan, Andrew; Fields, Paul; Pocock, Christopher; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Clipson, Alexandra; Sha, Chulin; Tooze, Reuben; Care, Matthew A; Griffiths, Gareth; ... (2019). Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The lancet oncology, 20(5), pp. 649-662. Elsevier 10.1016/S1470-2045(18)30935-5

Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J. M.; Rauch, Daniel; Wahlin, Björn E.; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J. M.; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; ... (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), pp. 353-362. American Society of Hematology 10.1182/blood-2018-10-879643

Herbrand, Amanda Katherina; Schmitt, Andreas Michael; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly Alba; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars G; Kasenda, Benjamin (2019). Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO open, 4(6), e000596. BMJ 10.1136/esmoopen-2019-000596

Novak, Urban (2019). Aggressive Lymphome & DLBCL – noch immer R-CHOP für alle? Leading Opinions. Hämatologie & Onkologie, 15(4), pp. 6-9. Universimed

Ferreri, Andres JM; Doorduijn, Jeanette K.; Cattaneo, Chiara; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Narni, Franco; Calimeri, Teresa; Re, Alessandro; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2019). Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial. Blood, 134(Suppl. 1), p. 353. American Society of Hematology 10.1182/blood-2019-129835

Conconi, Annarita; Zucca, Emanuele; Margiotta-Casaluci, Gloria; Darling, Katharine; Hasse, Barbara; Battegay, Manuel; Staehelin, Cornelia; Novak, Urban; Schmid, Patrick; Scherrer, Alexandra; Dirnhofer, Stephan; Kwee, Ivo; Nassi, Luca; Cavalli, Franco; Gaidano, Gianluca; Bertoni, Francesco; Bernasconi, Enos (2018). Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology, 36(5), pp. 757-764. Wiley 10.1002/hon.2536

Driessen, Christoph; Müller, Rouven; Novak, Urban; Cantoni, Nathan; Betticher, Daniel; Mach, Nicolas; Rüfer, Axel; Mey, Ulrich; Samaras, Panagiotis; Ribi, Karin; Besse, Lenka; Besse, Andrej; Berset, Catherine; Rondeau, Stephanie; Hawle, Hanne; Hitz, Felicitas; Pabst Müller, Thomas Niklaus; Zander, Thilo (2018). Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma. Blood, 132(19), pp. 2097-2100. American Society of Hematology 10.1182/blood-2018-05-851170

Novak, Urban (2018). Erstlinientherapie beim diffusen grosszelligen B-Zell-Lymphom: personalisierte Therapie oder alles R-CHOP? Schweizer Zeitschrift für Onkologie, 4, pp. 22-25. Rosenfluh Publikationen AG

Bargetzi, Mario; Baumann, Reto; Cogliatti, Sergio; Dietrich, Pierre-Yves; Duchosal, Michel; Goede, Jeroen; Hitz, Felicitas; Konermann, Carolin; Lohri, Andreas; Mey, Ulrich; Novak, Urban; Papachristofilou, Alexandros; Stenner, Frank; Taverna, Christian; Zander, Thilo; Renner, Christoph (2018). Diagnosis and treatment of follicular lymphoma: an update. Swiss medical weekly, 148, w14635. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14635

Suter, Thomas; Novak, Urban (2017). Kardiologie: Der Preis fürs Überleben – kardiovaskuläre Nebenwirkungen onkologischer Therapien. Swiss Medical Forum, 17(03), pp. 61-63. EMH Swiss Medical Publishers 10.4414/smf.2017.02860

Novak, Urban (2017). "Toys for boys?". Swiss Medical Forum, 17(05), p. 122. EMH Swiss Medical Publishers 10.4414/smf.2017.02894

Rinaldi, Andrea; Mian, Michael; Chigrinova, Ekaterina; Arcaini, Luca; Bhagat, Govind; Novak, Urban; Rancoita, Paola M. V.; De Campos, Cassio P.; Forconi, Francesco; Gascoyne, Randy D.; Facchetti, Fabio; Ponzoni, Maurilio; Govi, Silvia; Ferreri, Andrés J. M.; Mollejo, Manuela; Piris, Miguel A.; Baldini, Luca; Soulier, Jean; Thieblemont, Catherine; Canzonieri, Vincenzo; ... (2011). Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117(5), pp. 1595-1604. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-01-264275

Novak, Urban; Basso, Katia; Pasqualucci, Laura; Dalla-Favera, Riccardo; Bhagat, Govind (2011). Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. British journal of haematology, 155(3), pp. 362-5. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2011.08841.x

Reber, R; Chan, WC; Novak, U (2011). Assessing DLBCL subtypes by immunohistochemistry E-Letter in response to Gutierrez-Garcia et al. Blood(117: 4836-43) Washington, D.C.: American Society of Hematology

Novak, U; Pasqualucci, L; Dalla-Favera, R (2011). Molecular Biology of Lymphomas. In: DeVita, Vincent D.; Lawrence, Theodore S.; Rosenberg, Steven A. (eds.) CANCER: Principles & Practice of Oncology. Lippincott Williams & Wilkins

Novak, Urban (2010). [Molecular biology of malignant lymphomas for non-specialists]. Therapeutische Umschau, 67(10), pp. 501-4. Bern: Huber

Novak, U (2010). Molekularbiologie maligner Lymphome für den Nichtspezialisten. Therapeutische Umschau, pp. 501-4. Bern: Huber

Saito, Masumichi; Novak, Urban; Piovan, Erich; Basso, Katia; Sumazin, Pavel; Schneider, Christof; Crespo, Marta; Shen, Qiong; Bhagat, Govind; Califano, Andrea; Chadburn, Amy; Pasqualucci, Laura; Dalla-Favera, Riccardo (2009). BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 106(27), pp. 11294-9. Washington, D.C.: National Academy of Sciences NAS 10.1073/pnas.0903854106

Novak, Urban; Rinaldi, Andrea; Kwee, Ivo; Nandula, Subhadra V; Rancoita, Paola M V; Compagno, Mara; Cerri, Michaela; Rossi, Davide; Murty, Vundavalli V; Zucca, Emanuele; Gaidano, Gianluca; Dalla-Favera, Riccardo; Pasqualucci, Laura; Bhagat, Govind; Bertoni, Francesco (2009). The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood, 113(20), pp. 4918-21. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-08-174110

Nuoffer, Jean-Marc

Hilmenyuk, Tamara; Ruckstuhl, Carla A.; Hayoz, Michael; Berchtold, Christian; Nuoffer, Jean-Marc; Solanki, Shyam; Keun, Hector C.; Beavis, Paul A.; Riether, Carsten; Ochsenbein, Adrian F. (2018). T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma. Oncoimmunology, 7(1), e1365997. Landes Bioscience 10.1080/2162402x.2017.1365997

Näf, Pascal

Nüesch, Eveline

Oberli, Andrea Elisabeth

Oberson, Kevin

Obmann, Verena Carola

Ochsenbein, Adrian

Radpour, Ramin; Simillion, Cedric; Wang, Bofei; Abbas, Hussein A; Riether, Carsten; Ochsenbein, Adrian (2024). IL-9 Secreted by Leukemia Stem Cells Induces Th1-Skewed CD4+ T-Cells, which Promote Their Expansion. Blood, 144(8), pp. 888-903. American Society of Hematology 10.1182/blood.2024024000

Mastall, Maximilian; Roth, Patrick; Bink, Andrea; Fischer Maranta, Angela; Läubli, Heinz; Hottinger, Andreas Felix; Hundsberger, Thomas; Migliorini, Denis; Ochsenbein, Adrian; Seystahl, Katharina; Imbach, Lukas; Hortobagyi, Tibor; Held, Leonhard; Weller, Michael; Wirsching, Hans-Georg (2024). A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC cancer, 24(1), p. 82. BioMed Central 10.1186/s12885-023-11797-z

König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials. ESMO open, 7(2), p. 100455. Elsevier 10.1016/j.esmoop.2022.100455

Wirsching, Hans-Georg; Roelcke, Ulrich; Weller, Jonathan; Hundsberger, Thomas; Hottinger, Andreas F; von Moos, Roger; Caparrotti, Francesca; Conen, Katrin; Remonda, Luca; Roth, Patrick; Ochsenbein, Adrian; Tabatabai, Ghazaleh; Weller, Michael (2021). MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clinical cancer research, 27(1), pp. 179-188. American Association for Cancer Research 10.1158/1078-0432.CCR-20-2096

Radpour, Ramin; Stucki, Miriam; Riether, Carsten; Ochsenbein, Adrian F. (2021). Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia. Frontiers in oncology, 11, p. 663406. Frontiers Research Foundation 10.3389/fonc.2021.663406

Riether, Carsten; Ochsenbein, Adrian F. (2020). Genetic Alterations Impact Immune Microenvironment Interactions in Follicular Lymphoma. Cancer cell, 37(5), pp. 621-622. Cell Press 10.1016/j.ccell.2020.04.008

Salomé, Bérengère; Gomez-Cadena, Alejandra; Loyon, Romain; Suffiotti, Madeleine; Salvestrini, Valentina; Wyss, Tania; Vanoni, Giulia; Ruan, Dan Fu; Rossi, Marianna; Tozzo, Alessandra; Tentorio, Paolo; Bruni, Elena; Riether, Carsten; Jacobsen, Eva-Maria; Jandus, Peter; Conrad, Curdin; Hoenig, Manfred; Schulz, Ansgar; Michaud, Katarzyna; Della Porta, Matteo Giovanni; ... (2019). CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML. Blood advances, 3(22), pp. 3674-3687. American Society of Hematology 10.1182/bloodadvances.2018030478

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian (2017). Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. Clinical lung cancer, 18(3), pp. 303-309. Elsevier 10.1016/j.cllc.2016.11.007

Gautschi, O; Li, Q; Matter-Walstra, K; Betticher, D; Frueh, M; Rauch, Daniel; Pless, M; Froesch, P; Mach, N; Ochsenbein, Adrian (2016). 143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial. Journal of thoracic oncology, 11(4Suppl), S120-S120. Elsevier 10.1016/S1556-0864(16)30253-2

Gross, Stefanie; Lennerz, Volker; Gallerani, Elisa; Mach, Nicolas; Böhm, Steffen; Hess, Dagmar; von Boehmer, Lotta; Knuth, Alexander; Ochsenbein, Adrian; Gnad-Vogt, Ulrike; Forssmann, Ulf; Woelfel, Thomas; Kaempgen, Eckhart (2016). Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers. Cancer immunology research, 4(1), pp. 18-25. American Association for Cancer Research 10.1158/2326-6066.CIR-15-0105

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; ... (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998), pp. 1049-1056. Elsevier 10.1016/S0140-6736(15)60294-X

Trabanelli, Sara; Curti, Antonio; Lecciso, Mariangela; Salomé, Bérengère; Riether, Carsten; Ochsenbein, Adrian; Romero, Pedro; Jandus, Camilla (2015). CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis. Haematologica - the hematology journal, 100(7), e257-e260. Ferrata-Storti Foundation 10.3324/haematol.2014.119602

Riether, Carsten; Schürch, Christian; Ochsenbein, Adrian (2015). Regulation of hematopoietic and leukemic stem cells by the immune system. Cell death and differentiation, 22(2), pp. 187-198. Nature Publishing Group 10.1038/cdd.2014.89

Schürch, Christian; Riether, Carsten; Ochsenbein, Adrian (2014). Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell stem cell, 14(4), pp. 460-472. Elsevier 10.1016/j.stem.2014.01.002

Lennerz, Volker; Gross, Stefanie; Gallerani, Elisa; Sessa, Cristiana; Mach, Nicolas; Boehm, Steffen; Hess, Dagmar; von Boehmer, Lotta; Knuth, Alexander; Ochsenbein, Adrian; Gnad-Vogt, Ulrike; Zieschang, Juergen; Forssmann, Ulf; Woelfel, Thomas; Kaempgen, Eckhart (2014). Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer immunology, immunotherapy, 63(4), pp. 381-394. Springer 10.1007/s00262-013-1516-5

Schürch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F. (2013). Dendritic Cell-Based Immunotherapy for Myeloid Leukemias. Frontiers in immunology, 4(496), p. 496. Frontiers Research Foundation 10.3389/fimmu.2013.00496

Schürch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F. (2013). Interferons in hematopoiesis and leukemia. Oncoimmunology, 2(6), e24572. Landes Bioscience 10.4161/onci.24572

Riether, Carsten; Schürch, Christian; Ochsenbein, Adrian F. (2013). From "magic bullets" to specific cancer immunotherapy. Swiss medical weekly, 143, w13734. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13734

Schürch, Christian; Riether, Carsten; Matter, Matthias S; Tzankov, Alexandar; Ochsenbein, Adrian (2012). CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. Journal of clinical investigation, 122(2), pp. 624-38. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI45977

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mjhic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R; Swiss Group for Clinical Cancer Research, (SAKK) (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of oncology, 23(2), pp. 531-6. Oxford: Oxford University Press 10.1093/annonc/mdr126

Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendorf, Lukas; Ochsenbein, Adrian; Gautschi, Oliver; Oppliger Leibundgut, Elisabeth; Froesch, Patrizia; Stahel, Rolf; Hess, Thomas; Rauch, Daniel; Schmid, Petra; Mayer, Michael; Crowe, Susanne; Brauchli, Peter; Ribi, Karin; Pless, Miklos; on behalf of the Swiss Group for Clinical Cancer Research (SAKK), (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05). Lung cancer, 78(3), pp. 239-44. Amsterdam: Elsevier 10.1016/S1359-6349(09)71860-9

Riether, Carsten; Schürch, Christian; Ochsenbein, Adrian (2012). Modulating CD27 signaling to treat cancer. Oncoimmunology, 1(9), pp. 1604-1606. Austin, Tex.: Landes Bioscience 10.4161/onci.21425

Fahrner, René; Ochsenbein, Adrian; Schmid, Ralph A; Carboni, Giovanni L (2012). Long term survival after trimodal therapy in malignant pleural mesothelioma. Swiss medical weekly, 142, w13686. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13686

Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger; Swiss Group for Clinical Cancer Research, (SAKK) (2012). Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques. Case reports in oncology, 5(2), pp. 280-9. Basel: Karger 10.1159/000339300

Schraml, Peter; von Teichman, Adriana; Mihic-Probst, Daniela; Simcock, Mathew; Ochsenbein, Adrian; Dummer, Reinhard; Michielin, Olivier; Seifert, Bettina; Schläppi, Marc; Moch, Holger; von Moos, Roger (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology reports, 28(2), pp. 654-8. Athens: National Hellenic Research Foundation 10.3892/or.2012.1826

Ochsenbein, Adrian F; Schubert, Adrian D; Vassella, Erik; Mariani, Luigi (2011). Quantitative analysis of O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas. Journal of neuro-oncology, 103(2), pp. 343-51. Boston, Mass.: Springer US; http://www.springer-ny.com 10.1007/s11060-010-0395-2

Hofer, Silvia; Elandt, Katarzyna; Greil, Richard; Hottinger, Andreas F; Huber, Urs; Lemke, Dieter; Marosi, Christine; Ochsenbein, Adrian; Pichler, Josef; Roelcke, Ulrich; Weder, Patrik; Zander, Thilo; Wick, Wolfgang; Weller, Michael (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta oncologica, 50(5), pp. 630-5. Stockholm: Acta Oncologica 10.3109/0284186X.2011.572913

Stupp, Roger; Hegi, Monika E; Neyns, Bart; Goldbrunner, Roland; Schlegel, Uwe; Clement, Paul M J; Grabenbauer, Gerhard G; Ochsenbein, Adrian F; Simon, Matthias; Dietrich, Pierre-Yves; Pietsch, Torsten; Hicking, Christine; Tonn, Joerg-Christian; Diserens, Annie-Claire; Pica, Alessia; Hermisson, Mirjam; Krueger, Stefan; Picard, Martin; Weller, Michael (2010). Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Journal of clinical oncology, 28(16), pp. 2712-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.26.6650

Flatz, Lukas; Hegazy, Ahmed N.; Bergthaler, Andreas; Verschoor, Admar; Claus, Christina; Fernandez, Marylise; Gattinoni, Luca; Johnson, Susan; Kreppel, Florian; Kochanek, Stefan; Broek, Maries van den; Radbruch, Andreas; Lévy, Frédéric; Lambert, Paul-Henri; Siegrist, Claire-Anne; Restifo, Nicholas P.; Löhning, Max; Ochsenbein, Adrian F.; Nabel, Gary J. and Pinschewer, Daniel D. (2010). Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nature medicine, 16(3), pp. 339-345. New York, N.Y.: Nature Publishing Group 10.1038/nm.2104

Mumprecht, Sabine; Claus, Christina; Schürch, Christian; Pavelic, Viktor; Matter, Matthias S; Ochsenbein, Adrian F (2009). Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells. Blood, 113(19), pp. 4681-9. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-05-156471

Pavelic, Viktor; Matter, Matthias S; Mumprecht, Sabine; Breyer, Isabel; Ochsenbein, Adrian F (2009). CTL induction by cross-priming is restricted to immunodominant epitopes. European journal of immunology, 39(3), pp. 704-16. Weinheim: Wiley-VCH 10.1002/eji.200838901

Ochsenbein, Anne; Chai, Feng; Winter, Stefan; Traisnel, Michel; Breme, Jürgen; Hildebrand, Hartmut F (2008). Osteoblast responses to different oxide coatings produced by the sol-gel process on titanium substrates. Acta biomaterialia, 4(5), pp. 1506-17. Amsterdam: Elsevier 10.1016/j.actbio.2008.03.012

Matter, Matthias; Pavelic, Viktor; Pinschewer, Daniel D; Mumprecht, Sabine; Eschli, Bruno; Giroglou, Tsanan; von Laer, Dorothee; Ochsenbein, Adrian F (2007). Decreased tumor surveillance after adoptive T-cell therapy. Cancer research, 67(15), pp. 7467-76. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-06-4372

Ochsenbein, Adrian F. (2005). Immunological ignorance of solid tumors. Seminars in immunopathology, 27(1), pp. 19-35. Springer-Verlag 10.1007/s00281-004-0192-0

Olariu, Radu

Omlin, Aurelius Gabriel

Turco, Fabio; Armstrong, Andrew; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob G; Bulbul, Muhammad; Caffo, Orazio; Chi, Kim N; Clarke, Caroline S; Clarke, Noel; Davis, Ian D; de Bono, Johann; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; ... (2022). What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European urology, 82(1), pp. 6-11. Elsevier 10.1016/j.eururo.2022.02.010

Turco, Fabio; Armstrong, Andrew; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob G; Bulbul, Muhammad; Caffo, Orazio; Chi, Kim N; Clarke, Caroline; Clarke, Noel; Davis, Ian D; de Bono, Johann; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; ... (2022). Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 2022]. European urology, 82(1), e18-e19. Elsevier 10.1016/j.eururo.2022.04.004

Heinrich, Daniel; Bektic, Jasmin; Bergman, Andries M; Caffo, Orazio; Cathomas, Richard; Chi, Kim N; Daugaard, Gedske; Keizman, Daniel; Kindblom, Jon; Kramer, Gero; Olmos, David; Omlin, Aurelius Gabriel; Sridhar, Srikala S; Tucci, Marcello; van Oort, Inge; Nilsson, Sten (2018). The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer. Clinical genitourinary cancer, 16(1), e223-e231. Elsevier 10.1016/j.clgc.2017.08.020

Gillessen, Silke; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bossi, Alberto; Bristow, Rob; Carver, Brett; Castellano, Daniel; Chung, Byung Ha; Clarke, Noel; Daugaard, Gedske; Davis, Ian D; de Bono, Johann; Borges Dos Reis, Rodolfo; Drake, Charles G; Eeles, Ros; Efstathiou, Eleni; Evans, Christopher P; Fanti, Stefano; Feng, Felix; ... (2018). Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European urology, 73(2), pp. 178-211. Elsevier 10.1016/j.eururo.2017.06.002

Endt, Kathrin; Goepfert, Jens; Omlin, Aurelius Gabriel; Athanasiou, Alcibiade; Tennstedt, Pierre; Guenther, Anna; Rainisio, Maurizio; Engeler, Daniel S; Steuber, Thomas; Gillessen, Silke; Joos, Thomas; Schiess, Ralph (2017). Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer. PLoS ONE, 12(8), e0181557. Public Library of Science 10.1371/journal.pone.0181557

Vogt, Alexia; Schmid, Sabine; Heinimann, Karl; Frick, Harald; Herrmann, Christian; Cerny, Thomas; Omlin, Aurelius Gabriel (2017). Multiple primary tumours: challenges and approaches, a review. ESMO open, 2(2), e000172. BMJ 10.1136/esmoopen-2017-000172

Oppliger Leibundgut, Elisabeth

Wehrli, Marc; Oppliger Leibundgut, Elisabeth; Gattiker, Heinrich H; Manz, Markus G; Müller, Antonia M S; Goede, Jeroen S (2017). Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement. The oncologist, 22(4), pp. 480-483. AlphaMed Press 10.1634/theoncologist.2016-0354

Orlando, Eleonora

Pabst, Thomas Niklaus

Pabst, Thomas; Bacher, Ulrike (2024). Boosting CAR T cells against lymphomas. Blood, 144(7), pp. 689-691. American Society of Hematology 10.1182/blood.2024025378

Al Hamed, Rama; Labopin, Myriam; Wu, Depei; Gedde-Dahl, Tobias; Aljurf, Mahmoud; Forcade, Edouard; Salmenniemi, Urpu; Passweg, Jakob; Maertens, Johan; Pabst, Thomas; Versluis, Jurjen; Itäla-Remes, Maija; Huang, Xiao-Jun; Van Gorkom, Gwendolyn; Schroeder, Thomas; Sanz, Jaime; Blaise, Didier; Reményi, Péter; Schanz, Urs; Esteve, Jordi; ... (2024). Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. (In Press). Bone marrow transplantation Springer Nature 10.1038/s41409-024-02373-5

van der Maas, Niek G; Versluis, Jurjen; Nasserinejad, Kazem; van Rosmalen, Joost; Pabst, Thomas; Maertens, Johan; Breems, Dimitri; Manz, Markus; Cloos, Jacqueline; Ossenkoppele, Gert J; Floisand, Yngvar; Gradowska, Patrycja; Löwenberg, Bob; Huls, Gerwin; Postmus, Douwe; Pignatti, Francesco; Cornelissen, Jan J (2024). Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal, 14(56) Nature Publishing Group 10.1038/s41408-024-01037-3

Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J; Topp, Max S; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M; Keller, Ulrich Bernd; Krause, Stefan W; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; ... (2024). Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia, 38(1), pp. 160-167. Springer Nature 10.1038/s41375-023-02064-y

Chen, Jia; Labopin, Myriam; Pabst, Thomas; Zhang, Xi; Jiang, Erlie; Tucci, Alessandra; Cornelissen, Jan; Meijer, Ellen; Khevelidze, Irma; Polge, Emmanuelle; Wu, Depei; Mohty, Mohamad; Gorin, Norbert-Claude (2023). Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone marrow transplantation, 58(12), pp. 1322-1330. Nature Publishing Group 10.1038/s41409-023-02070-9

Tettero, Jesse M; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T; Kelder, Angèle; van de Loosdrecht, Arjan A; Manz, Markus G; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J; Cloos, Jacqueline; de Leeuw, David C (2023). Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere, 7(12), e981. Wolters Kluwer Health 10.1097/HS9.0000000000000981

Keil, Felix; Müller, Antonia M S; Berghold, Andrea; Riedl, Regina; Buxhofer-Ausch, Veronika; Schuster, Judith; Vorburger, Corinne; Böhm, Alexandra; Panny, Michael; Nösslinger, Thomas; Greil, Richard; Samaras, Panagiotis; Bencker, Celine; Rütti, Markus; Pabst, Thomas (2023). BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial. EClinicalMedicine, 66(102318), p. 102318. Elsevier 10.1016/j.eclinm.2023.102318

Sanz, Jaime; Labopin, Myriam; Pabst, Thomas; Versluis, Jurjen; Van Gorkom, Gwendolyn; Meijer, Ellen; Gedde-Dahl, Tobias; Montoro, Juan; Arcese, William; Pérez-Simón, Jose Antonio; Schaap, Nicolaas; Maertens, Johan; Vrhovac, Radovan; Lanza, Francesco; Gorin, Norbert Claude; Mohty, Mohamad; Ciceri, Fabio (2023). Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation, 58(11), pp. 1197-1202. Nature Publishing Group 10.1038/s41409-023-02075-4

Pabst, Thomas; Papayannidis, Cristina; Demirkan, Fatih; Doronin, Vadim; Fogliatto, Laura M; Guttke, Christina; Gyan, Emmanuel; Hamad, Nada; Herrera, Pilar; Hultberg, Anna; Jacobs, Julie; Johnson, Amy J; Langlois, Angélique; Ma, Xuewen; Martinelli, Giovanni; Arnan, Montserrat; Müller, Rouven; Nottage, Kerri; Ofran, Yishai; Özcan, Muhit; ... (2023). Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study. The Lancet. Haematology, 10(11), e902-e912. Elsevier 10.1016/S2352-3026(23)00207-7

Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline (2023). Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival. Haematologica - the hematology journal, 108(10), pp. 2794-2798. Ferrata-Storti Foundation 10.3324/haematol.2022.282639

Maru, Bruktawit; Messikommer, Alessandra; Huang, Linhui; Seipel, Katja; Kovecses, Olivia; Valk, Peter J M; Theocharides, Alexandre P A; Mercier, Francois E; Pabst, Thomas; McKeague, Maureen; Luedtke, Nathan W (2023). PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy. Cell reports. Medicine, 4(9), p. 101191. Elsevier 10.1016/j.xcrm.2023.101191

Sauer, Stephanie Tina; Christner, Sara Aniki; Schlaiß, Tanja; Metz, Corona; Schmid, Andrea; Kunz, Andreas Steven; Pabst, Thomas; Weiland, Elisabeth; Benkert, Thomas; Bley, Thorsten Alexander; Grunz, Jan-Peter (2023). Diffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat Saturation. Academic radiology, 30(9), pp. 1773-1783. Elsevier 10.1016/j.acra.2023.01.014

Haefliger, David; Marzolini, Catia; Lamoth, Frederic; Pabst, Thomas; Buclin, Thierry; Livio, Francoise (2023). Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole. British journal of clinical pharmacology, 89(7), pp. 2304-2308. Wiley-Blackwell 10.1111/bcp.15743

Hilberink, Jacobien R; van Zeventer, Isabelle A; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; ... (2023). Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal, 13(1), p. 93. Springer Nature 10.1038/s41408-023-00850-6

Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; ... (2023). Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood, 141(21), pp. 2657-2661. American Society of Hematology 10.1182/blood.2022019160

Qiu, Peiyong; Pabst, Thomas (2023). Characterization of particle size segregation and heterogeneity along the slopes of a waste rock pile using image analysis. Environmental Earth Science, 82(23), p. 573. Springer 10.1007/s12665-023-11229-y

Rüegsegger, Laura; Schanz, Urs; Seipel, Katja; Pabst, Thomas; Schwegler, Jürg; Schmidt, Elisabeth; Schmidt, Adrian (2022). Emberger Syndrome – A Family History Over 3 Generations (In Press). Healthbook TIMES oncology hematology, 14(4), pp. 34-40. The Healthbook Company 10.36000/hbT.OH.2022.14.092

Janssen, J J W M; Löwenberg, B; Manz, M; Biemond, B J; Westerweel, P E; Klein, S K; Fehr, M; Sinnige, H A M; Efthymiou, A; Legdeur, M C J C; Pabst, T; Gregor, M; van der Poel, M W M; Deeren, D; Tick, L W; Jongen-Lavrencic, M; van Obbergh, F; Boersma, R S; de Weerdt, O; Chalandon, Y; ... (2022). Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia, 36(9), pp. 2189-2195. Nature Publishing Group 10.1038/s41375-022-01657-3

Linnik, Janina; Syedbasha, Mohammedyaseen; Kaltenbach, Hans-Michael; Vogt, Dominik; Hollenstein, Yvonne; Kaufmann, Lukas; Cantoni, Nathan; Ruosch-Girsberger, Sabine; Müller, Antonia M S; Schanz, Urs; Pabst, Thomas; Stüssi, Georg; Weisser, Maja; Halter, Jörg; Stelling, Jörg; Egli, Adrian (2022). Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients. The journal of infectious diseases, 225(8), pp. 1482-1493. Oxford University Press 10.1093/infdis/jiab391

Grob, Tim; Al Hinai, Adil S A; Sanders, Mathijs A; Kavelaars, François G; Rijken, Melissa; Gradowska, Patrycja L; Biemond, Bart J; Breems, Dimitri A; Maertens, Johan; van Marwijk Kooy, Marinus; Pabst, Thomas; de Weerdt, Okke; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; Huls, Gerwin A; Cornelissen, Jan J; Beverloo, H Berna; Löwenberg, Bob; Jongen-Lavrencic, Mojca and Valk, Peter J M (2022). Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood, 139(15), pp. 2347-2354. American Society of Hematology 10.1182/blood.2021014472

Kreissl, Stefanie; Voltin, Conrad‐Amadeus; Kaul, Helen; Bühnen, Ina; Mettler, Jasmin; Pabst, Thomas; Eichenauer, Dennis A.; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas; Borchmann, Peter; Kobe, Carsten (2022). Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma. British journal of haematology, 197(1), e5-e8. Wiley-Blackwell 10.1111/bjh.17997

Bakunina, Katerina; Putter, Hein; Versluis, Jurjen; Koster, Eva A S; van der Holt, Bronno; Manz, Markus G; Breems, Dimitri A; Gjertsen, Bjorn T; Cloos, Jacqueline; Valk, Peter J M; Passweg, Jakob; Pabst, Thomas; Ossenkoppele, Gert J; Löwenberg, Bob; Cornelissen, Jan J; de Wreede, Liesbeth C (2022). The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed. Cancer medicine, 11(3), pp. 630-640. Wiley 10.1002/cam4.4392

Heidemeier, Anke; Thurner, Annette; Metz, Corona; Pabst, Thomas; Heidemeier, Heike; Rasche, Leo; Kortüm, K Martin; Einsele, Hermann; Grimm, Robert; Weiland, Elisabeth; Bley, Thorsten Alexander (2022). Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias. Academic radiology, 29(1), e1-e8. Elsevier 10.1016/j.acra.2020.09.016

Tettero, Jesse M; Al-Badri, Waleed K W; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; van Elssen, Catharina H M J; Fischer, Thomas; Gjertsen, Bjorn T; van Gorkom, Gwendolyn N Y; Gradowska, Patrycja; Greuter, Marjolein J E; Griskevicius, Laimonas; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Löwenberg, Bob; Ossenkoppele, Gert J; ... (2022). Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis. Frontiers in oncology, 12, p. 999822. Frontiers Research Foundation 10.3389/fonc.2022.999822

Peter, Raffaele; Halter, Joerg P; Heim, Dominik; Medinger, Michael; Pabst, Thomas; Stussi, Georg; Passweg, Jakob R; Gerull, Sabine (2021). Lack of association of travel time to transplant center and posttransplant care model with outcome parameters after allogeneic transplantation. Bone marrow transplantation, 56(8), pp. 2024-2026. Springer Nature 10.1038/s41409-021-01301-1

Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; ... (2021). PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. The Lancet. Haematology, 8(6), e398-e409. Elsevier 10.1016/S2352-3026(21)00101-0

Messikomer, A; Bruktawit, M; Seipel, Katja; Valk, P; Theocharides, A; Pabst, Thomas; Mckeague, M; Luedtke, N (25 May 2021). Cancer Prognosis According to Parthanatos Features (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2021.05.24.445484

Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja; Biemond, Bart J; Spertini, Olivier; Vellenga, Edo; Griskevicius, Laimonas; Tick, Lidwine W; Jongen-Lavrencic, Mojca; van Marwijk Kooy, Marinus; Vekemans, Marie-Christiane; van der Velden, Walter J F M; Beverloo, Berna; Michaux, Lucienne; Graux, Carlos; Deeren, Dries; de Weerdt, Okke; van Esser, Joost W J; Bargetzi, Mario; ... (2021). Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial. Blood advances, 5(4), pp. 1110-1121. American Society of Hematology 10.1182/bloodadvances.2020003855

Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672

Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; ... (2021). PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. The lancet oncology, 22(2), pp. 223-234. Elsevier 10.1016/S1470-2045(20)30601-X

Bröckelmann, Paul J; Müller, Horst; Guhl, Teresa; Behringer, Karolin; Fuchs, Michael; Moccia, Alden A; Rank, Andreas; Soekler, Martin; Vieler, Tom; Pabst, Thomas; Baues, Christian; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. Journal of clinical oncology, 39(2), pp. 107-115. American Society of Clinical Oncology 10.1200/JCO.20.00947

Moccia, Alden A; Taverna, Christian; Schär, Sämi; Vanazzi, Anna; Rondeau, Stéphanie; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Ruegsegger, Céline; Biaggi Rudolf, Christine; Rusterholz, Corinne; Hayoz, Stefanie; Ghielmini, Michele and Zucca, Emanuele (2020). Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood advances, 4(23), pp. 5951-5957. American Society of Hematology 10.1182/bloodadvances.2020002858

Averbuch, Diana; Tridello, Gloria; Hoek, Jennifer; Mikulska, Malgorzata; Pabst, Thomas; Yaňez San Segundo, Lucrecia; Akan, Hamdi; Özçelik, Tülay; Donnini, Irene; Klyasova, Galina; Botelho de Sousa, Aida; Zuckerman, Tsila; Tecchio, Cristina; de la Camara, Rafael; Aki, Sahika Zeynep; Ljungman, Per; Gülbas, Zafer; Nicolas-Virelizier, Emmanuelle; Calore, Elisabetta; Perruccio, Katia; ... (2020). Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality. Journal of infection, 81(6), pp. 882-894. Elsevier 10.1016/j.jinf.2020.11.002

Waitz, Markus; Engel, Corinna; Schloesser, Rolf; Rochwalsky, Ulrich; Meyer, Sascha; Larsen, Alexander; Hoffmann, Paul; Zemlin, Michael; Bohnhorst, Bettina; Peter, Corinna; Hoppenz, Marc; Pabst, Thomas; Zimmer, Klaus-Peter; Franz, Axel R; Haertel, Christoph; Frieauff, Eric; Sandkötter, Julia; Masjosthusmann, Katja; Deindl, Philipp; Singer, Dominique; ... (2020). Application of two different nasal CPAP levels for the treatment of respiratory distress syndrome in preterm infants-"The OPTTIMMAL-Trial"-Optimizing PEEP To The IMMAture Lungs: study protocol of a randomized controlled trial. Trials, 21(1), p. 822. BioMed Central 10.1186/s13063-020-04660-0

Huls, Gerwin; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; van Zeventer, Isabelle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; ... (2020). Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS. Blood advances, 4(18), pp. 4267-4277. American Society of Hematology 10.1182/bloodadvances.2020002846

Fagnan, Alexandre; Bagger, Frederik Otzen; Piqué-Borràs, Maria-Riera; Ignacimouttou, Cathy; Caulier, Alexis; Lopez, Cécile K; Robert, Elie; Uzan, Benjamin; Gelsi-Boyer, Véronique; Aid, Zakia; Thirant, Cécile; Moll, Ute; Tauchmann, Samantha; Kurtovic-Kozaric, Amina; Maciejewski, Jaroslaw; Dierks, Christine; Spinelli, Orietta; Salmoiraghi, Silvia; Pabst, Thomas; Shimoda, Kazuya; ... (2020). Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood, 136(6), pp. 698-714. American Society of Hematology 10.1182/blood.2019003062

Orvain, Corentin; Balsat, Marie; Tavernier, Emmanuelle; Marolleau, Jean-Pierre; Pabst, Thomas; Chevallier, Patrice; de Gunzburg, Noémie; Cacheux, Victoria; Huguet, Françoise; Chantepie, Sylvain; Caillot, Denis; Chalandon, Yves; Frayfer, Jamilé; Bonmati, Caroline; Lheritier, Véronique; Ifrah, Norbert; Dombret, Hervé; Boissel, Nicolas; Hunault-Berger, Mathilde (2020). Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood, 136(3), pp. 328-338. American Society of Hematology 10.1182/blood.2020004919

Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; A von dem Borne, P; Chalandon, Y; Cloos, J; Deeren, D; Fehr, M; Gjertsen, B; Graux, C; Huls, G; Janssen, J J J W; Jaspers, A; Jongen-Lavrencic, M; de Jongh, E; Klein, S K; van der Klift, M; ... (2020). Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, 34(7), pp. 1751-1759. Nature Publishing Group 10.1038/s41375-020-0725-0

Passweg, J R; Labopin, M; Christopeit, M; Cornelissen, J; Pabst, Thomas; Socié, G; Russel, N; Yakoub-Agha, I; Blaise, D; Gedde-Dahl, T; Labussière-Wallet, H; Malladi, R; Forcade, E; Maury, S; Polge, E; Lanza, F; Gorin, N C; Mohty, M; Nagler, A (2020). Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of blood and marrow transplantation, 26(4), pp. 659-664. Elsevier 10.1016/j.bbmt.2019.11.021

Messikommer, Alessandra; Seipel, Katja; Byrne, Stephen; Valk, Peter J. M.; Pabst, Thomas; Luedtke, Nathan W. (2020). RNA Targeting in Acute Myeloid Leukemia. ACS pharmacology & translational science, 3(6), pp. 1225-1232. ACS Publications 10.1021/acsptsci.0c00120

Zeijlemaker, Wendelien; Grob, Tim; Meijer, Rosa; Hanekamp, Diana; Kelder, Angèle; Carbaat-Ham, Jannemieke C; Oussoren-Brockhoff, Yvonne J M; Snel, Alexander N; Veldhuizen, Dennis; Scholten, Willemijn J; Maertens, Johan; Breems, Dimitri A; Pabst Müller, Thomas Niklaus; Manz, Markus G; van der Velden, Vincent H J; Slomp, Jennichjen; Preijers, Frank; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Löwenberg, Bob; ... (2019). CD34CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia, 33(5), pp. 1102-1112. Nature Publishing Group 10.1038/s41375-018-0326-3

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Driessen, Christoph; Duchosal, Michel A; Heim, Dominik; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Schmidt, Adrian; Taverna, Christian; Zander, Thilo; Renner, Christoph (2019). Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 2019(149), pp. 1-8. EMH Media 10.4414/smw.2019.20031

Jeker, Barbara; Pabst Müller, Thomas Niklaus; Novak, Urban (2019). CAR-T-Zelltherapie – eine neue Behandlungsoption. Info@Onkologie, 2019(1), pp. 18-20. Aerzteverlag medinfo AG

Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst Müller, Thomas Niklaus; Topp, Max S; Hitz, Felicitas; Bentz, Martin; ... (2018). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390(10114), pp. 2790-2802. Elsevier 10.1016/S0140-6736(17)32134-7

Mueller, Beatrice U; Seipel, Katja; Pabst Müller, Thomas Niklaus (2018). Myelodysplastic syndromes and acute myeloid leukemias in the elderly. European journal of internal medicine, 58, pp. 28-32. Elsevier 10.1016/j.ejim.2018.05.026

Seipel, Katja; Marques, Miguel A T; Sidler, Corinne; Mueller, Beatrice U; Pabst Müller, Thomas Niklaus (2018). MDM2- and FLT3-inhibitors in the treatment of -ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin. Haematologica - the hematology journal, 103(11), pp. 1862-1872. Ferrata-Storti Foundation 10.3324/haematol.2018.191650

von Tresckow, Bastian; Kreissl, Stefanie; Goergen, Helen; Bröckelmann, Paul J; Pabst Müller, Thomas Niklaus; Fridrik, Michael; Rummel, Mathias; Jung, Wolfram; Thiemer, Julia; Sasse, Stephanie; Bürkle, Carolin; Baues, Christian; Diehl, Volker; Engert, Andreas; Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. The Lancet. Haematology, 5(10), e462-e473. Elsevier 10.1016/S2352-3026(18)30140-6

Huguet, Françoise; Chevret, Sylvie; Leguay, Thibaut; Thomas, Xavier; Boissel, Nicolas; Escoffre-Barbe, Martine; Chevallier, Patrice; Hunault, Mathilde; Vey, Norbert; Bonmati, Caroline; Lepretre, Stéphane; Marolleau, Jean-Pierre; Pabst Müller, Thomas Niklaus; Rousselot, Philippe; Buzyn, Agnès; Cahn, Jean-Yves; Lhéritier, Véronique; Béné, Marie C; Asnafi, Vahid; Delabesse, Eric; ... (2018). Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial. Journal of clinical oncology, 36(24), pp. 2514-2523. American Society of Clinical Oncology 10.1200/JCO.2017.76.8192

Gorin, Norbert Claude; Labopin, Myriam; Blaise, Didier; Dumas, Pierre-Yves; Pabst Müller, Thomas Niklaus; Trisolini, Silvia Maria; Arcese, William; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2018). Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. American journal of hematology, 93(7), pp. 859-866. Wiley-Liss 10.1002/ajh.25105

Seipel, Katja; Marques, Miguel A T; Sidler, Corinne; Mueller, Beatrice U; Pabst Müller, Thomas Niklaus (2018). The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia. Cancers, 10(6) MDPI AG 10.3390/cancers10060170

Bacher, Vera Ulrike; Pabst Müller, Thomas Niklaus (2018). Aktuelle Entwicklungen in der hämato-onkologischen Diagnostik. JATROS. Hämatologie & Onkologie, 2018(5), pp. 46-49. Universimed

Jongen-Lavrencic, Mojca; Grob, Tim; Hanekamp, Diana; Kavelaars, François G; Al Hinai, Adil; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Gradowska, Patrycja L; Meijer, Rosa; Cloos, Jacqueline; Biemond, Bart J; Graux, Carlos; van Marwijk Kooy, Marinus; Manz, Markus G; Pabst Müller, Thomas Niklaus; Passweg, Jakob R; Havelange, Violaine; Ossenkoppele, Gert J; Sanders, Mathijs A; Schuurhuis, Gerrit J; ... (2018). Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England journal of medicine NEJM, 378(13), pp. 1189-1199. Massachusetts Medical Society MMS 10.1056/NEJMoa1716863

Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Müller, Tony A; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L; Melchinger, Wolfgang; Duquesne, Sandra; Schmitt-Graeff, Annette; Osswald, Lena; Yan, Kai-Li; Weber, Arnim; Tugues, Sonia; Spath, Sabine; Pfeifer, Dietmar; ... (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine, 24(3), pp. 282-291. Nature Publishing Group 10.1038/nm.4484

Schlenk, Richard F; Krauter, Jürgen; Raffoux, Emmanuel; Kreuzer, Karl-Anton; Schaich, Markus; Noens, Lucien; Pabst, Thomas; Vusirikala, Madhuri; Bouscary, Didier; Spencer, Andrew; Candoni, Anna; Gil, Jorge Sierra; Berkowitz, Noah; Weber, Hans-Jochen; Ottmann, Oliver (2018). Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials. Haematologica - the hematology journal, 103(1), e25-e28. Ferrata-Storti Foundation 10.3324/haematol.2017.172411

Mueller, Beatrice; Seipel, Katja; Bacher, Vera Ulrike; Pabst, Thomas (2018). Autologous Transplantation for Older Adults with AML. Cancers, 10(9), p. 340. MDPI AG 10.3390/cancers10090340

Voegeli, Michèle; Rondeau, Stephanie; Berardi Vilei, Simona; Lerch, Erika; Wannesson, Luciano; Pabst, Thomas; Rentschler, Jochen; Bargetzi, Mario; Jost, Lorenz; Ketterer, Nicolas; Bischof Delaloye, Angelika; Ghielmini, Michele (2017). Y(90) -Ibritumomab tiuxetan (Y(90) -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05). Hematological oncology, 35(4), pp. 576-583. Wiley 10.1002/hon.2348

Gorin, Norbert-Claude; Labopin, Myriam; Pabst, Thomas; Remenyi, Peter; Wu, Depei; Huynh, Anne; Volin, Liisa; Cahn, Jean Yves; Yakoub-Agha, Ibrahim; Mercier, Melanie; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2017). Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission. American journal of hematology, 92(12), pp. 1318-1323. Wiley-Liss 10.1002/ajh.24904

Averbuch, Diana; Tridello, Gloria; Hoek, Jennifer; Mikulska, Malgorzata; Akan, Hamdi; Yanez San Segundo, Lucrecia; Pabst, Thomas; Özçelik, Tülay; Klyasova, Galina; Donnini, Irene; Wu, Depei; Gülbas, Zafer; Zuckerman, Tsila; Botelho de Sousa, Aida; Beguin, Yves; Xhaard, Aliénor; Bachy, Emmanuel; Ljungman, Per; de la Camara, Rafael; Rascon, Jelena; ... (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical infectious diseases, 65(11), pp. 1819-1828. Oxford University Press 10.1093/cid/cix646

Versluis, Jurjen; Kalin, Burak; Zeijlemaker, Wendelien; Passweg, Jakob; Graux, Carlos; Manz, Markus G; Vekemans, Marie-Christiane; Biemond, Bart J; Legdeur, Marie-Cecile J C; Kooy, Marinus van Marwijk; de Weerdt, Okke; Wijermans, Pierre W; Hoogendoorn, Mels; Bargetzi, Mario J; Kuball, Juergen; Schouten, Harry C; van der Velden, Vincent H J; Janssen, Jeroen J W M; Pabst, Thomas; Lowenberg, Bob; ... (2017). Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission. JCO precision oncology, 1, pp. 1-13. American Society of Clinical Oncology 10.1200/PO.17.00078

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, Thomas; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone marrow transplantation, 52(4), pp. 650-652. Nature Publishing Group 10.1038/bmt.2016.339

Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; van Norden, Yvette; Biemond, Bart J; Schouten, Harry C; Spertini, Olivier; Vellenga, Edo; Graux, Carlos; Havelange, Violaine; de Greef, Georgine E; de Weerdt, Okke; Legdeur, Marie-Cecile J C; Kuball, Juergen; Kooy, Marinus van Marwijk; Gjertsen, Bjorn T; Jongen-Lavrencic, Mojca; van de Loosdrecht, Arjan A; van Lammeren-Venema, Daniëlle; Hodossy, Beata; ... (2017). Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Blood, 129(12), pp. 1636-1645. American Society of Hematology 10.1182/blood-2016-10-740613

Gorin, Norbert-Claude; Labopin, Myriam; Czerw, Tomasz; Pabst, Thomas; Blaise, Didier; Dumas, Pierre-Yves; Nemet, Damir; Arcese, William; Trisolini, Silvia Maria; Wu, Depei; Huynh, Anne; Zuckerman, Tsila; Meijer, Ellen; Cagirgan, Seckin; Cornelissen, Jan; Houhou, Mohamed; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer, 123(5), pp. 824-831. John Wiley & Sons 10.1002/cncr.30400

Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; Medinger, Micheal; Passweg, Jakob; Schanz, Urs; Samaras, Panagiotis; Chalandon, Yves; Pichard, Claude; Limonta, Alessandro; Wannesson, Luciano; Pabst, Thomas; Duchosal, Michel A; Hess, Urs; Stanga, Zeno; Mueller, Beat; Schuetz, Philipp (2017). Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition, 35, pp. 43-50. Elsevier 10.1016/j.nut.2016.10.007

Gössi, F; Spahn, Martin; Zweifel, Martin; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, Julian; Pabst, Thomas (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone marrow transplantation, 52(2), pp. 334-336. Nature Publishing Group 10.1038/bmt.2016.285

Fridle, Chantal; Medinger, Michael; Wilk, Matthias C; Seipel, Katja; Passweg, Jakob; Manz, Markus G; Pabst, Thomas (2017). Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & lymphoma, 58(5), pp. 1068-1075. Informa Healthcare 10.1080/10428194.2016.1235274

Versluis, J; In 't Hout, F E M; Devillier, R; van Putten, W L J; Manz, M G; Vekemans, M-C; Legdeur, M-C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J M; van der Reijden, B A; Meloni, G; Schouten, H C; Vellenga, E; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; ... (2017). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1), pp. 26-33. Nature Publishing Group 10.1038/leu.2016.183

Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British journal of haematology, 174(2), pp. 255-263. Wiley-Blackwell 10.1111/bjh.14049

Taverna, Christian; Martinelli, Giovanni; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Vanazzi, Anna; Laszlo, Daniele; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Biaggi Rudolf, Christine; Rondeau, Stéphanie; Rusterholz, Corinne; Heijnen, Ingmar A F M; Zucca, Emanuele; Ghielmini, Michele (2016). Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. Journal of clinical oncology, 34(5), pp. 495-500. American Society of Clinical Oncology 10.1200/JCO.2015.61.3968

Seipel, Katja; Marques, Miguel Teixera; Bozzini, Marie-Ange; Meinken, Christina; Mueller, Beatrice U; Pabst, Thomas (2016). Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia. Clinical cancer research, 22(3), pp. 746-756. American Association for Cancer Research 10.1158/1078-0432.CCR-15-1054

Pathak, Anand; Seipel, Katja; Pemov, Alexander; Dewan, Ramita; Brown, Christina; Ravichandran, Sarangan; Luke, Brian T; Malasky, Michael; Suman, Shalabh; Yeager, Meredith; Cancer GenomicsResearch Laboratory, Nci Dceg; Cancer Sequencing Working Group, Nci Dceg; Parry, Dilys M; Gatti, Richard A; Caporaso, Neil E; Mulvihill, John; Goldin, Lynn R; Pabst, Thomas; McMaster, Mary L and Stewart, Douglas R (2016). Whole-exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow-up of a large family. Haematologica - the hematology journal, 101(7), pp. 846-852. Ferrata-Storti Foundation 10.3324/haematol.2015.130799

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica - the hematology journal, 101(3), pp. 346-355. Ferrata-Storti Foundation 10.3324/haematol.2015.135780

Versluis, Jurjen; Hazenberg, Carin L E; Passweg, Jakob R; van Putten, Wim L J; Maertens, Johan; Biemond, Bart J; Theobald, Matthias; Graux, Carlos; Kuball, Jurgen; Schouten, Harry C; Pabst, Thomas; Löwenberg, Bob; Ossenkoppele, Gert; Vellenga, Edo; Cornelissen, Jan J (2015). Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis. The Lancet. Haematology, 2(10), e427-e436. Elsevier 10.1016/S2352-3026(15)00148-9

Walter, Roland B; Othus, Megan; Löwenberg, Bob; Ossenkoppele, Gert J; Petersdorf, Stephen H; Pabst, Thomas; Vekemans, Marie-Christiane; Appelbaum, Frederick R; Erba, Harry P; Estey, Elihu H (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica - the hematology journal, 100(10), e409-e411. Ferrata-Storti Foundation 10.3324/haematol.2015.130013

Tawana, Kiran; Wang, Jun; Renneville, Aline; Bödör, Csaba; Hills, Robert; Loveday, Chey; Savic, Aleksandar; Van Delft, Frederik W; Treleaven, Jennifer; Georgiades, Panayiotis; Uglow, Elizabeth; Asou, Norio; Uike, Naokuni; Debeljak, Maruša; Jazbec, Janez; Ancliff, Philip; Gale, Rosemary; Thomas, Xavier; Mialou, Valerie; Döhner, Konstanze; ... (2015). Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood, 126(10), pp. 1214-1223. American Society of Hematology 10.1182/blood-2015-05-647172

Schardt, Julian; Keller, Manuela; Seipel, Katja; Pabst, Thomas (2015). Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene. Biochimica et biophysica acta - gene regulatory mechanisms, 1849(9), pp. 1188-1197. Elsevier 10.1016/j.bbagrm.2015.07.003

Mamot, Christoph; Klingbiel, Dirk; Hitz, Felicitas; Renner, Christoph; Pabst, Thomas; Driessen, Christoph; Mey, Ulrich; Pless, Miklos; Bargetzi, Mario; Krasniqi, Fatime; Gigli, Federica; Hany, Thomas; Samarin, Andrei; Biaggi, Christine; Rusterholz, Corinne; Dirnhofer, Stephan; Zucca, Emanuele; Martinelli, Giovanni (2015). Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). Journal of clinical oncology, 33(23), pp. 2523-2529. American Society of Clinical Oncology 10.1200/JCO.2014.58.9846

Garg, Abhishek D; Galluzzi, Lorenzo; Apetoh, Lionel; Baert, Thais; Birge, Raymond B; Bravo-San Pedro, José Manuel; Breckpot, Karine; Brough, David; Chaurio, Ricardo; Cirone, Mara; Coosemans, An; Coulie, Pierre G; De Ruysscher, Dirk; Dini, Luciana; de Witte, Peter; Dudek-Peric, Aleksandra M; Faggioni, Alberto; Fucikova, Jitka; Gaipl, Udo S; Golab, Jakub; ... (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology, 6(588), p. 588. Frontiers Research Foundation 10.3389/fimmu.2015.00588

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 145, w14100. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14100

Voermans, Nicol C; Benveniste, Olivier; Minnema, Monique C; Lokhorst, Henk; Lammens, Martin; Meersseman, Wouter; Delforge, Michel; Kuntzer, Thierry; Novy, Jan; Pabst, Thomas; Bouhour, Françoise; Romero, Norma; Leblond, Veronique; Bergh, Peter van den; Vekemans, Marie-Christiane; Engelen, Baziel G van; Eymard, Bruno (2014). Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology, 83(23), pp. 2133-2139. Lippincott Williams & Wilkins 10.1212/WNL.0000000000001047

Morris, Curly; de Wreede, Liesbeth; Scholten, Marijke; Brand, Ronald; van Biezen, Anja; Sureda, Anna; Dickmeiss, Ebbe; Trneny, Marek; Apperley, Jane; Chiusolo, Patrizia; van Imhoff, Gustaaf W; Lenhoff, Stig; Martinelli, Giovanni; Hentrich, Marcus; Pabst, Thomas; Onida, Francesco; Quinn, Michael; Kroger, Nicolaus; de Witte, Theo and Ruutu, Tapani (2014). Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion, 54(10), pp. 2514-2522. Wiley-Blackwell 10.1111/trf.12759

Walter, R B; Othus, M; Burnett, A K; Löwenberg, B; Kantarjian, H M; Ossenkoppele, G J; Hills, R K; Ravandi, F; Pabst, Thomas; Evans, A; Pierce, S R; Vekemans, M-C; Appelbaum, F R; Estey, E H (2014). Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia, 29(2), pp. 312-320. Nature Publishing Group 10.1038/leu.2014.242

Terwijn, Monique; Zeijlemaker, Wendelien; Kelder, Angèle; Rutten, Arjo P; Snel, Alexander N; Scholten, Willemijn J; Pabst, Thomas; Verhoef, Gregor; Löwenberg, Bob; Zweegman, Sonja; Ossenkoppele, Gert J; Schuurhuis, Gerrit J (2014). Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia. PLoS ONE, 9(9), e107587. Public Library of Science 10.1371/journal.pone.0107587

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Terwijn, M.; van Putten, W. L. J.; Kelder, A.; van der Velden, V. H. J.; Brooimans, R. A.; Pabst, T.; Maertens, J.; Boeckx, N.; de Greef, G. E.; Valk, P. J. M.; Preijers, F. W. M. B.; Huijgens, P. C.; Drager, A. M.; Schanz, U.; Jongen-Lavrecic, M.; Biemond, B. J.; Passweg, J. R.; van Gelder, M.; Wijermans, P.; Graux, C.; ... (2013). High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study. Journal of clinical oncology, 31(31), pp. 3889-3897. American Society of Clinical Oncology 10.1200/JCO.2012.45.9628

Gutbrodt, K. L.; Schliemann, C.; Giovannoni, L.; Frey, K.; Pabst, Thomas; Klapper, W.; Berdel, W. E.; Neri, D. (2013). Antibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia. Science translational medicine, 5(201), 201ra118-201ra118. American Association for the Advancement of Science 10.1126/scitranslmed.3006221

Schlenk, R. F.; Taskesen, E.; van Norden, Y.; Krauter, J.; Ganser, A.; Bullinger, L.; Gaidzik, V. I.; Paschka, P.; Corbacioglu, A.; Gohring, G.; Kundgen, A.; Held, G.; Gotze, K.; Vellenga, E.; Kuball, J.; Schanz, U.; Passweg, J.; Pabst, Thomas; Maertens, J.; Ossenkoppele, G. J.; ... (2013). The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood, 122(9), pp. 1576-1582. American Society of Hematology 10.1182/blood-2013-05-503847

Hitz, F; Fischer, N; Pabst, Th; Caspar, C; Berthod, G; Eckhardt, K; Berardi Vilei, S; Zucca, E; Mey, U; On behalf of Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland (2013). Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial. Annals of hematology, 92(8), pp. 1033-1040. Berlin: Springer 10.1007/s00277-013-1751-z

Neubauer, Henning; Pabst, Thomas; Dick, Anke; Machann, Wolfram; Evangelista, Laura; Wirth, Clemens; Köstler, Herbert; Hahn, Dietbert; Beer, Meinrad (2013). Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatric radiology, 43(1), pp. 103-14. Berlin: Springer 10.1007/s00247-012-2492-1

Gröschel, Stefan; Schlenk, Richard F; Engelmann, Jan; Rockova, Veronika; Teleanu, Veronica; Kühn, Michael W M; Eiwen, Karina; Erpelinck, Claudia; Havermans, Marije; Lübbert, Michael; Germing, Ulrich; Schmidt-Wolf, Ingo G H; Beverloo, H Berna; Schuurhuis, Gerrit J; Ossenkoppele, Gert J; Schlegelberger, Brigitte; Verdonck, Leo F; Vellenga, Edo; Verhoef, Gregor; Vandenberghe, Peter; ... (2013). Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. Journal of clinical oncology, 31(1), pp. 95-103. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.41.5505

Wannesson, Luciano; Bargetzi, Mario; Cairoli, Anne; Cerutti, Alessandra; Heim, Dominik; Hess, Urs; Lerch, Erika; Pabst, Thomas; Renner, Christoph; Samaras, Panagiotis; Zucca, Emanuele (2013). Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Leukemia & lymphoma, 54(1), pp. 36-40. London: Informa Healthcare 10.3109/10428194.2012.702903

Pabst, Thomas; Vellenga, Edo; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Vekemans, Marie-Christiane; Biemond, Bart; Sonneveld, Peter; Passweg, Jakob; Verdonck, Leo; Legdeur, Marie-Cecile; Theobald, Matthias; Jacky, Emanuel; Bargetzi, Mario; Maertens, Johan; Ossenkoppele, Gert Jan; Löwenberg, Bob (2012). Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose-escalation of cytarabine. Blood, 119(23), pp. 5367-73. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-11-389841

Ossenkoppele, Gert J; Stussi, Georg; Maertens, Johan; van Montfort, Kees; Biemond, Bart J; Breems, Dimitri; Ferrant, August; Graux, Carlos; de Greef, Georgine E; Halkes, C J M; Hoogendoorn, Mels; Hollestein, Rene M; Jongen-Lavrencic, Mojca; Levin, Mark D; van de Loosdrecht, Arjan A; van Marwijk Kooij, Marinus; van Norden, Yvette; Pabst, Thomas; Schouten, Harry C; Vellenga, Edo; ... (2012). Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK). Blood, 120(24), pp. 4706-11. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-04-420596

Cornelissen, Jan J; Breems, Dimitri; van Putten, Wim L J; Gratwohl, Alois A; Passweg, Jakob R; Pabst, Thomas; Maertens, Johan; Beverloo, H Berna; van Marwijk Kooy, Marinus; Wijermans, Pierre W; Biemond, Bart J; Vellenga, Edo; Verdonck, Leo F; Ossenkoppele, Gert J; Löwenberg, Bob (2012). Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. Journal of clinical oncology, 30(17), pp. 2140-6. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.39.6499

O'Meara, A; Pabst, T; Heim, D; Gerull, S; Bucher, C; Halter, J; Arber, C; Rovò, A; Tichelli, A; Gratwohl, A; Stern, M (2011). High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML. Bone marrow transplantation, 46(5), pp. 636-40. London: Nature Publishing Group 10.1038/bmt.2010.181

Raschle, J; Ratschiller, D; Mans, S; Mueller, B U; Pabst, T (2011). High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma. British journal of cancer, 105(7), pp. 970-4. Basingstoke: Nature Publishing Group 10.1038/bjc.2011.329

Haefliger, Simon; Klebig, Christiane; Schaubitzer, Kerstin; Schardt, Julian; Timchenko, Nikolai; Mueller, Beatrice U; Pabst, Thomas (2011). Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML. Blood, 117(22), pp. 5931-40. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-08-304485

Löwenberg, Bob; Pabst, Thomas; Vellenga, Edo; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Biemond, Bart J; Gratwohl, Alois; de Greef, Georgine E; Verdonck, Leo F; Schaafsma, Martijn R; Gregor, Michael; Theobald, Matthias; Schanz, Urs; Maertens, Johan; Ossenkoppele, Gert J (2011). Cytarabine dose for acute myeloid leukemia. New England journal of medicine NEJM, 364(11), pp. 1027-36. Waltham, Mass.: Massachusetts Medical Society MMS

Schardt, Julian A; Mueller, Beatrice U; Pabst, Thomas (2011). Activation of the unfolded protein response in human acute myeloid leukemia. Methods in enzymology, 489, pp. 227-243. New York, N.Y.: Academic Press 10.1016/B978-0-12-385116-1.00013-3

Mueller, Beatrice U; Pabst, Thomas (2010). Lineage-specific transcription factor aberrations in AML. Cancer treatment and research, 145, pp. 109-125. New York, N.Y.: Springer Science+Business Media

Eich, Hans Theodor; Diehl, Volker; Görgen, Helen; Pabst, Thomas; Markova, Jana; Debus, Jürgen; Ho, Anthony; Dörken, Bernd; Rank, Andreas; Grosu, Anca-Ligia; Wiegel, Thomas; Karstens, Johann Hinrich; Greil, Richard; Willich, Normann; Schmidberger, Heinz; Döhner, Hartmut; Borchmann, Peter; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter and Engert, Andreas (2010). Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. Journal of clinical oncology, 28(27), pp. 4199-206. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.29.8018

Taverna, C; Bargetzi, M; Betticher, D; Gmür, J; Gregor, M; Heim, D; Hess, U; Ketterer, N; Lerch, E; Matthes, T; Mey, U; Pabst, T; Renner, C (2010). Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations. Swiss medical weekly, 140, w13054. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2010.13054

Löwenberg, Bob; Beck, Joachim; Graux, Carlos; van Putten, Wim; Schouten, Harry C; Verdonck, Leo F; Ferrant, Augustin; Sonneveld, Pieter; Jongen-Lavrencic, Mojca; von Lilienfeld-Toal, Marie; Biemond, Bart J; Vellenga, Edo; Breems, Dimitri; de Muijnck, Hilde; Schaafsma, Ron; Verhoef, Gregor; Döhner, Hartmut; Gratwohl, Alois; Pabst, Thomas; Ossenkoppele, Gert J; ... (2010). Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study. Blood, 115(13), pp. 2586-91. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-10-246470

Novy, Jan; Rosselet, Anne; Spertini, Olivier; Lobrinus, Johannes Alexander; Pabst, Thomas; Kuntzer, Thierry (2010). Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy. Muscle & nerve, 41(2), pp. 286-7. New York, N.Y.: John Wiley & Sons 10.1002/mus.21560

Weininger, Markus; Lauterbach, Brigitte; Knop, Stefan; Pabst, Thomas; Kenn, Werner; Hahn, Dietbert; Beissert, Matthias (2009). Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns. European journal of radiology, 69(2), pp. 339-45. Stuttgart: Thieme 10.1016/j.ejrad.2007.10.025

Löwenberg, Bob; Ossenkoppele, Gert J; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Maertens, Johan; Jongen-Lavrencic, Mojca; von Lilienfeld-Toal, Marie; Biemond, Bart J; Vellenga, Edo; van Marwijk Kooy, Marinus; Verdonck, Leo F; Beck, Joachim; Döhner, Hartmut; Gratwohl, Alois; Pabst, Thomas; Verhoef, Gregor (2009). High-dose daunorubicin in older patients with acute myeloid leukemia. New England journal of medicine NEJM, 361(13), pp. 1235-48. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0901409

Adès, Lionel; Sanz, Miguel A; Chevret, Sylvie; Montesinos, Pau; Chevallier, Patrice; Raffoux, Emmanuel; Vellenga, Edo; Guerci, Agnès; Pigneux, Arnaud; Huguet, Francoise; Rayon, Consuelo; Stoppa, Anne Marie; de la Serna, Javier; Cahn, Jean-Yves; Meyer-Monard, Sandrine; Pabst, Thomas; Thomas, Xavier; de Botton, Stéphane; Parody, Ricardo; Bergua, Juan; ... (2008). Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood, 111(3), pp. 1078-84. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-07-099978

Kirstetter, Peggy; Schuster, Mikkel B; Bereshchenko, Oksana; Moore, Susan; Dvinge, Heidi; Kurz, Elke; Theilgaard-Mönch, Kim; Månsson, Robert; Pedersen, Thomas A; Pabst, Thomas; Schrock, Evelin; Porse, Bo T; Jacobsen, Sten Eirik W; Bertone, Paul; Tenen, Daniel G; Nerlov, Claus (2008). Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer cell, 13(4), pp. 299-310. Cambridge, Mass.: Cell Press 10.1016/j.ccr.2008.02.008

Pabst, T; Mueller, B U (2007). Transcriptional dysregulation during myeloid transformation in AML. Oncogene, 26(47), pp. 6829-37. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1210765

Mueller, Beatrice U; Pabst, Thomas (2006). Cutaneous zygomycosis at catheter insertion site in AML-M4Eo. Annals of hematology, 85(3), pp. 194-5. Berlin: Springer-Verlag 10.1007/s00277-005-0053-5

Pagano, Flavia

Pais, Michael-Alexander

Panczak, Radoslaw

Panje, Cédric

Panos, Leonidas

Pape, Janna

Pegiazoglou, Ioannis

Peng, Ren-Wang

Peng, Shuang

Perren, Aurel

Perroud, Camille Héloïse

Pica, Alessia

Piechowiak, Eike Immo

Pilgram-Pastor, Sara Magdalena

Pirnia Borner, Farzaneh

Plasswilm, Ludwig

Polacek, Norbert

Polidori, Taisia

Pollak, Matthias

Porret, Naomi

Portmann, Simone

Prediletto, Irene

Pulido Quetglas, Carlos

Putora, Paul Martin

Pöllinger, Alexander

Que, Yok-Ai

Quintin, Aurelie

Rabaglio, Manuela Elena

Pagan, Eleonora; Ruggeri, Monica; Bianco, Nadia; Bucci, Eraldo Oreste; Graffeo, Rossella; Borner, Markus; Giordano, Monica; Gianni, Lorenzo; Rabaglio, Manuela; Freschi, Andrea; Cretella, Elisabetta; Seles, Elena; Farolfi, Alberto; Simoncini, Edda; Ciccarese, Mariangela; Rauch, Daniel; Favaretto, Adolfo; Honecker, Friedemann; Berardi, Rossana; Franzetti-Pellanda, Alessandra; ... (2024). Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast, 77(103765), p. 103765. Elsevier 10.1016/j.breast.2024.103765

Colombo, Nicoletta; Biagioli, Elena; Harano, Kenichi; Galli, Francesca; Hudson, Emma; Antill, Yoland; Choi, Chel Hun; Rabaglio, Manuela; Marmé, Frederic; Marth, Christian; Parma, Gabriella; Fariñas-Madrid, Lorena; Nishio, Shin; Allan, Karen; Lee, Yeh Chen; Piovano, Elisa; Pardo, Beatriz; Nakagawa, Satoshi; McQueen, John; Zamagni, Claudio; ... (2024). Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology, 25(9), pp. 1135-1146. Elsevier 10.1016/S1470-2045(24)00334-6

Chapman, Judith-Anne W; Bayani, Jane; SenGupta, Sandip; Bartlett, John M S; Piper, Tammy; Quintayo, Mary Anne; Virk, Shakeel; Goss, Paul E; Ingle, James N; Ellis, Matthew J; Sledge, George W; Budd, G Thomas; Rabaglio, Manuela; Ansari, Rafat H; Tozer, Richard; D'Souza, David P; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A; ... (2024). Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole. Journal of clinical oncology, 42(24), pp. 2887-2898. American Society of Clinical Oncology 10.1200/JCO.24.00835

Schneider, Caroline; Dierks, Annika; Rabaglio, Manuela Elena; Campbell, Kristin L; Wilhelm, Matthias; Eser, Prisca (2024). Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study. Swiss medical weekly, 154(6) SMW supporting association 10.57187/s.3588

Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Thompson, Alastair M; Rea, Daniel W; Stos, Paul M; Shepherd, Lois E; Stambolic, Vuk; Parulekar, Wendy R (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(35), pp. 5356-5362. 10.1200/JCO.23.00296

Ribi, Karin; Pagan, Eleonora; Sala, Isabella; Ruggeri, Monica; Bianco, Nadia; Bucci, Eraldo Oreste; Graffeo, Rossella; Borner, Markus; Giordano, Monica; Gianni, Lorenzo; Rabaglio, Manuela; Freschi, Andrea; Cretella, Elisabetta; Seles, Elena; Farolfi, Alberto; Simoncini, Edda; Ciccarese, Mariangela; Rauch, Daniel; Favaretto, Adolfo; Glaus, Agnes; ... (2023). Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland. Journal of Cancer Survivorship, 17(6), pp. 1847-1858. Springer 10.1007/s11764-022-01222-y

Baroutsou, Vasiliki; Duong, Vu; Signorini, Alice; Saccilotto, Ramon; Ciorba, Florina M; Bürki, Nicole; Caiata-Zufferey, Maria; Ryu, Jai Min; Kim, Sung-Won; Lim, Myong Cheol; Monnerat, Christian; Zürrer-Härdi, Ursina; Kim, Jisun; Heinimann, Karl; Graffeo, Rossella; Park, Ji Soo; Rabaglio, Manuela; Chappuis, Pierre Olivier; Kim, Sue and Katapodi, Maria C (2023). Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing. Cancers, 15(18) MDPI AG 10.3390/cancers15184485

Scherz, Amina; Stoll, Susanna; Rothlisberger, Benno; Rabaglio, Manuela (2023). A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report. The application of clinical genetics, 16, pp. 83-87. Dove Press 10.2147/TACG.S405120

Adam, Felicia; Fluri, Muriel; Scherz, Amina; Rabaglio, Manuela (2023). Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study. BMC medical genomics, 16(1), p. 7. BioMed Central 10.1186/s12920-023-01437-7

Sarki, Mahesh; Ming, Chang; Aceti, Monica; Fink, Günther; Aissaoui, Souria; Bürki, Nicole; Graffeo, Rossella; Heinimann, Karl; Caiata Zufferey, Maria; Monnerat, Christian; Rabaglio, Manuela; Zürrer-Härdi, Ursina; Chappuis, Pierre O; Katapodi, Maria C (2022). Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort. Journal of personalized medicine, 12(10) MDPI 10.3390/jpm12101740

Salikhanov, Islam; Heinimann, Karl; Chappuis, Pierre; Buerki, Nicole; Graffeo, Rossella; Heinzelmann, Viola; Rabaglio, Manuela; Taborelli, Monica; Wieser, Simon; Katapodi, Maria C (2022). Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives. Journal of medical genetics, 59(9), pp. 924-930. BMJ Publishing Group 10.1136/jmedgenet-2021-108062

Pedrazzani, Carla; Aceti, Monica; Schweighoffer, Reka; Kaiser-Grolimund, Andrea; Bürki, Nicole; Chappuis, Pierre O; Graffeo, Rossella; Monnerat, Christian; Pagani, Olivia; Rabaglio, Manuela; Katapodi, Maria C; Caiata-Zufferey, Maria (2022). The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer. Journal of personalized medicine, 12(8) MDPI 10.3390/jpm12081249

Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D; Mackey, John R; Abramson, Vandana G; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M; Rea, Daniel W; ... (2022). Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. JAMA : the journal of the American Medical Association, 327(20), pp. 1963-1973. American Medical Association 10.1001/jama.2022.6147

Sarki, Mahesh; Ming, Chang; Aissaoui, Souria; Bürki, Nicole; Caiata-Zufferey, Maria; Erlanger, Tobias Ephraim; Graffeo-Galbiati, Rossella; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Monnerat, Christian; Probst-Hensch, Nicole; Rabaglio, Manuela; Zürrer-Härdi, Ursina; Chappuis, Pierre Olivier; Katapodi, Maria C (2022). Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Cancers, 14(7) MDPI AG 10.3390/cancers14071636

Pedrazzani, Carla; Ming, Chang; Bürki, Nicole; Caiata-Zufferey, Maria; Chappuis, Pierre O; Duquette, Debra; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Graffeo-Galbiati, Rossella; Merajver, Sofia D; Milliron, Kara J; Monnerat, Christian; Pagani, Olivia; Rabaglio, Manuela; Katapodi, Maria C (2021). Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years. Cancers, 13(24) MDPI AG 10.3390/cancers13246254

Jerusalem, G; Farah, S; Courtois, A; Chirgwin, J; Aebi, S; Karlsson, P; Neven, P; Hitre, E; Graas, M P; Simoncini, E; Abdi, E; Kamby, C; Thompson, A; Loibl, S; Gavilá, J; Kuroi, K; Marth, C; Müller, B; O'Reilly, S; Gombos, A; ... (2021). Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Annals of oncology, 32(10), pp. 1256-1266. Elsevier 10.1016/j.annonc.2021.07.017

Kim, Sue; Aceti, Monica; Baroutsou, Vasiliki; Bürki, Nicole; Caiata-Zufferey, Maria; Cattaneo, Marco; Chappuis, Pierre O; Ciorba, Florina M; Graffeo-Galbiati, Rossella; Heinzelmann-Schwarz, Viola; Jeong, Joon; Jung, MiSook M; Kim, Sung-Won; Kim, Jisun; Lim, Myong Cheol; Ming, Chang; Monnerat, Christian; Park, Hyung Seok; Park, Sang Hyung; Pedrazzani, Carla A; ... (2021). Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study. JMIR research protocols, 10(6), e26264. JMIR Publications 10.2196/26264

Leone, Jose P; Cole, Bernard F; Regan, Meredith M; Thürlimann, Beat; Coates, Alan S; Rabaglio, Manuela; Giobbie-Hurder, Anita; Gelber, Richard D; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, Istvan; Bonnefoi, Herve; Wardley, Andrew; Goldhirsch, Aron; Di Leo, Angelo; Colleoni, Marco; Vaz-Luis, Ines; Lin, Nancy U (2021). Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial. Cancer, 127(5), pp. 700-708. Wiley 10.1002/cncr.33318

Zimmermann, Bettina M; Fanderl, Julia; Koné, Insa; Rabaglio, Manuela; Bürki, Nicole; Shaw, David; Elger, Bernice (2021). Examining information-seeking behavior in genetic testing for cancer predisposition: A qualitative interview study. Patient education and counseling, 104(2), pp. 257-264. Elsevier Ireland 10.1016/j.pec.2020.09.019

Rabaglio, Manuela; Sun, Zhuoxin; Maibach, Rudolf; Giobbie-Hurder, Anita; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, István; Bonnefoi, Hervé; Wardley, Andrew; Ruepp, Barbara; Castiglione, Monica; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Colleoni, Marco; Thürlimann, Beat; Regan, Meredith M (2020). Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast cancer research and treatment, 185(3), pp. 697-707. Springer 10.1007/s10549-020-05981-z

Ruggeri, M; Pagan, E; Bagnardi, V; Bianco, N; Gallerani, E; Buser, K; Giordano, M; Gianni, L; Rabaglio, Manuela; Freschi, A; Cretella, E; Clerico, M; Farolfi, A; Simoncini, E; Ciccarese, M; Rauch, D; Ramello, M; Glaus, A; Berardi, R; Pellanda, A Franzetti; ... (2019). Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. The breast, 47, pp. 85-92. Elsevier 10.1016/j.breast.2019.07.001

Dziadziuszko, Rafal; Smit, Egbert F; Dafni, Urania; Wolf, Juergen; Wasąg, Bartosz; Biernat, Wojciech; Finn, Stephen P; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A; Felip, Enriqueta; Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of thoracic oncology, 14(6), pp. 1086-1094. Elsevier 10.1016/j.jtho.2019.02.017

Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2019). Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 120(10), pp. 959-967. Springer Nature 10.1038/s41416-019-0435-4

Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Hervé; Jerusalem, Guy; Bartsch, Rupert; Rabaglio, Manuela-Poretti; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan, Meredith M and André, Fabrice (2019). Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial. The lancet oncology, 20(3), pp. 371-382. Elsevier 10.1016/S1470-2045(18)30812-X

Pimentel, Isabel; Chen, Bingshu E.; Lohmann, Ana Elisa; Ennis, Marguerite; Ligibel, Jennifer A.; Shepherd, Lois E.; Hershman, Dawn L.; Stambolic, Vuk; Mayer, Ingrid A.; Hobday, Timothy J.; Lemieux, Julie; Thompson, Alastair Mark; Rastogi, Priya; Gelmon, Karen A.; Whelan, Timothy Joseph; Rabaglio-Poretti, Manuela; Dowling, Ryan JO; Parulekar, Wendy R.; Goodwin, Pamela Jean (2019). The effect of metformin on sex hormones in non-diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy. Journal of clinical oncology, 37(15_suppl), p. 529. American Society of Clinical Oncology 10.1200/JCO.2019.37.15_suppl.529

Francis, PA; Pagani, O; Fleming, GF; Walley, BA; Colleoni, M; Láng, I; Gómez, HL; Tondini, C; Ciruelos, E; Burstein, HJ; Bonnefoi, HR; Bellet, M; Martino, S; Geyer, Jr. CE; Goetz, MP; Stearns, V; Pinotti, G; Puglisi, F; Spazzapan, S; Climent, MA; ... (2018). Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England journal of medicine NEJM, 379(2), pp. 122-137. Massachusetts Medical Society MMS 10.1056/NEJMoa1803164

Strasser-Weippl, Kathrin; Higgins, Michaela J; Chapman, Judith-Anne; Ingle, James; Sledge, George W; Budd, George T; Ellis, Matthew; Pritchard, Kathleen; Clemons, Mark J; Badovinac-Crnjevic, Tanja; Han, Lei; Gelmon, Karen A; Rabaglio, Manuela; Elliott, Catherine; Shepherd, Lois; Goss, Paul E (2018). Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27. Journal of the National Cancer Institute JNCI, 110(9), pp. 1003-1008. Oxford University Press 10.1093/jnci/djy017

Nikolaidis, Christos; Ming, Chang; Pedrazzani, Carla; van der Horst, Tina; Kaiser-Grolimund, Andrea; Ademi, Zanfina; Bührer-Landolt, Rosmarie; Bürki, Nicole; Caiata-Zufferey, Maria; Champion, Victoria; Chappuis, Pierre O; Kohler, Carmen; Erlanger, Tobias E; Graffeo, Rossella; Hampel, Heather; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Kurzeder, Christian; Monnerat, Christian; Northouse, Laurel L; ... (2018). Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop. Public health genomics, 21(3-4), pp. 121-132. Karger 10.1159/000496495

Lipton, Allan; Chapman, Judith-Anne W; Leitzel, Kim; Garg, Ashwani; Pritchard, Kathleen I; Ingle, James N; Budd, G Thomas; Ellis, Matthew J; Sledge, George W; Rabaglio, Manuela; Han, Lei; Elliott, Catherine R; Shepherd, Lois E; Goss, Paul E; Ali, Suhail M (2017). Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27. Cancer, 123(13), pp. 2444-2451. John Wiley & Sons 10.1002/cncr.30682

Rosell, Rafael; Dafni, Urania; Felip, E; Curioni-Fontecedro, A; Gautschi, O; Peters, S; Massuti, B; Palmero, R; Aix, SP; Carcereny, E; Früh, M; Pless, M; Popat, S; Kotsakis, A; Cuffe, S; Bidoli, P; Favaretto, A; Froesch, P; Reguart, N; Puente, J; ... (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. The lancet. Respiratory medicine, 5(5), pp. 435-444. Elsevier 10.1016/S2213-2600(17)30129-7

Borgquist, Signe; Giobbie-Hurder, Anita; Ahern, Thomas P; Garber, Judy E; Colleoni, Marco; Láng, István; Debled, Marc; Ejlertsen, Bent; von Moos, Roger; Smith, Ian; Coates, Alan S; Goldhirsch, Aron; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Regan, Meredith M; Thürlimann, Beat (2017). Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. Journal of clinical oncology, 35(11), pp. 1179-1188. American Society of Clinical Oncology 10.1200/JCO.2016.70.3116

Johansson, Harriet; Gray, Kathryn P; Pagani, Olivia; Regan, Meredith M; Viale, Giuseppe; Aristarco, Valentina; Macis, Debora; Puccio, Antonella; Roux, Susanne; Maibach, Rudolf; Colleoni, Marco; Rabaglio, Manuela; Price, Karen N; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Kammler, Roswitha; Bonanni, Bernardo; Walley, Barbara A (2016). Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast cancer research, 18(1), p. 110. BioMed Central Ltd. 10.1186/s13058-016-0771-8

Chirgwin, Jacquie H; Giobbie-Hurder, Anita; Coates, Alan S; Price, Karen N; Ejlertsen, Bent; Debled, Marc; Gelber, Richard D; Goldhirsch, Aron; Smith, Ian; Rabaglio, Manuela; Forbes, John F; Neven, Patrick; Láng, István; Colleoni, Marco; Thürlimann, Beat (2016). Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. Journal of clinical oncology, 34(21), pp. 2452-2459. American Society of Clinical Oncology 10.1200/JCO.2015.63.8619

Francis, Prudence A; Regan, Meredith M; Fleming, Gini F; Láng, István; Ciruelos, Eva; Bellet, Meritxell; Bonnefoi, Hervé R; Climent, Miguel A; Da Prada, Gian Antonio; Burstein, Harold J; Martino, Silvana; Davidson, Nancy E; Geyer, Charles E; Walley, Barbara A; Coleman, Robert; Kerbrat, Pierre; Buchholz, Stefan; Ingle, James N; Winer, Eric P; Rabaglio, Manuela; ... (2015). Adjuvant ovarian suppression in premenopausal breast cancer. New England journal of medicine NEJM, 372(5), pp. 436-446. Massachusetts Medical Society MMS 10.1056/NEJMoa1412379

Huober, J.; Cole, B. F.; Rabaglio, Manuela; Giobbie-Hurder, A.; Wu, J.; Ejlertsen, B.; Bonnefoi, H.; Forbes, J. F.; Neven, P.; Láng, I.; Smith, I.; Wardley, A.; Price, K. N.; Goldhirsch, A.; Coates, A. S.; Colleoni, M.; Gelber, R. D.; Thürlimann, B. (2014). Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast cancer research and treatment, 143(1), pp. 159-169. Springer 10.1007/s10549-013-2792-7

Regan, Meredith M; Pagani, Olivia; Fleming, Gini F; Walley, Barbara A; Price, Karen N; Rabaglio, Manuela; Maibach, Rudolf; Ruepp, Barbara; Coates, Alan S; Goldhirsch, Aron; Colleoni, Marco; Gelber, Richard D; Francis, Prudence A (2013). Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast, 22(6), pp. 1094-1100. Elsevier 10.1016/j.breast.2013.08.009

Crivellari, Diana; Gray, Kathryn P.; Dellapasqua, Silvia; Puglisi, Fabio; Ribi, Karin; Price, Karen N.; Láng, István; Gianni, Lorenzo; Spazzapan, Simon; Pinotti, Graziella; Lüthi, Jean-Marc; Gelber, Richard D.; Regan, Meredith M; Colleoni, Marco; Castiglione-Gertsch, Monica; Maibach, Rudolf; Rabaglio, Manuela; Coates, Alan S.; Goldhirsch, Aron (2013). Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. Breast, 22(2), pp. 130-137. Elsevier 10.1016/j.breast.2013.01.015

Goss, Paul E.; Ingle, James N.; Pritchard, Kathleen I.; Ellis, Matthew J.; Sledge, George W.; Budd, G. Thomas; Rabaglio, Manuela; Ansari, Rafat H.; Johnson, David B.; Tozer, Richard; D'Souza, David P.; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Liedke, Pedro E. R.; Lang, Istvan; Elliott, Catherine; Gelmon, Karen A.; Chapman, Judy-Anne W.; ... (2013). Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial. Journal of clinical oncology, 31(11), pp. 1398-1404. American Society of Clinical Oncology 10.1200/JCO.2012.44.7805

Ewertz, Marianne; Gray, Kathryn P; Regan, Meredith M; Ejlertsen, Bent; Price, Karen N; Thürlimann, Beat; Bonnefoi, Hervé; Forbes, John F; Paridaens, Robert J; Rabaglio, Manuela; Gelber, Richard D; Colleoni, Marco; Láng, István; Smith, Ian E; Coates, Alan S; Goldhirsch, Aron; Mouridsen, Henning T (2012). Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. Journal of clinical oncology, 30(32), pp. 3967-75. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.40.8666

Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group, ; International Breast Cancer Study Group (IBCSG), (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet oncology, 12(12), pp. 1101-8. Oxford: Elsevier 10.1016/S1470-2045(11)70270-4

Karlsson, P; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Collins, J; Murray, E; Zaman, K; Colleoni, M; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Annals of oncology, 22(10), pp. 2216-26. Oxford: Oxford University Press 10.1093/annonc/mdq735

Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754

Rabaglio, Manuela; Ruepp, Barbara (2010). Death due to liver failure during endocrine therapy for premenopausal breast cancer. Acta oncologica, 49(6), pp. 874-6. Stockholm: Acta Oncologica 10.3109/0284186X.2010.484813

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J-M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology, 20(9), pp. 1489-98. Oxford: Oxford University Press 10.1093/annonc/mdp033

Crivellari, Diana; Sun, Zhuoxin; Coates, Alan S; Price, Karen N; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, Robert J; Castiglione-Gertsch, Monica; Gelber, Richard D; Colleoni, Marco; Láng, István; Del Mastro, Lucia; Gladieff, Laurence; Rabaglio, Manuela; Smith, Ian E; Chirgwin, Jacquie H; Goldhirsch, Aron (2008). Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. Journal of clinical oncology, 26(12), pp. 1972-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.14.0459

Eicher, M; Rabaglio, M (2008). Kinderwunsch und Krebs: Wie kann Bedürfnissen betroffener Frauen und deren Partner begegnet werden? Hämato-onkologische Nachrichten(12) Köln: Biermann

Mouridsen, Henning; Keshaviah, Aparna; Coates, Alan S; Rabaglio, Manuela; Castiglione-Gertsch, Monica; Sun, Zhuoxin; Thürlimann, Beat; Mauriac, Louis; Forbes, John F; Paridaens, Robert; Gelber, Richard D; Colleoni, Marco; Smith, Ian; Price, Karen N; Goldhirsch, Aron (2007). Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. Journal of clinical oncology, 25(36), pp. 5715-22. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.12.1665

Mauriac, L; Keshaviah, A; Debled, M; Mouridsen, H; Forbes, JF; Thürlimann, B; Paridaens, R; Monnier, A; Láng, I; Wardley, A; Nogaret, JM; Gelber, RD; Castiglione-Gertsch, M; Price, KN; Coates, AS; Smith, I; Viale, G; Rabaglio, M; Zabaznyi, N; Goldhirsch, A; ... (2007). Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annals of oncology, 18(5), pp. 859-67. Oxford: Oxford University Press 10.1093/annonc/mdm001

Radojewski, Piotr

Radpour, Ramin

Negahdari, Samira; Zamani, Mina; Seifi, Tahereh; Sedighzadeh, Sahar; Mazaheri, Neda; Zeighami, Jawaher; Sedaghat, Alireza; Saberi, Alihossein; Hamid, Mohammad; Keikhaei, Bijan; Radpour, Ramin; Shariati, Gholamreza; Galehdari, Hamid (2020). Identification of Three Novel Mutations in the FANCA, FANCC, and ITGA2B Genes by Whole Exome Sequencing. International journal of preventive medicine, 11(117), p. 117. 10.4103/ijpvm.IJPVM_462_19

Radpour, Ramin; Forouharkhou, Farzad (2018). Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells. World journal of stem cells, 10(11), pp. 160-171. Baishideng Publishing Group 10.4252/wjsc.v10.i11.160

Radpour, Ramin (2017). Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy. World journal of stem cells, 9(10), pp. 169-178. Baishideng Publishing Group 10.4252/wjsc.v9.i10.169

Ramseier, Julia Friederike

Ratschiller, Daniel

Rau, Tilman

Rauch, Andri

Rauch, Daniel

Peters, Solange; Danson, Sarah; Ejedepang, Dunson; Dafni, Urania; Hasan, Baktiar; Radcliffe, Hoi-Shen; Bustin, Frederique; Crequit, Jacky; Coate, Linda; Guillot, Monica; Surmont, Veerle; Rauch, Daniel; Rudzki, Jakob; O'Mahony, Deirdre; Barneto Aranda, Isidoro; Scherz, Amina; Tsourti, Zoi; Roschitzki-Voser, Heidi; Pochesci, Alessia; Demonty, Gaston; ... (2021). Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung cancer, 161, pp. 76-85. Elsevier 10.1016/j.lungcan.2021.09.002

Rauch, Daniel A.; Conlon, Kevin C; Janakiram, Murali; Brammer, Jonathan E; Harding, John C; Ye, B Hilda; Zang, Xingxing; Ren, Xiaoxin; Olson, Sydney; Cheng, Xiaogang; Miljkovic, Milos D; Sundaramoorthi, Hemalatha; Joseph, Ancy; Skidmore, Zachary L; Griffith, Obi; Griffith, Malachi; Waldmann, Thomas A; Ratner, Lee (2019). Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade. Blood, 134(17), pp. 1406-1414. American Society of Hematology 10.1182/blood.2019002038

Xiang, Jingyu; Rauch, Daniel A.; Huey, Devra D; Panfil, Amanda R; Cheng, Xiaogang; Esser, Alison K; Su, Xinming; Harding, John C; Xu, Yalin; Fox, Gregory C; Fontana, Francesca; Kobayashi, Takayuki; Su, Junyi; Sundaramoorthi, Hemalatha; Wong, Wing Hing; Jia, Yizhen; Rosol, Thomas J; Veis, Deborah J; Green, Patrick L; Niewiesk, Stefan; ... (2019). HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia. JCI insight, 4(19) JCI Insight 10.1172/jci.insight.128713

Haddad, Robert; Guigay, Joel; Keilholz, Ulrich; Clement, Paul M; Fayette, Jérôme; de Souza Viana, Luciano; Rolland, Frédéric; Cupissol, Didier; Geoffrois, Lionnel; Kornek, Gabriela; Licitra, Lisa; Melichar, Bohuslav; Ribaldo Nicolau, Ulisses; Rauch, Daniel; Zanetta-Devauges, Sylvie; Cohen, Ezra E W; Machiels, Jean-Pascal; Tahara, Makoto; Vermorken, Jan; Geng, Yuan; ... (2019). Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial. Oral oncology, 97, pp. 82-91. Elsevier 10.1016/j.oraloncology.2019.08.004

Burtness, Barbara; Haddad, Robert; Dinis, José; Trigo, José; Yokota, Tomoya; de Souza Viana, Luciano; Romanov, Ilya; Vermorken, Jan; Bourhis, Jean; Tahara, Makoto; Martins Segalla, José Getulio; Psyrri, Amanda; Vasilevskaya, Irina; Nangia, Chaitali Singh; Chaves-Conde, Manuel; Kiyota, Naomi; Homma, Akihiro; Holeckova, Petra; Del Campo, Josep Maria; Asarawala, Nirav; ... (2019). Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. JAMA oncology, 5(8), pp. 1170-1180. American Medical Association 10.1001/jamaoncol.2019.1146

Stenner, Frank; Rothschild, Sacha I; Betticher, Daniel; Caspar, Clemens; Morant, Rudolf; Popescu, Razvan; Rauch, Daniel; Huber, Urs; Zenhäusern, Reinhard; Rentsch, Cyrill; Cathomas, Richard (2017). Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry. (In Press). Clinical genitourinary cancer Elsevier 10.1016/j.clgc.2017.08.003

Cinieri, Saverio; Chan, Arlene; Altundag, Kadri; Vandebroek, An; Tubiana-Mathieu, Nicole; Barnadas, Agusti; Dodyk, Patricia; Lazzarelli, Silvia; Botha, Michiel; Rauch, Daniel; Villanova, Gustavo; Coskun, Ugur (2017). Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. Clinical breast cancer, 17(2), 91-99.e1. Elsevier 10.1016/j.clbc.2016.06.014

Baty, Florent; Rothschild, Sacha; Früh, Martin; Betticher, Daniel; Dröge, Cornelia; Cathomas, Richard; Rauch, Daniel; Gautschi, Oliver; Bubendorf, Lukas; Crowe, Susanne; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Swiss Group for Clinical Cancer Research, on behalf of the (2013). EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. PLoS ONE, 8(9), e72966. Public Library of Science 10.1371/journal.pone.0072966

Früh, Martin; Cathomas, Richard; Siano, Marco; Tscherry, Gregor; Zippelius, Alfred; Mamot, Christoph; Erdmann, Andreas; Krasniqi, Fatima; Rauch, Daniel; Simcock, Mathew; Küttel, Erika; Fustier, Pierre; Pless, Miklos; Swiss Group for Clinical Cancer Research, (2013). Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08). Clinical lung cancer, 14(1), pp. 34-39. Elsevier 10.1016/j.cllc.2012.04.001

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2007). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of oncology, 19(4), pp. 739-745. Oxford: Oxford University Press 10.1093/annonc/mdm564

Hess, D; Koberle, D; Thurlimann, B; Pagani, O; Schonenberger, A; Mattmann, S; Rochlitz, C; Rauch, D; Schuller, J C; Ballabeni, P; Ribi, K (2007). Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Onkologie, 73(3-4), pp. 228-37. Basel: Karger 10.1159/000180915

Raykova, Ana Plamenova

Reber, Emilie

Rebmann-Chigrinova, Ekaterina

Ress, Angelika

Rhyner Agocs, Gaëlle Véronique

Riedo, Rahel

Rieger, Gregor

Riether, Carsten

Riether, Carsten (2022). Regulation of hematopoietic and leukemia stem cells by regulatory T cells. Frontiers in immunology, 13(1049301), p. 1049301. Frontiers Research Foundation 10.3389/fimmu.2022.1049301

Flieswasser, Tal; Van den Eynde, Astrid; Van Audenaerde, Jonas; De Waele, Jorrit; Lardon, Filip; Riether, Carsten; de Haard, Hans; Smits, Evelien; Pauwels, Patrick; Jacobs, Julie (2022). The CD70-CD27 axis in oncology: the new kids on the block. Journal of experimental & clinical cancer research, 41(1), p. 12. BioMed Central 10.1186/s13046-021-02215-y

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Schürch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F. (2013). Interferons in hematopoiesis and leukemia. Oncoimmunology, 2(6), e24572. Landes Bioscience 10.4161/onci.24572

Riether, Carsten; Schürch, Christian; Ochsenbein, Adrian (2012). Modulating CD27 signaling to treat cancer. Oncoimmunology, 1(9), pp. 1604-1606. Austin, Tex.: Landes Bioscience 10.4161/onci.21425

Riggenbach, Elena

Rihs, Silvia

Rizzi, Mattia

Roa Diaz, Zayne Milena

Rodríguez Calero, José Antonio

Rohner, Eliane

Romagna, Lorenz

Roth, Beat

Schardt, Julian; Roth, Beat; Seiler, Roland (2019). Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when? World journal of urology, 37(9), pp. 1759-1765. Springer-Verlag 10.1007/s00345-018-2544-8

Roth, Selina Moara

Rothenbühler, Simon Paul

Rothschild, Sacha

Rothschild, Sacha; Dolder, Mathias; Seifert, Burkhardt; Lütolf, Urs M; Ciernik, I Frank (2009). Radiation therapy for HIV-associated diffuse large cell non-Hodgkin lymphoma. Journal of the International Association of Physicians in AIDS Care JIAPAC, 8(4), pp. 239-48. Chicago, Ill.: International Association of Physicians in AIDS Care

Rothschild, Sacha; Ciernik, I Frank; Hartmann, Matthias; Schuknecht, Bernhard; Lütolf, Urs M; Huber, Alexander M (2009). Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. American journal of otolaryngology, 30(4), pp. 256-60. Philadelphia, Pa.: Elsevier 10.1016/j.amjoto.2008.06.011

Rottenberg, Sven

Roumet, Marie Camille

Rovó, Alicia

Rubin, Mark Andrew

Turco, Fabio; Armstrong, Andrew; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob G; Bulbul, Muhammad; Caffo, Orazio; Chi, Kim N; Clarke, Caroline; Clarke, Noel; Davis, Ian D; de Bono, Johann; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; ... (2022). Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 2022]. European urology, 82(1), e18-e19. Elsevier 10.1016/j.eururo.2022.04.004

Rheinbay, Esther; Nielsen, Morten Muhlig; Abascal, Federico; Wala, Jeremiah A; Shapira, Ofer; Tiao, Grace; Hornshøj, Henrik; Hess, Julian M; Juul, Randi Istrup; Lin, Ziao; Feuerbach, Lars; Sabarinathan, Radhakrishnan; Madsen, Tobias; Kim, Jaegil; Mularoni, Loris; Shuai, Shimin; Lanzos, Andrés; Herrmann, Carl; Maruvka, Yosef E; Shen, Ciyue; ... (2020). Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature, 578(7793), pp. 102-111. Springer Nature 10.1038/s41586-020-1965-x

Rubin, Philip Daniel

Rubino, Viviana

Ruckstuhl, Carla Alicia

Ruepp, Marc-David

Ruggeri, Giovanni

Ruzgys, Paulius

Ryffel, Christoph Philippe

Ryser, Christoph Oliver

Römmele, Michaela

Rösler, Helmuth

Rössler, Jochen Karl

Rösti, Elisa Simona

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Saar, Bettina

Sachpekidis, Christos

Sadlon, Angélique

Sadowski, Martin

Salanti, Georgia

Salis Gross Cöplü, Corina

Noth, Isabelle; Salis Gross Cöplü, Corina (7 May 2019). Der Club SRF: Impfskepsis – ein Virus mit tödlichen Folgen? In: Der Club. TV SRF 1

Salm, Fabiana

Salmen, Anke

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Sande Melon, Marcos

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Saner, Flurina Anna-Carina Maria

Sanz, Javier

Saurer, Leslie

Sauter, Thomas Christian

Schaffner, Thomas

Schankin, Christoph Josef

Schardt, Julian

Schardt, Julian (2020). [The use of immune checkpoint inhibitors in routine oncology]. Zeitschrift für Rheumatologie, 79(8), pp. 809-817. Springer-Medizin-Verlag 10.1007/s00393-020-00876-2

Cathomas, Richard; Schardt, Julian; Pless, Miklos; Llado, Anna; Mach, Nicolas; Riklin, Christian; Haefeli, Jenny; Fear, Simon; Stenner, Frank (2020). Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss medical weekly, 150(w20223), pp. 1-7. EMH Media 10.4414/smw.2020.20223

Bill, Ruben; Schardt, Julian (2019). [Immunotherapies - Overview, mode of action and clinical implications]. Therapeutische Umschau, 76(4), pp. 187-194. Hogrefe 10.1024/0040-5930/a001083

Lengwiler, Emanuel; Stampf, Susanne; Zippelius, Alfred; Salati, Emanuela; Zaman, Khalil; Schäfer, Niklaus; Schardt, Julian; Siano, Marco; Hofbauer, Günther (2019). Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. Swiss medical weekly, 149, w20078. EMH Media 10.4414/smw.2019.20078

Schefold, Jörg Christian

Scherz, Amina

Schiemann, Uwe Kurt

Schild, Christof

Schlapbach, Christoph

Schlootz, Saskia

Schläppi, Karin

Schmid, Julia Maria

Schmid, Ralph

Schmid, Sabine

Schmid, Sabine; Zhan, Luna; Garcia, Miguel; Dietrich, Kristen; Khan, Khaleeq; Chowdhury, Maisha; Herman, Michael; Patel, Devalben; Zaeimi, Fatemeh; Leighl, Natasha B; Sacher, Adrian; Feld, Ronald; Shepherd, Frances A; Donahoe, Laura; de Perrot, Marc; Cho, B C John; Liu, Geoffrey; Bradbury, Penelope A (2024). Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma. (In Press). Clinical lung cancer Elsevier 10.1016/j.cllc.2024.04.011

Fares, Aline F; Li, Yao; Jiang, Mei; Brown, M Catherine; Lam, Andrew C L; Aggarwal, Reenika; Schmid, Sabine; Leighl, Natasha B; Shepherd, Frances A; Wang, Zhichao; Diao, Nancy; Wenzlaff, Angela S; Xie, Juntao; Kohno, Takashi; Caporaso, Neil E; Harris, Curtis; Ma, Hongxia; Barnett, Matthew J; Leal, Leticia Ferro; Fernandez-Tardon, G; ... (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. The lancet. Public health, 8(9), e691-e700. Elsevier 10.1016/S2468-2667(23)00131-7

García-Pardo, Miguel; Czarnecka-Kujawa, Kasia; Law, Jennifer H; Salvarrey, Alexandra M; Fernandes, Roxanne; Fan, Zhen J; Waddell, Thomas K; Yasufuku, Kazuhiro; Liu, Geoffrey; Donahoe, Laura L; Pierre, Andrew; Le, Lisa W; Gunasegaran, Tharsiga; Ghumman, Noor; Shepherd, Frances A; Bradbury, Penelope A; Sacher, Adrian G; Schmid, Sabine; Corke, Lucy; Feng, Jamie; ... (2023). Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial. JAMA Network Open, 6(7), e2325332. American Medical Association 10.1001/jamanetworkopen.2023.25332

Zeuge, Ulf; Fares, Aline F; Soriano, Joelle; Hueniken, Katrina; Bajwa, Jaspreet; Wang, Wanning; Schmid, Sabine; Rudolph-Naiberg, Sarah; Brown, M Catherine; Yeung, Jonathan; Chen, Eric X; Jang, Raymond W; Xu, Wei; Elimova, Elena; Liu, Geoffrey; Rozenberg, Dmitry; McInnis, Micheal C (2023). Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma. Esophagus, 20(3), pp. 557-566. Springer 10.1007/s10388-022-00981-y

García-Pardo, Miguel; Chang, Amy; Schmid, Sabine; Dong, Mei; Brown, M Catherine; Christiani, David; Tindel, Hilary Aurora; Brennan, Paul; Chen, Chu; Zhang, Jie; Ryan, Brid M; Zaridze, David; Schabath, Matthew B; Leal, Leticia Ferro; Reis, Rui Manuel; Tardon, Adonina; Fernández-Tardon, Guillermo; Shete, Sanjay S; Andrew, Angeline; Brenner, Hermann; ... (2023). Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. Journal of thoracic oncology, 18(3), pp. 313-323. Elsevier 10.1016/j.jtho.2022.10.020

Schmid, Sabine; Cheng, Sierra; Chotai, Simren; Garcia, Miguel; Zhan, Luna; Hueniken, Katrina; Balaratnam, Karmugi; Khan, Khaleeq; Patel, Devalben; Grant, Benjamin; Raptis, Roula; Brown, M Catherine; Xu, Wei; Moriarty, Patrick; Shepherd, Frances A; Sacher, Adrian G; Leighl, Natasha B; Bradbury, Penelope A; Liu, Geoffrey (2023). Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical lung cancer, 24(1), pp. 40-50. Elsevier 10.1016/j.cllc.2022.09.007

Schmidhalter, Daniel

Schmidlin, Kurt

Schmiedel, Yvonne

Schmitt Kurrer, Anja

Schmitter-Schmidt, Karin Irene

Schmitz, Felix Michael

Schmücking, Michael

Schnabel, Kai

Schneider, Caroline

Schneider, Christoph

Schneider, Christoph; Illi, Marlies; Lötscher, Marius; Wehrli, Marc; von Gunten, Stephan (2017). Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid. Methods in molecular biology, 1643, pp. 23-31. Springer 10.1007/978-1-4939-7180-0_3

Schnüriger, Beat

Schnüriger, Noah Samuel

Schwacha-Eipper, Birgit

Schwappach, David

Schwarz, Christa

Schwarz, Kyriakos Alexandros

Schäfer, Stephan

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Schönauer, Roman

Schöni, Martin Heinrich

Schürch, Christian

Schürch, Christian M.; Riether, Carsten; Ochsenbein, Adrian F. (2013). Interferons in hematopoiesis and leukemia. Oncoimmunology, 2(6), e24572. Landes Bioscience 10.4161/onci.24572

Riether, Carsten; Schürch, Christian; Ochsenbein, Adrian (2012). Modulating CD27 signaling to treat cancer. Oncoimmunology, 1(9), pp. 1604-1606. Austin, Tex.: Landes Bioscience 10.4161/onci.21425

Schürch, Stefan

Scutelnic, Adrian

Seiffge, David Julian

Seiffge, Julian David

Seiler, Christian A.

Seiler, Kristina

Seiler-Blarer, Roland

Seipel, Katja

Seitz, Michael

Sendi, Parham

Sermaxhaj, Burim

Seyed Jafari, Seyed Morteza

Shafighi, Maziar

Shelan, Mohamed

Shun-Qing, Liang

Sidler, Daniel

Bocchi, F; Häfliger, S; Schmid, S; Sidler, D (2024). Immune checkpoint inhibitors and renal toxicity. Heliyon, 10(11) Elsevier 10.1016/j.heliyon.2024.e31911

Siebenrock, Klaus-Arno

Siegenthaler, Franziska Anna

Siegrist, Mark

Silimon, Norbert

Simon, Hans-Uwe

Tschan, M P; Simon, H-U (2010). The role of autophagy in anticancer therapy: promises and uncertainties. Journal of internal medicine, 268(5), pp. 410-8. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2010.02266.x

Slack, Emma

Sokol, Lena

Solass, Wiebke

Solenthaler, Max

Sommerstein, Rami

Spahn, Martin

Spanjol, Petar Marko

Speicher, Philip Alan

Spichiger, Elisabeth

Staehelin, Cornelia

Stanga, Zeno

Steck, Nicole

Steege, Andreas

Stein, Jens Volker

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Steinrücken, Julia

Stettler, Christoph

Stirnimann, Guido

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Stojkov, Darko

Stojkov, Kristina

Stoll, Carina Manon

Storni, Federico Lorenzo

Strasser, Florian

Pourmir, I; Van Halteren, H K; Elaidi, R; Trapani, D; Strasser, Florian; Vreugdenhil, G; Clarke, M (2024). A conceptual framework for cautious escalation of anticancer treatment: How to optimize overall benefit and obviate the need for de-escalation trials. Cancer treatment reviews, 124, p. 102693. Elsevier 10.1016/j.ctrv.2024.102693

Domeisen Benedetti, Franzisca; Fringer, André; Attoun-Knobel, Suzanne; Schmidt, Ellie B; Strasser, Florian; Schlögl, Mathias; Blum, David (2023). Development of a tool for palliative care needs assessment and intervention: mixed methods research at a Swiss tertiary oncology clinic. Annals of palliative medicine, 12(3), pp. 496-506. AME Publishing Company 10.21037/apm-22-994

Ribi, K; Kalbermatten, N; Eicher, M; Strasser, F (2022). Corrigendum to 'Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent': [ESMO Open volume 7 (2022) 100496]. ESMO open, 7(6), p. 100614. BMJ 10.1016/j.esmoop.2022.100614

Stroka, Deborah

Stuber Roos, Regula

Stuck, Andreas

Studer, Peter

Studer, Urs

Stutz, Emanuel

Stähli Klenk, Laurence

Surbek, Daniel

Suter, Franziska Marta

Suter, Thomas

Sutter, Nora

Szidat, Sönke

Szücs Farkas, Zsolt

Sédille-Mostafaie, Nazanin

Tal, Kali

Tapia, Coya

Tchinda, Joëlle

Terracciano, Luigi

Thalmann, George

Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah; Bowen, Jo; Lydon, Anna; ... (2022). Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. The lancet, 399(10323), pp. 447-460. Elsevier 10.1016/S0140-6736(21)02437-5

Theocharides, Alexandre

Thienger, Phillip Dominik

Thurian, Dario Flurin

Thöny, Harriet C.

Bains, Lauren J; Zweifel, Martin; Thoeny, Harriet C (2012). Therapy response with diffusion MRI: an update. Cancer imaging, 12(2), pp. 395-402. London: e-med 10.1102/1470-7330.2012.9047

Tièche, Colin

Tobler, Andreas

Fey, M. F.; Tobler, Andreas (1996). Tumour heterogeneity and clonality - an old theme revisited. Annals of oncology, 7(2), pp. 121-128. Oxford University Press 10.1093/oxfordjournals.annonc.a010537

Tonia, Thomai

Trachsel, Maria

Trappetti, Verdiana

Trelle, Sven

Trepp, Roman

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Triep, Karen

Triller, Kurt-Jürgen

Trippel, Mafalda Arasceli

Triscott, Joanna Catherine Caprio

Tschan, Mario

Yusuf, Dimas; Butland, Stefanie L; Swanson, Magdalena I; Bolotin, Eugene; Ticoll, Amy; Cheung, Warren A; Zhang, Xiao Yu Cindy; Dickman, Christopher T D; Fulton, Debra L; Lim, Jonathan S; Schnabl, Jake M; Ramos, Oscar H P; Vasseur-Cognet, Mireille; de Leeuw, Charles N; Simpson, Elizabeth M; Ryffel, Gerhart U; Lam, Eric W-F; Kist, Ralf; Wilson, Miranda S C; Marco-Ferreres, Raquel; ... (2012). The transcription factor encyclopedia. Genome biology, 13(3), R24. London: BioMed Central Ltd. 10.1186/gb-2012-13-3-r24

Tschan, Mario Paul

Tscharner, Gion Gudench

Tscharner, Gion Gudench; Bühler, Sabine; Borner, Markus; Hunziker, Thomas (2006). Grover's disease induced by cetuximab. Dermatology, 213(1), pp. 37-9. Basel: Karger 10.1159/000092836

Tsikkinis, Alexandros

Umlauft, Maria

Uroda, Tina

Urzì, Christian

Uth, Kristin

Vallabhapurapu, Subrahmanya

Vancura, Adrienne Nina

Vassella, Erik

Villiger, Peter

Vinzens Burgener, Sarah Maria

Vlaskou Badra, Eugenia

Vogel, Monique

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Volbers, Bastian

Von der Weid, Nicolas

Vorburger, Corinne Véronique

Vorburger, Stephan

Vynckier, Jan Luc

Waeber, Martin

Wagner, Franca

Wagner, Oliver

Walter, Martin Alexander

Wampfler, Julian

Wartenberg, Martin

Wasmer, Marie-Hélène Christin

Weber, Achim

Weber, Benjamin

Weber, Damien Charles

Weber, Walter

Wehrli, Marc

Weidlinger, Susanna

Weimann, Rosemarie

Wenemoser, Eliane

Wenger, Corina

Wenning, Anna Silvia

Wertli, Maria Monika

Westerhuis, Mira

Wiedemann, Gertrud

Wilhelm, Matthias

Williams, Hannah Louise

Wirtz, Christian

Wochner, Annette

Wohlfarth Schulz, Benny

Wojtalla, Anna

Wolf-Schnurrbusch, Ute

Wolfmeier, Heidi Annemarie

Worni, Mathias

Wyler, Kurt

Wyss, Natascha Marion

Wünsch, Alexander

Wünsch, Alexander; Jeske, Niklas; Röderer, Natalie; Meiss, Frank (2024). [Outpatient psychosocial screening in a skin cancer center: acceptance, psychosocial distress and utilization of support : A post hoc analysis in a quality management program]. Die Dermatologie, 75(8), pp. 629-639. Springer 10.1007/s00105-024-05347-2

Gür, Deniz; Offergeld, Christian; Fabry, Götz; Wünsch, Alexander (2024). [Communication training in otorhinolaryngology education : Comparison of an online and a classroom-based training course]. HNO, 72(5), pp. 334-340. Springer-Medizin-Verlag 10.1007/s00106-024-01475-2

Singer, Susanne; Wünsch, Alexander; Ihrig, Andreas; Bruns, Gudrun; Holz, Franziska; Jakob, Johannes; Besseler, Markus; Engesser, Deborah; Blettner, Maria; König, Jochem; Bayer, Oliver (2024). Men’s access to outpatient psychosocial cancer counseling. Deutsches Ärzteblatt international, 121(4), pp. 121-127. Deutscher Ärzte-Verlag 10.3238/arztebl.m2024.0005

Hanusch, Gitika Ulrike; Wünsch, Alexander (2023). »Die zwei blauen Augen«. Musiktherapeutische Umschau, 44(1), pp. 38-42. Vandenhoeck & Ruprecht 10.13109/muum.2023.44.1.38

Wünsch, Alexander; Bayer, Oliver; Adlkofer, Ulrike; Besseler, Markus; Bruns, Gudrun; Bochmann, Kathrin; Bohrmann, Monika; Eckhardt, Andrea; Engesser, Deborah; Götz, Sabine; Holz, Franziska; Hegestweiler, Annette; Ihrig, Andreas; Jakob, Johannes; Jung, Marianne; Lückert, Frank; Pereira Lita, Laura; Petridis, Franziska; Perzlmaier, Heide; Reuthlinger, Claudia; ... (2023). Outpatient cancer counseling centers: “An antidote to a racing mind”. Die Onkologie, 29(12), pp. 1078-1087. Springer 10.1007/s00761-023-01353-6

Lütke Lanfer, Sarah Susanne; Pfeifer, Ruth; Lahmann, Claas; Wünsch, Alexander (2022). How to Measure the Mental Health of Teachers? Psychometric Properties of the GHQ-12 in a Large Sample of German Teachers. International journal of environmental research and public health, 19(15) MDPI 10.3390/ijerph19159708

Wuensch, Alexander; Kirbach, Annette; Meyerding, Luca; Bengel, Jürgen; Pietsch, Stefanie (2022). Interventions for children of parents with cancer: an overview. Current opinion in oncology, 34(4), pp. 294-303. Wolters Kluwer Health 10.1097/CCO.0000000000000841

Heinen, Jana; Bäuerle, Alexander; Schug, Caterina; Krakowczyk, Julia Barbara; Strunk, Sven Erik; Wieser, Alexandra; Beckord, Jil; Jansen, Christoph; Dries, Sebastian; Pantförder, Michael; Erim, Yesim; Zipfel, Stephan; Mehnert-Theuerkauf, Anja; Wiltink, Jörg; Wünsch, Alexander; Dinkel, Andreas; Stengel, Andreas; Kruse, Johannes; Teufel, Martin and Graf, Johanna (2022). Mindfulness and skills-based eHealth intervention to reduce distress in cancer-affected patients in the Reduct trial: Intervention protocol of the make it training optimized. Frontiers in psychiatry, 13(1037158), p. 1037158. Frontiers 10.3389/fpsyt.2022.1037158

Xu, Duo

Yang, Haitang

Yang, Zhang

Yawalkar, Nikhil

Yeoh, Wen Jie

Yousefi, Shida

Zabini, Adam

Zahnd, Stefan Patrick

Zambrano Ramos, Sofia Carolina

White, Nicola; Oostendorp, Linda; Vickerstaff, Victoria; Gerlach, Christina; Engels, Yvonne; Maessen, Maud; Tomlinson, Christopher; Wens, Johan; Leysen, Bert; Biasco, Guido; Zambrano, Sofia; Eychmüller, Steffen; Avgerinou, Christina; Chattat, Rabih; Ottoboni, Giovanni; Veldhoven, Carel; Stone, Patrick (2019). An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol. BMC Palliative Care, 18(1), p. 36. BioMed Central 10.1186/s12904-019-0413-x

Zambrano Ramos, Sofia Carolina; Chur-Hansen, Anna; Crawford, Gregory B (2019). Beyond Right or Wrong: Attitudes and Practices of Physicians, Nurses, Psychologists, and Social Workers Regarding Attendance at Patient Funerals. Journal of palliative medicine, 22(4), pp. 400-407. Liebert 10.1089/jpm.2018.0234

Zambrano Ramos, Sofia Carolina (2018). Betreuung von Sterbenden: Was Ärztinnen und Ärzte erfahren und brauchen. Therapeutische Umschau, 75(2), pp. 135-144. Huber 10.1024/0040-5930/a000979

Zangemeister-Wittke, Uwe

Zaugg, Kathrin

Zbinden, Rut

Zbären, Noemi

Zeerleder, Sacha Sergio

Zenger, Franziska

Joerger, M; Metaxas, Y; Schmitt, AM; Koeberle, D; Zaman, K; Betticher, D; Mach, N; Renner, C; Mark, M; Petrausch, U; Caspar, C; Britschgi, C; Taverna, C; Zenger, F; Mingrone, W; Schulz, J; Kopp, C; Hayoz, S; Stathis, A and von Moos, R (2020). Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) (Unpublished). In: Virtual ESMO 2020.

Zens, Philipp Immanuel

Zha, Lisha

Mohsen, Mona O.; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V.; Riether, Carsten; Rösti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for immunotherapy of cancer, 7(1), p. 114. BioMed Central 10.1186/s40425-019-0587-z

Zhang, Yang

Ziegler, Katrin

Zimmer, Yitzhak

Zimmerli, Marc Andreas

Zimmerli, Stephan

Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.

Zimmermann, Arthur

Zindel, Joel

Zinkernagel, Martin Sebastian

Zlobec, Inti

Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group

Zoni, Eugenio

Zucca, Emanuele

Ferreri, A J M; Illerhaus, G; Doorduijn, J K; Auer, D P; Bromberg, J E C; Calimeri, T; Cwynarski, K; Fox, C P; Hoang-Xuan, K; Malaise, D; Ponzoni, M; Schorb, E; Soussain, C; Specht, L; Zucca, E; Buske, C; Jerkeman, M; Dreyling, M (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. (In Press). Annals of oncology Elsevier 10.1016/j.annonc.2023.11.010

Vannata, Barbara; Pirosa, Maria Cristina; Bertoni, Francesco; Rossi, Davide; Zucca, Emanuele (2022). Bacterial infection-driven lymphomagenesis. Current opinion in oncology, 34(5), pp. 454-463. Lippincott Williams & Wilkins 10.1097/CCO.0000000000000886

Zuppinger, Christian

Zwahlen, Diana

Zwahlen, Diana; Hagenbuch, Niels; Jenewein, Josef; Carley, Margaret I; Buchi, Stefan (2011). Adopting a family approach to theory and practice: measuring distress in cancer patient-partner dyads with the distress thermometer. Psycho-oncology, 20(4), pp. 394-403. Malden, Mass.: Wiley-Blackwell 10.1002/pon.1744

Zwahlen, Diana; Hagenbuch, Niels; Carley, Margaret I; Jenewein, Josef; Buchi, Stefan (2010). Posttraumatic growth in cancer patients and partners--effects of role, gender and the dyad on couples' posttraumatic growth experience. Psycho-oncology, 19(1), pp. 12-20. Malden, Mass.: Wiley-Blackwell 10.1002/pon.1486

Zwahlen, Marcel

Zwahlen, Susanne

Rakic, Milenko; Escher, Monica; Elger, Bernice S; Eckstein, Sandra; Pacurari, Nadia; Zwahlen, Susanne; Wienand, Isabelle (2018). Feelings of Burden in Palliative Care: A Qualitative Analysis of Medical Records. Journal of palliative care, 33(1), pp. 32-38. Sage 10.1177/0825859717750522

Wienand, Isabelle; Rakic, Milenko; Eckstein, Sandra; Escher, Monica; Pacurari, Sandra; Zwahlen, Susanne; Elger, Bernice (2018). The variety of hope: findings in palliative care patients’ medical records. Spiritual Care, 7(2), pp. 181-185. Walter de Gruyter GmbH 10.1515/spircare-2017-0039

Zweier, Christiane Gertrud

Zweifel, Martin

Zweifel, Martin; Thürlimann, Beat; Riniker, Salome; Weder, Patrik; von Moos, Roger; Pagani, Olivia; Bigler, Martin; Rothgiesser, Karin M; Pilop, Christiane; Hawle, Hanne; Brauchli, Peter; Tapia, Coya; Schoenfeld, Wolfgang; Sessa, Cristiana (2017). Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients. Endocrine Connections, 6(7), pp. 549-556. BioScientifica 10.1530/EC-17-0174

Roux, René Lynnette; Hall, Marcia Rosalind; Rustin, Gordon John Sampson; Zweifel, Martin (2015). Do Not Give Up. International journal of gynecological cancer, 27(6), pp. 1060-1062. Lippincott Williams & Wilkins 10.1097/IGC.0000000000000584

Lohri, Corinne; Schaltegger, Claudia S Hutzli; VAN DEN Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer research, 34(9), pp. 4693-4699. International Inst. of Anticancer Research

Zweifel, Martin; Rechsteiner, T.; Hofer, M.; Boehler, A. (2013). Detection of pulmonary amylase activity in exhaled breath condensate. Journal of breath research, 7(4), 046007. IOP Science 10.1088/1752-7155/7/4/046007

Stenner, Frank; Liewen, Heike; Göttig, Stephan; Henschler, Reinhard; Markuly, Norbert; Kleber, Sascha; Faust, Michael; Mischo, Axel; Bauer, Stefan; Zweifel, Martin; Knuth, Alexander; Renner, Christoph; Wadle, Andreas (2013). RP1 is a phosphorylation target of CK2 and is involved in cell adhesion. PLoS ONE, 8(7), e67595. Public Library of Science 10.1371/journal.pone.0067595

Patterson, Dan M; Zweifel, Martin; Middleton, Mark R; Price, Patricia M; Folkes, Lisa K; Stratford, Michael R L; Ross, Phil; Halford, Sarah; Peters, Jane; Balkissoon, Jai; Chaplin, Dai J; Padhani, Anwar R; Rustin, Gordon J S (2012). Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors. Clinical cancer research, 18(5), pp. 1415-25. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-11-2414

Bains, Lauren J; Zweifel, Martin; Thoeny, Harriet C (2012). Therapy response with diffusion MRI: an update. Cancer imaging, 12(2), pp. 395-402. London: e-med 10.1102/1470-7330.2012.9047

Nathan, Paul; Zweifel, Martin; Padhani, Anwar R; Koh, Dow-Mu; Ng, Matthew; Collins, David J; Harris, Adrian; Carden, Craig; Smythe, Jon; Fisher, Nita; Taylor, N Jane; Stirling, J James; Lu, Shiao-Ping; Leach, Martin O; Rustin, Gordon J S; Judson, Ian (2012). Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clinical cancer research, 18(12), pp. 3428-39. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-11-3376

Cummings, J; Zweifel, M; Smith, N; Ross, P; Peters, J; Rustin, G; Price, P; Middleton, M R; Ward, T; Dive, C (2012). Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial. British journal of cancer, 106(11), pp. 1766-71. Basingstoke: Nature Publishing Group 10.1038/bjc.2012.165

Luethy, Anita; Stenner, Frank; Lohri, Corinne; Muller, Christoph; Samaras, Panagiotis; Steiner, Rudolf; Van Den Broek, Maries; Mischo, Axel; Renner, Christoph; Knuth, Alexander; Ruegg, Curzio; Wenger, Roland H; Zweifel, Martin (2011). Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1. Anticancer research, 31(10), pp. 3115-24. Kapandriti: International Inst. of Anticancer Research

Samaras, Panagiotis; Blickenstorfer, Marcel; Haile, Sarah R; Siciliano, Raffaele Daniele; Petrausch, Ulf; Mischo, Axel; Zweifel, Martin; Honegger, Hanspeter; Schanz, Urs; Stussi, Georg; Taverna, Christian; Bauer, Stefan; Knuth, Alexander; Stenner-Liewen, Frank; Renner, Christoph (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss medical weekly, 141, w13203. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13203

Zwicky, Caroline

Zwyssig, Sandra Maria

Zysset, Daniel

Zürcher, Claudia

van Brummelen, Rosa Robin

van Geest, Gerrit Adriaan

von Gunten, Stephan

von Moos, Rodica

von Rohr, Esther

Wegberg, B.Van; Bacchi, M.; Heusser, P.; Helwig, S.; Schaad, R.; von Rohr, E.; Bernhard, J.; Hurny, C.; Castiglione, M.; Cerny, Th. (1998). The cognitive-spiritual dimension - an important addition to the assessment of quality of life: Validation of a questionnaire (SELT-M) in patients with advanced cancer. Annals of oncology, 9(10), pp. 1091-1096. Oxford University Press 10.1023/A:1008343219970

von Tengg-Kobligk, Hendrik

von Wolff, Michael

Özdemir, Berna

Özdemir, Berna C (2024). Removing barriers to address sex differences in anticancer drug toxicity. Nature reviews - cancer, 24(3), pp. 161-162. Nature Publishing Group 10.1038/s41568-023-00651-w

Richters, Anke; Robbrecht, Debbie G J; Meijer, Richard P; van der Heijden, Antoine G; Kiemeney, Lambertus A L M; van den Bosch, Joan; Suelmann, Britt B M; Özdemir, Berna C; Mehra, Niven; Aben, Katja K H (2024). Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort. European urology open science, 59, pp. 50-54. Elsevier 10.1016/j.euros.2023.11.010

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Özdemir, Berna C; Richters, Anke; Espinosa da Silva, Cristina; Berner, Alison May (2023). Cancer researchers' perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research. iScience, 26(4), p. 106212. Elsevier 10.1016/j.isci.2023.106212

Richters, Anke; Leliveld, Anna M; Goossens-Laan, Catharina A; Aben, Katja K H; Özdemir, Berna C (2022). Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry. World journal of urology, 40(9), pp. 2275-2281. Springer 10.1007/s00345-022-04080-6

Özdemir, Berna C; Wagner, Anna Dorothea (2022). Consideration of sex and gender aspects in oncology: rationale, current status, and perspectives. The Italian gender-specific medicine, 8(1), pp. 55-58. Il Pensiero Scientifico Editore 10.1723/3769.37567

Özdemir, Berna C; Gerard, Camille L; Espinosa da Silva, Cristina (2022). Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology. Endocrinology, 163(6) Endocrine Society 10.1210/endocr/bqac058

Özdemir, B C; Oertelt-Prigione, S; Adjei, A A; Borchmann, S; Haanen, J B; Letsch, A; Mir, O; Quaas, A; Verhoeven, R H A; Wagner, A D (2022). Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force. Annals of oncology, 33(2), pp. 126-128. Elsevier 10.1016/j.annonc.2021.11.011

Arangalage, Dimitri; Degrauwe, Nils; Michielin, Olivier; Monney, Pierre; Özdemir, Berna C. (2021). Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors. Cancer treatment reviews, 100, p. 102282. Elsevier 10.1016/j.ctrv.2021.102282

Arangalage, Dimitri; Pavon, Anna Giulia; Özdemir, Berna C; Michielin, Olivier; Schwitter, Jurg; Monney, Pierre (2021). Acute cardiac manifestations under immune checkpoint inhibitors-beware of the obvious: a case report. European heart journal - case reports, 5(8), ytab262. Oxford University Press 10.1093/ehjcr/ytab262

Ghisoni, E; Wicky, A; Bouchaab, H; Imbimbo, M; Delyon, J; Gautron Moura, B; Gérard, C L; Latifyan, S; Özdemir, B.C.; Caikovski, M; Pradervand, S; Tavazzi, E; Gatta, R; Marandino, L; Valabrega, G; Aglietta, M; Obeid, M; Homicsko, K; Mederos Alfonso, N N; Zimmermann, S; ... (2021). Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. European journal of cancer, 149, pp. 153-164. Elsevier 10.1016/j.ejca.2021.03.010

Ma, Min; Ghosh, Soumitra; Tavernari, Daniele; Katarkar, Atul; Clocchiatti, Andrea; Mazzeo, Luigi; Samarkina, Anastasia; Epiney, Justine; Yu, Yi-Ru; Ho, Ping-Chih; Levesque, Mitchell P; Özdemir, Berna C.; Ciriello, Giovanni; Dummer, Reinhard; Dotto, G Paolo (2021). Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis. The Journal of experimental medicine, 218(2) Rockefeller Univ. Press 10.1084/jem.20201137

Özdemir, Berna C (2021). Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology. Journal for immunotherapy of cancer, 9(2) BMJ Publishing Group 10.1136/jitc-2020-002220

Özdemir, Berna C. (2021). Androgen Signaling in the Tumor Microenvironment. In: Tumor Microenvironment, Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology: Vol. 1270 (pp. 169-183). Springer 10.1007/978-3-030-47189-7_10

This list was generated on Fri Dec 20 23:52:51 2024 CET.

Export as	RSS